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Monoclonal Antibody Production and Purification
Abstract
Monoclonal antibody (mAb) therapy is a form of immunotherapy that uses mAbs to bind mono-specifically
to certain cells or proteins. This may then stimulate the patient's immune system to attack those cells. MAbs
are currently used to treat medical conditions such as cancer, diabetes, arthritis, psoriasis, and Crohn’s Disease,
but have the potential to treat countless diseases and disorders. In 2015, the mAb market was valued at $85.4
billion, and is expected to reach $138.6 billion by 2024.1 In manufacturing, mAbs are typically produced in
suspension in a series of fed-batch bioreactors using genetically engineered cells originally obtained from
Chinese Hamster Ovaries (CHO).2 In this proposal, two upstream bioreactor designs were analyzed for
economic comparison given an annual production goal of 100 kg of mAb, with the first design culminating in
a 20,000 L volume at low mAb titer and the second design culminating with a 2,000 L volume at high mAb
titer. Following upstream mAb production, the protein was purified to meet clinical FDA standards using a
series of downstream purification techniques, including centrifugation, filtration, and chromatography. The
two designs can be modeled for both an on-patent and off-patent mAb in order to ensure long-term economic
viability. In this project, the drug was modeled based on Ocrevus (ocrelizumab), a humanized therapeutic
mAb brought to market in 2017 that targets a CD20-positive B cell to treat the symptoms of both primary
progressive and relapsing Multiple Sclerosis.3 For an off-patent drug, it is recommended that the mAb be
priced at $35,000 per 1200 mg annual treatment in order to earn a 15% Internal Rate of Return (IRR) within
5 years of market uptake. For an on-patent drug, a price of $65,000 per 1200 mg treatment should be used to
recover the R&D costs of developing a new drug and sunk cost of past unsuccessful drugs. After analyzing
both designs, it was concluded that the second, smaller design scheme is more scalable, less risky, and more
cost effective for the production of both the on- and off-patent drugs.
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April 17, 2018 
      
Professor Bruce Vrana 
University of Pennsylvania 
Department of Chemical and Biomolecular Engineering  
220 S. 33rd Street 
Philadelphia, PA 19104 
      
Dear Professor Vrana, 
      
Enclosed are detailed process designs and economic analyses comparing two different bioreactor 
design schemes for monoclonal antibody (mAb) drug substance production. The project proposal 
specified an annual production goal of 100 kg mAb with a 90% process uptime. The goal of our 
analysis was to design a process that would meet these requirements and recommend a selling 
price that would provide a 15% internal rate of return (IRR). To more accurately model this 
production project, we decided to base our design and economic decisions on a mAb that has 
recently entered the market, Ocrevus (ocrelizumab). Using these parameters, we evaluated the 
economic potential of our design schemes using both an on-patent and off-patent framework. 
 
After careful consideration of the variables affecting drug quality and manufacturing 
requirements, we designed two production schemes. The first upstream scheme culminates in a 
20,000 L large production bioreactor, resulting in 25 kg of mAb per batch after downstream 
purification. The second upstream scheme ends in a 2,000 L small production bioreactor to 
produce 6.3 kg mAb per batch after downstream purification. Both designs are capable of 
meeting the 100 kg annual production requirement within four to six months of the year. In order 
to earn a 15% IRR within 4-6 years of production launch, we recommend pricing the off-patent 
drug at $35,000 per 1200 mg annual treatment, and the on-patent drug at $65,000 per 1200 mg. 
Considering both the economic and engineering analyses, we recommend implementing the 
second, small bioreactor scheme, as it is more flexible, less risky, and more lucrative for the 
production of both the on- and off-patent drugs.  
 
Sincerely, 
 
 
 
 
       
Hope McMahon                      Jessica Schwartz                    Shritama Ray 
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1. Abstract 
Monoclonal antibody (mAb) therapy is a form of immunotherapy that uses mAbs to bind 
mono-specifically to certain cells or proteins. This may then stimulate the patient's immune 
system to attack those cells. MAbs are currently used to treat medical conditions such as cancer, 
diabetes, arthritis, psoriasis, and Crohn’s Disease, but have the potential to treat countless 
diseases and disorders. In 2015, the mAb market was valued at $85.4 billion, and is expected to 
reach $138.6 billion by 2024.1 In manufacturing, mAbs are typically produced in suspension in a 
series of fed-batch bioreactors using genetically engineered cells originally obtained from 
Chinese Hamster Ovaries (CHO).2 In this proposal, two upstream bioreactor designs were 
analyzed for economic comparison given an annual production goal of 100 kg of mAb, with the 
first design culminating in a 20,000 L volume at low mAb titer and the second design 
culminating with a 2,000 L volume at high mAb titer. Following upstream mAb production, the 
protein was purified to meet clinical FDA standards using a series of downstream purification 
techniques, including centrifugation, filtration, and chromatography. The two designs can be 
modeled for both an on-patent and off-patent mAb in order to ensure long-term economic 
viability. In this project, the drug was modeled based on Ocrevus (ocrelizumab), a humanized 
therapeutic mAb brought to market in 2017 that targets a CD20-positive B cell to treat the 
symptoms of both primary progressive and relapsing Multiple Sclerosis.3  For an off-patent drug, 
it is recommended that the mAb be priced at $35,000 per 1200 mg annual treatment in order to 
earn a 15% Internal Rate of Return (IRR) within 5 years of market uptake. For an on-patent drug, 
a price of $65,000 per 1200 mg treatment should be used to recover the R&D costs of developing 
a new drug and sunk cost of past unsuccessful drugs. After analyzing both designs, it was 
concluded that the second, smaller design scheme is more scalable, less risky, and more cost 
effective for the production of both the on- and off-patent drugs.  
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2. Introduction and Objective Time Chart 
2.1 Project Background 
Monoclonal antibodies (mAbs) are proteins that bind to specific cellular targets and 
activate the body’s immune system for subsequent destruction. MAbs are used in clinical therapy 
to treat medical conditions such as cancer, diabetes, arthritis, psoriasis, and Crohn’s Disease, and 
have been the focus of the biopharmaceutical industry in recent years. The mAb proteins are 
derived from a single immune cell and can target a specific cell surface receptor for destruction. 
The antibody derived from this immune cell can be isolated and engineered to be secreted by a 
host cell line for clinical treatment. MAbs are often have a high degree of similarity, allowing a 
given manufacturing scheme to be used for several mAb therapies with minimal alterations to 
process design.4 During bioreaction steps, mAbs are secreted by the cells into the liquid growth 
medium. Following production, the cell suspension undergoes a series of downstream process 
steps to purify, concentrate, stabilize, and package the mAbs using methods that preserve 
medicinal efficacy and ensure a virus-free product.2 An overview of a typical production scheme 
is shown in Figure 2.1.  
 
 
Figure 2.1 A typical mAb production process. The upstream steps grow the cells and express the protein, 
while the downstream steps isolate and purify the protein product.  
 
At the industrial scale, biopharmaceutical companies such as Genentech produce upwards 
of 100 kg of a given product every year, and must have the capacity to scale up or down as 
needed. To model typical production practices at companies with larger operations, this project 
process has been designed to achieve a 100 kg production goal of a mAb in a four to six month 
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span. Other recent trends in mAb production, such as the use of single-use disposable bioreactors 
and the implementation of high-throughput systems, are being implemented to reduce overall 
capital investment and labor costs. 
2.2 Design Schemes 
The growing demand for mAb therapies has given rise to the rapid development of high-
yielding and robust manufacturing processes. Production bioreactors can be as large as 25,000 L 
in many traditional scenarios. However, there are several risks and limitations associated with 
producing such large batch volumes. When scaling up to such large culture volumes, oxygen 
transfer decreases, aggregation of cells and mAb is more prevalent, and CO2 stripping becomes 
difficult to control without exceeding gas sparging flow rate limitations. This results in decreased 
cell viability, specific mAb productivity by the cells, and product quality.5 Also, there is a higher 
risk associated with each batch in the case of malfunction or contamination, in which case the 
entire batch would be void. To mitigate these outcomes, large upstream batch volumes must 
produce protein in low titers below 4 g/L. To eliminate these concerns, advances in mammalian 
cell culture techniques have increased mAb productivity of engineered host cell lines, which 
allow for higher protein titers well beyond 5 g/L to be produced in smaller batch volumes.6 For 
the same reasons outlined above, smaller batch volumes have lower risk, higher cell viability, 
and higher product quality.  
To compare these upstream production scenarios, two upstreams schemes have been 
designed with corresponding downstream designs. The first scheme is a large production 
bioreactor process with a low protein titer (2.97 g/L), and the second scheme is a small 
production bioreactor process with a higher protein titer (6.41 g/L). Both schemes make 
extensive use of disposable, single-use technologies. The recent industry uptake of single-use 
equipment has been robust, due to its increased efficiency and cost reduction potential.7 The 
design of these schemes is described in more detail in Section 10.  
2.3 Ocrevus ™ 
In order to evaluate this project under real-world constraints, a specific mAb product, 
Ocrevus, was selected. Ocrevus (ocrelizumab) is a humanized therapeutic mAb that targets a 
CD20-positive B cell. On March 28, 2017, Ocrevus was approved by the FDA for the treatment 
of relapsing and primary progressive forms of multiple sclerosis (MS). Ocrevus was discovered, 
developed, and now marketed by the Roche subsidiary, Genentech.3 
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MS is a chronic neurological disease without a cure, affecting over 400,000 people in the United 
States. In MS patients, the immune system attacks the insulation around nerve cells in the brain, 
spinal cord and/or optic nerves, resulting in inflammation and often debilitating symptoms. The 
majority of people living with MS either have a relapsing form (RMS) or primary progressive 
multiple sclerosis (PPMS) at the time of diagnosis. RMS is characterized by episodes of new or 
worsening symptoms, defined as relapses, followed by periods of recovery. PPMS is a highly 
disabling form of MS characterized by steadily worsening symptoms, usually without periods of 
improvement or remission.8 
Ocrevus is the first drug on the market to be approved for the PPMS in addition to RMS. 
In clinical studies, it was shown to reduce relapses per year by nearly half and reduce disability 
in RMS patients. It was also shown to be the first treatment to significantly slow disability 
progression in PPMS patients. Ocrevus is administered intravenously in 600 mg doses every six 
months. The first dose is a 300 mg intravenous infusion, followed by a second 300 mg infusion 
two weeks later. Going forward, patients receive 600 mg infusions every 6 months. The price for 
the first annual treatment of 1200 mg is $65,000. The market performance and attributes of this 
drug have been used for the design decisions and economic evaluation.  
2.4 Objective Time Chart 
N/A 
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2.5 Project Charter 
Project Name: Monoclonal Antibody Production, Purification, and Packaging 
Project Leaders: Hope McMahon, Shritama Ray, Jessica Schwartz 
Specific Goals: Design a process for producing mAbs within an existing 
biopharmaceutical company to obtain a sales price for an internal rate of return (IRR) of 15% 
based upon two schemes, one considering only capital investment and the other considering 
capital investment, research and development (R&D) costs, and risk adjustment. 
Project Scope 
In Scope: 
 Upstream manufacturing process for mAb including growing CHO cells from frozen 
inoculum of cells to final growth step and mAb production 
 Design process to include large production bioreactor (20,000L) 
 Design process to include multiple small production bioreactors (2,000L) 
 Downstream purification process starting with centrifugation to final sterile filtration 
and bulk drug substance storage.   
 Maintain process integrity and compliance by adhering to good manufacturing 
practices (GMP) 
 Compare both process designs including and excluding R&D costs to generate a sales 
price per gram to ensure a 15% IRR. 
 Determine which process design is optimal by evaluating cost, risk, and product 
quality 
Out of Scope:                     
 Research and development of monoclonal antibody 
 Cell line development 
 Packaging and distribution of drugs 
 Clinical Trials 
 FDA approval of process 
Deliverables   
Business Opportunity Assessment 
 What is the current market for monoclonal antibodies? 
Technical Feasibility Assessment 
 Is it feasible to produce 100 kg of mAb in 4-6 months using both design scenarios? 
Manufacturing Capability Assessment 
 What is the capital investment for the manufacturing facility? 
 Will the process satisfy the FDA for a pure, consistent product? 
Timeline       
Facility and process design along with 10 years of production & sales 
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3. Innovation Map  
N/A 
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4. Market and Competitive Analyses  
4.1 Competitive Landscape 
The motivation for this project stems from the increasing demand for mAb therapies and 
the rapidly evolving production platforms. The mAb market was valued at $85.4 billion in 2015 
and is expected to reach $138.6 billion by 2024.1 This growth will be driven by increasing R&D 
for mAbs and supportive government initiatives, which can be attributed to growing demands for 
personalized medicine in addition to specific benefits associated with mAb therapy such as fewer 
adverse effects, homogeneity, specificity, and large-scale production.  
Additionally, the MS treatment market was valued at an estimated $17.2 billion in 2015 
and is expected to grow at a 1.5% compound-annual growth rate (CAGR) to reach $20 billion by 
2024.9 Since Ocrevus is the first drug approved to treat multiple forms of MS, it is expected to be 
a blockbuster drug and the specialist community is certain that it will assume a dominant 
position in the MS market over the next 3 to 5 years. The drug has shown high efficacy in both 
forms of the disease, has a reasonable safety profile, and has a price tag of $65,000 per 1200 mg 
treatment, which is a 20% discount from the average list prices of its competitors.10 
Other MS treatments on the market include Biogen’s Tysabri and Tecfidera, Novartis’ 
Gilenya, and Teva’s Copaxone. Copaxone was previously a market leader, being the first non-
interferon to enter the market, while Tecfidera had the fastest market uptake in the field. 
Analysts expect 40%-50% erosion of Tysabri, and 30%-40% erosion of Tecfidera and Gilenya 
sales once Ocrevus is taken up by the market. Ocrevus is also anticipated to surpass historical 
performances due to its novel indication of use, high efficacy, convenient dosing, reasonable 
safety, and modest pricing.10  
4.2 Sales Forecast 
Since its approval in March 2017, Ocrevus saw 12-month sales of $1.4 billion from Q2 
2017 to Q1 2018.11 At $65,000 per treatment, it is estimated that 20,000 treatments were 
administered. The revenues are projected to grow rapidly and soon dominate the MS market. 
These metrics and predictions have been used to create sales forecasts in order to evaluate the 
economic viability of the two designs presented in this project.  
In order to build the forecast, 10-year sales for an Ocrevus competitor, Gilenya, were extracted 
from Novartis’ annual reports.12 The annual year-over-year (YOY) growth rates were calculated 
to build a model representative of the anticipated market uptake for an MS mAb drug. This 
8 
 
growth model was then applied to the known Year 1 Ocrevus sales to build an 8-year forecast, 
which is depicted in Table 4.1. The growth is rapid in the first few years during initial market 
uptake, but slows significantly after Year 4. This trend is illustrated in Figure 4.1. These 
forecasts are indicators of market demand and were used to design the annual production 
schedule. They also dictate the forecasted annual revenue, which is built into the profitability 
analysis in Section 21.  
Table 4.1. Sales Forecast Construction of Ocrevus. Gilenya YOY growth rates were applied to Year 1 
sales of Ocrevus to build a representative 8-year sales model.  
YEAR Gilenya Sales 
($MM) 
YOY % Growth Forecasted Ocrevus 
Sales ($MM) 
1 494 N/A 1,377 
2 1,195 142% 3,331 
3 1,934 62% 5,397 
4 2,477 28% 6,908 
5 2,776 12% 7,737 
6 3,109 12% 8,666 
7 3,185 2% 8,839 
8 N/A 2% 9,016 
 
 
Figure 4.1. Projected Ocrevus sales based on historical Gilenya sales data. The growth 
rate is plateaus around 2022 (Year 4).  
5. Customer Requirements  
N/A  
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6. Critical-to-Quality Variables  
Because therapeutic protein products impact human life, quality is an essential 
consideration in the highly regulated biopharmaceutical industry. The U.S. Food & Drug 
Administration (FDA) dictates and enforces Quality by Design (QbD), a systematic approach to 
development based on quality and risk-management. It begins with predefined objectives and 
emphasizes science-driven product and process understanding and control.13 This involves 
defining the Quality Target Product Profile (QTPP), a summary of the quality characteristics of 
the drug product that will ideally be achieved to ensure the desired quality while accounting for 
safety and efficacy. QTPP elements include dosage form & design, route of administration, 
dosage strength, pharmacokinetics, stability, and drug product quality attributes. 
Ocrevus is administered by intravenous (IV) infusion, and is supplied in single dose 15 
mL vials containing 300 mg of ocrelizumab at a nominal fill volume of 10.0 mL. The final 
formulation includes sodium acetate, trehalose dihydrate, and 0.02% (w/v) polysorbate 20, pH 
5.3. Prior to administration, it is diluted with 0.09% sodium chloride solution to reach a protein 
concentration of approximately 1.2 mg/mL.14 
As the scope of this project excludes drug product filling and packaging processes, the 
quality standards for the bulk drug substance are most relevant. The Critical Quality Attributes 
(CQA’s) of the Drug Substance are shown in Table 6.1. These attributes and requirements have 
guided the design of the operating parameters, equipment selection, and control strategy. 
  
10 
 
Table 6.1 Critical to Quality Attributes of the Drug Substance 
CQA Risk Origin 
Host Cell Protein (HCP) Safety & immunogenicity Process-related impurities 
Host Cell DNA Safety Process-related impurities 
Adventitious Viral 
Agents 
Safety Likely introduce during cell-
culture operations 
Bioburden Safety, Purity, and Efficacy; 
Degradation or modification 
of product by contaminating 
microorganisms 
Bioburden can be introduced by 
raw materials and throughout the 
manufacturing process 
Endotoxins Safety and Purity Endotoxins can be introduced by 
raw materials and throughout the 
manufacturing process 
Mycoplasma Safety  
Appearance (color, 
clarity, and opalescence) 
Safety and Efficacy N/A 
Leachables/extractables Safety Leachables and extractables 
could be introduced by any 
product contact equipment, 
containers, and consumables 
Osmolality Safety Osmolality is impacted by 
formulation. No change is 
expected during storage. 
Polysorbate 20 Safety Polysorbate 20 is added during 
DS formulation. 
 
  
11 
 
7. Product Concepts  
N/A 
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8. Superior Product Concepts  
N/A  
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9. Competitive Patent Analysis  
Many pharmaceutical companies file patents on their drug discoveries to claim rights to a 
formulation and ensure exclusivity in the marketplace. Currently, the term of a new patent is 20 
years from the date on which the application for the patent was filed in the U.S. During the 20 
year patent term, this company claims the sole rights to manufacture and distribute the drug.15 
Roche’s patent on Ocrevus was filed on September 24, 2007, and will thus expire in 2027. For 
the duration of the patent, only Roche is allowed to legally manufacture, sell, and administer 
Ocrevus. 
Once a patent term expires, other competitors are able to enter the market and administer 
the formulation as a generic, off-patent product. When this happens, the price of the drug almost 
always drops in order for companies to stay competitive. The typical price drop for a physician-
administered biopharmaceutical product is 38 - 48%.16 For example, when Ocrevus goes off-
patent in 2027, it can be expected that the price of a 1200 mg treatment will drop from $65,000 
to between $33,800 and $40,300.  
This pricing difference plays a key role in evaluating the economic viability of a drug 
manufacturing project. For this reason, two economic frameworks have been considered in this 
design. The first is an off-patent framework, in which only capital investment and annual 
operating costs will be considered in the profitability analysis. The second framework is 
designed for an on-patent drug, which will require all R&D expenditures, clinical trial 
operations, and drug success probabilities to be factored into the evaluation in addition to the 
capital investment and annual operating costs. Further details for these two evaluations are 
presented in Section 21.  
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10. Preliminary Process Synthesis 
The overall process flow of mAb production and processing is standardized across the 
industry.2 Figure 2.1 illustrates a general block flow diagram for this process, with each step 
representing opportunities for design decisions.The overall process is split into three upstream 
sections and three downstream sections. Because the upstream bioreaction and downstream 
purification steps are largely independent, design considerations for upstream and downstream 
steps were evaluated separately. Design decisions were made to determine the number, type, and 
capacity of seed and production bioreactors, the production capacity of the downstream process, 
and the types of chromatography used in later downstream purification steps. Since the 
downstream process uses smaller equipment in series, it can be scaled for several possible 
upstream combinations.  
When designing the upstream processes, the amount of mAb produced for the same 
liquid volume can be increased without significantly raising costs because the equipment and 
raw materials required for operation will not change. On the other hand, if the amount of mAb 
produced is kept constant, the cost of a given upstream design will scale with volume because 
the volume of media and bioreactor largely affect the cost. However, downstream unit capacity 
always scales with the amount of mAb product per batch, since its cost is based on product-
specific separation processes. Therefore, as product titer increases, the cost becomes increasingly 
dependent on downstream processes as compared to upstream processes.2  
Two designs were created for this project to compare a large volume, low titer and a 
small volume, high titer production scenario. The first design scheme, referred to as the Large 
Production Bioreactor Design, is illustrated in Figure 10.1. It illustrates a more traditional 
upstream process, in which the bioreaction steps culminate in a 20,000 L, stainless steel 
bioreactor. Selection of smaller volume bioreactors in inoculum preparation and cell seeding 
bioreactions was based on cell growth kinetics and production formation requirements as 
discussed in Section 11.2. The resulting product titer of this upstream design was 2.97 g/L, 
which is a typical low titer in mAb manufacturing processes.  
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Figure 10.1 Overall block flow diagram of the Large Production Bioreactor Design for mAb production 
and purification. This design represents a low volume, high titer manufacturing scenario. 
The second design scheme, referred to as the Small Production Bioreactor Design, 
represents a more modern upstream process, incorporating a production bioreactor that has a 
smaller volume capacity, but handles higher product titers with greater ease. The bioreaction 
steps in this scheme culminate in a 2,000 L single-use bioreactor, with a product titer of 6.41 g/L, 
which is approximately double that of the Large Production Bioreactor Design. Due to the 
smaller final upstream volume, less inoculum preparation and cell seeding steps were required.  
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Figure 10.2 Overall block flow diagram of the Small Production Bioreactor Design for mAb production 
and purification. This design represents a high volume, low titer manufacturing scenario. 
For both schemes, the downstream purification process was scaled to match the amount 
of product produced at the end of the upstream process. Based on this mass, the number of 
chromatography cycles needed per batch was calculated. Since mAb product is lost in separation 
and purification steps, an overall yield of 63% was calculated for the downstream process. The 
upstream processes for both schemes were then adjusted to meet the specified annual production 
goal of 100 kg of mAb.  
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11. Assembly of Database 
11.1 Chemical Components and Thermophysical properties  
Water was used as the main reference component for all thermophysical calculations of 
the mAb product and growth media. Air was also used in bioreaction steps. Other components 
present were considered negligible in a thermophysical context. Properties of water and air are 
listed in Table 11.1  
 
Table 11.1 Properties of relevant chemical components in mAb production and purification processes 
Chemical 
Component 
Molecular 
Weight (g/mol) 
Heat Capacity 
(J/g°C) 
Density 36.5°C,  
1 atm (kg/m3) 
Viscosity 
(kg/m s) 
Cost 
($/kg) 
Water (WFI) 18.02 4.184 1000 4.8x10-9 0.0047 
Air 28.96 1.006 1.14 -- -- 
 
11.2 Cell Growth Kinetics and mAb Production Rate 
Cell growth and mAb production occur in two phases. First, the cells must be grown to a 
specified peak viable cell density of 9x106 cells/mL, with at least 90% cell viability, as stated by 
the project charter. Then, the cells reach a growth plateau and product formation occurs linearly 
given a specific productivity of 3.3x10-10 g mAb per viable cell. From Equation 1 below, the 
final density of cells in a given bioreactor can be calculated based on the growth rate and growth 
time spent in the vessel. In the final process design and scheduling, one day was added to the 
specified growth time to account for the lag phase of the cells upon initial re-seeding. During the 
lag phase, the cells are adjusting to their new environment and adhering to the cell surface before 
entering the exponential log growth phase.  
𝑙𝑛 (
𝑁2
𝑁1
) = 𝜇(𝛥𝑡)     (1) 
where, N1 = initial cell density (cells/mL) 
 N2= final cell density (cells/mL) 
 μ = growth rate (day-1) 
 Δt = duration of cell growth (day) 
In the inoculum preparation steps of the upstream process, which occur within the first 7 
days of the overall process, an average growth rate of 0.63 day-1 was used. This value was 
obtained in a feed study utilizing the same CHO DG44 cell line and ActiPro, 7a, 7b feeding 
regime as will be used in this process.17 When cells are initially thawed from their cryogenic 
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state, it can require a few passages, or cell division cycles, to reach full potency. For the 
remaining duration of the upstream process, the growth rate was calculated from the project-
specified peak doubling time of 20 hours. From Equation 2 below, the growth rate was found to 
be 0.83 day-1.  
𝑡𝐷 =
𝑙𝑛(2)
𝜇
     (2) 
In order to maintain cell viability higher than 90%, which is a requirement for adequate 
product formation and quality for the given CHO DG44 cell line, cell dilution and scale-up factor 
are critical parameters to consider. In culture, cells cannot be diluted by more than a factor of 4 
or scaled by more than a factor of 10. If the cells are too dilute in the culture media, the cells will 
swell and will not take up the required nutrients for growth in order to maintain the osmotic 
pressure across the membrane and prevent bursting. If the cells are scaled up by more than a 
factor of 10, the number of cells dying as result of the natural cell cycle will become toxic to cell 
growth. In addition, the cells will become too crowded and begin to aggregate, which inhibits 
cell growth and promotes accelerated cell death. As a result, upstream design decisions were 
made to dilute cells by less than or equal to 4 and scale them up by less than or equal to 10 in 
equivalent volumes. Both bioreactor volumes and fed-batch strategies were based on these 
parameters.43 For culture volumes that are 250L or greater, the bioreactors are only filled to half 
of the intended final volume initially. The remaining half of the final bioreactor culture volume is 
fed to the cells in a daily bolus of culture media and feed supplements. These feed supplements 
provide additional nutrients and can be scaled based on manual daily samples to maintain 
optimal glucose and amino acid levels. This fed-batch feeding strategy increases the culture 
volume incrementally, prevents the cells from being too dilute while allowing scale up of factors 
greater than 10, especially in larger cell seeding steps and in the product formation step.2, 6 
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12. Process Flow Diagram and Material Balances 
The process flow diagrams (PFD) and mass balances listed below visualize and 
characterize the two main process designs. The upstream and downstream PFD’s are illustrated 
separately for both the Large and Small Production Bioreactor Designs. The two downstream 
processes have the same design, but were scaled for the appropriate volumes. Media preparation 
schemes are depicted below each of the upstream flowsheets.  
12.1 Upstream Process for Large Production Bioreactor Design 
The flowsheet in Figure 12.1 portrays the upstream portion of the Large Production 
Bioreactor design, which concludes in a 20,000 L stainless steel production bioreactor. The 
solution of media, cells, and mAb in this production bioreactor are then passed onto to the 
primary recovery step of downstream purification. Streams labeled “Media Prep” refer to the 
media preparation schemes illustrated in Section 12.1.1. The flowsheet for the corresponding 
downstream purification process are illustrated in Section 12.2.  
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12.1.1 Upstream PFD for Large Production Bioreactor Design (PFD 01) 
Figure 12.1 Upstream PFD for mAb production for the Large Production Bioreactor Design.  
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12.1.2 Media Preparation Scheme for PFD 01  
 
Figure 12.2 A detailed flow diagram of “Media Prep” streams in PFD 01 for mAb production in the Large 
Production Bioreactor scheme.  
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12.1.3 Overall Mass Balance for PFD 01  
Components (Name) IN (kg/batch) OUT (kg/batch) 
Cells 0.0000047 75.4 
mAB Product 0 40.1 
Water (H2O) 0.03 13500 
Glucose (C6H12O6) 721 0 
Glutamine (C5H10O3N2) 70 0 
Oxygen 2983 0 
Carbon Dioxide (CO2) 0 463 
Ammonia (NH3) 0 7.4 
Lactate (C3H6O3) 0 136.6 
TOTAL 3493 14223 
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12.2 Downstream Process for Large Production Bioreactor Design 
12.2.1  Downstream PFD for Large Production Bioreactor Design 
Figure 12.3 Downstream PFD for for mAb purification in the large production bioreactor design. The 
downstream will be run 1 time per batch. 
 
12.2.2 Overall Mass Balance for PFD 02 
Components (Name) IN (kg/batch) OUT (kg/batch) 
Cells 75.4 0 
Water (H2O) 13500 700 
mAb Product 40.1 25.2 
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12.3 Upstream Process for Small Production Bioreactor Design (PFD 03) 
The flowsheet in Figure 12.3 portrays the upstream portion of the Small Production Bioreactor 
design, which concludes in a 2,000L stainless steel production bioreactor. The solution of media, 
cells, and mAb in this production bioreactor are then passed onto to the primary recovery step of 
downstream purification. Streams labeled “Media Prep” refer to the media preparation schemes 
illustrated in Section 12.3.1. The flowsheet for the corresponding downstream purification 
process are illustrated in Section 12.4.  
12.3.1 Upstream PFD for Small Production Bioreactor Design  
 
Figure 12.4 Upstream PFD for mAb production in the Small Production Bioreactor scheme. The upstream 
will be run 1 time per batch. 
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12.3.2 Media Preparation Scheme for PFD 03 
 
Figure 12.5 A detailed flow diagram of “Media Prep” streams in PFD 03 for mAb production in the Small 
Production Bioreactor scheme.  
 
12.3.3 Overall Mass Balance for PFD 03 
Components (Name) IN (kg/batch) OUT (kg/batch) 
Cells 0.0000047 29.4 
mAB Product 0 40.1 
Water (H2O) 0.03 13500 
Glucose (C6H12O6) 333 0 
Glutamine (C5H10O3N2) 32 0 
Oxygen 2465 0 
Carbon Dioxide (CO2) 0 214 
Ammonia (NH3) 0 3.4 
Lactate (C3H6O3) 0 63 
TOTAL 2830 6590 
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12.4 Downstream Process for Small Production Bioreactor (PFD 04) 
 
 
Figure 12.6 Downstream PFD for for mAb purification in the small production bioreactor design. The 
design is the same as PFD 02, but the units are scaled appropriately. The downstream will be run 4 times 
per batch, with one cycle being run for each upstream 2,000L production bioreactor.  
 
 12.4.2 Overall Mass Balance for PFD 04 
Components (Name) IN (kg/batch) OUT (kg/batch) 
Cells 29.4 0 
Water (H2O) 1560 420 
mAb Product 10.0 6.30 
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13. Process Description 
MAb production and purification is divided into upstream and downstream processes. 
The upstream process objective is to grow the CHO cells up to peak viable cell density such that 
they secrete mAb into the surrounding growth media. Then, the downstream processes harvest 
the product from the cell culture solution and purify the remaining protein according to FDA 
quality standards for commercial use.  
13.1 Upstream Production Process Description 
In the upstream production of mAbs, there are two phases of growth: cell growth and 
mAb formation. The inoculum preparation and seed bioreaction steps achieve the first cell 
growth step, while the final production bioreaction step achieves the second step of mAb 
formation. The engineered CHO cell line selected for this process was CHO DG44, which was 
analyzed for nutrient requirements, initial average growth rate, and media formulations in a 
previous study that was discussed in Section 11.2 17. Section 11.2 also outlines how cell density 
and culture durations were calculated for all upstream processes. Proper preparation of cell 
culture media formulations in addition to precise control of operational parameters are detailed in 
the following sections as they are vital for optimal cell growth and product formation. Execution 
of inoculum preparation, seed bioreaction, and production bioreaction steps are then described 
for the Large and Small Production Bioreactor Processes. These steps are shown in the process 
flow diagrams in Sections 12.1 and 12.3.  
13.1.1 Media Preparation - Large & Small Production Bioreactor Designs 
For both processes, pre-formulated HyClone™ ActiPro™  cell culture medium 
from GE Healthcare Life Sciences will be used. The media has been designed for high-
yield recombinant protein production via CHO cells in a batch or fed-batch process, and 
is chemically defined and animal-derived-component-free. This provides consistency 
across batches as there are known concentrations of all chemical components and no 
complex contaminants. 
13.1.1.1 Growth Media 
For all inoculum steps and bioreactor, dry powder growth medium 
medium will be mixed with water-for-injection (WFI) at 25°C. The complete 
protocol for reconstituting dry powder ActiPro™ medium can be found in 
Appendix B. The final pH of the mixture should be in the neutral range with 
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osmolality ranging 270 to 330 mOsmol/kg. The prepared growth media will then 
flow perpendicularly through a sterile 0.2 µm, hydrophilic polyethersulfone (PES) 
membrane filter with a filtration area of 0.57 m2 to remove large contaminants. 
This is followed by transfer to a storage tank for storage at 4°C until further use. 
Transfer steps will occur via peristaltic pump at flow rates corresponding to the 
volume of media being prepared.  
13.1.1.2 Feed Supplement Media 
Feed supplements HyClone™ CellBoost™ 7a and CellBoost™ 7b will be 
used in production steps for both processes, which are also chemically defined 
and animal-derived-component-free for recombinant protein production. The 
feeds are concentrated nutrients that are complementary used in conjunction to 
maintain nutrient concentrations at appropriate values for growth. CellBoost 7a 
contains amino acids, vitamins, salts, glucose, and other trace elements. CellBoost 
7b contains concentrated amino acids. For preparation, each dry powder medium 
will be mixed with water-for-injection (WFI) at 25°C. The complete protocol for 
reconstituting the dry powder CellBoost™ media can also be found in Appendix 
B. The mixed CellBoost 7a should have a neutral pH, while the CellBoost 7b 
should have a basic pH. The prepared medias will each be filtered by a sterile 0.2 
µm, hydrophilic polyethersulfone (PES) membrane to remove large contaminants 
followed by transfer to respective storage tanks for storage at 4°C until further 
use. Transfer steps will occur via peristaltic pump at flow rates corresponding to 
the volume of media being prepared.  
13.1.2 Operation Set Points and Controls 
 Both cell culture and mAb production are very sensitive processes that require 
careful monitoring of conditions and tight control. Main conditions of interest are 
temperature, dissolved oxygen (dO2), dissolved carbon dioxide (dCO2), pH, and 
osmolality, which are all closely linked to metabolite levels, cell growth, cell viability, 
cell productivity, and product quality. The relationships between various controlled 
variables and cell and product variables is illustrated in Figure 13.1.18 Offline 
measurements will be performed for cell counting and cell viability, pH verification, 
osmolality, and metabolite concentrations. Cell counting and viability will be measured 
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using a hemocytometer assay, while metabolites will be monitored by taking samples 
from the cell culture. Metabolites of interest are: glucose, glutamine, glutamate, lactate, 
and ammonia. Glucose, glutamine, and glutamate are consumed by the cells while lactate 
and ammonia are produced by the cells. However, the cells can also use lactate as a 
source of potential energy over glucose. Osmolality levels of the culture medium should 
remain in the range of 270-330 mOsm/kg set during media preparation. Osmolality is 
measured daily using freezing-point depression osmometry, a technique based on the 
property that the freezing point of a known solvent decreases when solute is added. The  
 
Figure 13.1. Relationship between upstream operation parameters and their effect on both CHO cells and 
the secreted mAb product.  
 
freezing point is directly related to the number of solute particles present, therefore 
concentration can be measured with this method. It is preferred to keep osmolality values 
on the lower end of the acceptable range. In higher cell densities, high osmolality and 
high dCO2 levels can lead to growth inhibition and decreased cell productivity relating to 
mAb formation.  
 Real-time measurements of temperature, dO2, dCO2, and pH will also be 
performed. For the disposable bioreactors and cell incubator, temperature measurement 
and control is automated and comes with the devices. The temperature of the 20,000L 
stainless steel bioreactor in the Large Production Bioreactor scheme will be measured 
with a temperature probe connected to the heating and cooling jacket of the bioreactor for 
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control. An acceptable temperature range is between 36 and 37°C, with the ideal setpoint 
being at 36.5°C.  
Another parameter in the disposable bioreactors that has built in probes and controls is 
dO2. The setpoint for dO2 in these processes is 40% of air saturation, however an 
acceptable range is 20-50%. It is important to prevent low dO2 levels, as this will lead to 
excessive lactate synthesis by the cells and lower product yields. Similarly if the dO2 is 
too high, the cells will become toxic and likely die. In the 20,000L stainless steel 
production bioreactor, a Clark type electrode will measure dO2. To increase dO2, the 
agitation and air sparging rate should be increased. For rocking disposable bioreactors, 
the rocking speed should be increased along with an increase in air sparging. However, it 
is important that agitation and air sparging rates do not become too high.  If rocking or 
impelled speeds are too high this could result in damaging levels of shear stress on the 
cells and could lead to excessive bubble formation and foaming. When bubbles are 
introduced in the culture, they rise to the top and burst, releasing high and harmful energy 
on the cells below. If these methods do not appropriately correct dO2 levels, then pure O2 
will be sparged in separately instead of adding more air and creating too many big 
bubbles. Anti-foaming agent like a pluronic can also be added to reduce foaming and 
bubbles.  
 In addition, dCO2 levels are also extremely important, because CO2 can inhibit 
cell growth and product quality. If the dCO2 is too high, cell growth will be inhibited as 
CO2 displaces O2 in culture and results in an O2 limiting situation. If it is too low, the 
solution will become too basic and affect both glucose consumption and lactate 
production of the cells. Further, CO2 has a profound effect on the pH of the culture 
medium as increasing dCO2 increases the acidity of the solution and vice versa. This very 
careful balance is made more challenging by the fact that the cells produce 1 mole of CO2 
for every mole of O2 consumed. dCO2 will be measured by CO2 sensors and an offline 
blood-gas analyzer. An acceptable range for dCO2 is between 120 and 150 mmHg, with 
the ideal setpoint being 130 mmHg.  If CO2 is too low, sodium carbonate (Na2CO3) will 
be added and dissociated into CO2 and H2O in culture. Also, CO2 gas can be sparged into 
the culture. Using Na2CO3 is more ideal because it eliminates issues with sparging rates 
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like shear stress. It can also form an ionic bond with lactic acid in solution to form 
sodium lactate (NaC3H5O3), as seen by the chemical reaction below. 
Na2CO3 (s) + HC3H5O3 (aq.) → NaC3H5O3 (aq.) + CO2 (g) + H2O (l) 
This helps remove lactate as a potential energy source over glucose for the cells. If the 
CO2 is too high, either sterile air or pure O2 will be sparged in more to strip the CO2 from 
the medium.   
 pH levels are very heavily tied to dCO2 and lactate levels, and cell growth is very 
sensitive to pH. Even a 0.1 deviation from the optimum value of 7.1 can affect glucose 
consumption and lactate synthesis. The culture medium in itself has sodium bicarbonate 
(NaHCO3) to act as a buffering agent, however this alone is usually not enough to 
maintain tight control. The ideal pH setpoint is 7.1, although higher values are preferred 
during initial growth phase. This is because the initial cell growth phases produce a lot of 
lactate. pH probes will be used in the bioreactors for real-time measurements, however 
off-line measurements will also be performed since prolonged use of pH probes can 
result in reduced sensitivity. As lactate concentrations exceed the buffering capacity of 
the already present NaHCO3, the pH becomes more acidic. To increase the alkalinity of 
the culture medium, a base such as NaOH is added, which subsequently also increases 
osmolality of the medium. It is important to tightly control addition of base, as the 
additive effects of high pH, high lactate concentrations, and high osmolality lead to an 
acceleration of cell death and slowing of growth. To counteract medium that is too 
alkaline, Na2CO3 will be added to dissociate into CO2 and H2O with a bonus effect of 
forming NaC3H5O3, removing lactate as potential source of toxicity, delayed cell growth, 
and decreased product quality. 
 13.1.3 Inoculum Preparation - Large & Small Production Bioreactor Designs 
 Following recovery from cryogenic storage conditions, the CHO cells must be 
revived and acclimated to optimal culture conditions inoculation into seed and production 
bioreactors. Although cryogenic freezing maintains cell potential, the process of recovery 
is very harsh and the cells must undergo several cycles of replication before reaching a 
viable biomass that is compatible with aggressive volume scale-up strategies. Therefore, 
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the inoculum preparation steps are designed for small volumes and gentle culture 
conditions with ample nutrients and highly controlled atmospheric conditions.  
13.1.3.1 250 mL Shaker Flask 
To prepare the inoculum for cell seeding and growth, a 250mL Pyrex™ 
shaker flask with 125mL working volume will be filled with 95 mL of pre-
warmed growth media via a serological pipette in a HEPA filtered hood on site. 
Fifty percent working volume allows for adequate agitation, aeration, and room 
for cell growth. Recombinant CHO DG44 cells will be recovered from cryogenic 
storage in a lab on site to a volume of 30 mL at a density of 3.00 x 105 cells/mL. 
The recovery procedure can be found in Appendix A. The 30mL of cells will be 
added via serological pipette to the pre-filled shaker flask to an initial density of 
7.20x104 cells/mL. The flask will then be clamped to a flat, low speed orbital 
shaker at 60 rpm for agitation. The flask and shaker will be placed in a cell 
incubator at 36.5°C temperature and 5.0% CO2 with built-in controls for 3 days to 
reach a desired cell concentration of 2.54x105 cells/mL. The culture will be 
sampled once daily to ensure control setpoints are being met. Media or feed 
supplement boluses will be injected to correct for any nutrient deficiencies. Since 
the flasks are in a CO2 incubator, culture conditions will be altered accordingly if 
set point values are outside the desired ranges.  
13.1.3.2 25 L Single-Use Bioreactor 
To prepare for the next inoculation step, a 25L single-use, bag bioreactor 
with 12.5L working volume will be filled with sterile air and heated to 36.5°C 
with built-in controls. 12.4L of growth media will be transferred from a growth 
media storage tank to the bioreactor through jacketed pipe that contains 10% 
propylene glycol in water at 60°C in the outer annulus for heating. The transfer 
step will occur via peristaltic pump at a flow rate of 0.006 L/min. The rocking 
speed of the bioreactor will be initially set to 10 rpm at an angle of 6° and 
increased to 15 rpm and a 7°angle as media is added. After 1 hour of acclimating 
the media to the bioreactor, the cell culture from the shaker flask will be 
transferred via a peristaltic pump to the 25L bag bioreactor at a flow rate of 0.008 
L/min.  
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The cell culture will be grown for 3 days. The culture will be sampled once daily 
to ensure control setpoints are being met and that nutrient levels are within the 
acceptable ranges. Media or feed supplement boluses will be injected to correct 
for any nutrient deficiencies. To correct for offsets in set points, the bag 
bioreactor conditions will be controlled as outlined in Section 13.1.2. The desired 
final cell density after 3 days is 8.95 x 103 cells/mL.  
13.1.3 Bioreaction Processes - Large Production Bioreactor Design 
The following sections outline the remaining upstream processes after 
inoculum preparation for the Large Production Bioreactor Process Scheme, 
ending in a 20,000 L stainless steel production bioreactor. The seed bioreaction 
steps grow the cells to a peak viable cell density, while the production bioreaction 
step maximizes mAb product formation at a consistent cell density.  
13.1.3.1 100 L Single-Use Seed Bioreactor 
For cell seeding, a 100L single-use, bag bioreactor with 50L working 
volume will be filled with sterile air and heated to 36.5°C with built-in controls. 
37.5L of growth media will be transferred from a growth media storage tank to 
the bioreactor through jacketed pipe that contains 10% propylene glycol in water 
at 60°C in the outer annulus for heating. The transfer step will occur via peristaltic 
pump at a flow rate of 2.5 L/min. The rocking speed of the bioreactor will be 
initially set to 15 rpm at an angle of 6° and increased to 25 rpm and an 8° angle as 
media is added. After 1 hour of acclimating the media to the atmosphere of the 
bag, the 12.5L of cell culture from the 25L bioreactor will be transferred via a 
peristaltic pump to the 100L bag bioreactor at a flow rate of 0.83 L/min.  
The cell culture will be grown for a total of 3 days. The culture will be sampled 
once daily to ensure control setpoints are being met and that nutrient levels are 
within the acceptable ranges. To correct for offsets in set points, the bag 
bioreactor conditions will be controlled as outlined in Section 13.1.2. The desired 
final cell density after 3 days is 1.18x104 cells/mL. 
13.1.3.2 500 L Single-Use Seed Bioreactor - Two in Parallel 
To continue cell growth, two 500L single-use, bag bioreactors with 250L 
working volumes will be filled with sterile air and heated to 36.5°C with built-in 
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controls. Initially, the bioreactors will be filled to half of their working volume. 
100L of growth media will be transferred from a growth media storage tank to 
each bioreactor through jacketed pipe that contains 10% propylene glycol in water 
at 60°C in the outer annulus for heating. The transfer step will occur via a 
diaphragm pump at a flow rate of 6.7 L/min. The rocking speed of the bioreactor 
will be initially set to 5 rpm at an angle of 3° and increased to 15 rpm and a 4° 
angle as media is added. After 2 hours of acclimating the media to the bag, 25L of 
cell culture from the 100L bioreactor will be transferred via a peristaltic pump to 
each 500L bag bioreactor at a flow rate of 1.67 L/min. 
The cell culture will be grown for a total of 3 days. Each day after the first 
day, a media bolus of 62.5L containing 3.00% by volume of CellBoost™ 7a and 
0.30% by volume of CellBoost™ 7b will be added to each bioreactor. This helps 
maintain nutrient levels and prevent overcrowding. The culture will be sampled 
once daily to ensure control setpoints are being met and that nutrient levels are 
within the acceptable ranges. Media or feed supplement boluses will be injected 
to correct for any nutrient deficiencies. To correct for offsets in set points, the bag 
bioreactor conditions will be controlled as outlined in Section 13.1.2. The desired 
final cell density in each bioreactor after 3 days is 6.21 x 103 cells/mL. 
13.1.3.3 2,000 L Single-Use Seed Bioreactor - Two in Parallel 
After 3 days of culture, two single-use, 2,000 L bag bioreactors with 
1,600L working volumes will be filled with sterile air and heated to 36.5°C with 
built-in controls. Initially, the bioreactors will be filled to only half of the final 
volume. 550L of growth media will be transferred from a growth media storage 
tank to each bioreactor through jacketed pipe that contains 10% propylene glycol 
in water at 60°C in the outer annulus for heating. The transfer step will occur via a 
diaphragm pump at a flow rate of 19.0 L/min. The agitation speed of the 
bioreactor will be initially set to 100 rpm and increased to 110 rpm as media is 
added.  After 2 hours of acclimating the media to the atmosphere of the bag, 250L 
of cell culture from each 500L bioreactor will be transferred via a peristaltic pump 
to each 2,000L bag bioreactor at a flow rate of 16.7 L/min.  
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The cell culture will be grown for a total of 3 days. Each day after the first day, a 
media bolus of 400L containing 3.00% by volume of CellBoost 7a and 0.30% by 
volume of CellBoost 7b will be added to each bioreactor. This helps maintain 
nutrient levels and prevent overcrowding. The culture will be sampled once daily 
to ensure control setpoints are being met and that nutrient levels are within the 
acceptable ranges. Media or feed supplement boluses will be injected to correct 
for any nutrient deficiencies. To correct for offsets in set points, the bag 
bioreactor conditions will be controlled as outlined in Section 13.1.2. The desired 
final cell density in each bioreactor after 3 days is 5.12 x 103 cells/mL.  
13.1.3.4 20,000 L Stainless Steel Stirred Tank Production Bioreactor 
After cell seeding is complete, the final production bioreactor will grow 
the culture up to peak density and then maximize production formation and 
secretion from the cells. A 20,000L stainless steel, cylindrical bioreactor with 
pitch-blade impellers, a heating jacket, and sparging apparatuses for sterile air and 
sterile O2 will be will be filled with sterile air and heated to 36.5°C using 
proportional–integral–derivative (PID) controllers. The agitation speed of the 
bioreactor’s impeller power will be set to 0.055 W/kg and then adjusted as 
needed.  Air will be sparged in at a rate of 0.019 volume of air per volume of 
liquid per minute (vvm), which assumes that only 30% of the sparged air is taken 
up by the cells. This calculation can be found in Appendix D. Initially, the 
bioreactor will be filled with media to only half of the final volume. 3,550L of 
growth media will be transferred from a growth media storage tank to each 
bioreactor through jacketed pipe that contains 10% propylene glycol in water at 
60°C in the outer annulus for heating. The transfer step will occur via a peristaltic 
pump at a flow rate of 29.6 L/min. After 4 hours of acclimating the media to the 
tank conditions, 3,200L of cell culture from both 2,000L bioreactor bags will be 
transferred via a diaphragm pump to the production bioreactor at a flow rate of 
26.7 L/min.  
The total production duration is 19 days, over which growth media and feed 
supplements will be added each day to maintain nutrient levels and prevent 
overcrowding. Each subsequent day of production, a media bolus of 375L 
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containing 3.00% by volume of CellBoost 7a and 0.30% by volume of CellBoost 
7b will be added to the bioreactor. The culture will be sampled once daily to 
ensure control setpoints are being met, that nutrient levels are within the 
acceptable ranges, and that mAb production is occurring at an acceptable rate. 
Media or feed supplement boluses will be injected to correct for any nutrient 
deficiencies. The bioreactor conditions will be controlled via PID control to keep 
pH, osmolality, sparging rates, mixing rates, dO2, dCO2, and venting within 
setpoints outlined in Section 13.1.2. The desired final cell density in the 
bioreactor after the first 12 days is 9.00 x 106 cells/mL, which is the specified 
peak viable cell density. For the remaining 7 days, mAb production will be 
maximized at a constant cell density to reach a final mass of 40.1 kg in a volume 
of 13,500L for a final titer of 2.97 g/L. At the end of the production period, the 
culture is transferred to a centrifuge for downstream primary recovery. 
13.1.4 Bioreaction Processes - Small Production Bioreactor Design 
The following sections outline the remaining upstream processes after inoculum 
preparation for the Small Production Bioreactor Scheme, ending in a 2,000 L single-use 
production bioreactor. As compared to the Large Production Bioreactor Design, this 
design only contains one seed bioreactor, because the final bioreactor volume is smaller. 
However, to ensure proper dilution ratio and scale up conditions, the cells are held for a 
longer time in this seed bioreactor. The seed bioreaction steps grow the cells to a peak 
viable cell density, while the production bioreaction step maximizes mAb product 
formation at a consistent cell density. The two designs use the same equipment for the 
inoculum stages, but this design only has two additional bioreactors after this: a 500L 
bioreactor which feeds the final 2,000L production bioreactor.  
The following sections outline the remaining upstream processes after inoculum 
preparation for the Small Production Bioreactor Process Scheme, ending in a 2,000 L 
single-use bag production bioreactor.  
13.1.4.1 500 L Single-Use Seed Bioreactor 
This seed bioreaction step utilizes the same 500L single-use, bag 
bioreactor as described in Section 13.1.3.2, but the following changes will be 
made. 112.5 L of fresh cell culture media will be transferred from a media storage 
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tank to the bioreactor via peristaltic pump at a flow rate of 7.50 L/min. After 2 
hours of acclimating the media to the bioreactor environment, 12.5 L of cells from 
the previous bioreactor will be transferred to the 500 L bioreactor via a peristaltic 
pump at a flow rate of 0.83 L/min. After the initial transfer step, a media bolus of 
59.4 L containing regular growth media, CellBoost 7a, and 7b will be fed to the 
bioreactor daily for the remaining bioreaction period. The cell culture will be 
grown for 6 days to a final cell density of 3.09x104. All other conditions and 
process steps including culture sampling and set point correction, are the same as 
described in Section 13.1.3.2. 
13.1.4.2 2,000 L Single-Use Production Bioreactor  
The production bioreactor process for optimal product formation utilizes 
the same 2000L bag bioreactor described in Section 13.1.3.3 with the following 
changes.  Upon the start of the production period, the bioreactors will be filled to 
half of the total final volume with 580L of growth media. This volume will be 
transferred from a media storage tank to the bioreactor via a peristaltic pump at a 
flow rate of 18.4 L/min. After 2 hours of acclimating the media to the atmosphere 
of the bag, 250L of cell culture from the previous bioreactor will be transferred 
via a peristaltic pump to the 2,000L bag bioreactor at a flow rate of 13.3 L/min. A 
media bolus of 43.3 L containing regular growth media, CellBoost 7a, and 7b will 
be fed to the bioreactor daily for the remainder of the production period, which is 
19 days. The desired final cell density after the first 12 days is 9.00x106 cells/mL, 
which is the specified peak viable cell density. For the remaining 7 days, mAb 
production will be maximized at a constant cell density to reach a final mass of 
approximately 10.0 kg of mAb, with a final titer of 6.41 g/L. All other conditions 
and process steps including culture sampling and set point correction, are the 
same as described in Section 13.1.3.3. At the end of the production period of each 
bioreactor, the culture is transferred to a centrifuge for downstream primary 
recovery. 
13.2 Downstream Purification Process Description 
The mAbs are secreted from the cells grown in the upstream process. After this process is 
complete, the product must be separated from the cell mass and purified according to FDA 
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standards. The purification process is needed to remove process impurities such as host cell 
proteins, nucleic acids, and lipids. At the end of the upstream process, the protein titers are 2.97 
g/L and 6.41 g/L for the Large and Small Production Bioreactor Designs, respectively. During 
the purification process, there are several volume reduction steps that will increase the protein 
titer. However, there is an upper limit for protein titer of 150g/L because at high titers, the 
protein aggregates solution becomes too viscous. The downstream process consists of three 
major parts: primary recovery, purification, and polishing steps. These steps are shown in the 
process flow diagrams in Sections 12.2 and 12.4.  
13.2.1 Primary Recovery 
The primary recovery steps consist of both centrifugation and depth filtration, 
which is used for the removal of cells and cell debris from the culture broth and 
clarification of the cell culture supernatant that contains the antibody product.  
13.2.1.1 Centrifugation 
Contents of the final production bioreactor are transferred into the 
centrifuge via a peristaltic pump. The centrifuge separates the extracellular 
product from the cells and other solid waste. Because the product is secreted, the 
cells are no longer needed for the process and they will be disposed of. 
Centrifugation operating conditions will be chosen to ensure the cells are not 
lysed because this would release additional contaminants in the product solution. 
It is assumed that the cells take up a negligible volume in the bioreactors, so the 
protein titer is constant for this step, with the large production bioreactor design 
having a protein titer of 2.97 g/L of solution and the small production bioreactor 
design having a protein titer of 6.41 g/L of solution. 
The centrifuge operates in a continuous manner, processing 4,000 L/hr for 
the large production bioreactor design and 780 L/hr for the small production 
bioreactor design. It is operated at 25°C and has a product yield of 96% with 
about 4% of desired product being discarded in the solid waste stream. 
Centrifugation for the Large Production Bioreactor Design will require a time of 4 
hours and an additional 2 hours for CIP and SIP. Centrifugation for the Small 
Production Bioreactor Design will require a time of 2 hours and an additional 2 
hours for CIP and SIP. 
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13.2.1.2 Depth Microfiltration 
In addition to centrifugation, depth filtration will be used as a second 
recovery step to eliminate large solid particles from the media. A depth filter is 
used because there is a limit to the particle size that can be removed by 
centrifugation. Similar to centrifugation, it will be assumed that the volume 
reduction from this step is negligible, keeping the protein titer constant. The 
supernatant from the centrifuge is applied to the filters. The feed will be filtered at 
a speed of 21 L/min/m2 with a yield of 97%. For the Large Production Bioreactor 
Design, it will take 9 hours and for the Small Production Bioreactor Design, it 
will take 1.5 hours.  
13.2.2 Initial Purification  
The purification steps include the Protein A chromatography and cation exchange 
chromatography, with a diafiltration unit separating them. These units are used as a 
capture step in separating the product from smaller impurities and as a concentration step 
in reducing the overall volume.  
13.2.2.1 Buffer Preparation 
Many downstream unit operations, including the chromatography 
columns, will require various buffers to be prepared for each batch. Buffers will 
be purchased from Millipore Sigma and mixed with WFI in single-use storage 
containers. Single use containers will help minimize cleaning and sterilization 
procedures and reduce contamination. Once prepared, the pH and conductivities 
of the buffers will be checked and controlled until the buffers are used.  
13.2.2.2 Protein A Chromatography 
Protein A Chromatography is the first of three chromatography steps in 
the downstream process. It aims to isolate the mAb product by using a resin that 
selectively binds the IgG molecule. Protein A is Staphylococcus aureus cell wall 
protein that binds selectively to the Fc region of IgG. Protein A contains five 
regions that bind to the Fc region of IgG and one molecule of protein A (on a 
resin matrix) can bind at least two molecules of IgG. It is a naturally occuring on 
the gram-positive bacterium, and it has been engineered for protein purification 
applications19. This step is used to remove process-related impurities such as host 
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cell proteins, DNA, cell culture media components, and endogenous and 
adventitious virus particles with a high purity and yield. The MabSelect SuRe LX 
media resin chosen for this process consists of an alkali- and protease stabilized, 
recombinant protein A ligand coupled to a rigid, agarose matrix. The stability of 
the protein A ligand minimizes ligand leakage and allows for cleaning procedures 
based on NaOH. In addition, the highly cross-linked agarose matrix of the resin 
enables the use of high flow velocities at production scale.20 
This operation is the first volume reduction step in the downstream process. Once 
the protein has been loaded onto the column, it will be eluted with a smaller 
volume in order to concentrate the product. For the Large Production Bioreactor 
Design, the working volume will be reduced from 13,500L to 3,200L. For the 
Small Production Bioreactor Design, the working volume will be reduced from 
1,560L to 750L. This increases the protein titer to 10.7 g/L and 11.5 g/L, 
respectively.  
Before the harvest cell culture fluid is passed over the column, the column 
is equilibrated with 5 column volumes (CV) of equilibration buffer (20 mM 
sodium phosphate, 150 mM NaCl at a pH of 7.4). After this step, the filtrate from 
the depth filtration is loaded onto the column. Then, there are two wash steps that 
wash away any impurities that are not bound to the resin. The first wash step uses 
3.5 CVs of an equilibration buffer and the second wash step uses 1 CV of a wash 
buffer (50 mM acetate at a pH of 6). The mAbs are then washed from the column 
using 4 CVs of an elution buffer (50 mM acetate at a pH of 3.5). The low pH 
allows for the removal of the product as well as inactivation of viruses present in 
the solution. The elution stream is collected and transferred to a storage tank. The 
column is regenerated using 3 CV of buffer (100 mM sodium acetate, pH 2.9) and 
CIP uses 4 CVs of 100 mM NaOH. Following CIP, the SIP will be performed 
after each batch.21 The column is expected to produce a 92% yield with a 98% 
purity. For the Large Production Bioreactor Design, it will require 19 hours to 
process all of the input, which will be processed in 4 cycles. For the Small 
Production Bioreactor Design, it will require 4 hours to process each input, which 
will require one cycle.  
41 
 
13.2.2.3 Virus Inactivation 
CHO cells used to manufacture the mAbs produce endogenous 
retroviruses and are occasionally infected with adventitious viruses during 
processing. The best approach to ensure adequate viral clearance is to have 
multiple, orthogonal virus-removal steps and at least one virus inactivation steps. 
Virus inactivation methods include low pH, heat, irradiation, and chemical agents. 
For this process, the method for inactivating the viruses will be holding the 
solution in a low pH buffer. This method was chosen because it can be combined 
with the elution step from the Protein A chromatography column to create a more 
integrated process. The product will be eluted from the column with an low pH 
buffer and once all of the eluent has been collected, the solution will be held for 2 
hours before starting diafiltration. This time will allow the viruses to be 
inactivated in the acidic conditions.22 
13.2.2.4 Ultrafiltration / Diafiltration (UF/DF) 
Ultrafiltration and diafiltration are size-exclusion, pressure-driven 
membrane processes used for protein concentration and buffer exchange. The 
desired separation is created by the different filtration rates of the various species 
and the applied pressure driving force. Solvent, buffer salts, and other small 
molecules migrate through the membrane while the protein is retained. The 
ultrafiltration will be carried out in the tangential flow filtration (TFF) mode. 
Tromethamine (Tris base) (pKa = 8.1) will be added to the retentate system at the 
same rate that filtrate is removed. This will ensure the protein is in a new buffer to 
prime the product for the next chromatography step.  
The UF/DF process will be run continuously using membrane cassettes totaling 
2.5 m2 in area and with a pore size of 30 kDa. The product in the large production 
bioreactor design will be concentrated from 10.7 g/L to 52.1 g/L.  The product in 
the small production bioreactor design will be concentrated from 11.5 g/L to 55.4 
g/L. The total processing time for the Large Production Bioreactor Design will be 
4 hours and 1.5 hours for the Small Production Bioreactor Design. 
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13.2.2.5 Cation Exchange Chromatography 
Cation exchange chromatography uses a resin modified with negatively 
charged functional groups to bind positively charged proteins. For this process, 
Capto S resin will be used, which has a -SO3 functional group. It is typically used 
for mAbs with neutral to basic pI values. Because the pI of the protein is 9.2, it 
will be positively charged at its working pH of 5.5. The antibody is bound onto 
the resin during the loading step and eluted with a increasing salt buffer, while 
keeping pH constant. The increased salt concentration causes the sodium cations 
to exchange with mAb. The most negatively charged impurities are removed 
during the load and wash steps. These impurities include DNA, some host cell 
protein, and leached protein A.23    
First, the column is packed with the resin and equilibrated using 5 CV of 
20 mM sodium acetate buffer. Then, the sample is loaded with the filtrate from 
the previous diafiltration step. The wash step uses 5 CV of 20 mM sodium acetate 
buffer. The product is then eluted with 2 CV of a buffer consisting of 20 mM 
sodium acetate with 0.5M sodium chloride and collected for additional 
purification. The column is regenerated using 2 CVs of 20 mM sodium acetate 
with 1M sodium chloride and CIP is performed with 3 CV of 0.5 M NaOH. The 
column is expected to have a 92% yield. For the Large Production Bioreactor 
Design, it will require 16 hours to process all of the input, which will be 
processed in 4 cycles. For the Small Production Bioreactor Design, it will require 
4 hours to process each input, which will require one cycle. Similar to the Protein 
A chromatography column, the volume of the product solution is determined by 
the elution step. However, for this column, there will be an increase in the volume 
because of the volume required to remove the protein from the resin. The Large 
Production Bioreactor Design will have a volume increase from 640 L to 1290 L 
and the Small Production Bioreactor Design will have an increase from 150 L to 
320 L. At this point, the protein titers for the two designs are 30.7 g/L and 
24.0g/L, respectively.  
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13.2.3 Polishing Steps 
The polishing steps consist of virus filtration, hydrophobic interaction 
chromatography, and two final filtration steps (ultrafiltration/diafiltration and sterile 
filtration). These steps are used to remove viruses, aggregated protein, and any other 
impurities before storing the proteins.28 The same processes will be used in the 
downstream process for both upstream schemes, but they will be adjusted in capacity. At 
various points in the downstream purification process, the product will be checked to 
ensure quality standards are met.24  
13.2.3.1 Virus Filtration  
The virus filtration step is used to remove the virus particles that were 
previously inactivated. For safety requirements, the product must contain less than 
one virus particle per million doses, which translates to 12-18 log10 clearance of 
endogenous retroviruses and 6 log10 clearance for adventitious viruses. The US 
Food and Drug Administration (FDA) requires that manufacturers of biotech 
products that use murine cell lines (including CHO cells) are to demonstrate the 
clearance capability of their manufacturing processes with one relevant retrovirus. 
Because the virus particles have a diameter of 18–26 nm, but a typical 
monoclonal IgG antibody has a hydrodynamic diameter of 8–12 nm, filters are 
required to have a very narrow pore size distribution to achieve a high clearance 
and yield.25  
Four filters will be used and the filtration unit can be run continuously in four 
cycles during which the hollow-fiber membrane will retain the virus waste. This 
will take 10 hours for the Large Production Bioreactor Design and 6 hours for the 
Small Production Bioreactor Design. 
13.2.3.2 Hydrophobic Interaction Chromatography 
Hydrophobic interaction chromatography (HIC) is commonly used as a 
polishing step in mAb purification processes. It is an effective step for removing 
trace product and process-related impurities such as aggregates. It is important to 
remove protein aggregates because they may lead to an immunogenic reaction 
when administered to the patient.26 HIC is a tool used to separate proteins based 
on their hydrophobicity. For this process, it will be run in flow through mode, 
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meaning the product will flow through while the impurities bind to the resin. 
These impurities have chemical properties very similar to the target but they will 
be more hydrophobic than the target protein. They will bind at relatively low salt 
concentrations to the resin, while the mAb will not bind unless there is a high salt 
concentration.27 Depending on the mAb product, HIC may not be required if 
cation exchange can adequately purify the product. If only two chromatography 
steps are required, this step can be easily eliminated.  
The column is equilibrated with 5 CVs of 1.3 M ammonium sulfate, 50 
mM sodium phosphate, adjusted to pH 7 using 1M tris base and conductivity 
adjusted to 110mS/cm using ammonium sulfate. The filtrate from the virus 
filtration unit is loaded onto the column. The product pool is then collected, with a 
pH of 7 upon elution, and is quenched with 1M acetic acid to a final pH of 5.5 
prior to analysis. The column is then washed with 5 CV of equilibration buffer. 
The resin is cleaned with 5 CVs of WFI followed by 5 CVs of 1 M NaOH. The 
column is expected to have a 92% yield. For the Large Production Bioreactor 
Design, it will require 13 hours to process all of the input, which will be 
processed in 4 cycles. For the Small Production Bioreactor Design, it will require 
7 hours to process each input, which will require one cycle. This chromatography 
step will result in an increase in the working volume so the protein titer will 
decrease from 22.6 g/L to 7.7 g/L for the large production bioreactor design and 
from 22.8 g/L to 3.2 g/L for the small production bioreactor design. 
13.2.3.3 Ultrafiltration / Diafiltration (UF/DF) 
A second UF/DF process will be run to achieve the final desired protein 
concentration and resuspend the protein in sterile PBS.28 Similar to the first 
UF/DF, the filtration will be performed in the tangential flow mode and will 
concentrate the product from 7.7 g/L to 37.0 g/L and suspend the product protein 
in PBS in preparation for the final product sterilization.  
13.2.3.4 Sterile Filtration  
Sterile filtration serves as the last purification step to remove any final 
contaminants. The product will be directly filtered into the final storage containers 
using a 0.2 um membrane cartridges to ensure sterility. For the Large Production 
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Bioreactor Design, 70 filters will be run in parallel, one for each of the final 
storage containers, and it will take 3 hours to process all input. For the Small 
Production Bioreactor Design, 42 filters will be run in parallel and it will also take 
3 hours to process all input. The filters are expected to recover 97% of the 
product.  
13.2.3.5 Final Storage 
The purified product will be stored in 10 L polycarbonate Nalgene 
biotainers at -80°C. The product will be stored in bulk current market. Depending 
on the demand, the product will be sent to the formulation group who will 
package the mAbs for patient use in the correct dosage. 70 bottles will be used for 
the Large Production Bioreactor Design and 42 will be used for the Small 
Production Bioreactor Design. The product will be stored at a titer of 36 g/L and 
15 g/L for the two designs.  
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14. Energy Balance and Utility Requirements 
The major utility requirements for this process are electricity and steam. It is assumed 
that since this plant is part of a larger operation, utility supply systems are already installed. The 
utility consumption is the only cost consideration.  
The Large Production Bioreactor scheme requires 79,300 kWh of electricity. At the PECO 
(Philadelphia Electric Company) rate of $0.085/kWh, this results in a per batch cost of $6,740 28. 
Steam is another heavily used utility, at $0.02/kg resulting in a $5,007 expenditure. A large 
portion of these utilities will be used for operating the large 20,000 L bioreactor, as well as for 
CIP and SIP processes. The Small Production Bioreactor scheme, therefore, requires much less 
electricity and steam in the upstream process, since the maximum bioreactor size is 2,000 L and 
no CIP/SIP is required since all units are disposable. The total utility cost for the small bioreactor 
scheme is $6,600 which is less than half that of the large bioreactor scheme.  
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15. Equipment List and Unit Descriptions 
15.1 Upstream Production Process Units 
The equipment used in the two designs (Large and Small Production Bioreactor) are 
described in the following sections. Each section references the unit in the process flow sheets 
from Section 12. The equipment used for the two designs will be similar, but will be adjusted 
based on volumes.  
15.1.1 Large Production Bioreactor Design 
15.1.1.1 Blending Tank (PFD 01/P-1) 
This blending tank is used to mix ActiPro dry powder media with WFI 
before being filtered and then transferred to a storage tank until further use. The 
tank will be manufactured from polyethylene with a volume of 75L, a working 
capacity of 80%, and a height to diameter ratio of 2 to 1. Clean-in-place (CIP) and 
Steam-in-place (SIP) will be conducted after each batch, the procedures for which 
can be found in Appendix C. The tank operates at room temperature and 1 bar. 
The tank is manufactured by White Mountain Process and costs $12,500. 
15.1.1.2 Dead-End Filter (PFD 01/P-3) 
This dead-end filter is used to filter and remove large contaminants from 
blended media before being transferred to storage until further use. The filter pore 
size is 0.2 µm and the filtration area is 0.57 m2. The membrane filter material is 
polyethersulfone (PES) with a polyethylene film edge and polyester supports. The 
maximum differential pressure at room temperature is 6.9 bar with a throughput 
of 2000 L/m2/h. The filters are sterile, disposable, and come in disposable housing 
units, which are replaced after every batch. Filter P-19 is connected to blending 
tank P-1 for filtration of ActiPro media. The capsules are manufactured by 
Millipore Sigma and cost $400. 
15.1.1.3 Storage/Blending Tank (PFD 01/P-5) 
This storage tank is used to store blended and filtered ActiPro culture 
media at 4°C until being transferred to the 250mL Shaker Flask, 25L Single-Use 
Bioreactor, and 100L Single-Use Seed Bioreactor. The tank will be manufactured 
from polyethylene with a volume of 75L, a working capacity of 80%, and a height 
to diameter ratio of 2 to 1. Clean-in-place (CIP) and Steam-in-place (SIP) will be 
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conducted after each batch, the procedures for which can be found in Appendix C. 
The tank operates at 4°C via electric cooling and 1 bar. The estimated cost of the 
storage tank is $12,500. 
15.1.1.4 250 mL Shaker Flask with Orbital Shaker & Incubator (PFD 01/P-7) 
A baffled 250 mL shaker flask manufactured by Corning is used for the 
first inoculum preparation step after cryogenic recovery of the cells (Appendix 
A). The flask is made from Pyrex and must be autoclaved at 121°C for 60 minutes 
before use. The flask will be placed on a low speed orbital shaker with a flat 
platform manufactured by Corning LSE. The orbital shaker is 25.5 cm long, 32.0 
cm wide, and 16.0 cm in height, with maximum speed of 60 rpm. The flask and 
shaker apparatus will be placed inside an Thermo Scientific Forma Series 3 Water 
Jacketed CO2 Incubator. The incubator comes equipped with temperature, CO2, 
O2, and humidity controls. The incubator is manufactured from stainless steel 
with inner dimensions 54.1 cm in length, 68.1 cm in width, and 50.8 cm in height. 
The incubator will be set to 36.5°C, 1 bar, a pH of 7.1, 5.0% CO2, and 40% dO2. 
The process time for the shaker flask, orbital shaker, and incubator is 3 days. The 
shaker flasks are purchased in quantities of six for $157.80 from Corning. The 
orbital shaker is a one-time purchase from Corning for $900.00. The incubator is 
also a one-time purchase from Thermo Fisher Scientific for $7,900. 
15.1.1.5 25 L Single-Use Bioreactor (PFD 01/P-9) 
The second inoculum preparation step uses the single-use ReadyToProcess 
WAVE™ 25 L rocking bioreactor system from GE Healthcare Life Sciences. The 
system consists of a rocker, CBCU gas mixers, pumps, and disposable, pre-
sterilized, 22L Cellbags for cell expansion and growth in suspension. It is also 
equipped with high level sensors and stable, automated control for temperature, 
liquid transfer, dO2, and pH. Cellbags are easily attachable and all operations are 
managed with the accompanying UNICORN software installed on a computer. 
The base unit dimensions are 0.40 m long, 0.21 m wide, and 0.56 m high. The 
tray dimensions to hold the Cellbag are 0.8 m long, 0.07 m wide, and 0.61 m high. 
The rocker allows for temperature control integrated into the base unit, stable 
mixing, and real-time load measurements. Rocking also helps maintain dissolved 
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oxygen levels. The CBCU delivers gases to the culture and is connected to optical 
sensors in the cell bag bioreactor for online pH and dO2 control. A maximum of 
two CBCU gas mixers and three pump units can be connected to the main rocker. 
Because the cell bags are pre-sterilized and disposable, there are no CIP or SIP 
steps required and there is minimal cross-contamination between batches. The cell 
bags are manufactured from clear, multilayer, laminated USP Class VI plastics 
and are replaced between each batch. The unit is kept at 36.5°C, 21 bar, pH at 7.1, 
and 40% dO2. The rocker is set to a final agitation speed of 15 rpm at a 7° angle. 
The process time for the unit is 3 days. The rocker and CBCU gas mixer are 
purchased from GE Healthcare Life Sciences for $60,000 and $1,000, 
respectively. The disposable 22L Cellbag is purchased for $500.00.  
15.1.1.6 100 L Single-Use Seed Bioreactor (PFD 01/P-29) 
Cell seeding and scale-up uses the single-use ReadyToProcess WAVE 
Bioreactor 200 system.  The system consists of a rocker base unit and a 
disposable, pre-sterilized 100L Cellbag. It is also equipped with high level sensors 
and PID control for aeration, temperature, dO2, and pH. All operations are 
managed with the accompanying UNICORN software installed on a computer. 
The unit dimensions including the Cellbag are 1.85 m long, 1.10 m wide, and 1.12 
m high. The rocker produces a wave-like motion that mixes the culture, suspends 
the cells, and helps provide effective oxygen transfer from the bioreactor 
headspace. The degree of mixing and oxygen transfer will be controlled by 
adjusting the rocking speed and angle. Oxygen transfer is also supplied by an 
internal air pump that passes air through the headspace to continuously supply 
oxygen and strip waste gases. O2 is also connected to a separate port to mix air 
with O2 if necessary.  dO2 levels are controlled either by altering the concentration 
of O2 in air pumped into the headspace or by altering rocking speed or angle. A 
configured dO2 system with a sensor provides control for both of these options. 
On the underside of the rocker is a heating plate that controls temperature along 
with a temperature sensor inserted into the Cellbag. An electrochemical pH probe 
measures online pH and is connected to pumps for addition of Na2CO3 in H2O for 
acid or NaOH in H2O for base. Because the cell bags are pre-sterilized and 
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disposable, there are no CIP or SIP steps required and there is minimal cross-
contamination between batches. The cell bags have a 50% working volume, are 
manufactured from clear, multilayer, laminated USP Class VI plastics, and are 
replaced between each batch. The maximum operating pressure is 0.1 bar, and the 
recommended operating pressure is 5 to 7.5 mbar. The unit is kept at 36.5°C, 
0.007 bar, pH at 7.1, and 40% dO2.  The final rocking speed is set to 25 rpm at an 
8° angle. The process time for the unit is 3 days. The rocker and 100L CellBag 
are purchased from GE Healthcare Life Sciences for $90,000 and $800, 
respectively.  
15.1.1.7 Blending Tanks (PFD 01/P-11; P-17; P-23) 
Blending tank P-22 is identical to the unit described in 15.1.1.1, but has a 
volume of 4,000L and costs $51,000. 
Blending tank P-17 is identical to the unit described in 15.1.1.1, but it is 
used to mix feed supplement CellBoost™ 7a dry powder media with WFI before 
being filtered and transferred to a storage tank until further use. The tank will 
have a volume of 7,000L and cost $63,200. 
Blending tank P-23 is is identical to the unit described in 15.1.1.1, but it is 
used to mix feed supplement CellBoost™ 7b dry powder media with WFI before 
being filtered and transferred to a storage tank until further use. The tank will 
have a volume of 700L and cost $24,300. 
15.1.1.8 Dead-End Filters (PFD 01/P-13; P-19; P-25) 
These dead-end filters are the same as previously described in Section 
15.1.1.2, connected to blending tanks P-11, P-17, and P-23, respectively. 
15.1.1.9 Storage/Blending Tanks (PFD 01/P-15; P-21; P-27) 
Storage tank P-15 is identical to the unit described in 15.1.1.3, but has a 
volume of 4,000L and is used to store blended and filtered ActiPro culture media 
at 4°C until being transferred to the 500L and 2,000L Single-Use Seed 
Bioreactors. The tank costs $51,000.  
Storage tank P-21 is identical to tank P-15, but stores blended and filtered 
feed supplement CellBoost 7a media and has a volume of 250L. The storage tank 
costs $18,000. 
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Storage tank P-27 is identical to P-21 is but stores blended and filtered 
feed supplement CellBoost 7b media and has a volume of 25L. The storage tank 
costs $9,200. 
15.1.1.10 500 L Single-Use Seed Bioreactors (PFD 01/P-32,33) 
Cell seeding continues with use of another single-use ReadyToProcess 
WAVE Bioreactor 500/1000 system.  The system consists of a rocker base unit, 
and a disposable, pre-sterilized 500L Cellbag. It is also equipped with high level 
sensors and PID control for aeration, temperature, dO2, and pH. All operations are 
managed with the accompanying UNICORN software installed on a computer. 
The unit dimensions including the Cellbag are 2.26 m long, 1.24 m wide, and 1.60 
m high. The rocker produces a wave-like motion that mixes the culture, suspends 
the cells, and helps provide effective oxygen transfer from the bioreactor 
headspace. The degree of mixing and oxygen transfer will be controlled by 
adjusting the rocking speed and angle.  Oxygen transfer is also supplied by an 
internal air pump that passes air through the headspace to continuously supply 
oxygen and strip waste gases. O2 is also connected to a separate port to mix air 
with O2 if necessary.  dO2 levels are controlled either by altering the concentration 
of O2 in air pumped into the headspace or by altering rocking speed or angle. A 
configured dO2 system with a sensor provides control for both of these options. 
On the underside of the rocker is a heating plate that controls temperature along 
with a temperature sensor inserted into the Cellbag. An electrochemical pH probe 
measures online pH and is connected to pumps for addition of Na2CO3 in H2O for 
acid or NaOH in H2O for base. Because the cell bags are pre-sterilized and 
disposable, there are no CIP or SIP steps required and there is minimal cross-
contamination between batches. The cell bags have a 50% working volume, are 
manufactured from clear, multilayer, laminated USP Class VI plastics, and are 
replaced between each batch. The maximum operating pressure is 0.1 bar, and the 
recommended operating pressure is 5 to 7.5 mbar. Each unit is kept at 36.5°C, 
0.007 bar, pH at 7.1, and 40% dO2. The final rocking speed is set to 15 rpm at an 
4° angle. The process time for the unit is 3 days. Each rocker and 500L CellBag 
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are purchased from GE Healthcare Life Sciences for $150,000 and $1,000, 
respectively. Two rockers and CellBags are required per batch.  
15.1.1.11 2,000 L Single-Use Seed Bioreactors (PFD 01/P-36,37) 
The last cell seeding step is performed with use of another single-use 
system, the Xcellerex XDR-2000 cell culture bioreactor systems from GE 
Healthcare Life Sciences.  The system consists of a jacketed bioreactor vessel, an 
I/O and gas mixing cabinet, a control console, and a bioreactor bag assembly,. 
The jacketed vessel, manufactured from 304 grade stainless steel, provides 
temperature control via an external temperature control (PID) unit. It has a height 
to diameter aspect ratio of 1.5 to 1. The vessel also has built in load cells for 
weight measurement, inlet and exhaust filter holders, and sidewall ports. The 
sidewall ports allow for sterile sampling and sterile probe insertion for pH, dO2, 
dCO2 and temperature measurements. The I/O cabinet houses probe transmitters 
and peristaltic pumps, while the gas management cabinet houses mass flow 
controllers for delivery of gases to the bag sparger or headspace. The control 
console visualizes all measurements and manages controls of the Xcellerex XDR 
system. The bag assembly consists of a bioreactor bag incorporated with an 
impeller/sparger assembly mounted on the bottom for efficient mixing and 
oxygen transfer. The impeller is magnetically coupled, has 4 blades at a pitch of 
40°, and the impeller diameter to bag diameter aspect ratio is 0.34. The assembly 
is also comprised of tubing, complete with weldable and aseptic connectors for 
liquid transfer, a disposable pressure sensor, and filters for inlet, exhaust, and 
headspace gas transfer. The bag itself has a 100% working volume of 2,000L, is 
manufactured from clear, multilayer, laminated USP Class VI plastics, and is 
replaced between each batch.  Because the bags are pre-sterilized and disposable, 
there are no CIP or SIP steps required and there is minimal cross-contamination 
between batches. The maximum operating pressure is 0.05 bar. Each unit is kept 
at 36.5°C, 0.007 bar, pH at 7.1, and 40% dO2. The agitation speed is set to 110 
rpm. The process time for the unit is 3 days. Each Xcellerex XDR vessel and 
2,000L Probag are purchased from GE Healthcare Life Sciences for $250,000 and 
$5,000, respectively. Two vessels and Probags are required per batch.  
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15.1.1.12 Blending Tank (PFD 01/P-46)  
Blending tank P-46 is identical to the first unit described in 15.1.1.1 for 
mixing regular ActiPro growth media, but has a volume of 6,000L and costs 
$59,400. 
15.1.1.13 Dead-End Filters (PFD 01/P-48) 
These dead-end filters are the same as previously described in Section 
15.1.1.2, connected to blending tank P-48. 
15.1.1.14 Storage/Blending Tanks (PFD 01/P-50; P-41; P-44) 
Storage tank P-50 is identical to the first unit described in 15.1.1.9, but has 
a volume of 6,000L and costs $59,400. 
Storage tank P-41 is identical to the second unit described in 15.1.1.9, but 
has a volume of 7,500L and costs $69,400. 
Storage tank P-44 is identical to the third unit described in 15.1.1.9, but 
has a volume of 750L and costs $25,500. 
15.1.1.15 20,000 L Stainless Steel Production Bioreactor (PFD 01/P-52) 
The mAb production step is performed with a traditional stainless-steel, 
custom, jacketed bioreactor with a 20,000 L volume and a 16,000 L working 
volume. The tank is cylindrical, with a height to diameter ratio is 2 to 1. The 
bioreactor is equipped with an impeller, which has a total diameter that is 1/3 the 
diameter of the tank. Each impeller blade is 1/5 the diameter of the impeller in 
height, and 1/4 the diameter of the impeller in width. There are 4 blades on the 
impeller at an angle of 40°. The bioreactor is also equipped with gas sparging 
elements and filter ports for sterile air and O2, along with mass flow ports and 
filters for fed-batch media and feed supplement transfers, anti-foaming agent, 
aqueous Na2CO3, and aqueous NaOH. The vessel will be heated by a water-
jacket. There will also be aseptic vessel ports for pH, dO2, dCO2, and temperature 
probes, in addition to sampling ports for daily cell density and viability 
measurements. The exhaust port will contain a filter and heater to prevent 
condensation. All set points will be controlled with PID controls. Following each 
batch, CIP and SIP will be conducted to sterilize the vessel. The vessel is operated 
at 36.5°C, 2 bar, pH at 7.1, and 40% dO2. The specific agitation power is 0.055 
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W/kg, and air is sparged at 0.00981 vvm assuming that 30% of all sparged air is 
taken up by the cells. This calculation can be found in Appendix D. The process 
time for the unit is 19 days. The estimated total purchase cost of the vessel is 
$1,500,000. 
15.1.2 Small Production Bioreactor Design 
15.1.2.1 Blending Tank (PFD 03/P-1) 
This blending tank is identical to the unit described in 15.1.1.1 for mixing 
regular ActiPro growth media, but has a volume of 300L and costs $18,100.  
15.1.2.2 Dead-End Filter (PFD 03/P-3) 
This dead-end filter is identical to the unit described in 15.1.1.2 and is 
connected to blending tank P-1.  
15.1.2.3 Storage/Blending Tank (PFD 03/P-5) 
This storage tank is identical to the unit described in 15.1.1.3, but has a 
volume of 300L and costs $18,100.  
15.1.2.4 250 mL Shaker Flask with Orbital Shaker & Incubator (PFD 03/P-7) 
This shaker flask is identical to the unit described in 15.1.1.4. 
15.1.2.5 25 L Single-Use Bioreactor (PFD 03/P-9) 
This 25L Single-Use WAVE Bioreactor from GE Healthcare Life Science 
is identical to the unit described in 15.1.1.5. 
15.1.2.6 Blending Tanks (PFD 03/P-11; P-17) 
Blending tank P-11 is identical to the second unit described in 15.1.1.7 for 
mixing CellBoost 7a media, but has a volume of 900L and costs $26,000. 
Blending tank P-17 is identical to the third unit described in 15.1.1.7 for 
mixing CellBoost 7b media, but has a volume of 90L and costs $12,700 
15.1.2.7 Dead-End Filters (PFD 03/P-13; P-19) 
These dead-end filters are identical to the unit described in 15.1.1.2 and 
are connected to blending tanks P-11 and P-17, respectively.  
15.1.2.8 Storage/Blending Tanks (PFD 03/P-15; P-21) 
Storage tank P-15 is identical to the second unit described in 15.1.1.7 for 
CellBoost 7a storage, but has a volume of 50L and costs $10,700. 
55 
 
Storage tank P-21 is identical to the third unit described in 15.1.1.7 for 
CellBoost 7b storage, but has a volume of 25L and costs $9,100. 
15.1.2.9 500 L Single-Use Seed Bioreactor (PFD 03/P-23) 
This 500L Single-Use WAVE Bioreactor from GE Healthcare Life 
Sciences is identical to the unit described in 15.1.1.6. The operating time for this 
unit is 6 days. Only one rocker and 500L CellBag will be purchased for $150,000 
and $1,000. 
15.1.2.10 Blending Tank (PFD 03/P-31) 
Blending tank P-31 is identical to the unit described in 15.1.1.1 for mixing 
regular ActiPro growth media, but has a volume of 1,100L and costs $28,200. 
15.1.2.11 Dead-End Filter (PFD 03/P-33) 
This dead-end filter is identical to the unit described in 15.1.1.2 and 
isconnected to blending tanks P-31. 
15.1.2.12 Storage/Blending Tanks (PFD 03/P-35; P-26; P-29) 
Storage tank P-35 is identical to the 15.1.1.3 for ActiPro growth media 
storage, but has a volume of 1,100L and costs $28,200. 
Storage tank P-26 is identical to the first unit described in 15.1.2.8 for 
CellBoost 7a storage, but has a volume of 850L and costs $25,600. 
Storage tank P-26 is identical to the first unit described in 15.1.2.8 for 
CellBoost 7b storage, but has a volume of 90L and costs $12,700. 
15.1.2.13 2,000 L Single-Use Production Bioreactors (PFD 03/P-37) 
This 2000L single-use Xcellerex XDR-2000 cell culture bioreactor system 
from GE Healthcare Life Sciences is identical to the unit described in 15.1.1.11. 
Only one rocker and 2,000L Probag will be purchased for $250,000 and 
$2,500.00, respectively.  
15.2 Downstream Purification Process Units 
The equipment used in for the downstream operations are described in the following 
sections. Each section references the unit in the process flow sheets from Section 12. The 
equipment used will be based on the corresponding upstream design and the differences are 
noted below.  
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15.2.1 Primary Recovery 
15.2.1.1 Centrifuge (PFD 02/P-54, PFD 04/P-39) 
The contents of the production bioreactor must be separated into a solid 
waste stream and liquid stream containing the desired product. A disc-stack 
centrifuge produced by GEA is used. The CSE 170 model, constructed with 
Stainless Steel 316, will be used for the large production bioreactor design and 
can be purchased for $1,500,000. It can process throughputs of 3,000-6,000 L/h. 
For the small production bioreactor scheme, a smaller centrifuge (CSC 20) will be 
used, which can process 500-1000L/hr. It will be purchased from GEA for 
$1,200,000. The unit operates in a continuous manner and will process all the 
contents of the production bioreactor immediately following its completion. After 
each batch, the unit will be sterilized with CIP and SIP. The unit operates at 25°C. 
15.2.1.2 Storage Tank 6 (PFD 02/P-56, PFD 04/P-41) 
This storage tank will be used to collect the liquid contents of the 
centrifuge and store it so that batches can be sent for further purification. It will be 
sized to match the size of the production bioreactor.  For the large production 
bioreactor, the storage tank will have a volume of 20,000 L and for the small 
production bioreactor, will be 2,000 L. The maximum working capacity will be 
80%. CIP and SIP will be conducted after each upstream batch is processed. The 
20,000L tank will be purchased for $104,700 and the 2,000L tank for $36,000 
15.2.1.3 Depth Filtration Unit (PFD 02/P-58, PFD 04/P-43) 
Depth filtration is used to further clarify the solution containing the mAbs 
after centrifugation. The unit housing can hold up to 30 filters at once. For the 
large production bioreactor, the three rack housing will be used with 30 filters 
running per cycle. For the small production bioreactor, 10 filters will be used per 
cycle. The unit is purchased from Millipore Sigma and each filter costs $750. The 
housing unit for the 30 filter costs unit costs $67,300 and the housing unit for the 
10 filters costs $29,200. The model is the Millistak+® Multilayer Process Scale 
Pod Filter with X0HC media. This filter media is meant for secondary 
clarification (post-centrifugation) and was chosen based on the specifications of 
the mAb product. The Pod filter system was chosen because it can easily scale 
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depending on the batch size by adding more or less filters. In addition, the filters 
are disposable, which eliminates the need for CIP. It has a maximum operating 
pressure of 3.5 bar at 25 °C and has a recommended feed flow rate of 21 
L/min/m2.  
15.2.1.4 Storage Tank 7 (PFD 02/P-60, PFD 04/P-45) 
This storage tank will collect the filtrate from the depth filtration unit and 
store it until it needs to be passed to the Protein A chromatography column in the 
correct. The unit has a capacity of 80% and is 20,000L for the large production 
bioreactor and 2,000L for the small production bioreactor design. The 20,000L 
tank will be purchased for $104,700 and the 2,000L tank for $35,900. 
15.2.2 Initial Purification 
15.2.2.1 Protein A Chromatography Column (PFD 02/P-62 PFD 04/P-47) 
The Protein A affinity chromatography column is used to further purify 
the filtrate and isolates the product by selectively binding the mAbs. The 
Chromaflow 1000/100-300 column will be purchased from GE Healthcare for 
$250,000. The column is made with 316 Stainless Steel and is packed with 
MabSelect Sure LX resin, which can be be purchased from GE Healthcare Life 
Sciences for $8,000 per liter. The column operates as a packed bed, which will 
have a bed height of 0.25m and diameter of 1 m. The bed volume is 200 L and the 
resin has a binding capacity of 50 g mAb/L. The amount of resin required is 
determined by the binding capacity of the resin. For this process, 9.8 kg mAb are 
purified per Protein A chromatography cycle and this value is determined by 
(50g/L)*(200L bed volume) to get a maximum value of 10 kg mAb. The binding 
capacity of the resin decreases slightly after each run, but it was determined that 
50 g/L is an accurate estimate of the average binding capacity. The resin can be 
used for 150-200 cycles and will be re-purchased every five years. The operating 
linear velocity used will be 250-400 cm/hr, depending on the buffer being used. 
For the large production bioreactor design, four cycles of Protein A 
chromatography are required. For the small production bioreactor, one cycle of 
Protein A chromatography is required for each 2,000 L bioreactor.  
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15.2.2.2 Storage Tank 8 (Virus Inactivation) (PFD 02/P-64, PFD 04/P-49) 
This storage tank will be used to store the output from the Protein A 
column and is the mixing tank where the virus inactivation occurs. The unit will 
have a volume of 5,000L for the large production bioreactor design and 1,000L 
for the small production bioreactor scheme, both with 80% capacity. For 
sterilization, CIP and SIP will be conducted after each batch. The 5,000L tank 
will be purchased for $55,100 and the 1,000L tank for $26,600. 
15.2.2.3 Ultrafiltration/Diafiltration (PFD 02/P-66, PFD 04/P-51) 
This unit is used to concentrate the protein product as well as perform a 
buffer exchange. The system used is a Cogent Process Scale TFF system with a 
100 L tank. The filtration membrane is provided by a Pellicon 2 cassette with a 
2.5 m2 membrane area. The product is retained by the filter, while smaller 
particles are passed through it. Then, it washed away using the new buffer that is 
required to bring the pH of the solution up. Two filters will be needed for each 
batch for the large production bioreactor design and one filter will be needed for 
each batch in the small production bioreactor design. The cost of the system is 
$500,000 while the disposable membrane cassette is $3,600 per unit. 
15.2.2.4 Storage Tank 9 (PFD 02/P-68, PFD 04/P-53) 
This storage tank is used to collect the retentate from the diafiltration 
column.  For the large production bioreactor design, it will be a 2,000L tank and 
for the small production bioreactor design, it will be a 500L tank, both with a 
maximum of 80% capacity. For sterilization, CIP and SIP will be conducted after 
each batch. The 2,000 L tank will be purchased for $35,900 and the 500L tank 
will be purchased for $22,550.  
15.2.2.5 Cation Exchange Chromatography Column (PFD 02/P-70, PFD 
04/P-55) 
The cation exchange chromatography column is used to further purify the 
solution and removed impurities. The Chromaflow 1000 column will be used with 
the Capto S resin and both will be purchased from GE Healthcare Life Sciences. 
The column is made of Stainless Steel 316. The column has a bed height of 0.2m 
and diameter of 1.0m with a volume of 160 L. The resin has a binding capacity of  
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60 g mAb/L and a working linear velocity of up to 600 cm/hr. Similar to the 
Protein A chromatography column, the amount of mAb processed per cycle is 
determined by the volume of the bed and the binding capacity of the resin. For 
this column, 9.4 kg mAb will be processed per cycle which was determined by 60 
g mAb/L*160 L. The column is operated at 25°C, at 1 bar. The cost of the column 
is $250,000 and the resin is $1500 per liter. For the large production bioreactor 
design, four cycles of cation exchange chromatography are required. For the small 
production bioreactor design, one cycle of cation exchange chromatography is 
required for each 2,000 L bioreactor.  
15.2.2.6 Storage Tank 10 (PFD 02/P-72, PFD 04/P-57) 
This storage tank is used to collect the effluent from the cation exchange 
chromatography column. For the large production bioreactor design, it will be a 
2,000L tank and for the small production bioreactor design, it will be a 500L tank, 
both with a maximum of 80% capacity. For sterilization, CIP and SIP will be 
conducted after each batch. The 2,000 L tank will be purchased for $35,900 and 
the 500L tank will be purchased for $22,600.  
15.2.3 Polishing Steps  
15.2.3.1 Virus Filtration Unit (PFD 02/P-74, PFD 04/P-59) 
This unit will remove the virus particles that were previously inactivated. 
For safety requirements, the product must contain less than one virus particle per 
million doses, which translates to 12-18 log10 clearance of endogenous 
retroviruses and 6 log10 clearance for adventitious viruses. This unit is placed at 
towards the end of the purification process because the risk of blockage is the 
lowest. The membrane used will be a Virosart HF Process Module with a 0.8 m2 
area, priced at $10,084 per filter. The Virosart CPV system targets the removal of 
both small non-enveloped viruses (20 nm) and larger enveloped viruses (>50 nm). 
Each membrane is housed in a Sartopore 2 XLG MaxiCap.  Four filtration units 
will be used per batch for the large production bioreactor design and one unit will 
be used for the small production bioreactor design batch. These virus filtration 
units cost $10,000 each. 
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15.2.3.2 Hydrophobic Interaction Chromatography Column (PFD 02/P-76, 
PFD 04/P-61) 
The hydrophobic interaction chromatography column is used as a 
polishing step and to remove any aggregates that may have formed due to the pH 
changes. The Chromaflow 1000 column from GE Healthcare Life Sciences will 
be used with the POROS Benzyl Ultra resin from Thermo Fisher Scientific. The 
column is made of Stainless Steel 316. The column has a bed height of 0.25m and 
diameter of 1.0m, with a volume of 200L. The resin can used with a working 
linear velocity of up to 600 cm/hr. The column is operated at 25°C, with a 
pressure of 1 bar. The cost of the column is $250,000 and the resin is $380 per 
liter. For the large production bioreactor, four cycles of HIC are required. For the 
small production bioreactor, one cycle of HIC is required for each 2,000 L 
bioreactor.  
15.2.3.3 Storage Tank 11 (PFD 02/P-78, PFD 04/P-63) 
This storage tank is used to collect the product flow through from the 
hydrophobic interaction chromatography column. For the large production 
bioreactor design, it will be a 5,000L tank and for the small production bioreactor 
design, it will be a 2,500L tank, both with a maximum of 80% capacity. For 
sterilization, CIP and SIP will be conducted after each batch.The 5,000 L tank 
will be purchased for $55,100 and the 2,500L tank will be purchased for $38,700.  
15.2.3.4 Ultrafiltration / Diafiltration Unit (PFD 02/P-80, PFD 04/P-65) 
Similar to the previous UF/DF operation, the Cogent Process Scale TFF 
System will be used to concentrate the product to its final titer and ensure sterility 
of the buffer. As before, Pellicon 2 cassettes will provide 2.5 m2 of membrane 
area.   
15.2.3.5 Sterile Filtration (PFD 02/P-82, PFD 04/P-67) 
Sterile filtration is used as a final step and the product is filtered directly 
into the storage containers. This is an important step to ensure sterility before the 
product is frozen and stored. The filters have pore sizes of 0.2 µm and are 
Sartopore 2 filters from Sartorius. They can be purchased for $650 per filter.  
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15.2.3.6 Final Storage (PFD 02/P-84, PFD 04/P-69) 
The final product from the purification process will be stored in 10L 
Nalgene Biotainers. These biotainers are polycarbonate and will be stored at -
80°C. For the large production bioreactor design, 70 bottles will be used and 42 
bottles will be used for the small production bioreactor design. The containers 
will be purchased for $100 from Thermo Fisher Scientific.  
15.3 Additional Units 
15.3.1 Pumps and Tubing 
Peristaltic or diaphragm pumps will be used to transfer contents between each unit 
in the upstream operations. The peristaltic pump model that will be used in upstream 
processes is the 800 series Watson-Marlow Bredel, specifically the 825 series hygienic 
pump model. This model is made for shear sensitive products and has CIP and SIP in-line 
capability. It has a maximum operable flow rate of 33 L/min, maximum pressure of 3.5 
bar, and maximum motor speed of 101 rpm. Each pump costs approximately $3,000. The 
two diaphragm pump models that will be used are quaternary diaphragm pumps QF150S 
and QF1200S from Quattroflow for bio-pharma application.  These pumps have four 
possible flow directions, operate in the laminar flow regime with minimal shear, with 
maximum motor speeds of 50 Hz. The 150S model will be operated at 4 bar at varying 
flow rates between its minimum flow rate of 0.017 L/min and maximum flow rate of 3 
L/min. The 1200S 5° Eccentric Shaft model that will be used will be operated at 3 bar at 
varying flow rates between its minimum flow rate of 0.17 L/min and its maximum flow 
rate of 20 L/min. Both the 150S and 1200S pump models are CIP and SIP sterilizable and 
cost $3,000 and $4,000, respectively. 
In the downstream processes, only peristaltic pumps will be used. The 800 series 
Watson-Marlow Pump used will be the 840 model. The pump has a maximum flow rate 
of 8,140 L/hr, maximum pressure of 3.5 bar, and maximum motor speed of 102 rpm. 
Each pump costs approximately $3,000.  
The tubing used between pump-heads for both upstream and downstream 
operations is Cole-Parmer MasterFlex BioPharm Plus Tubing. The tubing is made of 
platinum silicone, which provides a smooth, sterile, biocompatible surface for sensitive 
biopharmaceutical applications. It can be autoclaved and meets FDA standards. It can 
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also withstand temperatures up to 232°C, which exceeds any temperature used in this 
process design. The cost per foot of tubing is $49.00. 
15.3.2 Heating and Cooling 
All upstream units either containing cells or transferring fluids to cellular 
environments will be heated to 36.5°C using various methods. All WAVE bioreactor 
systems will be heated using electric heating with temperature sensors and control of the 
trays that hold the cell bags. The Xcellerex XDR bioreactor system in addition to the 
custom 20,000L stainless steel bioreactor will use a controlled heating jacket flowing 
heated sterile water at around 60°C. For all media transfer steps, the upstream process 
requires heating to 36.5°C before entering a bioreactor. Likewise, all cell transfer steps 
require that the temperature be maintained between 36 and 37°C during transfer to 
prevent cell death or slowed product formation. For both of these operations, the 
platinum silicone tubing described above in Section 15.3.1 will be jacketed with carbon-
steel piping. 10% propylene glycol in U.S. Pharmacopeia (USP) grade water heated to 
60°C will flow through the jacket primarily to heat culture media as it is transferred from 
storage tanks at 4°C to bioreactors at 36.5°C. Lastly, all media storage tanks will have a 
cooling jacket to cool media to 4°C. Chilled water will flow through the cooling jacket 
Water-glycol solutions will be heated using a Chromalox water-glycol heater 
engineered from welded steel with copper sheath heating elements in itst electric heating 
core. The heating unit operates at a maximum temperature of 150°C and comes with 
electronic digital temperature process control. Water heaters (purchased from PVI 
Industries, LLC), cooling water units (purchased from Cole-Parmer), and water-glycol 
heaters (purchased from Chromalox) will already be in the plant and will be included in 
the annual expenses.  
15.3.3 Cell Storage Tank 
The engineered CHO cells will be stored in a cryogenic storage tank to maintain 
viability until use. The cells come in 1 mL cryogenic vials that can be stored in Thermo 
Scientific Nalgene cryogenic storage boxes, which can withstand temperatures below -
180°C without deformation. Each box fits one hundred 1mL vials and fits into 
Thermolyne stainless steel, Locator 8 Cryogenic Storage Vessel. This system is built to 
hold liquid nitrogen with vacuum insulation, uniform temperature control, and a liquid 
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level monitor. Liquid nitrogen levels must be monitored precisely and replaced when the 
levels get too low to maintain the cells in a cryogenic state. The tank holds 60 Nalgene 
boxes in 90L of liquid nitrogen, which evaporates at 0.4 L/day. The costs of the storage 
boxes, storage vessel, and liquid nitrogen supply will be $1,700, $2,700, and 0.05$ per 
gallon respectively 
15.3.4 Biosafety Cabinet 
A biosafety cabinet will be required to provide a sterile environment to handle 
and transfer the vial of cells into the bag bioreactors in the inoculum prep section. The 
biosafety cabinet is manufactured by Thermo Scientific. The biosafety cabinet is part of 
the existing plant and will be included in annual expenses. 
15.3.5 Product Refrigeration Unit 
Until the final mAb product is shipped out of the plant for packaging and 
commercial sale, it must be refrigerated at -80°C. The product refrigeration units will be 
purchased from Thermo Scientific, sized at 33.5 cubic feet, which can hold about 900L. 
The units have a temperature range of -86 to -50°C. Three refrigeration units will be 
purchased for the Large Production Bioreactor Scheme, while two units will be 
purchased for the Small Production Bioreactor Scheme. The refrigerators will cost 
$15,100. 
15.3.6 Biowaste and Neutralization Holding Tank 
All biowaste produced in the process will need to be treated before disposal. All 
waste potentially containing live culture is sent to the biowaste tank. All other waste, 
such as used buffers, is sent directly to a neutralization tank. The neutralization tank will 
need to hold 56,700 L for the large production bioreactor scheme so four 20,000 L tanks 
will be used and it will need to hold 13,290 L for the small production bioreactor scheme 
so two 20,000L tanks will be used.  
In addition, there is waste from the disposable equipment such as filters and 
bioreactor bags that will be handled by a waste management company. The Land 
Disposal Restrictions (LDR) regulations require the treatment of all hazardous 
pharmaceutical waste, most commonly by hazardous waste incineration, before it can be 
discarded in a hazardous waste landfill. 30 
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15.3.7 Water for Injection Still 
The WFI still is used to purify water used throughout process that needs to meet 
FDA guidelines. WFI is used to ensure sterility of both the product and the process 
equipment to help eliminate cross-contamination issues. The WFI still will already be in 
the plant (purchased from Telstar) and the costs will be included in the annual expenses. 
15.3.8 Sterile Air Compressor and Filtration 
Compressed, sterile air is required for all upstream bioreaction processes, since 
sparged air is the source of oxygen for the cells. An air compressor containing a medical-
grade filtration unit will be purchased from Greeloy Medical. The unit requires 3200W, 
with a capacity of 620 L/min at 0 bar. The maximum pressure of the unit is 8 bar and the 
tank can process up to 120 L of air. The internal air filter only needs to be replaced once 
every year, but will be replaced every six months to ensure continued sterility. 10 units 
will be purchased for the Large Production Bioreactor Scheme, while 6 units will be 
purchased for the Small Production Bioreactor Scheme. These costs will be included in 
the annual expenses.  
Further, sterile compressed air is also filtered just before entering each of the 
bioreactors as a quality control step. The air filters that will be inserted into the air inlet 
ports will be the Opticap® XL Disposable Capsule Filters with 0.22 µm Hydrophobic 
Durapore® Membrane purchased from Millipore Sigma. The same filters will be used to 
filter all of the vented gases from the bioreactors.  The filters have a filtration area of 0.69 
m2are, are constructed from polyvinylidene fluoride (PVDF), and can be sterilized by 
autoclave at 126°C for 30 minutes. The filters will be replaced after each batch and cost 
about 400$ per filter.  
15.3.9 Clean Steam Generator 
The clean steam generator uses WFI to produce steam for the SIP procedures. The 
clean steam generator will already be in the plant, purchased from Spirax Sarco, and the 
costs will be included in the annual expenses. It has a maximum output of 3800 kg/hour 
and a maximum steam pressure of 12 bar.  
15.3.10 CIP Skids 
 Clean-in-place (CIP) technique is used to clean equipment before the next use. 
The CIP Skid used in this process will be portable with a capacity to clean process tanks 
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up to 3 meters in diameter. The skid will include an option for steam heating to heat the 
cleaning solution to 85°C. The cost of CIP skids will be included in the annual expenses.  
15.3.11 Buffer Transfer Containers 
Buffer transfer containers are used to transfer buffer to the chromatography 
columns and diafiltration units. These containers will be used to mix the buffers before 
being used and it will be filtered before being used. CIP and SIP operations will be used 
to clean these containers after each batch. For the large production bioreactor design, 
5,000L tanks will be used and for the small production bioreactor design, 1,000L tanks 
will be used.  
15.3.12 Filter Integrity Test 
A filter integrity test will be purchased from Millipore. This will be used to ensure 
that all filters are functional and do not have any tears or blockages prior to each batch. 
This is important in minimizing loss from manufacturing error and will be included in the 
annual expenses.  
15.3.13 Water Treatment Package 
Although WFI will be used for most of the water requirements in the process, 
U.S. Pharmacopeia (USP) grade water is needed for temperature control needs in the 
bioreactor process. This water will not be in contact with the cell culture, but it will 
inserted into the stainless steel bioreactor jackets for heating and cooling purposes. The 
cost for the water treatment package (MECO’s MASTERpak™ LT) is included in the 
annual expenses.  
15.3.14 Biowaste Inactivation System 
The biowaste inactivation system is needed to kill any live cells remaining in the 
bio-waste tank. This includes liquid volumes from all CIP and SIP washes from the main 
bioreactors and primary recovery. The biowaste inactivation system is part of the existing 
plant.  
15.3.15 Waste Neutralization System 
The waste neutralization system is used to adjust the pH of liquid waste, which 
contains no cells, to 7.0. The waste can be disposed directly into the sewer line. The 
waste neutralization system is part of the existing plant and will be included in the annual 
expenses.   
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15.3.16 Quality Control Lab 
A quality control lab will be used to ensure the manufactured product meets the 
quality specifications and FDA regulations. Various samples will be taken throughout the 
process, including all upstream bioreactors, and downstream virus inactivation and virus 
filtration units. This lab is part of the existing plant and will be included in the annual 
expenses 
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16. Specification Sheets 
Blending Tank (PFD 01/P-1) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
 
Characteristics 
 
 
 
 
Operation Conditions 
 
 
 
 
Purchase Cost 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This blending tank will mix cell culture media powder with 
WFI.  
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Dry Media  1.19   0 
Water   49.7   0 
NaOH   0.065   0 
NaHCO3  0.140   0 
Wet Media  0   50.0 
 
 
Volume:    75 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
Temperature:    25C 
Pressure:   1 bar 
   
 
Blending Tank:  $12,500 
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Dead-End Filter (PFD 01/P-3) 
Description and Function  
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
Characteristics 
 
 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The 0.2 µm dead-end filter is used to remove larger 
contaminants from blended culture media. The filter capsules 
and housing are disposable and ready-to-use. 
 
 
Millipore Sigma 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Wet Media  50.0   50.0 
 
 
Model:    Opticap XLT10, Sterile 
Filtration Area:  0.57 m2 
Throughput:   2,000 L/m2/h 
Max. Differential Pressure:  6.9 bar at 25C  
Sterilization:    Disposable 
 
 
 
Temperature:    25C 
Pressure:   0.5 bar 
 
Filter Membrane & Housing:  $400
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Storage Tank (PFD 01/P-21) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
Characteristics 
 
 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
 
 
 
The storage tank holds blended and filtered cell culture media 
at 4C until further use. 
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch)  
Wet Media   50.0   0.00 
 
 
Volume:    75 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
 
Temperature:    4C 
Pressure:    2 bar 
 
 
Storage Tank:    $12,500 
70 
 
250 mL Shaker Flask (PFD 01/P-7) 
Description and Function  
 
 
 
 
 
Vendor 
 
 
Operation 
 
Materials Handled  
 
 
 
 
Characteristics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Operation Conditions 
 
 
 
 
 
Purchase Cost 
 
 
The 250 mL Shaker Flask is used for cell growth in first 
inoculum preparation step after cryogenic recovery of the 
CHO cells. The Shaker Flask is placed on a low speed orbital 
shaker and the combined apparatus is incubated in a CO2 
Incubator. 
   
Corning (Flask & Orbital Shaker) 
Thermo Fisher Scientific (Incubator) 
 
Batch 
 
    Input (kg/batch) Output (kg/batch)  
Cells:   0.00000471  0.0000166 
Wet Media   0.030   0.125 
Product  0.00   0.00 
 
Model:      Corning 4444-250 
Flask Capacity:    250 mL 
Working Capacity:    80% 
Material:     Pyrex 
Packaging:      6 pc 
Sterilization:     Autoclave, 121C, 60 minutes 
 
Model:      Corning LSE 6780-FP 
Speed:      60 rpm 
Frequency Range:    50/60 Hz 
Tray Size:        30 cm x 30 cm 
Base Size:     25.5 cm x 32.0 cm x 16.0 cm 
 
Model:      Thermo Scientific Forma Series 3 
Interior Material:    Stainless Steel 304 
Dimensions (LxWxH) :  54.1 cm x 68.1 cm x 50.8 cm 
 
Temperature:      36.5C 
Pressure:      1 bar 
pH:      7.1 
dO2:      40% 
Duration:     3 days 
 
Shaker Flask:     $160  
Orbital Shaker:    $900 
Incubator:     $7,900 
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25 L Single-Use Bioreactor (PFD 01/P-9)
Description and Function  
 
 
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
Characteristics 
 
 
 
 
 
 
 
 
Operation Conditions 
 
 
 
 
 
 
 
Purchase Cost 
 
 
 
 
 
 
 
 
 
 
The 25L WAVE Bioreactor is used for cell growth in second 
inoculum preparation step. The single-use system is equipped 
with a rocker, gas mixers, pumps, and cell bags. The bags are 
disposable and pre-sterilized. The system also offers high 
level sensors and automated control for temperature, liquid 
transfer, dissolved oxygen, and pH.  
   
GE Healthcare and Life Sciences 
 
Batch 
 
    Input (kg/batch) Output (kg/batch)  
Cells   0.0000166  0.0000586 
Wet Media   0.125   12.5 
Product  0.00   0.00 
 
 
Model:    ReadyToProcess WAVE 25  
Rocker Dimensions:   404 mm x 205 mm x 560 mm 
Tray 50 Dimensions:  800 mm x 70 mm x 610 mm 
Lid 50 Dimensions:  800 mm x 260 mm x 610 mm 
CBCU Dimensions:  276 mm x 115 mm x 280 mm 
Frequency:    50/60 Hz 
Bag Size:    22 L 
Sterilization:   Plastic, Disposable 
 
Temperature:    36.5C 
Pressure:    2 bar 
pH:    7.1 
dO2:    40% 
Agitation Speed:  15 rpm 
Rocking Angle:  7 
Duration:   3 days 
 
Bioreactor with control: $60,000 
CBCU gas mixer:  $1,000 
Disposable Cellbag:  $500 
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Diaphragm Pumps (PFD 01/P-16,22,[38/39])
Description and Function  
 
 
 
 
 
Vendor 
 
Operation 
 
 
Characteristics 
 
 
 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
 
The pumps are used to transfer media and cells for upstream 
bioreaction steps. The pumps are sterile and designed for 
shear-sensitive biopharmaceutical applications. The 
diaphragm pumps have 4 inlet and 4 outlets per pump 
   
 
QuattroFlow 
 
Batch 
 
 
Model:    150 S 
Pumphead Material:   Stainless Steel 316 L 
Minimum Flow Rate:  0.01 L/min 
Maximum Flow Rate:  3.00 L/min 
Maximum Pressure:  6 bar 
Sterilization:   CIP, SIP 
 
 
Pressure:    4 bar 
Flow Rate:   Variable (0.01-33 L/min) 
 
 
Pump:    $3,000 
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Diaphragm Pumps (PFD 01/P-28,[30/31])
Description and Function  
 
 
 
 
 
Vendor 
 
Operation 
 
 
Characteristics 
 
 
 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
 
 
The pumps are used to transfer media and cells for upstream 
bioreaction steps. The pumps are sterile and designed for 
shear-sensitive biopharmaceutical applications. The 
diaphragm pumps have 4 inlet and 4 outlets per pump 
   
 
QuattroFlow 
 
Batch 
 
 
Model:    1200 S 
Pumphead Material:   Stainless Steel 316 L 
Minimum Flow Rate:  0.33 L/min 
Maximum Flow Rate:  20 L/min 
Maximum Pressure:  6 bar 
Sterilization:   CIP, SIP 
 
 
Pressure:    3 bar 
Flow Rate:   Variable (0.33-20 L/min) 
 
 
Pump:    $4,000 
  
74 
 
100 L Single-Use Bioreactor (PFD 01/P-29) 
Description and Function  
 
 
 
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
Characteristics 
 
 
 
 
Operation Conditions 
 
 
 
 
 
 
 
 
Purchase Cost 
 
 
 
The 100L WAVE Bioreactor is used for cell growth in cell 
seeding. The single-use system is equipped with a rocker base 
unit with internal gas pumps and cell bags. The bags are 
disposable and pre-sterilized. The system also offers high 
level sensors and automated control for temperature, liquid 
transfer, dissolved oxygen, and pH.  
 
 
GE Healthcare and Life Sciences 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0.0000586  0.000308 
Wet Media   12.5   50.0 
Product  0.00   0.00 
 
 
Model:    WAVE Bioreactor 200 
Dimensions:   1.85 m x 1.10 m x 1.12 m  
Frequency:    50/60 Hz 
Bag Size:   100 L 
Sterilization:   Plastic, Disposable 
 
Temperature:            36.5C 
Pressure:            2 bar 
pH:            7.1 
dO2:        40% 
Agitation Speed:  25 rpm 
Rocking Angle:  8 
Duration:           3 days 
 
Bioreactor w control:  $90,000 
Disposable Cellbag:   $800 
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Blending Tank (PFD 01/P-11) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost   
This blending tank will mix cell culture media powder with 
WFI. 
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Dry Media  67.1   0.00 
Water   2980   0.00 
NaOH   3.90   0.00 
NaHCO3  8.40   0.00 
Wet Media  0.00   3000 
 
 
Volume:    4,000 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
Temperature:   25C 
Pressure:   1 bar 
 
Blending Tank:   $51,000 
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Blending Tank (PFD 01/P-17)
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This blending tank will mix feed supplement CellBoost 7a 
media powder with WFI. 
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Dry Media  978   0.00 
Water   5370   0.00 
NaOH   7.54   0.00 
Wet Media  0.00   5400 
 
Volume:    7,000 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
Temperature:    25C 
Pressure:   1 bar 
 
 
Blending Tank:  $63,200
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Blending Tank (PFD 01/P-23) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
This blending tank will mix feed supplement CellBoost 7b 
media powder with WFI. 
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Dry Media  51.1   0.00 
Water   537   0.00 
NaOH   0.754   0.00 
Wet Media  0.00   540 
 
Volume:    700 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
Temperature:   25C 
Pressure:   1 bar 
 
Blending Tank:  $24,300
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Dead-End Filter (PFD 01/P-13)
Description and Function  
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
The 0.2 µm dead-end filter is used to remove larger 
contaminants from blended culture media. The filter capsules 
and housing are disposable and ready-to-use. 
 
 
Millipore Sigma 
 
Batch 
 
    Input (kg/batch) Output (kg/batch)  
Wet Media  3000   3000 
 
 
Model:    Opticap XLT10, Sterile 
Filtration Area:  0.57 m2 
Throughput:   2,000 L/m2/h 
Max. Differential Pressure:  6.9 bar at 25C  
Sterilization:    Disposable 
 
Temperature:    25C 
Pressure:    0.5 bar 
 
Filter Membrane & Housing:  $400
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Dead-End Filter (PFD 01/P-19) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
The 0.2 µm dead-end filter is used to remove larger 
contaminants from blended feed supplement 7a media. The 
filter capsules and housing are disposable and ready-to-use. 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Wet Media  5400   5400 
 
 
 
Model:    Opticap XLT10, Sterile 
Filtration Area:  0.57 m2 
Throughput:   2,000 L/m2/h 
Max. Differential Pressure:  6.9 bar at 25C  
Sterilization:    Disposable 
 
Temperature:   25C 
Pressure:   0.5 bar 
 
Filter Membrane & Housing:  $400
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Dead-End Filer (PFD 01/P-25)
Description and Function  
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
Characteristics 
 
 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
The 0.2 µm dead-end filter is used to remove larger 
contaminants from blended culture media. The filter capsules 
and housing are disposable and ready-to-use. 
 
Millipore Sigma 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Wet Media  540   540 
 
 
Model:    Opticap XLT10, Sterile 
Filtration Area:  0.57 m2 
Throughput:   2,000 L/m2/h 
Max. Differential Pressure:  6.9 bar at 25C  
Sterilization:    Disposable 
 
 
Temperature:    25C 
Pressure:   0.5 bar 
 
 
Filter Membrane & Housing:  $400
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Storage Tank (PFD 01/P-15) 
Description and Function  
 
 
Operation 
 
Materials Handled  
 
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
 
 
 
The storage tank holds blended and filtered cell culture media 
at 4C until further use. 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Wet Media  3000   0.00 
 
 
Volume:    4,000 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
 
Temperature:    4C 
Pressure:    2 bar 
 
Storage Tank:    $51,000 
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Storage Tank (PFD 01/P-21)
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The storage tank holds blended and filtered cell culture media 
at 4C until further use. 
   
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Wet Media   200   0.00 
 
 
Volume:    250 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
Temperature:    4C 
Pressure:    2 bar 
 
Storage Tank:    $18,000 
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Storage Tank (PFD 01/P-27) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
 
 
The storage tank holds blended and filtered cell culture media 
at 4C until further use. 
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Wet Media   20.0   0.00 
 
 
Volume:    25 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
Temperature:    4C 
Pressure:    2 bar 
 
Storage Tank:    $9,200 
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500 L Single-Use Seed Bioreactors (PFD 01/P-32,33)
Description and Function  
 
 
 
 
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
 
 
 
 
 
Purchase Cost 
 
 
The 500L WAVE Bioreactor is used for cell growth in cell 
seeding. The single-use system is equipped with a rocker base 
unit with internal gas pumps and cell bags. The bags are 
disposable and pre-sterilized. The system also offers high 
level sensors and automated control for temperature, liquid 
transfer, dissolved oxygen, and pH. Two of these bioreactors 
operate in parallel.  
 
 
GE Healthcare and Life Sciences 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0.000308  0.000813 
Wet Media   25.0   250 
Product  0.00   0.00 
 
 
Model:  WAVE Bioractor 500/1000 system 
Dimensions: 2.26 m x 1.24 m x 1.60 m  
Frequency:  50/60 Hz 
Bag Size: 500 L 
Sterilization: Plastic, Disposable 
 
Temperature:    36.5C 
Pressure:    2 bar 
pH:    7.1 
dO2:    40% 
Agitation Speed:  15 rpm 
Rocking Angle:  4 
Duration:   3 days 
 
Bioreactor with control: $150,000 
Disposable Cellbag:  $1,000 
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2,000 L Single-Use Seed Bioreactors (PFD 01/P-36,37)
Description and Function  
 
 
 
 
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
Characteristics 
 
 
 
 
 
 
Operation Conditions 
 
 
 
 
 
 
Purchase Cost 
 
 
 
The 2000L Xcellerex XDR Bioreactor is used for cell growth 
in cell seeding. The single-use system is equipped with a 
jacketed bioreactor vessel, gas mixing cabinet, control 
console, and cell bags. The bags are disposable and pre-
sterilized. The system also offers high level sensors and 
automated control for temperature, liquid transfer, dissolved 
oxygen, and pH. Two of these bioreactors operate in parallel.  
 
   
GE Healthcare and Life Sciences 
 
Batch 
 
    Input (kg/batch) Output (kg/batch)Cells
   0.00429  0.000813 
Wet Media   250   1600 
Product  0.00   0.00 
 
 
Model:    Xcellerex XDR-2000 system 
Height/Diameter Ratio: 1.5/1 
Impeller Type, Angle:  4 blades, 40 pitch 
Impeller/Bag Diameter Ratio: 0.34 
Bag Size:   2000 L 
Sterilization:   Plastic, Disposable 
 
Temperature:    36.5C 
Pressure:    2 bar 
pH:    7.1 
dO2:    40% 
Agitation Speed:  110 rpm 
Duration:   3 days 
 
Bioreactor with control: $250,000 
Disposable Cellbag:  $2,500 
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Blending Tank (PFD 01/P-46) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
This blending tank will mix cell culture media powder with 
WFI. 
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Dry Media  107   0.00 
Water   4470   0.00 
NaOH   5.85   0.00 
NaHCO3  12.6   0.00 
Wet Media  0.00   4500 
 
 
Volume:    6,000 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
Temperature:   25C 
Pressure:   1 bar 
 
Blending Tank:   $59,400
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Dead-End Filter (PFD 01/P-48)
Description and Function  
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
Characteristics 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
The 0.2 µm dead-end filter is used to remove larger 
contaminants from blended culture media. The filter capsules 
and housing are disposable and ready-to-use. 
 
Millipore Sigma 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Wet Media  4500   4500 
 
 
Model:    Opticap XLT10, Sterile 
Filtration Area:  0.57 m2 
Throughput:   2,000 L/m2/h 
Max. Differential Pressure:  6.9 bar at 25C  
Sterilization:    Disposable 
 
 
Temperature:    25C 
Pressure:   0.5 bar 
 
 
Filter Membrane & Housing:  $400
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Storage Tank (PFD 01/P-50)
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
 
The storage tank holds blended and filtered cell culture media 
at 4C until further use. 
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Wet Media   4500   0.00 
 
 
Volume:    6,000 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
Temperature:    4C 
Pressure:    2 bar 
 
Storage Tank:    $59,400 
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Storage Tank (PFD 01/P-41) 
Description and Function  
 
 
Operation 
 
Materials Handled  
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
 
The storage tank holds blended and filtered cell culture media 
at 4C until further use. 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Wet Media   5200   0.00 
 
 
Volume:    7,500 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
Temperature:    4C 
Pressure:    2 bar 
 
Storage Tank:    $69,400 
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Storage Tank (PFD 01/P-44) 
Description and Function  
 
 
Operation 
 
Materials Handled  
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
The storage tank holds blended and filtered cell culture media 
at 4C until further use. 
 
Batch 
 
Input (kg/batch) Output (kg/batch) 
Wet Media   520   0.00 
 
 
Volume:    750 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
Temperature:    4C 
Pressure:    2 bar 
 
Storage Tank:    $25,500 
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20,000 L Stainless Steel Production Bioreactor (PFD 01/P-16) 
Description and Function  
 
 
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
Characteristics 
 
 
 
 
 
 
 
 
 
 
Operation Conditions 
 
 
 
 
 
 
 
 
Purchase Cost 
 
 
 
 
The 20,000L Bioreactor is used for cell growth to peak 
density followed by maximum product formation. The system 
is equipped with a heating jacket, mixing and sparging units, 
and PID control for temperature, liquid transfer, dissolved 
oxygen, dissolved carbon dioxide and pH. 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0.00429  63.6 
Wet Media   3200   13500 
Product  0.00   40.1 
 
 
Volume:     20,000 L 
Working Capacity:    80% 
Material:     Stainless Steel 316 
Height/Diameter Ratio:  2/1 
Impeller/Tank Diameter Ratio: 1/3 
Blade Height/Impeller Diameter:  1/5 
Blade Width/Impeller Diameter: 1/4 
Number of Blades, Pitch:  4, 40 
Sterilization:     CIP/SIP 
 
 
Temperature:    36.5C 
Pressure:    2 bar 
pH:    7.1 
dO2:    40% 
Agitation Power:   0.055 W/kg 
Air Sparging Rate:  0.0194 vvm 
Duration:   19 days 
 
 
Total Bioreactor:   $1,500,000  
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Peristaltic Pumps (PFD 01/P-2,4,6,8,10,12,14,18,20,24,26,34,35,40,42,43,45,47,49,50,53)
Description and Function  
 
 
 
Vendor 
 
Operation 
 
 
 
Characteristics 
 
 
 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
 
The pumps are used to transfer media and cells for upstream 
bioreaction steps. The pumps are sterile and designed for 
shear-sensitive biopharmaceutical applications.  
   
 
Watson-Marlow 
 
Batch 
 
Model:    825 series 
Pumphead Material:   Aluminum alloy 
Support and Frame Material: Stainless steel 304 
Maximum Flow Rate:  33 L/min 
Maximum Pressure:  3.5 bar 
Sterilization:   CIP, SIP 
 
 
Pressure:    3 bar 
Flow Rate:   Variable (0.1-33 L/min) 
 
 
 
Pump:    $3,000 
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Centrifuge (PFD 02/P-54) 
Description and Function  
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This centrifuge will separate the cells from the cell culture 
liquid that has the solubilized monoclonal antibody product.  
 
 
GEA 
 
Continuous 
 
    Input (kg/batch) Output (kg/batch) 
Cells   75.4   0 
Media    0   0 
Water    13500   13500 
Product  40.1   38.5 
 
 
 
Model:   CSE 170 
Centrifuge Type:  Disc Stack Centrifuge 
Material:   Stainless Steel 316 
Capacity Range:  3000-6000 L/h 
Sterilization:   CIP/SIP 
 
Temperature:   25C 
Throughput:   3375 L/h 
 
Centrifuge:  $1,500,000 
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Storage Tank 6 (PFD 02/P-56) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
Characteristics 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
This storage tank will collect the liquid product from the 
centrifuge.  
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    13500   13500 
Product  38.5   38.5 
 
Material:   Stainless Steel 316 L  
Volume:   20,000L   
Sterilization:   CIP/SIP 
 
Temperature:   25C 
Pressure:   1 bar 
 
Centrifuge:  $104,700 
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Depth Microfiltration Unit (PFD02/P-58)
Description and Function  
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The depth filter is used to remove larger particles not removed 
from centrifugation. It has two distinct layers with different 
pore sizes (0.1-1m) to avoid plugging and increase filter 
capacity.   
 
Millipore Sigma 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    13500   13500 
Product  38.5   37.3 
 
 
Model:    Millistak Pod Filter 
Filter:    X0HC  
Protein Throughput:  21 L/min/m2 
Max. Differential Pressure:  2.1 bar 
Max. Operating Pressure:  3.5 bar 
Filter effective area:  1.1 m2 
Unit Sterilization:   SIP  
Filter Sterilization:   Disposable 
 
Temperature:   25C 
Operating Pressure: 1 bar 
 
Filter Housing:  $67,300 
Filter:    $750 each
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Storage Tank 7 (PFD 02/P-60) 
Description and Function  
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
Characteristics 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
This storage tank will collect the filtrate liquid from the depth 
filtration unit.   
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    13500   13500 
Product  37.3   37.3 
 
Material:   Stainless Steel 316 
Volume:   20,000L   
Sterilization:   CIP/SIP 
 
Temperature:   25C 
Pressure:   1 bar 
 
Tank:   $104,700
97 
 
Protein A Chromatography Column (PFD 02/P-62)
Description and Function  
 
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
The Protein A Chromatography column uses a resin that 
selectively binds the monoclonal antibody product. This step 
is the first isolation step in the purification process and is 
useful in eliminating host cell proteins, DNA, cell culture 
media components.  
 
GE Healthcare Life Sciences  
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
  
Cells    0   0 
Media     0   0 
Centrifuge effluent   13500      0 
Equilibration buffer  6800   0  
Wash buffer   800   0 
Elution buffer   3200   3200 
Regeneration buffer   2400   0 
CIP buffer    3200   0 
Protein A waste  0   26700 
Product   37.3   34.4 
 
 
Model:    Chromaflow 1000/100-300 
Column Diameter:   1.0 m 
Bed Height:    0.25 m 
Material of Construction:  Stainless Steel 316 L 
Bed Volume:    200 L 
Resin:     MabSelect Sure LX 
Binding Capacity:   50 g mAB/L resin 
Working Linear Velocity:  250-400 cm/hr 
pH Stability:   3-12 
Sterilization:    CIP/SIP 
 
 
Temperature:    25C 
Pressure:    1 bar 
 
Column:    $250,000 
Resin:    $8,000/liter
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Storage Tank 8 (PFD 02/P-64) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
Characteristics 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
This storage tank will collect the eluent from the Protein A 
Chromatography column.   
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    3200   3200 
Product  34.4   34.4 
 
Material:   Stainless Steel 316  
Volume:   5,000L  
Sterilization:   CIP/SIP 
 
Temperature:   25C 
Pressure:   1 bar 
 
Tank:   $55,100 
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Ultrafiltration/Diafiltration Unit (PFD 02/P-66)
Description and Function  
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
 
 
Operation Conditions 
 
Purchase Cost 
 
 
This unit is used for buffer exchange to raise the pH of the 
solution and concentrate it by 5 times. It is done using 
tangential flow filtration.  
 
 
Millipore Sigma 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    3200   640 
Product  34.4   33.3 
 
 
Model:    Cogent® TFF System  
Protein Throughput:  21 L/min/m2 
Max. Operating Pressure:  6.8 bar 
Filter effective area:  1.1 m2 
Unit Sterilization:   SIP  
Filter Sterilization:   Disposable 
 
Temperature:   25C 
 
Unit:    $500,000 
Filter:    $3600/filter
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Storage Tank 9 (PFD 02/P-68) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
Characteristics 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
This storage tank will collect the retentate from the 
diafiltration operation.   
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    640   640 
Product  33.3   33.3 
 
Material:   Stainless Steel 316  
Volume:   2,000L  
Sterilization:   CIP/SIP 
 
Temperature:   25C 
Pressure:   1 bar 
 
Tank:   $35,900 
 
101 
 
Cation Exchange Chromatography Column (PFD 02/P-70)
Description and Function  
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
 
 
 
 
The cation exchange chromatography column binds positively 
charged proteins and is used eliminate DNA, some host cell 
proteins, and leached Protein A.  
   
 
GE Healthcare Life Sciences 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
  
Cells    0   0 
Media     0   0 
Diafiltration effluent   640   0 
Equilibration buffer  3200   0 
Wash buffer   3200   0  
Elution buffer   1290   1290 
Regeneration buffer   1280   0 
CIP buffer    1920   0 
Cation exchange waste 0   10240  
Product   33.3   30.7 
 
 
Model:    Chromaflow 1000/100-300 
Column Diameter:   1.0 m 
Bed Height:    0.2 m 
Material of Construction:  Stainless Steel 316 L 
Bed Volume:    160 L 
Resin:     Capto S 
Binding Capacity:   60 g mAB/L resin 
Working Linear Velocity:  200-600 cm/hr 
Sterilization:    CIP/SIP 
 
 
Temperature:    25C 
Pressure:    1 bar 
 
Filter Housing:   $250,000 
Filter:     $1,500/L 
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Storage Tank 10 (PFD 02/P-72) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
Characteristics 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
This storage tank will collect the eluent from the Cation 
Exchange Chromatography.  
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    1290   1290 
Product  30.7   30.7 
 
Material:   Stainless Steel 316  
Volume:   2,000L   
Sterilization:   CIP/SIP 
 
Temperature:   25C 
Pressure:   1 bar 
 
Tank:   $35,900 
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Virus Filtration Unit (PFD 02/P-74)
Description and Function  
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
Characteristics 
 
 
 
 
Operation Conditions 
 
Purchase Cost 
 
 
The virus filtration unit is used to remove viruses using size 
based membrane separation.  
 
 
Sartorius  
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    1290   1290 
Product  30.7   29.1 
 
 
Model:   Virosart® CPV  
Filter effective area: 1.8 m2 
Sterilization:   SIP  
Membrane:   Disposable 
 
Temperature:   25C 
 
Filter:    $10,100/filter 
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Hydrophobic Interaction Chromatography Column (PFD 02/P-76)
Description and Function  
 
 
 
 
Vendor 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
 
 
The hydrophobic interaction chromatography column is run in 
flow through mode and removes product and process-related 
impurities, such as aggregates. 
   
 
Column: GE Healthcare and Life Sciences  
Resin: Thermo Fisher Scientific 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
  
Cells    0   0 
Media     0   0 
Filtrate     1290   1290 
Equilibration buffer  4000   0 
Wash buffer   2210   2210 
Elution buffer   4000   0 
Regeneration buffer   2400   0 
CIP buffer    4000   0 
Cation exchange waste 0   14400  
Product   29.1   26.8 
 
 
Model:    Chromaflow 1000/100-300 
Column Diameter:   1.0 m 
Bed Height:    0.25 m 
Material of Construction:  Stainless Steel 316 L 
Bed Volume:    200 L 
Resin:     POROS Benzyl Ultra 
Working Linear Velocity:  200-500 cm/hr 
Sterilization:    CIP/SIP 
 
 
Temperature:    25C 
Pressure:    1 bar 
 
Column:    $250,000 
Resin:     $3,800/10 L 
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Storage Tank 11 (PFD 02/P-78) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
 
Characteristics 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
This storage tank will collect the product stream from the 
hydrophobic interaction chromatography.   
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    3500   3500 
Product  26.8   26.8 
 
 
 
Material:   Stainless Steel 316  
Volume:   5,000L 
Sterilization:   CIP/SIP 
 
Temperature:   25C 
Pressure:   1 bar 
 
Tank:   $55,100 
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Ultrafiltration/Diafiltration Unit (PFD 02/P-80)
Description and Function  
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
 
Operation Conditions 
 
Purchase Cost 
 
 
The diafiltration unit is used for buffer exchange for the final 
solution that the product will be stored in PBS. The 
ultrafiltration is used to concentrate the solution by 5 times.  
 
 
Millipore Sigma 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    3500   700 
Product  26.8   26.0 
 
 
Model:    Cogent® TFF System  
Protein Throughput:  21 L/min/m2 
Max. Operating Pressure:  6.8 bar 
Filter effective area:  1.1 m2 
Unit Sterilization:   SIP  
Filter Sterilization:   Disposable 
 
Temperature:    25C 
 
Unit:     $500,000 
Filter:     $3600/filter
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Sterile Filtration Unit (PFD 02/P-82) 
Description and Function  
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
The sterile filters are 0.2 μm filters that are used as the final 
purification step. It is used to create a sterile product before it 
is frozen and then sent to formulation.  
 
 
Sarotorius 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    700   700 
Product  26.0   25.2 
 
 
Model:    Sartopore 2 0.2μm  
Membrane Filter Material: Polyethersulfone (PES) 
Max. Differential Pressure:  5 bar at 20C 
Filtration Area:  1.8 m2 
Unit Sterilization:   SIP  
Filter Sterilization:   Disposable 
 
Temperature:    25C 
Operating Pressure:  1 bar 
 
 
Filter:     $650/filter 
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Final Storage (PFD 02/P-84) 
Description and Function  
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
Characteristics 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
The purified product will be stored in 10L containers and 
stored at -80C.  
 
 
 
Thermo Fisher Scientific  
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    700   700 
Product  25.2   25.2 
 
 
Volume:    10 L  
Material:   Polycarbonate 
Sterilization:    Disposable 
 
 
Temperature:    25C 
Operating Pressure:  1 bar 
 
 
Filter:     $100/container 
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Pumps (PFD 02/P-55, P-57, P-59, P-61, P-63, P-65, P-67, P-69, P-71, P-73, P-75, P-77, P-79, 
P-81) 
Description and Function  
 
 
 
 
Vendor 
 
Operation 
 
 
Characteristics 
 
 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The pumps are used to transfer liquid. These are high-flow 
hygienic pumps that are designed for low-shear sanitary 
pumping. They are ideal for viscous or shear sensitive 
products.  
  
Watson-Marlow 
 
Batch 
 
 
Model:    840 Peristaltic Pump  
Pumphead Material:  Aluminum Alloy  
Flow Rate:    65-8140 L/hr 
Max Pressure:   3.5 bar 
Sterilization:    CIP/SIP 
 
 
Temperature:    25C 
Power:    0.55-3 kW 
 
 
Pump:    $3000 
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Blending Tank (PFD 03/P-1) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
 
Characteristics 
 
 
 
 
Operation Conditions 
 
 
 
 
Purchase Cost 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This blending tank will mix cell culture media powder with 
WFI.  
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Dry Media  5.14   0.00 
Water   229   0.00 
NaOH   0.299   0.00 
NaHCO3  0.644   0.00 
Wet Media  0.00   230 
 
 
Volume:    300 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
Temperature:    25C 
Pressure:   1 bar 
   
 
Blending Tank:  $18,100 
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Dead-End Filter (PFD 03/P-3) 
Description and Function  
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
Characteristics 
 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The 0.2 µm dead-end filter is used to remove larger 
contaminants from blended culture media. The filter capsules 
and housing are disposable and ready-to-use. 
 
 
Millipore Sigma 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Wet Media  230   230 
 
 
Model:    Opticap XLT10, Sterile 
Filtration Area:  0.57 m2 
Throughput:   2,000 L/m2/h 
Max. Differential Pressure:  6.9 bar at 25C  
Sterilization:    Disposable 
 
 
 
Temperature:    25C 
Operating Pressure:  0.5 bar 
 
Filter Membrane and Housing: $400
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Storage Tank (PFD 03/P-5) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
Characteristics 
 
 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
 
 
 
The storage tank holds blended and filtered cell culture media 
at 4C until further use. 
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch)  
Wet Media   230   230 
 
 
Volume:    300 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
 
Temperature:    4C 
Pressure:    2 bar 
 
 
Storage Tank:    $18,100 
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250 mL Shaker Flask (PFD 03/P-7) 
Description and Function  
 
 
 
 
 
Vendor 
 
 
Operation 
 
Materials Handled  
 
 
 
 
Characteristics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Operation Conditions 
 
 
 
 
 
Purchase Cost 
 
 
The 250 mL Shaker Flask is used for cell growth in first 
inoculum preparation step after cryogenic recovery of the 
CHO cells. The Shaker Flask is placed on a low speed orbital 
shaker and the combined apparatus is incubated in a CO2 
Incubator. 
   
Corning (Flask & Orbital Shaker) 
Thermo Fisher Scientific (Incubator) 
 
Batch 
 
    Input (kg/batch) Output (kg/batch)  
Cells:   0.00000471  0.0000166 
Wet Media   0.030   0.125 
Product  0.00   0.00 
 
Model:      Corning 4444-250 
Flask Capacity:    250 mL 
Working Capacity:    80% 
Material:     Pyrex 
Packaging:      6 pc 
Sterilization:     Autoclave, 121C, 60 minutes 
 
Model:      Corning LSE 6780-FP 
Speed:      60 rpm 
Frequency Range:    50/60 Hz 
Tray Size:        30 cm x 30 cm 
Base Size:     25.5 cm x 32.0 cm x 16.0 cm 
 
Model:      Thermo Scientific Forma Series 3 
Interior Material:    Stainless Steel 304 
Dimensions (LxWxH) :  54.1 cm x 68.1 cm x 50.8 cm 
 
Temperature:      36.5C 
Pressure:      1 bar 
pH:      7.1 
dO2:      40% 
Duration:     3 days 
 
Shaker Flask:     $160  
Orbital Shaker:    $900 
Incubator:     $7,900 
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25 L Single-Use Bioreactor (PFD 03/P-9)
Description and Function  
 
 
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
Characteristics 
 
 
 
 
 
 
 
Operation Conditions 
 
 
 
 
 
 
 
Purchase Cost 
 
 
 
 
 
 
 
 
The 25L WAVE Bioreactor is used for cell growth in second 
inoculum preparation step. The single-use system is equipped 
with a rocker, gas mixers, pumps, and cell bags. The bags are 
disposable and pre-sterilized. The system also offers high 
level sensors and automated control for temperature, liquid 
transfer, dissolved oxygen, and pH.  
   
GE Healthcare and Life Sciences 
 
Batch 
 
    Input (kg/batch) Output (kg/batch)  
Cells   0.0000166  0.0000586 
Wet Media   0.125   12.5 
Product  0.00   0.00 
 
 
Model:    ReadyToProcess WAVE 25  
Rocker Dimensions:   404 mm x 205 mm x 560 mm 
Tray 50 Dimensions:  800 mm x 70 mm x 610 mm 
Lid 50 Dimensions:  800 mm x 260 mm x 610 mm 
CBCU Dimensions:  276 mm x 115 mm x 280 mm 
Bag Size:    22 L 
Sterilization:   Plastic, Disposable 
 
Temperature:    36.5C 
Pressure:    2 bar 
pH:    7.1 
dO2:    40% 
Agitation Speed:  15 rpm 
Rocking Angle:  7 
Duration:   3 days 
 
Bioreactor:   $60,000 
CBCU gas mixer:  $1,000 
Disposable Cellbag:  $500 
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500 L Single-Use Seed Bioreactors (PFD 03/P-23) 
Description and Function  
 
 
 
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
 
 
 
 
 
Purchase Cost 
 
 
The 500L WAVE Bioreactor is used for cell growth in cell 
seeding. The single-use system is equipped with a rocker base 
unit with internal gas pumps and cell bags. The bags are 
disposable and pre-sterilized. The system also offers high 
level sensors and automated control for temperature, liquid 
transfer, dissolved oxygen, and pH.  
 
 
GE Healthcare and Life Sciences 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0.0000586  0.00162 
Wet Media   25.0   250 
Product  0.00   0.00 
 
 
Model:  WAVE Bioractor 500/1000 system 
Dimensions: 2.26 m x 1.24 m x 1.60 m  
Frequency:  50/60 Hz 
Bag Size: 500 L 
Sterilization: Plastic, Disposable 
 
Temperature:    36.5C 
Pressure:    2 bar 
pH:    7.1 
dO2:    40% 
Agitation Speed:  15 rpm 
Rocking Angle:  4 
Duration:   6 days 
 
Bioreactor with control: $150,000 
Disposable Cellbag:  $1,000
116 
 
Blending Tank (PFD 03/P-11)
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This blending tank will mix feed supplement CellBoost 7a 
media powder with WFI. 
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Dry Media  126   0.00 
Water   690   0.00 
NaOH   0.904   0.00 
Wet Media  0.00   695 
 
Volume:    900 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
Temperature:    25C 
Pressure:   1 bar 
 
 
Blending Tank:  $26,000
117 
 
Blending Tank (PFD 03/P-17) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
This blending tank will mix feed supplement CellBoost 7b 
media powder with WFI. 
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Dry Media  6.62   0.00 
Water   69.5   0.00 
NaOH   0.0910   0.00 
Wet Media  0.00   70.0 
 
Volume:    90 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
Temperature:   25C 
Pressure:   1 bar 
 
Blending Tank:  $12,700
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Dead-End Filter (PFD 03/P-13) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
The 0.2 µm dead-end filter is used to remove larger 
contaminants from blended feed supplement 7a media. The 
filter capsules and housing are disposable and ready-to-use. 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Wet Media  695   695 
 
 
 
Model:    Opticap XLT10, Sterile 
Filtration Area:  0.57 m2 
Throughput:   2,000 L/m2/h 
Max. Differential Pressure:  6.9 bar at 25C  
Sterilization:    Disposable 
 
Temperature:   25C 
Pressure:   0.5 bar 
 
Filter Membrane & Housing:  $400
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Dead-End Filter (PFD 03/P-19)
Description and Function  
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
Characteristics 
 
 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
The 0.2 µm dead-end filter is used to remove larger 
contaminants from blended culture media. The filter capsules 
and housing are disposable and ready-to-use. 
 
Millipore Sigma 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Wet Media  70.0   70.0 
 
 
Model:    Opticap XLT10, Sterile 
Filtration Area:  0.57 m2 
Throughput:   2,000 L/m2/h 
Max. Differential Pressure:  6.9 bar at 25C  
Sterilization:    Disposable 
 
 
Temperature:    25C 
Pressure:   0.5 bar 
 
 
Filter Membrane & Housing:  $400
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Storage Tank (PFD 03/P-15) 
Description and Function  
 
 
Operation 
 
Materials Handled  
 
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
 
 
 
The storage tank holds blended and filtered cell culture media 
at 4C until further use. 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Wet Media  45.0   0.00 
 
 
Volume:    50 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
 
Temperature:    4C 
Pressure:    2 bar 
 
Storage Tank:    $10,700 
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Storage Tank (PFD 03/P-21)
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
 
 
The storage tank holds blended and filtered cell culture media 
at 4C until further use. 
   
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Wet Media   5.00   0.00 
 
 
Volume:    25 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
Temperature:    4C 
Pressure:    2 bar 
 
Storage Tank:    $9,100 
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Blending Tank (PFD 03/P-31) 
Description and Function  
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
 
 
This blending tank will mix cell culture media powder with 
WFI. 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Dry Media  19.7   0.00 
Water   874   0.00 
NaOH   1.44   0.00. 
NaHCO3  3.11   000 
Wet Media  0.00   880 
 
Volume:    1,100 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
Temperature:   25C 
Pressure:   1 bar 
 
Blending Tank:   $28,200 
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Dead-End Filter (PFD 03/P-33) 
Description and Function  
 
 
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
 
 
 
The 0.2 µm dead-end filter is used to remove larger 
contaminants from blended culture media. The filter capsules 
and housing are disposable and ready-to-use. 
 
 
Millipore Sigma 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Wet Media  880   880 
 
 
Model:    Opticap XLT10, Sterile 
Filtration Area:  0.57 m2 
Throughput:   2,000 L/m2/h 
Max. Differential Pressure:  6.9 bar at 25C  
Sterilization:    Disposable 
 
 
Temperature:    25C 
Pressure:   0.5 bar 
 
 
Filter Membrane & Housing:  $400
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Storage Tank (PFD 03/P-35) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
Characteristics 
 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
The storage tank holds blended and filtered cell culture media 
at 4C until further use. 
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Wet Media   880   0.00 
 
 
Volume:    1,100 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
Temperature:    4C 
Pressure:    2 bar 
 
Storage Tank:    $28,200 
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Storage Tank (PFD 03/P-26)
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
 
The storage tank holds blended and filtered feed supplement 
7a media at 4C until further use. 
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Wet Media   650   0.00 
 
 
Volume:    850 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
Temperature:    4C 
Pressure:    2 bar 
 
Storage Tank:    $25,600 
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Storage Tank (PFD 03/P-29) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
 
The storage tank holds blended and filtered feed supplement 
7b media at 4C until further use. 
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Wet Media   65.0   0.00 
 
 
Volume:    90 L 
Working Capacity:   80% 
Material:    Stainless Steel 316 
Height/Diameter Ratio: 2/1 
Sterilization:    CIP/SIP 
 
Temperature:    4C 
Pressure:    2 bar 
 
Storage Tank:    $12,700 
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2,000 L Single-Use Seed Bioreactor (PFD 03/P-37)
Description and Function  
 
 
 
 
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
Characteristics 
 
 
 
 
 
 
Operation Conditions 
 
 
 
 
 
 
Purchase Cost 
 
 
 
The 2000L Xcellerex XDR Bioreactor is used for cell growth 
to peak density followed by maximum product formation The 
single-use system is equipped with a jacketed bioreactor 
vessel, gas mixing cabinet, control console, and cell bags. The 
bags are disposable and pre-sterilized. The system also offers 
high level sensors and automated control for temperature, 
liquid transfer, dissolved oxygen, and pH. Four of these 
bioreactors operate in parallel.  
   
GE Healthcare and Life Sciences 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0.00162  7.35 
Wet Media   250   1560 
Product  0.00   40.1 
 
 
Model:    Xcellerex XDR-2000 system 
Height/Diameter Ratio: 1.5/1 
Impeller Type, Angle:  4 blades, 40 pitch 
Impeller/Bag Diameter Ratio: 0.34 
Bag Size:   2000 L 
Sterilization:   Plastic, Disposable 
 
Temperature:    36.5C 
Pressure:    2 bar 
pH:    7.1 
dO2:    40% 
Agitation:    110 rpm 
Duration:   19 days 
 
Bioreactor with control: $250,000 
Disposable Cellbag:  $2,500 
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Peristaltic Pumps (PFD 03/P-2,4,6,8,10,12,14,16,18,20,22,24,28,30,32,34,36,38)
Description and Function  
 
 
 
Vendor 
 
Operation 
 
 
 
Characteristics 
 
 
 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The pumps are used to transfer media and cells for upstream 
bioreaction steps. The pumps are sterile and designed for 
shear-sensitive biopharmaceutical applications.  
   
 
Watson-Marlow 
 
Batch 
 
 
Model:    825 series 
Pumphead Material:   Aluminum alloy 
Support and Frame Material: Stainless steel 304 
Maximum Flow Rate:  33 L/min 
Maximum Pressure:  3.5 bar 
Sterilization:   CIP, SIP 
 
 
Pressure:    3 bar 
Flow Rate:   Variable (0.1-33 L/min) 
 
 
 
Pump:    $3,000 
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Centrifuge (PFD 04/P-39) 
Description and Function  
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This centrifuge will separate the cells from the cell culture 
liquid that has the solubilized monoclonal antibody product.  
 
 
GEA 
 
Continuous 
 
    Input (kg/batch) Output (kg/batch) 
Cells   75.4   0 
Media    0   0 
Water    1560   1560 
Product  10.0   9.62 
 
 
 
Model:   CSC 20 
Centrifuge Type:  Disc Stack Centrifuge 
Material:   Stainless Steel 316 
Capacity Range:  500-1000 L/h 
Sterilization:   CIP/SIP 
 
Temperature:   25C 
Throughput:   780 L/h 
 
Centrifuge:  $1,200,000 
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Storage Tank 6 (PFD 04/P-41) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
Characteristics 
 
 
 
Operation Conditions 
 
 
Purchase Cost
This storage tank will collect the liquid product from the 
centrifuge.  
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    1560   1560 
Product  9.62   9.62 
 
 
Material:   Stainless Steel 316 L  
Volume:   2,000L   
Sterilization:   CIP/SIP 
 
Temperature:   25C 
Pressure:   1 bar 
 
Tank:   $35,857 
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Depth Microfiltration Unit (PFD 04/P-43)
Description and Function  
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The depth filter is used to remove larger particles not removed 
from centrifugation. It has two distinct layers with different 
pore sizes (0.1-1m) to avoid plugging and increase filter 
capacity.   
 
Millipore Sigma 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    1560   1560 
Product  9.62   9.34 
 
 
Model:    Millistak Pod Filter 
Filter:    X0HC  
Protein Throughput:  21 L/min/m2 
Max. Differential Pressure:  2.1 bar 
Max. Operating Pressure:  3.5 bar 
Filter effective area:  1.1 m2 
Unit Sterilization:   SIP  
Filter Sterilization:   Disposable 
 
Temperature:    25C 
Operating Pressure:  1 bar 
 
Filter Housing:   $29,200 
Filter:     $750 each
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Storage Tank 7 (PFD 04/P-45) 
Description and Function  
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
Characteristics 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
This storage tank will collect the filtrate liquid from the depth 
filtration unit.   
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    1560   1560 
Product  9.34   9.34 
 
 
Material:   Stainless Steel 316  
Volume:   2,000L   
Sterilization:   CIP/SIP 
 
 
Temperature:   25C 
Pressure:   1 bar 
 
Tank:   $35,900 
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Protein A Chromatography Column (PFD 04/P-47)
Description and Function  
 
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
The Protein A Chromatography column uses a resin that 
selectively binds the monoclonal antibody product. This step 
is the first isolation step in the purification process and is 
useful in eliminating host cell proteins, DNA, cell culture 
media components.  
 
GE Healthcare Life Sciences  
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
  
Cells    0   0 
Media     0   0 
Centrifuge effluent   1560      0 
Equilibration buffer  1700   0  
Wash buffer   200   0 
Elution buffer   750   750 
Regeneration buffer   600   0 
CIP buffer    800   0 
Protein A waste  0   4860 
Product   9.34   8.59 
 
 
Model:    Chromaflow 1000/100-300 
Column Diameter:   1.0 m 
Bed Height:    0.25 m 
Material of Construction:  Stainless Steel 316 L 
Bed Volume:    200 L 
Resin:     MabSelect Sure LX 
Binding Capacity:   50 g mAB/L resin 
Working Linear Velocity:  250-400 cm/hr 
pH Stability:   3-12 
Sterilization:    CIP/SIP 
 
 
Temperature:    25C 
Pressure:    1 bar 
 
Column:    $250,000 
Resin:     $8,000/liter
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Storage Tank 8 (PFD 04/P-49) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
 
Characteristics 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
This storage tank will collect the eluent from the Protein A 
Chromatography column.   
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    750   750 
Product  8.59   8.59 
 
 
 
Material:   Stainless Steel 316  
Volume:   1,000L  
Sterilization:   CIP/SIP 
 
Temperature:   25C 
Pressure:   1 bar 
 
Tank:   $26,600 
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Ultrafiltration/Diafiltration Unit (PFD 04/P-51)
Description and Function  
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
This unit is used for buffer exchange to raise the pH of the 
solution and concentrate it by 5 times. It is done using 
tangential flow filtration.  
 
 
Millipore Sigma 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    750   150 
Product  8.59   8.33 
 
 
Model:    Cogent® TFF System  
Protein Throughput:  21 L/min/m2 
Max. Operating Pressure:  6.8 bar 
Filter effective area:  1.1 m2 
Unit Sterilization:   SIP  
Filter Sterilization:   Disposable 
 
Temperature:    25C 
 
 
 
Filter Housing:   $500,000 
Filter:     $3600/filter
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Storage Tank 9 (PFD 04/P-53) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
 
Characteristics 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
This storage tank will collect the retentate from the 
diafiltration operation.   
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    150   150 
Product  8.33   8.33 
 
 
 
Material:   Stainless Steel 316  
Volume:   500L 
Sterilization:   CIP/SIP 
 
Temperature:   25C 
Pressure:   1 bar 
 
Tank:   $22,600 
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Cation Exchange Chromatography Column (PFD 04/P-55)
Description and Function  
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
 
 
 
 
The cation exchange chromatography column binds positively 
charged proteins and is used eliminate DNA, some host cell 
proteins, and leached Protein A.  
   
 
GE Healthcare Life Sciences 
 
Batch 
 
    Input (kg/batch) Output (kg/batch)  
Cells    0   0 
Media     0   0 
Diafiltration effluent   150   0 
Equilibration buffer  800   0 
Wash buffer   800   0 
Elution buffer   320   320 
Regeneration buffer   320   0 
CIP buffer    480   0 
Cation exchange waste    2550  
Product   8.33   7.66 
 
 
Model:    Chromaflow 1000/100-300 
Column Diameter:   1.0 m 
Bed Height:    0.2 m 
Material of Construction:  Stainless Steel 316 L 
Bed Volume:    160 L 
Resin:     Capto S 
Binding Capacity:   60 g mAB/L resin 
Working Linear Velocity:  200-600 cm/hr 
Sterilization:    CIP/SIP 
 
 
Temperature:    25C 
Pressure:    1 bar 
 
Column:    $250,000 
Resin:     $1,500/1L 
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Storage Tank 10 (PFD 04/P-57) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
 
Characteristics 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
This storage tank will collect the eluent from the Cation 
Exchange Chromatography.  
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    320   320 
Product  7.66   7.66 
 
 
 
Material:   Stainless Steel 316  
Volume:   500L   
Sterilization:   CIP/SIP 
 
Temperature:   25C 
Pressure:   1 bar 
 
Tank:   $22,600 
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Virus Filtration Unit (PFD 04/P-59)
Description and Function  
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
The virus filtration unit is used to remove viruses using size 
based membrane separation.  
 
 
Sartorius  
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    320   320 
Product  7.66   7.28 
 
 
Model:   Virosart® CPV  
Filter effective area: 1.8 m2 
Sterilization:   SIP  
Membrane:   Disposable 
 
 
 
Temperature:   25C 
 
 
 
Filter:    $10,000/filter
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Hydrophobic Interaction Chromatography Column (PFD 04/P-61)
Description and Function  
 
 
 
 
Vendor 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
 
 
 
The hydrophobic interaction chromatography column is run in 
flow through mode and removes product and process-related 
impurities, such as aggregates. 
   
 
Column: GE Healthcare and Life Sciences  
Resin: Thermo Fisher Scientific 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
  
Cells    0   0 
Media     0   0 
Filtrate     320   320 
Equilibration buffer  1000   0 
Wash buffer   1780   1780 
Elution buffer   1000   0 
Regeneration buffer   600   0 
CIP buffer    1000   0 
Cation exchange waste 0   3600  
Product   7.28   6.70 
 
Model:    Chromaflow 1000/100-300 
Column Diameter:   1.0 m 
Bed Height:    0.3 m 
Material of Construction:  Stainless Steel 316 L 
Bed Volume:    200 L 
Resin:     POROS Benzyl Ultra 
Working Linear Velocity:  200-500 cm/hr 
Sterilization:    CIP/SIP 
 
Temperature:    25C 
Pressure:    1 bar 
 
Column:    $250,000 
Resin:     $3,800/10 L 
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Storage Tank 11 (PFD 04/P-63) 
Description and Function  
 
 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
 
Characteristics 
 
 
 
Operation Conditions 
 
 
Purchase Cost 
This storage tank will collect the product stream from the 
hydrophobic interaction chromatography.   
 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    2100   2100 
Product  6.70   6.70 
 
 
 
Material:   Stainless Steel 316  
Volume:   2,500L   
Sterilization:   CIP/SIP 
 
Temperature:   25C 
Pressure:   1 bar 
 
Tank:   $35,900
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Ultrafiltration/Diafiltration Unit (PFD 04/P-65)
Description and Function  
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
The diafiltration unit is used for buffer exchange for the final 
solution that the product will be stored in PBS. The 
ultrafiltration is used to concentrate the solution by 5 times.  
 
 
Millipore Sigma 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    2100   420 
Product  6.70   6.50 
 
 
Model:   Cogent® TFF System 
Protein Throughput: 21 L/min/m2 
Filter effective area: 1.1 m2 
Sterilization:   SIP  
Membrane:   Disposable 
 
Temperature:   25C 
 
 
 
Unit:    $500,000 
Filter:    $3600/filter
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Sterile Filtration Unit (PFD 04/P-67) 
Description and Function  
 
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
Characteristics 
 
 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
The sterile filters are 0.2 μm filters that are used as the final 
purification step. It is used to create a sterile product before it 
is frozen and then sent to formulation.  
 
 
Sarotorius 
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    420   420 
Product  6.50   6.30 
 
 
Model:    Sartopore 2 0.2μm  
Membrane Filter Material: Polyethersulfone (PES) 
Max. Differential Pressure:  5 bar at 20C 
Filtration Area:  1.8 m2 
Unit Sterilization:   SIP  
Filter Sterilization:   Disposable 
 
Temperature:    25C 
Operating Pressure:  1 bar 
 
 
Filter:     $650/filter 
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Final Storage (PFD 04/P-69) 
Description and Function  
 
 
 
Vendor 
 
Operation 
 
Materials Handled  
 
 
 
 
 
 
Characteristics 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The purified product will be stored in 10L containers and 
stored at -80C.  
 
 
Thermo Fisher Scientific  
 
Batch 
 
    Input (kg/batch) Output (kg/batch) 
Cells   0   0 
Media    0   0 
Water    420   420 
Product  6.30   6.30 
 
 
Volume:    10 L  
Material:   Polycarbonate 
Sterilization:    Disposable 
 
Temperature:    25C 
Operating Pressure:  1 bar 
 
 
Filter:     $100/container 
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Pumps (PFD 04/P-40, P-42, P-44, P-46, P-48, P-50, P-52, P-54, P-56, P-58, P-60, P-62, P-64, 
P-66) 
Description and Function  
 
 
 
 
Vendor 
 
Operation 
 
 
Characteristics 
 
 
 
 
 
Operation Conditions 
 
 
 
Purchase Cost 
 
 
The pumps are used to transfer liquid. These are high-flow 
hygienic pumps that are designed for low-shear sanitary 
pumping. They are ideal for viscous or shear sensitive 
products.  
  
Watson-Marlow 
 
Batch 
 
 
Model:    840 Peristaltic Pump  
Pumphead Material:  Aluminum Alloy  
Flow Rate:    65-8140 L/hr 
Max Pressure:   3.5 bar 
Sterilization:   CIP/SIP 
 
Temperature:    25C 
Power:    0.55-3 kW 
 
 
Pump:    $3000 
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17. Equipment Cost Summary 
17.1 Large Production Bioreactor Design Equipment  
Inoculum Preparation 
PFD 01 Type Specification  Vendor Purchase Cost 
P-8 Pump 825 series Watson- Marlow $3,000 
P-9 WAVE Bioreactor 25 L GE Healthcare Life Sciences $1,000 
P-10 Pump 825 series Watson- Marlow $3,000 
P-1 Blending Tank 75 L  $12,500 
P-2 Pump 825 series Watson- Marlow $3,000 
P-4 Pump 825 series Watson- Marlow $3,000 
P-5  Storage Tank  75 L  $12,500 
P-6 Pump 825 series Watson-Marlow $3,000 
 
Seed Bioreactions 
PFD 01 Type Specification  Vendor Purchase 
Cost 
P-29 WAVE Bioreactor 100 L GE Healthcare Life Sciences $90,000 
P-30, 31 Pump 150S QuattroFlow $3,000 
P-32, 33 WAVE Bioreactor 500 L GE Healthcare Life Sciences $300,000 
P-34, 35 Pump 825 series Watson- Marlow $3,000 
P-36, 37 XDR-2000 2000 L GE Healthcare Life Sciences $500,000 
P-38, 39 Pump 825 series Watson- Marlow $3,000 
P-39 Pump 825 series Watson- Marlow $3,000 
P-11 Blending Tank 4000 L  $51,000 
P-12 Pump 825 series Watson- Marlow $3,000 
P-14 Pump 825 series Watson- Marlow $3,000 
P-15  Storage Tank  4000 L  $51,000 
P-16 Pump 1200S 5˚ QuattroFlow $4,000 
P-17 Blending Tank 7000 L  $63,200 
P-18 Pump 825 series Watson- Marlow $3,000 
P-20 Pump 825 series Watson- Marlow $3,000 
P-21 Storage Tank  250 L  $18,000 
P-22 Pump 1200S 5˚ QuattroFlow $4,000 
P-23 Blending Tank 700 L  $24,300 
P-24 Pump 825 series Watson- Marlow $3,000 
P-26 Pump 825 series Watson- Marlow $3,000 
P-27  Storage Tank  25 L  $9,200 
P-28 Pump 150S QuattroFlow $3,000 
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Production Bioreactions 
PFD 01 Type Specification  Vendor Purchase Cost 
P-52 Stainless Steel 
Bioreactor 
20,000 L  GEA $1,500,000 
P-40 Pump 825 series Watson- Marlow $3,000 
P-41 Storage Tank 7500 L  $69,400 
P-42 Pump 825 series Watson- Marlow $3,000 
P-43 Pump 825 series Watson- Marlow $3,000 
P-44 Storage Tank 750 L  $25,500 
P-45 Pump 825 series Watson- Marlow $3,000 
P-46 Blending Tank 6000 L  $59,400 
P-47 Pump 825 series Watson- Marlow $3,000 
P-49 Pump 825 series Watson- Marlow $3,000 
P-50 Storage Tank  6000 L  $59,400 
P-51 Pump 825 series Watson- Marlow $3,000 
 
Primary Recovery 
PFD 02 Type Specification  Vendor Purchase Cost 
P-54 Centrifuge 3000 – 6000 
L/hr 
GEA $1,500,000 
P-55 Pump 840 series Watson- Marlow $3,000 
P-56 Storage Tank 6 20,000 L  $104,700 
P-57 Pump 840 series Watson- Marlow $3,000 
P-58 Depth Filtration 
Unit 
21 L/min/m2 Millipore Sigma $67,300 
P-59 Pump 
 
840 series Watson- Marlow $3,000 
P-60 Storage Tank 7 20,000 L  $104,700 
P-61 Pump 840 series Watson- Marlow $3,000 
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Initial Purification 
PFD 
02 
Type Specification Vendor Purchase 
Cost  
P-62 Protein A Column 1.0 m  GE Healthcare Life Sciences $250,000 
P-63 Pump 
 
840 series Watson- Marlow $3,000 
P-64 Storage Tank 8 5,000 L  $55,100 
P-65 Pump 840 series Watson- Marlow $3,000 
P-66 Diafiltration Unit 750 L/hr Millipore Sigma $500,000 
P-67 Pump 
 
840 series Watson- Marlow $3,000 
P-68 Storage Tank 9 2,000 L  $35,900 
P-69 Pump 840 series Watson- Marlow $3,000 
P-70 Cation Exchange 
Column 
1.0 m GE Healthcare Life Sciences $250,000 
P-71 Pump 840 series Watson-Marlow $3,000 
P-72 Storage Tank 10 2,000 L  $36,000 
 
Polishing Steps 
PFD 02 Type Specification  Vendor Purchase Cost  
P-73 Pump 840 series Watson- Marlow  
P-75 Pump 840 series Watson- Marlow $2,950 
P-76 HIC Column 1.0 m GE Healthcare Life Sciences $250,000 
P-77 Pump  840 series Watson- Marlow  
P-78 Storage Tank 11 5,000L  $55,140 
P-79 Pump 840 series Watson- Marlow $2,950 
P-80 Diafiltration 750 L/hr Millipore Sigma $500,000 
P-81 Pump  840 series Watson- Marlow $2,950 
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Large Production Bioreactor Scheme: Additional Units 
Type Specification  Units Vendor Purchase 
Cost  
Orbital Shaker 
 
60 rpm 
 
1 Corning $900 
 
CO2 Incubator 5.0% CO2 1 Thermo Scientific $7,900 
Cryogenic Storage 
Vessel 
Locator 8 
90 L liquid N2 
1 Thermolyne $2,700 
CBCU Gas mixer -- 5 GE Healthcare Life 
Sciences 
$5,000 
Pump Tubing MasterFlex 1000 Cole-Parmer $48,900,000 
Product 
Refrigeration 
-80˚C, 33.5 ft3 
900 L capacity 
4 Thermo Scientific $60,300 
Biowaste tank 100 L 1  $13,500 
Neutralization tank 20,000 L 4  $400,000 
Sterile Air 
Compressor 
620 L/min 
120 L capacity 
10 Greeloy Medical $7,000 
CIP Skids Up to 3m processes 3 Sani-matic $300,000 
Buffer Transfer 
Container 
5,000 L 10  $359,000 
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17.2 Small Production Bioreactor Design Equipment  
Inoculum Preparation 
PFD 03 Type Specification  Vendor Purchase Cost 
P-8 Pump 825 series Watson- Marlow $3,000 
P-9 WAVE Bioreactor 25 L GE Healthcare Life Sciences $1,000 
P-10 Pump 825 series Watson- Marlow $3,000 
P-1 Blending Tank 300 L  $18,100 
P-2 Pump 825 series Watson- Marlow $3,000 
P-4 Pump 825 series Watson- Marlow $3,000 
P-5  Storage Tank  300 L  $36,200 
P-6 Pump 825 series Watson-Marlow $3,000 
 
Seed Bioreactions 
PFD 03 Type Specification  Vendor Purchase Cost 
P-23 WAVE Bioreactor 500 L GE Healthcare Life Sciences $150,000 
P-24 Pump 825 series Watson- Marlow $3,000 
P-11 Blending Tank 900 L  $26,000 
P-12 Pump 825 series Watson- Marlow $3,000 
P-14 Pump 825 series Watson- Marlow $3,000 
P-15 Storage Tank 50 L   $10,700 
P-16 Pump  Watson- Marlow $3,000 
P-17 Blending Tank 90 L  $12,700 
P-18 Pump 825 series Watson- Marlow $3,000 
P-20 Pump 825 series Watson- Marlow $3,000 
P-21 Storage Tank 25 L   $9,100 
P-22 Pump  Watson- Marlow $3,000 
 
Production Bioreactions 
PFD 03 Type Specification  Vendor Purchase Cost 
P-37 XDR-2000 2000 L GE Healthcare Life Sciences $250,000 
P-31 Blending Tank 1100 L  $28,200 
P-32 Pump 825 series Watson- Marlow $3,000 
P-34 Pump 825 series Watson- Marlow $3,000 
P-35  Storage Tank  1100 L  $28,200 
P-36 Pump 825 series Watson- Marlow $3,000 
P-25 Pump 825 series Watson- Marlow $3,000 
P-26 Storage Tank  850 L  $51,200 
P-27 Pump 825 series Watson- Marlow $3,000 
P-28 Pump 825 series Watson- Marlow $3,000 
P-29  Storage Tank  90 L  $25,400 
P-30 Pump 825 series Watson- Marlow $3,000 
 
  
 151 
 
Primary Recovery 
PFD 04 Type Specification  Vendor Purchase Cost 
P-39 Centrifuge 500 – 1000 
L/hr 
GEA $1,200,000 
P-40 Pump 840 series Watson- Marlow $2,950 
P-41 Storage Tank 6 2,000 L  $35,857 
P-42 Pump 840 series Watson- Marlow $2,950 
P-43 Depth Filtration 
Unit 
21 L/min/m2 Millipore Sigma $29,160 
P-44 Pump 
 
840 series Watson- Marlow $2,950 
P-45 Storage Tank 7 2,000 L  $35,857 
P-46 Pump 840 series Watson- Marlow $2,950 
 
Initial Purification 
PFD 04 Type Specification Vendor Purchase Cost 
P-47 Protein A Column 1.0 m GE Healthcare Life Sciences $250,000 
P-48 Pump 
 
840 series Watson- Marlow $2,950 
P-49 Storage Tank 8 1,000 L  $26,567 
P-50 Pump 840 series Watson- Marlow $2,950 
P-51 Diafiltration Unit 750 L/hr Millipore Sigma $500,000 
P-52 Pump 
 
840 series Watson- Marlow $2,950 
P-53 Storage Tank 9 500L  $22,550 
P-54 Pump 840 series Watson- Marlow $2,950 
P-55 Cation Exchange 
Column 
1.0 m GE Healthcare Life Sciences $250,000 
P-56 Pump 840 series Watson-Marlow $2,950 
P-57 Storage Tank 10 2,000 L  $35,857 
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Polishing Steps 
PFD 04 Type Specification Vendor Purchase Cost 
($/batch) 
P-58 Pump 
 
840 series Watson- Marlow  
P-60 Pump 
 
840 series Watson- Marlow $2,950 
P-61 HIC Column 1.0 m GE Healthcare Life Sciences $250,000 
P-62 Pump 840 series Watson- Marlow  
P-63 Storage Tank 11 2,500 L  $38,704 
P-64 Pump 
 
840 series Watson- Marlow $2,950 
P-65 Diafiltration 750 L/hr Millipore Sigma $500,000 
P-66 Pump 840 series Watson- Marlow $2,950 
 
 
 
Small Production Bioreactor Scheme: Additional Units 
Type Specification Units Vendor Purchase 
Cost 
Orbital Shaker 
 
60 rpm 
 
1 Corning $900 
 
CO2 Incubator 5.0% CO2 1 Thermo Scientific $7,900 
Cryogenic Storage 
Vessel 
Locator 8 
90 L liquid N2 
1 Thermolyne $2,700 
CBCU Gas mixer -- 5 GE Healthcare Life 
Sciences 
$5,000 
Pump Tubing MasterFlex 1000 Cole-Parmer $48,900,000 
Product 
Refrigeration 
-80˚C, 33.5 ft3 
900 L capacity 
3 Thermo Scientific $45,200 
Biowaste tank 50 L 1  $10,700 
Neutralization tank 20,000 L 2  $200,000 
Sterile Air 
Compressor 
620 L/min 
120 L capacity 
6 Greeloy Medical $4,200 
CIP Skids Up to 3m processes 3 Sani-matic $300,000 
Buffer Transfer 
Container 
1,000 L 10  $265,000 
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Additional Equipment Included in Annual Expenses for Both Designs 
Type Units Vendor 
Water-glycol heater 1 Chromalox 
Water heater 2 PVI Industries, LLC 
Cooling water unit 2 Cole-Parmer 
Biosafety Cabinet 2 Thermo Scientific 
WFI Still 1  
Clean Steam Generator 1 Spirax Sarco 
Filter Integrity Test 1 Millipore 
Water Treatment Package 1 MECO 
Biowaste Inactivation System 1  
Waste Neutralization System 1  
Quality Control Lab 1  
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18. Scheduling  
Scheduling and process duration is important to consider for both the design and 
operation of biopharmaceutical plants. Both the Large and Small Production Bioreactor Schemes 
require 24-hour operation and supervision.  
Tables 18.1 and 18.2 illustrate the Gantt chart and schedules for the Large Production 
Bioreactor Scheme and Small Production Bioreactor Scheme, respectively. For the Large 
Production Bioreactor Scheme, the batch time is 45 days and 14 hours with the start of each 
batch occuring every 21 days and 13 hours. Since this scheme produces 25.2 kg per batch, four 
batches will be required to reach the production goal of 100 kg of mAb per year.  Therefore, the 
total time required to reach the production goal is 111 days and 4 hours, or approximately 4 
months. For the Small Production Bioreactor Scheme, the batch time is 30 days and 8 hours with 
the start of each batch occuring every 9 days and 4 hours. Both the batch and cycle time are 
shorter for than for the Large Production Bioreactor Scheme, however this smaller scheme is 
designed to produce only 6.3 kg per batch. This requires a total of sixteen batches to reach the 
annual production goal. The total time to complete sixteen batches is 178 days and 13 hours, or 
approximately 6 months.  
The major headings of the combined upstream and downstream processes are labeled on 
the left as: Inoculum Preparation, Seeding, Production, Primary Recovery, Purification, and 
Polishing. These headings correspond to the titles in the block flow diagrams in Figures 10.1 and 
10.2 in Section 10. Scheduled units are labeled in accordance with the corresponding labels on 
the computer-drawn flowsheets in Figures 12.1 through 12.6 and with descriptive labels for 
simplicity. Each color indicates a new batch.  
Although the Small Production Bioreactor Design takes longer, the smaller production 
volume actually results in higher product quality and lower batch risk, as discussed in Section 
2.2. The smaller design also provides more scalability with the capability to produce quantities 
between 6.30 and 201 kg annually. Comparatively, the larger design produces quantities between 
25.2 kg and 302 kg annually. Given the projected sales forecast of OCREVUS, both schemes can 
match the maximum required annual mAb production for the duration of the patent. Likewise, in 
an off-patent scenario, it is unlikely that annual production will exceed that of the on-patent 
market, since competitors reduce the market available for sales. A specific, detailed economic 
analysis of the advantages and disadvantages of each scheme will be discussed in Section 21. 
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Table 18.1 Gantt chart for the Large Production Bioreactor Process (PFD 01 and PFD 02). 
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Table 18.2 Gantt chart for the Small Production Bioreactor Process (PFD 03 and PFD 04). 
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19. Fixed-Capital Investment Summary 
Assuming that this plant is part of a pre-existing plant, only 4-6 months out of the year 
will be dedicated to Ocrevus production. During this time, production will take place 24 hours 
per day, 7 days per week in four shifts. Eight operators will be working in any given shift and 
will be paid $42 per hour. Technical assistance will be provided by engineers and control 
laboratory staff. These labor costs amount to about $1.3 million (MM) per large batch. Other 
fixed costs include Maintenance and Overhead items which can be modeled as a fraction of 
wages and depreciable capital. These costs total to about $3.1 MM per large bioreactor batch of 
25 kg mAb and $1.8 MM per small bioreactor batch of 6.3 kg mAb. 
The total investment required prior to the start of production is about $33.6 MM for the 
large bioreactor scheme and $19.4 MM for the small bioreactor scheme. This includes the total 
bare module costs of all equipment units, site preparations and service facilities, as well as any 
contingencies and start-up costs. The bare module factor accounts for the costs of installation 
materials and labor, freight and insurances, as well as construction overhead. While the factor for 
a typical chemical engineering plant is around 3.21, a slightly lower factor will be used for this 
process because most of the equipment is highly specialized for biopharmaceutical applications 
and is easy to install. An average bare module factor of 2.8 will be used for all equipment cost 
estimations. In the on-patent analysis, all R&D activities and clinical trial costs will also be 
included in the annual fixed costs.  
A summary of the investment is provided in Appendix F.1 and fixed costs are provided in 
Appendix F.2.  
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20. Operating Cost- Cost of Manufacture 
The operating costs include all raw materials, utilities, and general expenses which scale 
with the plant productivity. These costs will be incurred annually and on an ongoing basis. Table 
20.1 shows the required raw materials for each production batch in the Large Production 
Bioreactor scheme. Table 20.2 shows the same for the Small Production Bioreactor scheme.  
 
Table 20.1 Raw Materials: Large Production Bioreactor Design 
Upstream & Downstream Raw Materials: Large Production Bioreactor 
Raw Materials Units Specifications Vendor 
Purchase Cost 
($/batch) 
Cryovials 1 1000/pack Sigma-Aldrich $400 
Cryogenic storage 
boxes 
3 25/pack Thermo Scientific $1,700 
Liquid Nitrogen 2 55 gallon drum  $60 
ActiPro Powder 
Medium 
302 25 L bottle 
GE Healthcare Life 
Sciences 
$311,100 
CellBoost 7a Powder 
Medium 
580 10 L bottle 
GE Healthcare Life 
Sciences 
$1,044,000 
CellBoost 7b Powder 
Medium 
58 10 L bottle 
GE Healthcare Life 
Sciences 
$194,900 
Antifoam 50 2.5 L bottle 
GE Healthcare Life 
Sciences 
$8,500 
L-glutamine 100 500 mL bottle Millipore Sigma $3,000 
Sodium Hydroxide 
Pellets 
25 35 kg drum Millipore Sigma $640,000 
Sodium Bicarbonate 1 45 kg drum Millipore Sigma $900 
Propylene Glycol 6 55 gal drum 
Dow Chemical 
Company 
$4,200 
CHO Cell vials 1 
1 mL per vial 
3x105 cells/mL 
Thermo Fisher 
Scientific 
$600 
Media Filters 7 
Opticap XLT 10 
0.57 m2, 0.2µm 
Millipore Sigma $2,800 
Shake Flask 1 50 mL Corning $8.00 
Shake Flask 1 
250 mL 
6/pack 
Corning $160.00 
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Shaker Flask Clamp 1  Eppendorf $40 
Cellbag 1 22 L 
GE Healthcare Life 
Sciences 
$500 
Cellbag 1 100 L 
GE Healthcare Life 
Sciences 
$800 
Cellbag 2 500 L 
GE Healthcare Life 
Sciences 
$2,000 
XDR-200 Probag 2 2000 L 
GE Healthcare Life 
Sciences 
$5,000 
Air Filters 10 
Durapore 
0.69m2, 0.22 µm 
GE Healthcare Life 
Sciences 
$4,000 
Depth Filters 90 
Millistak Pod 
1.1 m2 
Millipore Sigma $67,400 
Protein A Resin 200 
MabSelect Sure LX 
1 L bottle 
GE Healthcare Life 
Sciences 
$1,600,000* 
Protein A Buffers -- 16400 L Millipore Sigma $16,200 
Diafiltration Filters 2 
Pellicon 2 Cassettes 
30 kDa 
Millipore Sigma $7,200 
Tromethamine 
Diafiltration Buffer 
1 50 kg Sigma-Aldrich $5,700 
PBS Diafiltration 
Buffer 
700 1 L bottle Millipore Sigma $23,000 
Capto S Cation Ex. 
Resin 
16 10 L bottle 
GE Healthcare Life 
Sciences 
$240,000* 
Cation Ex.  Buffers -- 10900 L Millipore Sigma $15,200 
Virus Filters 4 Virosart CPV Sartorius $40,300 
HIC Resin 20 
Poros Benzyl Ultra 
10 L bottle 
Thermo Fisher 
Scientific 
$76,000* 
HIC Buffers  16610 L Millipore Sigma $13,300 
Diafiltration Filters 2 
Pellicon 2 Cassettes 
30 kDa 
Millipore Sigma $7,200 
Sterile Filters 70 
Sartopore 
0.2 µm 
Sartorius $45,500 
Biotainers 70 
Nalgene 
10 L 
Thermo Fisher 
Scientific 
$7,100 
Bleach -- 56700 L  $153,400 
Autoclave bags 160 2.5 L 
Thermo Fisher 
Scientific 
$400 
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Table 20.2 Raw Materials: Small Production Bioreactor Design 
Upstream & Downstream Raw Materials: Small Production Bioreactor 
Raw Materials Units Specifications Vendor 
Purchase Cost 
($/batch) 
Cryovials 1 1000/pack Sigma-Aldrich $400 
Cryogenic storage 
boxes 
3 25/pack Thermo Scientific $1,700 
Liquid Nitrogen 2 55 gallon drum  $60 
ActiPro Powder 
Medium 
45 25 L bottle 
GE Healthcare Life 
Sciences 
$45,700 
CellBoost 7a Powder 
Medium 
70 10 L bottle 
GE Healthcare Life 
Sciences 
$125,100 
CellBoost 7b Powder 
Medium 
7 10 L bottle 
GE Healthcare Life 
Sciences 
$23,500 
Antifoam 10 2.5 L bottle 
GE Healthcare Life 
Sciences 
$440 
L-glutamine 100 500 mL bottle Millipore Sigma $3,000 
Sodium Hydroxide 
Pellets 
1 35 kg drum Millipore Sigma $700 
Sodium Bicarbonate 1 45 kg drum Millipore Sigma $900 
Propylene Glycol 1 55 gal drum 
Dow Chemical 
Company 
$800 
CHO Cell vials 1 
1 mL per vial 
3x105 cells/mL 
Thermo Fisher 
Scientific 
$600 
Media Filters 6 
Opticap XLT 10 
0.57 m2, 0.2µm 
Millipore Sigma $2,400 
Shake Flask 1 50 mL Corning $8.00 
Shake Flask 1 
250 mL 
6/pack 
Corning $160 
Shaker Flask Clamp 1  Eppendorf $40.00 
Cellbag 1 22 L 
GE Healthcare Life 
Sciences 
$500 
Cellbag 1 500 L 
GE Healthcare Life 
Sciences 
$1,000 
XDR-200 Probag 1 2000 L 
GE Healthcare Life 
Sciences 
$2,500 
Air Filters 10 
Durapore 
0.69m2, 0.22 µm 
GE Healthcare Life 
Sciences 
$4,000 
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Depth Filters 8 
Millistak Pod 
1.1 m2 
Millipore Sigma $6,000 
Protein A Resin 200 
MabSelect Sure LX 
1 L bottle 
GE Healthcare Life 
Sciences 
$1,600,000* 
Protein A Buffers -- 4100 L Millipore Sigma $4,000 
Diafiltration Filters 1 
Pellicon 2 Cassettes 
30 kDa 
Millipore Sigma $14,000 
Tromethamine 
Diafiltration Buffer 
1 25 kg Sigma-Aldrich $800 
PBS Diafiltration 
Buffer 
420 1 L  Millipore Sigma $13,900 
Capto S Cation Ex. 
Resin 
16 10 L bottle 
GE Healthcare Life 
Sciences 
$240,000* 
Cation Ex.  Buffers -- 2720 L Millipore Sigma $3,800 
Virus Filters 1 Virosart CPV Sartorius $10,000 
HIC Resin 23 
Poros Benzyl Ultra 
10 L bottle 
Thermo Fisher 
Scientific 
$89,000* 
HIC Buffers  5380L Millipore Sigma $4,300 
Diafiltration Filters 1 
Pellicon 2 Cassettes 
30 kDa 
Millipore Sigma $3,600 
Sterile Filters 42 
Sartopore 
0.2 µm 
Sartorius $27,300 
Biotainers 42 
Nalgene 
10 L 
Thermo Fisher 
Scientific 
$4,300 
Bleach -- 1400 L  $3,600 
Autoclave bags 160 2.5 L 
Thermo Fisher 
Scientific 
$200 
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21. Profitability Analyses- Business Case 
In order to validate the feasibility of these proposed process designs, a detailed 
profitability analysis has been performed. It is assumed that a 15% internal rate of return (IRR) 
will be desired within five years of the production start date. Production Year (PY) 5 has been 
selected as the reasonable time point by which a return would be desired, and also provides a 
uniform frame of reference for comparing all schemes. An effective tax rate of 37% has been 
used for all analyses. These constraints allow the required selling price of the mAb to be 
determined, and the superior design scheme to be selected.  
The two process designs have been evaluated using two separate frameworks. The first is 
the “off-patent” analysis, in which only the capital costs and operating costs are  considered in 
the economic evaluation. All R&D expenditures are exempt from the cash flow construction. 
This represents the expenditures incurred by a company that is trying to manufacture a generic 
drug from an existing drug whose patent has recently expired.  
The second is the “on-patent” analysis, in which the R&D expenditures, extended 
timeline, and probability of success of the drug has been factored in. In this case, the 15% IRR 
needs to be achieved before the patent expiration date.  
The Sales Forecast (Section 4) constructed from historical market data implies rapid 
uptake in the first few years, with a slight, small annual growth rate after about six years of 
production. Translating the sales forecast to the mass of mAb allows the required annual 
production capacity to be determined. This calculation has been performed using the market 
selling price of Ocrevus, at $65,000 per 1200 mg annual treatment. The results of this analysis 
are shown in Table 21.1. 
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Table 21.1 Annual Production Requirements 
YEAR Forecasted Ocrevus 
Sales ($MM) 
Treatments 
Administered 
mAb Required (kg) 
1 1,377 21,180 25 
2 3,331 51,250 62 
3 5,397 83,030 100 
4 6,908 106,280 128 
5 7,737 119,030 143 
6 8,666 133,320 160 
7 8,839 135,980 163 
8 9,016 138,700 166 
9 9,196 141,480 170 
10 9,380 144,310 173 
 
These production requirements determine how capacity is expected to scale up from year to year 
and has been factored into the operating costs on the cash flow analysis. 
 The desired internal rate of return (IRR) is 15%, which represents the percentage rate 
earned on each dollar invested within a given time frame. This can be calculated by calculating 
the net present value (NPV) of all cash flows using a discount rate equivalent to the IRR. The 
formula for NPV is, 
𝑁𝑃𝑉 = ∑
𝐶𝑡
(1 + 𝑟)𝑡
− 𝐶𝑜
𝑇
𝑡=1
 
where Ct is the cumulative cash flow at year t, Co is the total initial investment, r is the discount 
rate, and t is the number of years. The year at which the cumulative NPV is equal to 0, or 
become positive, is the “breakeven” year, representing to year at which the IRR has been earned.  
21.1 Off-Patent Analysis 
 In the off-patent analysis, it has been assumed that the project timeline starts in 
2018. Year 1 is dedicated to plant set-up and capital investment, while the first year of 
operations and sales is Year 2, or 2019. As explained in the patent analysis (Section 9), 
the price of a physician-administered drug drops between 38 and 48% following patent 
expiration.16 For this reason, a conservative selling price of $35,000, or a reduction of 
46% has been used in the off-patent profitability analyses.  
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21.1.1 Large Production Bioreactor Design 
An economic evaluation of the Large Production Bioreactor Design under 
this framework shows that a 15% IRR on the $33.6 MM initial investment cannot 
be earned within 5 years. Using the baseline price tag of $35,000 per 1200 mg 
treatment, the desired 15% IRR can be achieved by 2024, or the sixth year of 
production. At the end of Production Year 10, the cumulative Net Present Value 
(NPV) is about $9.1 billion. Though the desired outcome is not achieved, this is 
still a profitable scenario and can be explored and optimized further to achieve the 
desired return. A summarized cash flow analysis is shown in Table 21.2. The 
complete cash flow sheet for this analysis is shown in Appendix F.4.1  
Table 21.2 Condensed Cash Flow for Off-Patent Large Production Bioreactor Design 
YEAR Cash Flow ($MM) Cumulative NPV at 
15% IRR ($MM)  
2018 -3,093 -3,093 
2019 -1,516 -4,411 
2020 -890 -5,085 
2021 1,532 -4,077 
2022 3,171 -2,264 
2023 3,775 -387 
2024 5,199 1,860 
2025 5,734 4,016 
2026 5,850 5,929 
2027 5,967 7,625 
2028 6,087 9,130 
 
21.1.2 Small Production Bioreactor Design 
 Since the Small Production Bioreactor Design requires a smaller equipment and 
thus a reduced capital investment, the outcome from this analysis is slightly more 
profitable. Using the same baseline price of $35,000 per 1200 mg treatment, the desired 
15% IRR on the initial investment of $19.7 MM can be attained before the end of 2022, 
or the 4th year of production, and the cumulative NPV at the end of PY10 is $12.9 B. A 
summarized cash flow analysis is shown in Table 21.3. The complete cash flow sheet for 
this analysis is shown in Appendix F.4.2.  
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Table 21.3 Condensed Cash Flow for Off-Patent Small Bioreactor Design 
YEAR Cash Flow ($MM) Cumulative NPV at 
15% IRR ($MM)  
2018 -1,951 -1,951 
2019 -393 -2,293 
2020 -46 -2,328 
2021 2,205 -878 
2022 3,791 -1,289 
2023 4,280 3,417 
2024 5,279 5,700 
2025 5,720 7,850 
2026 5,775 9,738 
2027 5,951 11,429 
2028 6,071 12,930 
 
21.1.3 Price Sensitivity Analysis  
The profitability findings reported above reflect the projections for a selling price 
of $35,000 per 1200 mg treatment. This price estimate may need to be adjusted based on 
market conditions, competitive products, and the company’s financial situation. Figure 
21.1 shows how the selling price would affect the return on investment at Production 
Year (PY) 5 for both design schemes. Figure 21.2 shows the year at which the desired 
15% IRR will be attained at different prices. These analyses assume that the sales 
projections remain constant regardless of price. 
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Figure 21.1 Expected Return on Investment at the end of the 5th year  
of production as a function of treatment price 
 
 
 
Figure 21.2 This chart shows the year at which the desired 15% IRR will 
 be achieved as a function of treatment price 
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21.1.4 Sales Volume Sensitivity Analysis 
Another factor that heavily influences the profitability is the sales forecast. The 
revenues will depend on the number of treatments administered annually, which can only 
be forecasted from market data. The sales forecast, therefore, is subject to variability and 
a sensitivity analysis has been conducted to make an educated decision about the price 
point given the volatility of future market conditions. A range of forecasts has been 
constructed by multiplying the default annual administered treatments by several factors. 
Figure 21.3 shows how the sales forecast would affect the return on investment for both 
design schemes. Figure 21.4 shows how long it will take to achieve a 15% IRR given the 
range of sales forecasts.  
 
Figure 21.3 This graph shows the expected return on investment at the end of production year 5 
as a function of the percentage of forecasted sales truly realized 
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Figure 21.4 This chart shows the year at which the desired 15% IRR will be attained as a function 
of the sales forecast factor 
 
21.2 On-Patent Analysis 
The on-patent analysis requires evaluating the project over a longer timeline and 
with several additional cost and logistical considerations. Of all the discovery and 
development activities undertaken by research institutions and biopharmaceutical 
companies, very few products are able to ultimately be sold on the market. Many 
molecules are abandoned early in the development process, while others may fail to pass 
the final Phase III clinical trials. According to a study conducted by the Tufts Center for 
the Study of Drug Development, the probability of success for a biopharmaceutical drug 
is on average 11.83%.31 Factoring in this low success rate, the effective estimated average 
pre-tax industry cost for a new prescription drug approval is $2.56 billion, for which the 
timeline from discovery to market is approximately 128 months. This includes all 
activities associated with R&D, pilot plant development, and FDA regulated clinical 
trials. Of the $2.56 billion cost, 30.8% goes towards pre-human expenditures, meaning all 
activities before the product is tested in human patients. The FDA data for Ocrevus 
reveals that the clinical trial start date was March 15, 2011 and the final approval date 
was March 28, 2017. Based on this data, the timeline has been adjusted such that R&D 
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activities start in 2012, 7 years prior to the production start date. Pre-human expenditures 
have been spread across the four years from patent filing to the clinical trial start date, 
while the remaining 69.2% of the cost are incurred during the seven years in clinical 
trials. The baseline selling price for this framework is $65,000 per annual treatment, 
which is the Roche list price for the patented drug, Ocrevus. 
21.2.1 Large Production Bioreactor Design 
In the Large Production Bioreactor Design, the on-patent economic analysis 
shows that the desired 15% IRR will be achieved by 2023, or Production Year 5. This is 
earlier than what was found in the off-patent analysis, since the higher investment cost is 
more than offset by the increased revenues from the higher sales price. By Production 
Year 10 or 2028, the patent expiration date, the cumulative NPV is $5.3 B. A 
summarized cash flow analysis is shown in Table 21.4. The complete cash flow sheet for 
this analysis is shown in Appendix F.4.3.  
  
 171 
 
 
    Table 21.4 Condensed Cash Flow for On-Patent Large Production Bioreactor Design 
YEAR Cash Flow ($MM) Cumulative NPV at 
15% IRR ($MM)  
2008 -197 -197 
2009 -197 -369 
2010 -197 -518 
2011 -197 -647 
2012 -253 -792 
2013 -253 -918 
2014 -253 -1,027 
2015 -253 -1,122 
2016 -253 -1,205 
2017 -253 -1,277 
2018 -3,093 -2,042 
2019 -746 -2,202 
2020 -973 -2,020 
2021 4,550 -1,280 
2022 7,035 -286 
2023 8,102 709 
2024 10,045 1,783 
2025 10,678 2,775 
2026 10,892 3,655 
2027 11,110 4,436 
2028 14,393 5,315 
 
    
21.2.2 Small Production Bioreactor Design 
In the Small Production Bioreactor Design, the on-patent analysis shows a 15% 
IRR attained by the end of 2022, or Production Year 4. This scheme is slightly more 
profitable, with an NPV of $6.2 B by 2028. A summarized cash flow analysis is shown in 
Table 21.5. The complete cash flow sheet for this analysis is shown in Appendix F.4.4.  
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  Table 21.5 Condensed Cash Flow for On-Patent Small Production Bioreactor Design 
YEAR Cash Flow ($MM) Cumulative NPV at 
15% IRR ($MM)  
2008 -197 -197 
2009 -197 -369 
2010 -197 -518 
2011 -197 -647 
2012 -253 -792 
2013 -253 -918 
2014 -253 -1,027 
2015 -253 -1,122 
2016 -253 -1,205 
2017 -253 -1,277 
2018 -1,951 -1,759 
2019 377 -1,678 
2020 1,817 -1,338 
2021 5,224 -490 
2022 7,654 592 
2023 8,607 1,650 
2024 10,126 2,732 
2025 10,663 3,723 
2026 10,817 4,597 
2027 11,094 5,378 
2028 13,249 6,186 
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21.2.3 Price Sensitivity Analysis 
Although the selected sales price is representative of the true market price of 
Ocrevus, it is possible that the price will need to be adjusted higher or lower depending 
on the competitive landscape or the company’s financial situation. If the 15% IRR needs 
to be achieved sooner than the current forecast, a higher price tag may be required. Figure 
20.5 shows the price sensitivity to the rate of return at PY 4, while Figure 21.6 shows the 
years required to achieve a 15% IRR at a range of selling points.  
 
Figure 21.5 Expected Return on Investment at the end of the 5th year  
of production as a function of treatment price 
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Figure 21.6 This graph shows the year at which the desired 15% IRR  
will be achieved as a function of the treatment sales price 
 
21.2.4 Sales Volume Sensitivity Analysis 
As was true for the off-patent analysis, the sales forecast is an important factor in 
the profitability analysis. A range of forecasts has been constructed by assuming the true 
sales realized are 25%, 50%, 100% 150%, or 200% of the forecasted sales. Figure 21.7 
shows how the sales forecast would affect the return on investment for both design 
schemes. Figure 21.8 shows how long it will take to achieve a 15% IRR given the range 
of realized sales.  
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Figure 21.7 This graph shows the expected return on investment at the end of the fifth 
production year as a function of the percentage of forecasted sales that are actually realized 
 
 
Figure 21.8 This graph shows the year at which the desired 15% IRR will be attained as a 
function of the percentage of forecasted sales truly realized 
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21.3 Summary 
 From the analyses of the Large and Small Production Bioreactor Designs under both off-
patent and off-patent frameworks, it is clear that the Small Production Bioreactor Design is 
always more profitable. This is attributed to the smaller batch size, which downsizes the required 
equipment and thus the initial capital investment. Comparing the on-patent and off-patent 
frameworks, it can be seen that the desired 15% IRR can be earned within a shorter time period 
in the on-patent analysis, even though there are additional R&D investments required. This can 
be explained by the selling price of on-patent drugs, which is typically almost double that of the 
generic, off-patent counterpart.  
 
22. Additional Considerations 
22.1 Environmental Impact 
The manufacturing process for monoclonal antibodies, or for any biopharmaceutical 
product, has a sizeable environmental impact in the form of energy and water use and waste 
disposal. Aqueous wastes such as cell media and purification buffers are the most significant 
effluents in this process.32 In order to minimize the associated biohazard, these streams along 
with the solid cell waste will be inactivated with heat and neutralized through pH adjustment 
before they can be safely disposed.33 Further design initiatives could also be taken to explore the 
possibility of recycling reagents and streams back to the process.  
While the power and water consumption for traditional manufacturing processes is quite 
high, the use of single-use (SU), disposable equipment significantly reduces the carbon footprint 
of this project. Rigorous comparative analyses indicate that SU bioprocess technologies exhibit 
lower environmental impact than reusable bioprocessing technologies in all impact categories 
examined, from terrestrial ecotoxicity to marine eutrophication to ozone depletion. Several life-
cycle assessments (LCAs) conducted by ThermoFisher have demonstrated that single-use 
systems use less water and energy, and have a lower overall environmental impact compared to 
conventional fixed systems.34 For a typical commercial mAb production process at 3 x 2,000 L 
scale, a SU system used 87% less water, 29% less energy, and created 25% less CO2 emissions 
than a fixed system. These differences are mainly attributed to the water usage and energy 
consumption required for cleaning and sterilization processes. 
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In addition to the liquid and solid waste produced, there is a large amount of carbon 
dioxide that will be released. The major source for this CO2  are from the vented bioreactors, 
which release the gases unused by the cells. Because air is sparged in, the cells take up the 
oxygen for growth and CO2  is released. The amount CO2  released is calculated in Appendix E. 
Using Sanofi as an example pharmaceutical manufacturing company, their CO2 emissions were 
used as a basis for comparison. It was calculated that this process produces 4.1 million kg of CO2 
annually, which is approximately percent of their 455 million kg produced in their company 
annually. This means that this process produces approximately 6,400 kg CO2 per kg of mAb 
produced, using a four month time span to produce 100 kg. 35 
 
22.2 FDA Regulations  
The U.S Food and Drug Administration (FDA) regulates almost every facet of 
prescription drugs, including testing, manufacturing, labeling, advertising, marketing, efficacy, 
and safety. The Center for Drug Evaluation and Research (CDER) is the main player in the drug 
development and approval process, and has different requirements for the three main drug 
product types: new drugs, generic drugs, and over-the-counter drugs.  
Typically, once a promising compound is identified for developments, researchers 
conduct experiments to gather information on the metabolism, mechanisms of action, optimal 
dosage and administration, side-effects, biological variation, interactions, and efficacy. Before 
testing the drug in people, researchers must perform either in vivo or in vitro toxicity research, 
following FDA defined good laboratory practices (GLP), which set the minimum basic 
requirements for study conduct, personnel, facilities, equipment, written protocols, operating 
procedures, study reports, and quality assurance. The next step is to submit an Investigational 
New Drug (IND) application to CDER. Thirty days after the submission, clinical research phase 
trials may begin.36  
The purpose of the Phase 1 trial is to test the safety and dosage of the drug in 20-100 
healthy volunteers or people with the disease/condition. Approximately 70% of all drugs move 
on to Phase 2, in which up to several hundred participants with the disease and tested for upto 
two years for drug efficacy and side effects. This phase has a 33% passing rate. The Phase 3 
study tests for efficacy and monitors adverse reactions for 1-4 years in 300-3,000 volunteers with 
 178 
 
the disease or condition. The final Phase 4 is  another safety and efficacy trial for several 
thousand volunteer patients.  
If early evidence is positive, a New Drug Application (NDA) may be submitted to 
demonstrate that a drug is safe and effective for its intended use in the population studied. The 
review team then has 6 to 10 months to approve the drug. The approval process involves a 
project manager, medical officer, statistician, pharmacologist, pharmakineticist, chemist, and 
microbiologist. Each member reviews the relevant sections of the application, while FDA 
inspectors travel to the clinical study sites to conduct a routine inspection. The project manager 
then assembles an “action package” presenting the review team’s recommendation, and a senior 
FDA official makes a decision. The time and money involved in these steps has all been factored 
into the on-patent economic framework.  
The FDA continues to stay involved and performs routine inspections of the 
manufacturing facilities and performs post-market drug safety monitoring. Manufacturers are 
required to comply with the Current Good Manufacturing Practice (CGMP) regulations, which 
contain minimum requirements for the methods, facilities, and controls used in manufacturing, 
processing and packing of a drug product.37 To meet these requirements, the staff will be well-
trained and operators will monitor various quality checkpoints throughout the process. The use of 
disposable equipment enhances sterility by preventing cross-contamination.  
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23. Conclusions and Recommendations 
Based on the design exercises and economic analyses, it is recommended that the Small 
Production Bioreactor Design be implemented for the Ocrevus production project. This scheme, 
which makes use of disposable single-use bioreactors and staggers processes into small volume 
batches, is more cost effective both from a capital and operating cost perspective. It is also the 
preferred choice from an engineering perspective, as it is more flexible in terms of production 
scaling, it is easier to control operating conditions in smaller volume tanks, and there is reduced 
risk associated with a faulty batch. 
While the sales forecasts are subject to error, it can be concluded that a 15% IRR can be 
achieved with both an off-patent and on-patent product. For an off-patent sales price of $35,000 
per annual treatment, a 15% IRR can be achieved by 2024 even if sales are only 50% of the 
projected number. For an on-patent sales price of $65,000, a 15% IRR can be achieved by 2022 
under similar sales projections. Therefore, it is recommended that the off-patent drug be priced at 
$35,000 and the on-patent drug at $65,000 per 1200 mg annual treatment. These prices will 
ensure a 15% IRR within 6 years of production launch even if sales are much lower than 
forecasted.  
If a quicker return is desired, or if the market calls for the sales price to be lower than 
this, the incurred costs can be reduced by choosing less specialized operating equipment. Many 
of the reactors and processing units selected for this design are top-of-the-line and make use of 
sophisticated control units. By employing more traditional controls and choosing generic 
equipment manufacturers, many of these capital and operating costs may be reduced.  
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Appendix A - Cryogenic Recovery of the CHO Cells 
 The CHO cells will be stored in a cryogenic freezing tank, and must be recovered before 
the start of the inoculum preparation steps, which is the first step in mAb production and 
processing. The protocol for recovering CHO cells are as follows.44  
1. The frozen 1mL vial of CHO cells must be removed from the cryogenic storage vessel 
and thawed to room temperature 
2. Fresh ActiPro growth medium, which contains 2.8 g/L of sodium bicarbonate, should be 
added to a 15mL conical tube along with the thawed cells..  
3. The cells should be centrifuged at 1,000 rpm for 5 minutes. After centrifugation, the cells 
should be in pellet form at the bottom of the conical tube. 
4. Excess culture media should be suctioned from the conical tube without suctioning up the 
cells, and the cells should be resuspended in 1 mL of fresh media.  
5. After counting the cells with a hemocytometer, the cells should be re-inoculated in fresh 
ActiPro growth medium at a density of 3x106 cells/mL in a T-75 cell culture flask. 
6. The flask containing the cell culture should be incubated at 36.5°C and 7.5% CO2 for 3 
days. 
7. The cells should be passaged according to CHO specific protocols, but follow general 
steps of: media wash to remove dead cells, trypsin incubation for cell detachment from 
the culture surface, trypsin neutralization and centrifugation, and counting for 
resuspension at a density of 3x106 cells/mL in a T-75 cell culture flask. 
8. The cells should be passaged as in Step 7 at least 2 times before transferring cells to 
inoculum preparation steps. 
9. Just before seeding into the inoculum preparation steps, the cells should be counted for 
resuspension at a density of 3x105cells/mL in 30 mL of fresh ActiPro growth media.  
 
  
 186 
 
Appendix B - Growth Media and Feed Supplement Reconstitution 
The media used in the upstream production process will be purchased as a powder. 
Before being added to the bioreactors, it needs to be reconstituted with WFI, as shown in the 
media prep trains in Section 12. The following protocols will be used.  
ActiPro Medium Reconstitution Protocol38 
1. Fill a clean mixing vessel to 96% of the final volume with high-quality purified 
water, such as WFI, at ambient temperature (18°C to 25°C) and start mixing.  
2. Add 22.36 g/L ActiPro powder slowly to the vessel, avoiding formation of 
clumps. Mix until no clumps of powder remain. The solution will remain cloudy 
in this step, but should be clear of any clumps or dry powder residues. 
3. Slowly add 6.5mL/L of a 5 N NaOH solution or 3.25 mL/L of a 10 N NaOH 
solution and mix until solution is clear.  
4. Add 1.8g/L sodium bicarbonate into the vessel and mix until dissolved. 
5. Adjust the pH to between 6.90 and 7.35 by dropwise addition of 5 N or 10 N 
NaOh or HCl. After adjusting, continue mixing for an additional 20 minutes to 
ensure that all components are completely dissolved.  
6. Adjust to the final volume with WFI and mix for an additional 10 minutes. 
7. Measure and record the final pH and osmolality. The expected pH is 6.90 and 
7.55 and the expected osmolality is 270 to 330 mOsmol/kg.  
8. Sterilize immediately by membrane filtration. Use a low-binding filter membrane.  
9. Store the reconstituted medium protected from light at 2°C to 8°C until use.  
CellBoost 7a Powder Supplement Reconstitution39 
1. Fill a clean mixing vessel to 80% of the final volume with WFI at ambient 
temperature and start stirring.  
2. Add 181.04 g/L CellBoost 7a powder slowly to the vessel, avoiding formation of 
clumps. Mix for 30 minutes. The solution will remain cloudy in this step, but 
should be clear of any clumps or dry powder residues.  
3. Slowly add 18.6 mL/L of a 5 N NaOH solution or 9.3 mL/L of a 10 N NaOH 
solution and mix for 60 minutes.  
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4. Adjust the pH to between 6.60 and 6.80 by dropwise addition of 5 or 10 N NaOH 
or HCl. After adjusting, continue stirring for an additional 60 minutes to ensure 
that all components are completely dissolved.  
5. Adjust to the final volume with high-quality purified water, such as WFI, and stir 
for an additional 10 minutes.  
6. Measure and record the final pH and osmolality.  The expected pH is 6.60 and 
6.80 and the expected osmolality is 247 to 303 mOsmol/kg.  
7. Sterilize immediately by membrane filtration. Use a low-binding filter membrane 
type. 
8. Store the reconstituted supplement protected from light at 2°C to 8°C until use. 
CellBoost 7b Powder Supplement Reconstitution39 
1. Fill a clean mixing vessel to 80% of the final volume with WFI at ambient 
temperature and start stirring.  
2. Add 94.6 g/L CellBoost 7b powder slowly to the vessel, avoiding formation of 
clumps. Mix for 30 minutes. The solution will remain cloudy in this step, but 
should be clear of any clumps or dry powder residues.  
3. Slowly add 160.5 mL/L of a 5 N NaOH solution or 80.25 mL/L of a 10 N NaOH 
solution and mix for 60 minutes.  
4. Adjust the pH to between 11.0 and 11.4 by dropwise addition of 5 or 10 N NaOH 
or HCl. After adjusting, continue stirring for an additional 60 minutes to ensure 
that all components are completely dissolved.  
5. Adjust to the final volume with high-quality purified water, such as WFI, and stir 
for an additional 10 minutes.  
6. Measure and record the final pH and osmolality.  The expected pH is 11.0 and 
11.4 and the expected osmolality is 218 to 266 mOsmol/kg.  
7. Sterilize immediately by membrane filtration. Use a low-binding filter membrane 
type. 
8. Store the reconstituted supplement protected from light at 2°C to 8°C until use.  
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Appendix C - Clean-in-Place (CIP) & Steam-in-Place (SIP) Protocol 
Clean-in-Place Protocol40 
The Clean-in-place (CIP) process typically involves three cycles after draining the 
process tank, which can be accomplished during harvest or transfer of the cells. 
1.  Initially rinse the tank using room temperature, or warm, water for injection 
(WFI) using a volume proportioned to the inner surface area of the vessel at a 
flow rate sufficient to forcefully-impinge on the vessel surface to flush the easy-
to-remove contents/debris. 
2.  Clean/wash using heated caustic solution at about a 3 to 8 wt% sodium hydroxide 
aqueous solution, at a flow rate sufficient to forcefully-impinge on the vessel 
surface. This solution may me heated to 85°C. The wash volume used may equal 
the rinse volume used in Step 1.  
3. Wash with WFI for a final rinse. The totalized final rinse volume used may equal 
the rinse volume used in Step 1. 
 
 Steam-in-place Protocol41 
Once the CIP cycle is complete it will be followed by a Sterilize (or Steam) In 
Place (SIP) step. This involves flowing steam into and through the vessel and all process 
connections that require thermal sterilization, such as transfer lines, vent lines, and 
valves. Once all surfaces are brought to greater than 121°C, the system is held at that 
temperature for more than 15 minutes, often 30 to 60 minutes. Once the SIP time period 
has elapsed, the steam flow is stopped, and sterile air is admitted into the tank to displace 
the steam and to maintain a slight positive pressure to ensure no-entry of native 
contamination. Often live steam will continue to be supplied to lines connected to sterile, 
process vessels, with closed, isolation valves used to prevent additional steam from 
entering the sterile vessel. Steam traps are connected to the low-points of these lines, 
served with live steam, to provide an exit point for steam condensate. To estimate the 
amount of steam needed for each piece of equipment, an estimate is needed of: the 
volume of steam needed to fill the vessel and all related pipeline connections plus the 
steam needed to bring the temperature of the process equipment mass from its starting 
temperature to the SIP/sterilization temperature. Manufacturing facilities often have on-
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site fossil-fuel powered boilers; however, if lacking this an electrically-powered steam 
generator (often significantly smaller than gas or oil fired, will serve the purpose if the 
peak steam usage rate can be met.  
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Appendix D - Oxygen Transfer and Gas Sparging 
Oxygen mass transfer and gas sparging rates are critical parameters for cell survival and 
high product formation in the upstream cell bioreactions. Oxygen (O2) mass transfer was 
calculated based on a desired setpoint of 40% dissolved O2 and a given requirement of 0.19 pmol 
of O2 per cell per hour. Using Equation D.1, the oxygen uptake rate by the cells was calculated.  
𝑂𝑈𝑅 =  𝑞𝑂2 × [𝐶𝑒𝑙𝑙𝑠]𝑚𝑎𝑥 × 𝑀𝑊𝑂2    (D.1) 
where, OUR = oxygen uptake rate [g/L/h] 
 qO2 = oxygen requirement [mol/cell/h] 
[Cells]max = maximum cell concentration in the reactor [cells/L] 
MWO2 = molecular weight of oxygen [g/mol] 
 
Then, assuming the oxygen uptake rate was equivalent to the oxygen transfer rate (OTR), 
an oxygen mass transfer coefficient was calculated using Equation D.2  
𝑂𝑈𝑅 =  𝑂𝑇𝑅 =  𝑘𝐿𝑎 × 𝐶𝑂2
∗ × (1 − 𝐷𝑂)  (D.2) 
where, OTR = oxygen transfer rate [g/L/h] 
 kLa = oxygen mass transfer coefficient [h
-1] 
 C*O2 = solubility of O2 in water at 1 atm, 36.5°C [g/L] 
 DO = setpoint for dissolved oxygen in water  
 
Using the calculated oxygen mass transfer coefficient, which should have a value 
between 12 and 15 h-1, the Van’t Riet equation shown in Equation D.3 was applied to find the 
superficial gas velocity assuming the total specific energy dissipation rate in the bioreactor was 
55 W/m3, or 0.055 W/kg, assuming water is the main volumetric component in the bioreactor. 
The total specific energy dissipation rate includes both the impeller and gas sparging 
operations.42 
𝑘𝐿𝑎 =  𝐴(𝜀𝑇)
𝛼(𝑢𝑠)
𝛽    (D.3) 
where,  A = constant, coalesced system 
⍺, β = constants, coalesced system 
 ɛT = total specific energy dissipation rate [W/kg] 
 us = superficial gas velocity [m/s] 
 
By multiplying the newly calculated superficial gas velocity by the cross-sectional area of 
the tank, the required sparged flow rate of oxygen for adequate cell growth can be evaluated. 
Note that the cross-sectional area of the tanks were calculated based on the assumption of 
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cylindrical geometry with a height to diameter ratio of 2:1. The relevant equations for these 
calculations can be found in Equations D.4 and D.5. 
𝑄𝑂2 =  𝑢𝑠 × 𝐶𝑆𝐴 × 1000   (D.4)  
𝑄𝑎𝑖𝑟 =
𝑄𝑂2×𝜌𝑂2×𝑀𝑊𝑂2×𝑅×𝑇
0.21×𝑃
   (D.5) 
𝑄𝑣𝑣𝑚,𝑎𝑖𝑟 =
𝑄𝑎𝑖𝑟×60
𝑉𝑡𝑎𝑛𝑘
   
where,  QO2 = required flow rate of sparged oxygen [L/h] 
 CSA = cross-sectional area of a cylindrical tank [m2] 
 ⍴O2 = density of O2 at 1 atm, 36.5°C [g/L] 
 R = gas constant [J/mol K] 
 T = temperature of bioreactor [K] 
 P = pressure of bioreactor [Pa] 
 Qair = required flow rate of sparged air [L/h] 
Qvvm, air = required flow rate of sparged air [vvm, volume of air sparged 
under standard conditions per volume of liquid per minute] 
Vtank = volume of the bioreactor [L] 
 
 ɛT = total specific energy dissipation rate [W/kg] 
 us = superficial gas velocity [m/s] 
 
Because the solubility of oxygen in water at atmospheric pressure and 36.5°C is so low at 
a value of 0.00678 mg/L, it is not accurate to assume 100% of the sparged air will be taken up by 
the cells. Therefore, a conservative estimate of 30% of the sparged air was assumed to be taken 
up by the cells as oxygen, with the remaining gases filling the headspace and eventually being 
vented. 
All gas sparging rates should be below values of 0.05 vvm to reduce foaming and 
prevent formation of large bubbles that will be toxic to the cells upon dissipation.42 
All values for known variables, along with the calculated air sparging rates for larger 
bioreactor volumes are listed below in Table D.   
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Table D. Oxygen mass transfer rate and gas flowrates for large volume bioreactors 
Known Variables 
qO2     
[Cells]max     
MWO2       
(mol/cell/h) 
(cells/L) 
(g/mol) 
0.19 
9x103 
32 
C*O2                                   
DO                                           
 (g/L)   0.00678 
0.4 
A 
α 
β 
εT                                   
 
 
 
(W/kg) 
0.026 
0.4 
0.5 
0.055 
CSA, H/D = 2     
 
(m2) 6.80 
ρO2, 1 atm, 36.5˚C             
MWO2                            
R                                
T                                          
P                                         
Vtank                                                              
 (g/L) 
(g/mol)     
(J/mol K) 
(K) 
(Pa) 
(L) 
1.26 
32 
8.31 
310 
200,000 
20,000 
Tank Size Air sparging rate [vvm], assuming 
30% uptake 
500 L  0.0423 
2,000 L 0.0211 
20,000 L 0.00981 
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Appendix E - Exhaust Venting Rates 
Because only 30% of sparged air is taken up by the cells, this leaves 70% of the sparged 
air to fill the remaining headspace and eventually to be released into the atmosphere through the 
exhaust vents in each of the bioreactors. In addition, to O2 and N2, CO2 must also be stripped 
from the culture solution and vented from the bioreactors. Cells produce CO2 as a result of 
glucose uptake and use as energy, however CO2 concentration is a highly controlled parameter 
that acutely affects cell growth and product quality. It can also displace oxygen as the main gas 
dissolved in the culture media, which limits further the amount of oxygen available for cellular 
uptake. The molar ratio of O2 uptake to CO2 production by the cells was assumed to be 1, and 
from this the amount of CO2 that needs to be stripped and vented can be calculated. All values 
for known variables, along with the calculated CO2, O2, and N2 venting rates for larger bioreactor 
volumes are listed below in Table E. 
 
Table E. Venting rates for Oxygen, Nitrogen, and Carbon Dioxide in large volume bioreactors 
Known Variables 
ρO2, 1 atm, 36.5˚C             
ρN2, 1 atm, 36.5˚C             
ρCO2, 1 atm, 36.5˚C             
(g/L)  
(g/L) 
(g/L) 
1.26 
1.09 
1.72 
qCO2 (mol/cell/h) 0.19x10
-12 
Tank Size CO2 
venting 
[kg/h] 
O2 venting 
[kg/h] 
N2 venting 
[kg/h] 
500 L  0.000026 0.116 0.38 
2,000 L 0.0000685 0.464 1.53 
20,000 L 1.02 2.15 7.09 
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Fig 1. ReadyToProcess WAVE 25 bioreactor system.
ReadyToProcess™
The single-use ReadyToProcess WAVE™ 25 rocking bioreactor 
system is a reliable and intuitive cell culture system for working 
volumes up to 25 L (Fig 1). The system is based on a well-known 
rocking technology that provides mixing and aeration to the culture, 
which is maintained in an inflated, disposable Cellbag™ bioreactor 
cultivation chamber.
With ReadyToProcess WAVE 25, the rocking technology is enhanced 
with features such as advanced sensors and intelligent control 
strategies. System operation is easily managed via the intuitive 
and user-friendly UNICORN™ system control software. The system 
is designed for fast installation and convenient handling, and it 
delivers a reliable and accurate performance suitable for research, 
process development, and manufacturing operations.
ReadyToProcess WAVE 25 offers the following benefits:
• Robust and reliable performance
• Intelligent and accurate process control
• Designed for ease of use
• Flexible operations with possibility of use in single or 
dual culture mode
• Suitable for manufacturing in a regulated environment
System benefits
Robust and reliable performance
ReadyToProcess WAVE 25 is designed to make hardware, 
consumables, and software work together in an integrated 
manner. The system has been tested in real applications for 
reliable performance. To decrease the risk for data losses, 
the system comprises two, mirrored, solid-state drives 
for data storage.
Intelligent and accurate process control
The system is equipped with advanced sensors and automated 
controllers for temperature, liquid handling, pH, and dissolved 
oxygen (DO). The system dynamics have been methodically 
characterized and the results used to create a library of 
predefined control parameters tailored for different cultivation 
WAVE 25 rocking 
bioreactor system
volumes. The system can automatically determine suitable 
parameters for a run, a feature that facilitates fast start-up and 
enables accurate and stable control.
Easy to use
ReadyToProcess WAVE 25 system is designed for ease of use. 
Cellbag bioreactor attachment is straightforward and system 
operation is conveniently managed with the UNICORN software, 
with menus and process pictures that are easily accessible 
and interpretable. The harvest operation is facilitated by an 
innovative tilt function that avoids the need for heavy lifting.
Flexible operations with possibility of use in single or 
dual culture mode
With ReadyToProcess WAVE 25, one or two cultures can be run 
at the same time with high control accuracy. When dual mode is 
used, two cultivations can be run using the same or different bag 
sizes and/or working volumes. Parameters such as temperature, 
pH, and DO can be controlled independently in the two Cellbag 
bioreactors. Separate pump units control liquid addition and/or 
removal, for example, to enable tailored feeding strategies, base 
addition, or perfusion in the two parallel cultures.
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Suitable for manufacturing in a regulated environment
ReadyToProcess WAVE 25 is designed to meet the demands and 
standards that are required in a regulated environment. The 
documentation is extensive and includes material certificates, 
system specifications, installation and operational qualification 
(IQ/OQ) protocols, and a detailed user manual. The UNICORN 
software is suitable for use in a manner that complies with 21 CFR 
Part 11 and Good Automated Manufacturing Practice (GAMP™) 5.
System overview
ReadyToProcess WAVE 25 system components
The ReadyToProcess WAVE 25 system consists of a rocker, CBCU 
gas mixers, and pumps, all operated by the UNICORN software 
installed on a client computer. The rocker is the main unit and is 
used together with a tray and a disposable Cellbag bioreactor. 
When operated in dual culture mode, culturing can be performed 
in two separate Cellbag bioreactors simultaneously, although 
controlled separately. The rocker has multiple functions, amongst 
them including temperature control, culture mixing, and weight 
measurement. The CBCU contains a gas mixer that delivers gas 
of a defined composition to the culture and is used together with 
the optical sensors of the Cellbag bioreactor for online control of 
culture pH and DO. Liquid is delivered accurately to the culture 
by ReadyToProcess Pump 25. The pump unit has a flow range 
covering multiple applications, from additions of feed and base to 
perfusion culturing. Up to two CBCU gas mixers and up to three 
pump units can be connected to ReadyToProcess WAVE 25. An 
overview of the ReadyToProcess WAVE 25 system is shown in 
Figure 2. The individual components are described in detail below.
Graphical user 
interface
Client computer 
Installed with UNICORN software. 
Can control up to three 
ReadyToProcess WAVE 25 systems
UNICORN software
• Administration
• System control
• Method editor
• Evaluation
UNICORN software
At home or within
enterprise network
UNICORN
database
LAN
OPC
System setup and integration of subunits
ReadyToProcess WAVE 25, rocker
Rocker, temperature sensors, 
scale, embedded controller, 
and dual hard drives
ReadyToProcess WAVE 25, rocker
• Rocking
• Weight measurement
• Temperature measurement
Controller with
dual hard drives
ReadyToProcess Pump 25
Peristaltic pump
ReadyToProcess Pump 25
• Acid/base for pH control
• Feed/harvest for perfusion or medium addition
• Up to three pump 25 units can be connected
ReadyToProcess CBCU
• Gas flow/mix
• pH measurement
• DO measurement
• Up to two CBCU can be connected
Lid
Tray ReadyToProcess CBCU
Gas flow/mix controller, 
pH and DO sensors
E-mail 
notifications
Firewall
SCADA
(not included)
Fig 2. ReadyToProcess WAVE 25 system overview. The System Control module on the client computer is used to start and monitor the cultivation process. 
One UNICORN client can control up to three ReadyToProcess WAVE 25 systems simultaneously. SCADA = supervisory control and data acquisition, 
OPC = open platform communications, LAN = local area network.
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ReadyToProcess WAVE 25, rocker
The rocker is the main hardware unit of the system and provides 
mixing through the rocking, reliable temperature measurement 
from integrated sensors, and accurate weight measurement 
from integrated load cells. The ergonomic design makes handling 
convenient and easy. The ability to handle the bioreactor in a 
tilt position facilitates sampling and harvest (Fig 3). The minimal 
footprint facilitates placement when space is limited.
Fig 3. (A) The ergonomic design makes activities such as sampling and 
harvest convenient and easy. (B) ReadyToProcess WAVE 25 in tilt position.
Fig 4. The tray has an easy lock mechanism for convenient and proper 
attachment of Cellbag bioreactors.
(A) (B)
Trays and lids
Trays are available in three different sizes for culturing of up to 
5 L, 10 L, and 25 L, respectively. The trays are easily attached to 
the rocker when in the tilt position. A snap lock mechanism allows 
Cellbag bioreactors to be correctly installed and rapidly changed 
(Fig 4). To protect light-sensitive components of the culture 
medium and to prolong the life of the optical sensors, lids are 
available for all tray sizes.
Temperature control
Efficient and evenly distributed heating is provided by the tray 
heater plate. The temperature control is managed by sensors 
that are integrated in the rocker base unit to enable reliable 
temperature measurement and to minimize the need for 
calibration when changing trays (Fig 5). To minimize the risk 
for overheating, heating is only enabled when the rocker is in 
motion. For accurate, stable, and fast temperature control, the 
heater power output is automatically adjusted based on the 
Cellbag bioreactor size and content weight. Temperature control 
in two separate Cellbag bioreactor cultures when using the dual 
functionality is shown in Figure 6.
40
0 60 90
Time (min)
Te
m
pe
ra
tu
re
 (°
C)
30
35
30
25
20
Heating, left culture
Temp. set point, left culture
Heating, right culture
Temp. set point, right culture
Temperature sensors
Snap locks
Fig 5. Integrated temperature sensors for convenient handling and reliable 
temperature control.
Fig 6. Temperature is accurately controlled independently in two separate 
5 L cultures using the dual functionality (ambient temperature 22°C).
Mixing and gas transfer
The adjustable rocking parameters are speed, angle, and motion. 
The parameter settings, in combination with the cell culture 
volume, affect the mixing and gas transfer rate in the Cellbag 
bioreactor. The speed parameter determines the number of 
rocking cycles per minute, and the angle parameter relates to the 
tray’s degree of tilting at the turning points. The motion parameter 
determines the acceleration profile. The lowest motion parameter 
setting, 15%, gives an almost constant speed throughout the 
rocking cycle. In contrast, the highest setting, 100%, gives a faster 
speed in the middle of the cycle and slower at the turning points. 
Whereas oxygen transfer coefficient increases with increasing 
rocking speed and angle, the rocking motion pattern only has a 
minor effect on the oxygen transfer rate (Fig 7).
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Fig 7. 4D contour plot of the oxygen transfer coefficient at the highest (100%) and lowest (15%) rocking motion parameter settings.
Weight measurement
Load cells integrated in the rocker provide accurate and 
continuous weight measurement of the culture and eliminate 
the need for external scales. In dual mode, separate weight 
measurements are provided for each Cellbag bioreactor. The 
load cells communicate with the system control function 
for proper media handling and tailored regulation of pH and 
temperature. The weight measurement functionality is also used 
for automatic calibration of the pumps in perfusion cultures. An 
adjustable foot enables equal weight distribution between the 
load cells even on nonlevel surfaces, for increased precision of 
the weight measurement.
Data storage and communication
Data and control parameters from the cell culture run are stored 
on two independent, mirrored, solid-state drives integrated in 
the rocker. Thus, once cultivation has been started and data 
from the instrument modules have been collected, the run can 
continue without the need for a network connection. The use of 
two solid-state drives enables culturing without losing any data 
even if only one drive is functional. After a run, data is stored in 
a UNICORN database on an external computer. For facilitated 
integration into a larger manufacturing operation, the rocker also 
contains software for enabling direct communication with the 
system via an open platform communication (OPC) link.
ReadyToProcess CBCU
The ReadyToProcess CBCU gas mixer is a compact unit with 
multiple functions. The unit is primarily used for providing gas to 
the culture and for monitoring of pH and DO. The unit contains 
a mass flow controller, sensors for gas pressure and O2 and CO2 
concentrations, and transmitters for pH and DO (Table 1).
Table 1. ReadyToProcess CBCU gas mixer overview
Feature Description
CO2/O2/air mix 
controller
Depending on the configuration, air is mixed with CO2 
and/or O2 according to the set-points. Nitrogen can 
be used instead of air for maintaining a low oxygen 
environment for near-anaerobic applications.
Gas flow controller The gas-mix flow is measured and controlled by a 
mass flow controller (MFC). A correct volumetric flow 
is achieved by compensation for CO2 concentration. 
Quick filling of gas into the Cellbag bioreactor, enabled 
by the fast-fill function, significantly reduces start-up 
time. An alarm will inform the user if pressure sensors 
detect under or overpressure at the gas inlets or 
within the Cellbag bioreactor.
pH measurement The pH is measured with optical pH sensors 
preinstalled in Cellbag bioreactors of pHOPT 
type. The sensor is connected to the CBCU via an 
optical fiber cable.
DO measurement The DO level is measured with optical DO sensors 
preinstalled in Cellbag bioreactors of DOOPT 
type. The sensor is connected to the CBCU via an 
optical fiber cable.
Three CBCU configurations are available:
• CO2, O2, and pH
• CO2, O2, and DO
• CO2, O2, pH, and DO
The most suitable CBCU configuration will depend on the 
specific application.
ReadyToProcess Pump 25
The ReadyToProcess Pump 25 is a peristaltic unit incorporating 
two roller pumps for feed, harvest, and pH control. The pump 
design makes tubing installation convenient and easy. Tubing sizes 
from 0.5 mm (1/50”) to 4.8 mm (3/16”) internal diameter can be 
used to support flow rates from 0.07 to 100 mL/min. Flow rate is 
regulated by weight feedback from the scale and is controlled by 
automatic adjustments of the pump speed. Manual adjustment of 
the flow rate is also possible.
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Up to three pump units with a total of six pump heads can be 
connected to the rocker. Up to six pump roles can be selected 
from a set of 12 options (left: acid, base, feed1, feed2, feed3, or 
harvest; and right: acid, base, feed1, feed2, feed3, or harvest) for 
the dual mode and seven options (acid, base, feed1, feed2, feed3, 
feed4, or harvest) for the single mode.
Media handling and perfusion using calibrated pumps
Calibration of pumps can be performed manually or automatically 
during an ongoing perfusion process. Automatic calibration is 
possible for flow rates above 3.5 L/d and is easily managed by 
entering the tubing diameter in the UNICORN control software.
Automated pH control
To minimize fluctuations in pH during adjustments with CO2/base 
or acid/base, the flow rate of the acid/base pumps needs to be 
rigorously controlled. The ReadyToProcess WAVE 25 system uses 
combined information from the load cells, the current process pH 
value, the pump tubing diameter, and the acid/base molarity for 
calculation of the needed flow rate during the run.
Automation of process parameters in pH and DO control
The UNICORN software automatically sets the desired PID 
(Proportional-integral-derivative) control parameters based on 
Cellbag bioreactor size and gas flow set-point. The system also 
adapts the parameters during the run, for optimization to reach a 
new set-point or to maintain a current set-point.
UNICORN software
UNICORN system control software consists of four modules: 
Administration, Method editor, System control, and Evaluation. A 
comprehensive help tool is also included.
Administration
The Administration module is used to administer all functions of 
the UNICORN software. Available functions include user and email 
setup, controlling access to groups and network users, defining 
and editing system properties, database management, and 
logging records of usage and activity.
Method editor
Instructions to control a bioreactor run can be defined in a 
method. The Method editor module is used to create, edit, save, 
and work with methods. An existing method can be changed 
to simplify the editing process. Individual changes can be saved 
for later use on systems that have the same instrument and 
component configuration.
System control
The System control module is used to connect to the system as 
well as to start, view, and control a run (Fig 8). Default parameter 
values for an instrument can be viewed and edited in the System 
settings dialog before a run is started or during an ongoing 
run using manual instructions. It is also possible to connect 
to other systems.
Fig 8. Monitoring and controlling all aspects of the culture is managed 
through the user-friendly interface.
The user-friendly and intuitive Process picture pane enables 
manual interaction with the system and provides status of the 
run parameters. Data is shown in the process picture but can also 
be viewed as curves in the Charts tab. Curves and information 
about the run are saved in a database, which can be opened in 
the Evaluation module. The default view shows the curves most 
commonly used. The user can customize which curves to display 
and the color and style of the displayed curves.
Evaluation
In the Evaluation module, content of the result files can be viewed, 
analyzed, and compiled as reports. Reports can be customized, 
saved, and printed.
Alarms, notifications, and data logging
The UNICORN software allows easy access to all operations, data, 
and alarm conditions. A dynamic, graphical user interface shows 
the real-time status of the run, while data are automatically saved. 
From the UNICORN software, the system is easily configured 
to trigger an alarm when certain conditions are met. Individual 
deviation alarms can be set for all essential parameters (heating, 
gas flow, weight, O2, CO2, pH, and DO). The regulation of alarm 
sensitivity and delay is defined by the user. If such an alarm 
condition is triggered, the part of the system generating the alarm 
is highlighted in the graphical user interface and an alarm dialog 
is displayed. The alarm dialog displays information about the 
alarm, such as date and time of occurrence, as well as a help text 
describing the cause of the alarm and how to solve the problem. 
The system is easily configured to send email notifications of 
alarms and errors.
Regulatory readiness
The ReadyToProcess WAVE 25 system is suitable for 
biomanufacturing of regulated products under various Quality 
Management Systems. The use of UNICORN software in a 21 CFR 
Part 11 and GAMP 5 compliant manner enables use of the system 
in a regulated environment. Individual user access permissions 
can be set and individual users are password-protected. Active 
processes can be locked to enable unattended operations 
without the risk of unauthorized interference. All records are 
stored in a single, unalterable database, including results and 
6  KA1658100118DF
extended run documentation. Additional validation support 
includes comprehensive documentation on control system 
validation as well as IQ/OQ services. The IQ/OQ offers proven 
test procedures, verifying that the equipment has been installed 
in accordance with system drawings and specifications. The 
IQ/OQ also assures that the system operates as specified in the 
design, satisfying functional requirements. The IQ/OQ protocols 
enable quality assurance and allow regulatory reviewers to verify 
that all functional testing of the quality critical equipment and 
components, including the requirements of 21 CFR Part 11, has 
been performed and documented.
Available validation support documentation includes:
• Detailed description of the development model used for 
UNICORN software
• 21 CFR Part 11 system assessment in checklist format
• Audit report and 21 CFR Part 11 conclusion on functionality by 
an external, independent expert
Networking capabilities
UNICORN 7 operates in Windows® 7 and Windows 10 environments, 
and the network ability allows real-time control from a remote 
or local computer. Communication is Ethernet-based and each 
instrument is controlled by a built-in instrument server. One 
database can be connected to 32 systems, and up to three 
instruments can be controlled simultaneously from one UNICORN 
client. Results are saved locally, in the rocker, during the run and then 
stored on the database server. Because results and instructions are 
saved locally on the embedded drives, a run can continue even in the 
event of a network communication failure.
Many users within biopharmaceutical and pharmaceutical 
operations require automation in seed train and process 
development. Although UNICORN provides the capability to 
control standalone WAVE 25 bioreactors, many users of the 
Emerson DeltaV™ Distributed Control System (DCS) prefer a 
single interface to monitor and control all unit operations together, 
including a WAVE 25 bioreactor system.
OPC UaGateway®
As an alternative to UNICORN communication, a WAVE 25 system 
can also be setup to communicate set points and monitor process 
values from the DeltaV operator station. To accomplish this, the 
Open Platform Communications (OPC) UaGateway option that 
comes with the WAVE 25 system can be used. The OPC UaGateway 
provides a more streamlined connection for process control 
and monitoring; it eliminates complexities associated with the 
Distributed Component Object Model (DCOM)-based configuration.
The bags are manufactured from multilayer, laminated, clear 
USP Class VI plastics and are easily connected to the full suite 
of ReadyToProcess cell culture, purification, and fluid handling 
products. Table 2 shows possible combinations of Cellbag 
bioreactors and trays when culturing in single or dual mode.
Cellbag bioreactors are available in two films: Bioclear™ 10 and the 
low-antioxidant Bioclear 11. For more information about Cellbag 
bioreactors, see data file 28951136.
Air outlet 
filter
Inoculation/
harvest lines
Optional 
tubing
Cellbag rod
Air inlet 
filter
Optical 
pH sensor
embedded
in bag
Optional 
tubing
Optional 
tubing
Optical 
DO sensor
embedded
in bag
Needleless
sampling port
Fig 11. Presentation of typical Cellbag bioreactor fittings.
Fig 9. Setup of the WAVE 25 Bioreactor System on a client PC with DeltaV.
OPC
communication
Fig 10. UaGateway architecture.
WAVE 25 EPC External PC
UNICORN DeltaV™
UNICORN OPC layer OPC mirror
OPC DA to UaGateway OPC UA to DA Gateway
GE owned GE owned – New Non GE
The architecture in Figure 9 shows a system consisting of an 
embedded personal computer (EPC) on the WAVE 25 system and a 
Client PC (any Windows system) on DeltaV.
UaGateway is used as data communication tunneller between the 
WAVE 25 and the DeltaV systems.  Two OPC UaGateway instances 
are required for communication: the first instance is installed on 
the WAVE 25 system, the second instance goes on the DeltaV OPC 
server on the user’s network. Because two OPC servers do not 
communicate directly according to the OPC protocol, a third-party 
data manager or an OPC bridge software needs to be added and 
configured to allow communication between the two OPC servers.
Please note that UNICORN client license is still required to perform for 
the system’s initial configuration and definition. It is recommended 
to install UNICORN on the OPC server on the DeltaV network. Please 
contact your local representative for further information.
Cellbag bioreactors
Presterilized Cellbag bioreactors are single-use bags for the 
noninvasive mixing of culture medium and cells during cultivation 
(Fig 11). Cellbag bioreactors require no sterilization or cleaning 
steps. The disposable bioreactors provide a suitable environment 
for cell growth while minimizing the cross-contamination risk.
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Table 2. Possible combinations of Cellbag bioreactors and trays when 
culturing in single or dual mode
Cellbag 
bioreactor 
size (L)*
Bioreactor 
culture 
volume (L)
Tray
Single 
culture mode
Dual 
culture mode
2 0.3† to 1 Tray 10, Tray 20 Tray 20
10 0.5 to 5 Tray 10, Tray 20 Tray 20
20 1 to 10 Tray 20 Not applicable
22 1 to 10 Tray 50 Tray 50
50 5 to 25 Tray 50 Not applicable
*  All Cellbag bioreactor sizes are available with internal perfusion filter for perfusion cultures and/or 
can be equipped with single use optical pH (pHOPT) and DO (DOOPT II) sensors.
†  Cellbag bioreactors with optical sensors require 300 mL minimal working volume. Depending on 
application and configuration, it might be possible to cultivate below the recommended minimum 
volume. However, it is highly recommended to stay above this volume for applications that require 
high agitation and pH and DO control. The temperature, pH, and DO sensors need to be submerged 
in liquid throughout the complete rocking cycle to function correctly.
System specifications
System specifications are listed in Table 3.
Table 3. ReadyToProcess WAVE 25 system specifications
General system specifications
Control system UNICORN 6.3.2 or later version
Dimensions, W × H × D
Rocker
Tray 10
Tray 20
Tray 50
Lid 10
Lid 20
Lid 50
CBCU
Pump 25
404 × 205 × 560 mm
475 × 60 × 430 mm
740 × 70 × 480 mm
800 × 70 × 610 mm
475 × 230 × 430 mm
740 × 245 × 480 mm
800 × 260 × 610 mm
276 × 117 × 360 mm
275 × 115 × 280 mm
Weight
Rocker
Tray 10
Tray 20
Tray 50
Lid 10
Lid 20
Lid 50
CBCU
Pump 25
24.0 kg
4.5 kg
7.3 kg
9.5 kg
1.7 kg
3.3 kg
3.9 kg
4.8 kg
3.8 kg
Power supply 100 to 240 V, ~ 50 to 60 Hz
Power consumption 1500 VA
Enclosure protective class IP 21
Gas supply (per CBCU)
External air supply, 1.0 to 1.5 bar
External CO2 supply, 1.0 to 1.5 bar
External O2 supply, 1.0 to 1.5 bar
Normal use
1.3 L/min
0.2 L/min
0.7 L/min
Fast fill
3.5 L/min
0.5 L/min
1.7 L/min
Environmental aspects
Operating ambient temperature range 15°C to 32°C
Operating humidity range 20% to 80% relative humidity 
(noncondensing)
ReadyToProcess WAVE 25, rocker
Rocking speed control range1 2 to 40 rpm
Rocking angle control range1 2° to 12°
Rocking motion control range 15% to 100%
Medium weight control range 0.2 to 25 kg
Scale, absolute accuracy ± (0.050 + 1% of load) kg
Scale, left/right absolute 
accuracy (dual mode)
± (0.1 + 6% of load) kg
Temperature sensor Pt100 Class A
Temperature measurement range 2°C to 50°C
Temperature measurement accuracy ± 0.3°C in the range of 15°C to 
50°C within ± 5°C from calibration 
temperature
Temperature control range (ambient temperature + 5°C) to 40°C
Temperature control accuracy 
(excl. measurement error)
± 0.2°C
Temperature set point 
difference (dual mode)
Max. 10°C at ambient temperature 
(21°C)
Set point difference reduced by 
1°C for each °C increase in ambient 
temperature (e.g., at ambient 25°C, 
max. set point difference is 6°C)
1  When cultivating in a 50 L Cellbag bioreactor at maximum working volume of 25 L, rocking speed 
and angle multiplied should not exceed 240 rpm degrees. For example, if the rocking angle is set to 
12 degrees, the rocking speed should not be set higher than 20 rpm.
ReadyToProcess CBCU
Gas flow control range 50 to 1000 mL/min
Total gas flow accuracy 
(reference flow – set point)
± (10 + 3% of read value) mL/min
Fast-fill flow ~ 3 L/min
CO2 control range 0% to 15% CO2
CO2 measurement
accuracy at 5% CO2
± 0.5% CO2 when mixed only
with air/N2
CO2 control accuracy 
(versus set point)
± 0.4% CO2
O2 control range 0% to 50% O2 when mixed with N2, 
21% to 50% O2 when mixed with air
O2 measurement accuracy ± (0.6% + 1% of read value) % O2
within 0% to 50% O2 when mixed
only with air/N2
O2 control accuracy 
(versus set point)
± 0.6% O2
pH measurement range pH 4.5 to 8.5
pH control range pH 6.0 to 8.0
pH measurement accuracy ± 0.05 pH within ± 0.25 pH from offset 
calibration pH 
± 0.1 pH within 0.25 to 0.5 pH from 
offset calibration
pH control accuracy
(versus set point)
± 0.05 pH
DO measurement range 0% to 250% air saturation
DO measurement accuracy ± 5% air saturation (excl. atmospheric 
pressure variations)
DO control range 0% to 100% air saturation
ReadyToProcess Pump 25
Pump flow rate range 0.1 to 144 L/d (0.07 to 100 mL/min)
Pump flow accuracy ± (0.1 + 5% of read value) mL/min 
after calibration
Accumulated pumped
volume accuracy
± 10% of measured volume
Supported tubing dimensions i.d. 0.5 to 4.8 mm (1/50” to 3/16“) 
wall thickness: 1.6 mm (1/16”)
Applications
ReadyToProcess WAVE 25 is designed for a variety of cell culture 
applications involving mammalian, insect, and plant cells:
• Batch culture
• Fed-batch culture
• Perfusion culture
• Cultivation of adherent cells
Ordering information
* One delivered with the rocker, additional needed for dual functionality.
† Depending on configuration, one or two fiber cables are delivered with the CBCU unit.
‡ One delivered with the rocker.
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The Xcellerex XDR bioreactor product line offers the benefits 
of single-use technology and stirred-tank design in a modular, 
turnkey, bioreactor platform (Fig 1). Designed for scalability and 
robustness, the XDR bioreactor systems provide the performance 
and flexibility needed from process development to large-scale 
biopharmaceutical manufacturing. XDR bioreactor systems can be 
operated in batch, fed-batch, and perfusion modes.
XDR bioreactor systems offer the following benefits:
• Separation of gas and electrical power for enhanced safety
• Scalable and predictable stirred-tank performance up to 2000 L
• Single-use technology eliminates costly and time-consuming 
cleaning and cleaning validation
• Advanced automation and modular system design 
to support a variety of installation scenarios
• Process and operational support from staff with 
extensive manufacturing experience
System overview
The full line of XDR bioreactor systems are designed and 
characterized to deliver scalable process equivalence from 4.5 L to 
2000 L working volume, in both GMP and non-GMP environments. 
The system design is based on the same foundational principles 
as conventional stainless steel bioreactors. Consistent vessel 
geometries, tight relationship between consumables and 
equipment features, and a host of accessories combine for 
an easily scalable, single-use product line. Traditional scaling 
methodology, based on measures such as shear, tip speed, 
power per unit volume, kLa, and specific process sensitivities, 
can be used during scale-up. Technology transfer using the XDR 
systems is straightforward, minimizing the need for costly and 
time-consuming process redesign. For enhanced utility across the 
bioreactor platform, the minimum working volume is as low as 
20% of the maximum working volume.
Fig 1. Bioreactor system components: XDR vessel and X-Station 
mobile control console.
The bioreactor bag assembly (XDA) is disposed after culture 
termination and eliminates costly and time-consuming 
cleaning-in-place (CIP) and steam-in-place (SIP) operations. The 
XDA bag assembly is prepackaged with a low profile impeller, a 
variety of sparge components, filters, and tubing, for quick and 
hassle-free installation. The flexibility of single-use technology 
enables quick changeover between productions, for efficient 
equipment utilization. Interconnection of bioreactor bag and 
equipment is key in achieving the excellent performance that XDR 
bioreactor systems deliver.
The modularity of the XDR product line stems from three 
main subsystem components: bioreactor vessel with frame, 
I/O cabinet, and X-Station mobile control console. The XDR 
product line is further enhanced by the dual-panel I/O cabinet 
design, which separates gas management from electrical 
power. Additionally, high and low voltage power are in separate 
subsections of the main I/O cabinet. The system components 
can be used together for a complete turnkey system with true 
plug-and-play performance. Alternatively, the components can 
be used separately and integrated into existing infrastructure, 
for enhanced flexibility. The jacketed vessel has a consistent 
design and delivers integrated heating and cooling for efficient 
gelifesciences.com/xcellerex
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temperature control throughout all scales. The versatile I/O 
cabinet houses all critical process instrumentation such as 
probe transmitters and peristaltic pumps: up to four internal 
and two external pumps are configurable. The gas management 
cabinet can be configured or customized with up to six mass flow 
controllers as well as up to four internal and two external pumps. 
The X-Station mobile control console is the heart of the product 
line’s turnkey capability. The power and versatility of the X-Station 
allow for up to six XDR bioreactor systems to be controlled 
from one single control unit. This truly modular design creates a 
process-ready system upon delivery and also supports integration 
into a user-preferred automation platform.
XDR system components
Well-mixed bioreactor vessel
Constructed of 304 grade stainless steel (304 SS), the jacketed 
vessel enables efficient heat transfer and, together with an external 
temperature control unit (TCU), offers highly accurate temperature 
control of the cell culture. The bioreactor vessel features load cells for 
weight measurement and locking casters with leveling feet. Other 
features include a bioreactor bag tubing manager for convenient 
positioning and routing of the bag tubing and a high-performance, 
bottom-mounted, magnetically coupled drive system. Because of 
the bottom drive, there are no shafts to install from the top of the 
bioreactor vessel, minimizing ceiling height requirements. To aid 
in coupling and decoupling of the drive system with the bioreactor 
bag, motor lifting assistive devices are integral with the two largest 
bioreactor systems.
The systems are equipped with inlet and exhaust filter holders and 
vessel sidewall viewing ports. A lower sidewall port opening makes 
room for a sampling port as well as probes for pH, dissolved oxygen 
(DO), and temperature. An optional perfusion-specific bag loading 
door is available to accommodate cell retention devices. The 1000 L 
and 2000 L systems feature integrated bag loading doors that, along 
with the semiautomatic bag hoist, simplifies bag insertion without 
the need for climbing ladders. An efficient exhaust gas filter heater 
is also included to avoid condensate that could compromise exhaust 
filter performance.
The complete XDR bioreactor system product portfolio supports 
operating volumes from 4.5 L up to 2000 L. The smallest 
process development system is discussed in detail in a separate 
data file (29092927).
Versatile I/O cabinet
Two 304 SS I/O cabinets functionally separate devices for gas 
management, as well as pumps and transmitters for pH and 
DO measurement. Standard XDR gas and liquid management 
configurations cover the majority of cell culture applications. 
Probes on the bioreactor system provide real-time data, 
monitored throughout the process run using Wonderware™ 
software. Profibus™ communication standard is used for device 
communication and communication to the X-Station. For custom 
installations, direct Profibus communication between the I/O 
cabinet and other automation systems (e.g., Rockwell, DeltaV™, 
Honeywell, Siemens) can be accomplished.
Liquid management
The I/O cabinet can be configured with up to four pumps including 
on-off and variable speed peristaltic pumps. The on-off pumps 
utilize a Watson-Marlow™ 114 pump head, while the variable 
speed pumps utilize Watson-Marlow 313 or 520 pump heads 
depending on configuration. The pumps have ranges to support 
liquid addition or removal. They can also be programmed for 
fed-batch and perfusion culturing and easily calibrated using 
Wonderware software.
Gas management
Up to six mass flow controllers offer multiple sparging regimes, 
CO2 abatement at large-scale, and overlay gas addition. The XDR 
systems include a gas manifold to distribute the various gases to 
the available bag destinations: sparger or headspace. The dual-panel 
XDR now includes a separate gas management cabinet.
Measurements of DO and pH
DO and pH can be measured using conventional polarographic 
sensors and glass electrodes, respectively. These sensors 
can be autoclaved prior to use in a specially designed probe 
sheath. Aseptic insertion into the bioreactor bag is conveniently 
done using single-use connector technology. Alternatively, 
an optical DO sensor and a single-use pH probe are available 
ready for use to minimize start-up time. The flexibility of the 
system allows the sensor technology to be mixed for use of 
conventional and single-use technologies simultaneously. 
All sensors are connected to the I/O cabinet transmitters. 
The dual-panel XDR includes options for Rosemount 56 and 
Mettler-Toledo MT-800 transmitters.
Measurement of dissolved carbon dioxide
Conventional, reusable, insertion-type probe technology is used for 
monitoring of dissolved carbon dioxide. A dedicated transmitter is 
available optionally for integration into the I/O cabinet.
Plug-and-play X-Station mobile control console
X-Station is a stand-alone, mobile control console featuring intuitive 
process control, data historian, and industrial-quality automation 
hardware and software (Fig 2). The control system provides real-time 
data acquisition, enables accurate process control, and offers 
convenient, real-time trending. X-Station is capable of measuring and 
controlling up to six XDR bioreactor systems simultaneously.
Fig 2. The X-Station 
mobile control console.
Inside the 304 SS cover is housed a 
scalable programmable logic controller 
(PLC)/programmable automation 
controller (PAC) and a server-class 
computer running user interface and 
data historian software. X-Station 
comes with a 19” touchscreen, 
industrial, wash down-resistant 
mouse, a QWERTY keyboard, and 
a built-in uninterruptible power 
supply (UPS). Profibus and Ethernet 
communication standards are 
included for equipment and local area 
network connectivity.
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Additional bag components include tubing with a combination 
of weldable sections and aseptic connectors for liquid 
addition/removal, a disposable pressure sensor, and filters for 
exhaust, sparge, and overlay/headspace gas. XDA bioreactor 
bags support both insertion-type reusable probes and single-use 
probes. Probe configurations include reusable probes only, 
single-use probes only, or mixed reusable and single-use probes. 
For details on probes, see section “Measurement of DO and pH”.
To assist in efficient bioreactor operation, a number of 
supplementary XDA bag-related accessories are optionally 
available. Like the main bioreactor bags, these accessories are 
tightly coupled to the equipment design to be adaptable to varied 
process requirements and to support operational efficiency. XDA 
accessories include seal-and-store sample manifolds, foam traps, 
X-Connect tubing sets, and exhaust filter tubing sets.
Qualification support
The XDR bioreactor systems are designed for use in environments 
that require 21 CFR Part 11 and GAMP™ 5. The systems are 
delivered with an operating manual, system specification, 
drawings to support qualification, and major component 
documentation. Industry standard installation and operation 
qualification (IQ/OQ) packages are available as an option.
XDA bioprocessing consumables
The XDA bioreactor bag is an essential part of the process 
performance achieved with XDR bioreactor systems. Constructed 
with a contact layer of USP class VI-compliant low-density 
polyethylene (LDPE) plastic, the bioreactor bags are robust to 
withstand process conditions. All bioreactor bag assemblies 
incorporate a seal-less, bottom-mounted, impeller/sparger 
assembly with a centrally positioned integral magnet (Fig 3A). 
Installed in the bioreactor vessel, the impeller/sparger assembly 
couples with the magnetic drive head, creating a powerful and 
robust agitation system with minimal risk of seal leakage. Up 
to eight sparge elements are included in the impeller/sparge 
assembly (Fig 3B). Each sparge element can be configured with 
various porosities, drilled holes, or a combination of both to 
support both macro- and microsparging. Each of the standard 
sparge elements has been validated to provide out-of-the-box 
performance consistent with current cell culture practices.
A) B)
Fig 3. (A) Impeller for XDR-2000 with four pitched blades. (B) Impeller/sparger 
assembly for XDR-200 with three pitch blades and eight sparge elements.
Fig 4. XDR-2000 Pro bag assembly.
The XDA bioreactor bags are available in Pro, Development, 
or Custom formats (Fig 4). Pro-type bags are available for all 
bioreactor systems and have validated sparge configurations, 
established based on customer feedback and our own 
biomanufacturing experience. Development bags are available 
for XDR-50 and XDR-200 bioreactor systems and differ from the 
Pro bags primarily in the configuration of the sparge elements. 
Development bags can be used in a broad array of process 
development activities where various micro- or macrosparging 
regimes are evaluated. Custom bioreactor bags can be modified 
with tubing type and quantity, connection type, filter element, 
or sparger configuration. Custom bags can also incorporate 
a CO2-removal sparge wand to address processes sensitive 
to dissolved CO2.
All bioreactor bags for cell culture include a magnetically coupled, 
M40e 40°, pitched-blade impeller with ceramic bearings. Ceramic 
bearings, originally developed for aggressive mixing applications 
and fermentation, provide excellent overall performance. The 
medical-grade ceramic bearings meet the relevant industry 
requirements for leachables, extractables, and particulates 
according to the bag validation guide (for more information, 
please contact your sales representative). Special impellers are 
available for microcarrier applications.
Liquid addition
and gas overlay
Sensor ports
Thermowell
Sample line
Drain line
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Table 1. Specifications of standard configuration XDR cell culture bioreactor systems
XDR-50* XDR-200 XDR-500 XDR-1000 XDR-2000
Specifications
Max. working volume (L) 50 200 500 1000 2000
Min. working volume (L) 22 40 100 200 400
Volume turn-down ratio 2.2:1 5:1 5:1 5:1 5:1
Aspect ratio (H/D) 2.25:1 1.5:1 1.5:1 1.5:1 1.5:1
Vessel Jacketed 304 SS
Filter heat assembly 1
Additional lter heater assemblies (optional) 1
Bag hoist Not applicable Not applicable Not applicable Semi-automatic Semi-automatic
Impeller, M40e pitched-blade type 3 blades at
40° pitch
3 blades at
40° pitch
3 blades at
40° pitch
3 blades at
40° pitch
4 blades at
40° pitch
Custom bag assembly 3 3 4 4 4
Process instrumentation
pH probes† 1 (2 optional) 2 2 2 2
DO probes† 1 (2 optional) 2 2 2 2
CO2 probes (optional) 1 internal, 1 external
MFC§ (standard) 4
Additional MFC‡ (optional) 2
Internal pumps (standard) 4 (2x low flow, 2x high flow)
External pumps (optional)§ 2
Temperature control unit¶ (heating, 
kW/cooling, HP)
3/1 9/1.5 9/1.5 9/1.5 9/1.5
Load cells 3 4 4 4 4
X-Station control unit
Interfaces 19”/52.4 mm touchscreen, wash-down compatible keyboard and mouse; includes built-in UPS
Hardware Rockwell™/Allen Bradley™
Operator interface Wonderware HMI††
HMI†† Data Historian Wonderware
Compliance 21 CFR Part 11 compliant‡‡
* For specifications of XDR-50 MO fermentation system, please see data file 29092929.
† Single-use or reusable probes
‡ Thermal mass flow controllers
§ External pumps are Profibus devices and might be Watson-Marlow 520, 620, or 720 series depending on required flow rate.
¶ Optional standalone heating/cooling TCU listed. Other TCU configurations available, including units that use facility chilled water/glycol.
†† Human-machine interface
‡‡ Customer will need to implement appropriate operating procedures to be fully 21 CFR Part 11 compliant. The XDR is built to support this two-part compliance.
Note: For specifications of XDR-10 bioreactor system, please see data file 29092927
Vessel specifications
Standard cell culture specifications are listed in Table 1.
Applications
XDR cell culture bioreactor systems have successfully been 
used to cultivate a wide range of cell types and organisms 
including CHO cells, Vero cells, and MDCK cells. In addition, 
a fermentor system is available for microbial applications 
including E. coli, Pseudomonas spp., and yeast (see data 
file 29092929). XDR bioreactor systems can be operated 
in batch, fed-batch, and perfusion (or chemostat) modes. 
Bioreactor bag design can be process-dependent, requiring 
customization for proper use and performance.
Customization
The XDR bioreactor offers standard configurations capable 
of addressing a broad set of cell culture applications. 
The product platform offers a variety of customizable 
options, which broaden its application. Contact your local 
GE representative to match your process to the XDR 
configuration that is right for your application.
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Table 2. Specifications of standard configuration for XDA bags for XDR cell culture bioreactor systems
Product description Product code
XDR-50 DEV
Minimum volume: 22 L; nominal volume: 50 L; headspace volume: 13 L
Impeller: M40e, 3 blades, 8.5 in diameter, Di/Dt*: 0.61, 40° pitch, center
Film: ASI™ PL-01026/01077
A, B, D, G, H: 1 in of 1/4” × 3/8” C-Flex® 374
E: 1 in of 3/8” × 5/8” C-Flex 374
A, G, H (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 48 in 1/8 in × 1/4 in C-Flex 374, 
plugged, pinch clamp
B, D (liquid additions): 48 in of 1/4 in × 7/16 in C-Flex 374, plugged, pinch clamp
C (vent filter): CFVTV0.2-33A filter (Meissner), T with 6 in of 1/2 in × 3/4 in C-Flex 374 terminated with 
ReadyMate™ connector, pinch clamp
E (liquid addition): 60 in of 3/8 in × 9/16 in Platinum-cured Silicon to 18 in of 3/8 in × 5/8 in C-Flex 374 terminated 
with ReadyMate connector, pinch clamp
F (headspace gas): pressure sensor, A50V002P2NV filter (Pall), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated with 
instant tube fitting, pinch clamp
I (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
J, K (probe ports): female Kleenpak™ port for probe connection
L (sample lines): 12 in of 1/8 in × 1/4 in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
M, O (liquid additions): 10 in of 3/4 in ×1 in C-Flex 374 terminated with ReadyMate connector
N (liquid addition): 18 in of 3/8 in × 5/8 in C-Flex 374 reduced to 18 in of 1/4 in × 7/16 in C-Flex 374, 
plugged, pinch clamp
Sparge 2: 2 µm sintered disk
Sparge 4, 6: 2 µm sintered disk with 5 × 0.5 mm drilled holes
Sparge 5: 20 µm sintered disk
Sparge 8: 2 µm sintered disk with 5 × 1 mm drilled holes
Sparge 2 and 5: tubing from each port combined to A50V002P2NV filter (Pall) to 3 in of 1/4 in × 7/16 in C-Flex 374 
terminated with instant tube fitting, pinch clamp
Sparge 4, 6 and 8: tubing from each port combined to A50V002P2NV filter (Pall) to 3 in of 1/4 in × 7/16 in C-Flex 
374 terminated with instant tube fitting, pinch clamp
Sparge 1 , 3 and 7 (drain): tubing from each port combined to 48 in of 3/8 in × 5/8 in C-Flex 374 terminated with 
ReadyMate connector, pinch clamp
888-0356-C
XDR-50 PRO
Minimum volume: 22 L; nominal volume: 50 L; headspace volume: 13 L
Impeller: M40e, 3 blades, 8.5 in diameter, Di/Dt*: 0.61, 40° pitch, center
Film: ASI PL-01026/01077
A, B, D, G, H: 1 in of 1/4 in × 3/8 in C-Flex 374
E: 1 in of 3/8 in × 5/8 in C-Flex 374
A, G, H (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 48 in 1/8 in × 1/4 in C-Flex 374, 
plugged, pinch clamp
B, D (liquid additions): 48 in of 1/4 in × 7/16 in C-Flex 374, plugged, pinch clamp
C (vent filter): CFVTV0.2-33A filter (Meissner), T with 6 in of 1/2 in × 3/4 in C-Flex 374 terminated with ReadyMate 
connector, pinch clamp
E (liquid addition): 48 in of 3/8 in × 5/8 in C-Flex 374, plugged, pinch clamp
F (headspace gas): pressure sensor, A50V002P2NV filter (Pall), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated with 
instant tube fitting, pinch clamp
I (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
J, K (probe ports): female Kleenpak port for probe connection
L (sample lines): 12 in of 1/8 in × 1/4 in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
Sparge 5: 2 µm sintered disk, 48 in of 1/4 in × 7/16 in C-Flex 374 to A50V002P2NV filter (Pall) to 3 in 
of 1/4 in × 7/16 in C-Flex 374 terminated with instant tube fitting, pinch clamp
Sparge 1, 3 and 7 (drain): tubing from each port combined to 48 in of 3/8 in × 5/8 in C-Flex 374, plugged, pinch clamp
888-0086-C
* Impeller diameter to bioreactor bag diameter
† Resistance temperature detectors
Consumable specifications
A B C D E F G H
I J K L5
1
IMP3 7
A B C D E F G H
I J K L5
1
IMP3 7
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XDR-50 PRO FLEX
Minimum volume: 22 L; nominal volume: 50 L; headspace volume: 13 L
Impeller: M40e, 3 blades, 8.5 in diameter, Di/Dt*: 0.61, 40° pitch, center
Film: ASI PL-01026/01077
A, B, D, G, H: 1 in of 1/4 in × 3/8 in C-Flex 374
E: 1 in of 3/8 in × 5/8 in C-Flex 374
A, G, H (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 48 in 1/8 in × 1/4 in C-Flex 374, plugged, 
pinch clamp
B, D (liquid additions): 48 in of 1/4 in × 7/16 in C-Flex 374 terminated with ReadyMate connector, pinch clamp
C (vent filter): CFVTV0.2-33A1 filter (Meissner), T with 6 in of 1/2 in × 3/4 in C-Flex 374 terminated with 
ReadyMate connector, pinch clamp
E (liquid addition): 48 in of 3/8 in × 5/8 in C-Flex 374 terminated with ReadyMate connector, pinch clamp
F (headspace gas): pressure sensor, A50V002P2NV filter (Pall), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated with 
instant tube fitting, pinch clamp
I (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
J, K (probe ports): female Kleenpak port for probe connection
L (sample lines): 12 in of 1/8 in × 1/4 in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
Sparge 5: 2 µm sintered disk, 48 in of 1/4 in × 7/16 in C-Flex 374 to A50V002P2NV filter (Pall) to 3 in of 
1/4 in × 7/16 in C-Flex 374 terminated with instant tube fitting, pinch clamp
Sparge 6: 2 µm sintered disk with 5 × 1 mm drilled holes, 48 in of 1/4 in × 7/16 in C-Flex 374 to A50V002P2NV 
filter to (Pall) 3 in of 1/4 in × 7/16 in C-Flex 374 terminated with instant tube fitting, pinch clamp
Sparge 1, 3 and 7 (drain): tubing from each port combined to 48 in of 3/8 in × 5/8 in C-Flex 374 terminated with 
ReadyMate connector, pinch clamp
888-0086-F
XDR-200 DEV
Minimum volume: 40 L; nominal volume: 200 L; headspace volume: 60 L
Impeller: M40e, 3 blades, 8.5 in diameter, Di/Dt*: 0.38, 40° pitch, 15° off center
Film: ASI PL-01026/01077
A, B (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 120 in 1/8 in × 1/4 in C-Flex 374, 
plugged, pinch clamp
C, D, F (liquid additions): 18 in of 1/2 in × 3/4 in C-Flex 374 terminated with female Kleenpak connector, pinch clamp
E (headspace gas): pressure sensor, CFVTV0.2-33A filter (Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated 
with instant tube fitting
G (liquid addition): 120 in of 1/2 in × 3/4 in C-Flex 374, plugged, pinch clamp
H (sample lines): 12 in of 1/8 in × 1/4 in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
I, J, K, L (probe ports): female Kleenpak port for probe connection
M (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
N (drain): 36 in of 1/2 in × 3/4 in C-Flex 374 terminated with female Kleenpak connector, pinch clamp
O (vent filter): KA3V002PV1G filter (Pall), T with 6 in of 1/2 in × 3/4 in C-Flex 374 terminated with female 
Kleenpak, pinch clamp
Sparge 1 and 5: 20 µm sintered disk
Sparge 2, 6: 2 µm sintered disk
Sparge 3 and 7: 2 µm sintered disk with 5 × 1 mm drilled holes
Sparge 4 and 8: 2 µm sintered disk with 5 × 0.5 mm drilled holes
Sparge 1 & 5, 2 & 6, 3 & 7, 4 & 8: tubing from each port for each pair combined to 84 in of 1/8 in × 1/4 in C-Flex 374 
to CFVTV0.2-33A filter (Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated with instant tube fitting
888-0151-C
* Impeller diameter to bioreactor bag diameter
† Resistance temperature detectors
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XDR-200 PRO
Minimum volume: 40 L; nominal volume: 200 L; headspace volume: 60 L
Impeller: M40e, 3 blades, 8.5 in diameter, Di/Dt*: 0.38, 40° pitch, 15° off center
Film: ASI PL-01026/01077
A, B (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 120 in 1/8 in × 1/4 in C-Flex 374, 
plugged, pinch clamp
C, D, F (liquid additions): 18 in of 1/2 in × 3/4 in C-Flex 374 terminated with female Kleenpak connector, pinch clamp
E (headspace gas): pressure sensor, CFVTV0.2-33A filter (Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated 
with instant tube fitting
G (liquid addition): 120 in of 1/2 in × 3/4 in C-Flex 374, plugged, pinch clamp
H (sample lines): 12 in of 1/8 in × 1/4 in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
I, J, K, L (probe ports): female Kleenpak port for probe connection
M (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
N (drain): 36 in of 1/2 in × 3/4 in C-Flex 374 terminated with female Kleenpak connector, pinch clamp
O (vent filter): KA3V002PV1G filter (Pall), T with 6 in of 1/2 in × 3/4 in C-Flex 374 terminated with female 
Kleenpak, pinch clamp
Sparge 1, 4 and 6: 2 µm sintered disk
Sparge 1, 4 and 6: tubing from each port combined to 96 in of 1/8 in × 1/4 in C-Flex 374 to CFVTV0.2-33A filter 
(Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated with instant tube fitting, pinch clamp
888-0067-C
XDR-500 PRO
Minimum volume: 100 L; nominal volume: 500 L; headspace volume: 125 L
Impeller: M40e, 3 blades, 10.5 in diameter, Di/Dt*: 0.35, 40° pitch, 15° off center
Film: ASI PL-01026/01077
A, B (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 120 in 1/8 in × 1/4 in C-Flex 
374, plugged, pinch clamp
C, D, F (liquid additions): 18 in of 1/2 in × 3/4 in C-Flex 374 terminated with female Kleenpak connector, pinch clamp
E (headspace gas): pressure sensor, CFVTV0.2-33A filter (Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated 
with instant tube fitting
G (liquid addition): 120 in of 1/2 in × 3/4 in C-Flex 374, plugged, pinch clamp
H (sample lines): 12 in of 1/8 in × 1/4 in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
I, J, K, L (probe ports): female Kleenpak port for probe connection
M (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
N (drain): 36 in of 1/2 in × 3/4 in C-Flex 374 terminated with female Kleenpak connector, pinch clamp
O (vent filter): KA3V002PV1G filter (Pall), T with 6 in of 1/2 in × 3/4 in C-Flex 374 terminated with female 
Kleenpak, pinch clamp
Sparge 1, 3, 5 and 7: 2 µm sintered disk
Sparge 1, 3, 5 and 7: tubing from each port combined to 96 in of 1/4 in × 7/16 in C-Flex 374 to CFVTV0.2-33A filter 
(Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated with instant tube fitting, pinch clamp
888-0070-C
XDR-500 PRO FLEX
Minimum volume: 100 L; nominal volume: 500 L; headspace volume: 125 L
Impeller: M40e, 3 blades, 10.5 in diameter, Di/Dt*: 0.35, 40° pitch, 15° off center
Film: ASI PL-01026/01077
A, B (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 120 in 1/8 in × 1/4 in C-Flex 374, 
plugged, pinch clamp
C, D, F (liquid additions): 18 in of 1/2 in × 3/4 in C-Flex 374 terminated with ReadyMate connector, pinch clamp
E (headspace gas): pressure sensor, CFVTV0.2-33A1 filter (Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 
terminated with instant tube fitting
G (liquid addition): 120 in of 1/2 in × 3/4 in C-Flex 374 terminated with ReadyMate connector, pinch clamp
H (sample lines): 12 in of 1/8 in × 1/4 in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
I, J, K, L (probe ports): female Kleenpak port for probe connection
M (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
N (sparge line): 96 in of 1/4 in × 7/16 in C-Flex 374 to CFVTV0.2-33A1 filter (Meissner), 3 in of 1/4 in × 7/16” C-Flex 
374 terminated with instant tube fitting, pinch clamp with internal 2 mm drilled hole Sparge-T
O (drain): 36 in of 3/4 in × 1 in C-Flex 374 terminated with ReadyMate connector
P (vent filter): KA3V002PV1G filter (Pall), T with 6 in of 1/2 in × 3/4 in C-Flex 374 terminated with ReadyMate 
connector, pinch clamp
Sparge 1, 3, 5 and 7: 2 µm sintered disk
Sparge 1, 3, 5 and 7: tubing from each port combined to 96 in of 1/4 in × 7/16 in C-Flex 374 to CFVTV0.2-33A1 
filter (Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated with instant tube fitting, pinch clamp
888-0070-F
* Impeller diameter to bioreactor bag diameter
† Resistance temperature detectors
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XDR-1000 PRO
Minimum volume: 200 L; nominal volume: 1000 L; headspace volume: 210 L
Impeller: M40e, 3 blades, 12.5 in diameter, Di/Dt*: 0.33, 40° pitch, 15° off center
Film: ASI PL-01026/01077
A, B (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 120 in 1/8 in × 1/4 in C-Flex 374, 
plugged, pinch clamp
C, D, F (liquid additions): 18 in of 1/2 in × 3/4 in C-Flex 374 terminated with female Kleenpak connector, pinch clamp
E (headspace gas): pressure sensor, CFVTV0.2-33A filter (Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated 
with instant tube fitting
G (liquid addition): 120 in of 1/2 in × 3/4 in C-Flex 374, plugged, pinch clamp
H (sample lines): 12 in of 1/8 in × 1/4 in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
I, J, K, L (probe ports): female Kleenpak port for probe connection
M (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
N (drain): 36 in of 1/2 in × 3/4 in C-Flex 374 terminated with female Kleenpak connector, pinch clamp
O (vent filter): KA3V002PV1G filter (Pall), T with 6 in of 1/2 in × 3/4 in C-Flex 374 terminated with female 
Kleenpak, pinch clamp
Sparge 1 to 8: 2 µm sintered disk, all ports combined to 96 in of 1/4 in × 7/16 in C-Flex 374 to CFVTV0.2-33A filter 
(Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated with instant tube fitting, pinch clamp
888-0071-C
XDR-1000 PRO FLEX
Minimum volume: 200 L; nominal volume: 1000 L; headspace volume: 210 L
Impeller: M40e, 3 blades, 12.5 in diameter, Di/Dt*: 0.33, 40° pitch, 15° off center
Film: ASI PL-01026/01077
A, B (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 120 in 1/8 in × 1/4 in C-Flex 374, 
plugged, pinch clamp
C, D, F (liquid additions): 18 in of 1/2 in × 3/4 in C-Flex 374 terminated with ReadyMate connector, pinch clamp
E (headspace gas): pressure sensor, CFVTV0.2-33A filter (Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated 
with instant tube fitting
G (liquid addition): 120 in of 1/2 in × 3/4 in C-Flex 374, ReadyMate Connector, pinch clamp
H (sample lines): 12 in of 1/8 in × 1/4” in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
I, J, K, L (probe ports): female Kleenpak port for probe connection
M (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
N (Sparge-T): 2 mm drilled hole Sparge-T
O (vent filter): 48 in of 1 in × 1 3/8 in C-Flex 374 terminated with ReadyMate connector
Sparge 1 to 8: 2 µm sintered disk, all ports combined to 96 in of 1/4 in × 7/16 in C-Flex 374 to CFVTV0.2-33A filter 
(Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated with instant tube fitting, pinch clamp
888-0071-F
XDR-2000 PRO
Minimum volume: 400 L; nominal volume: 2000 L; headspace volume: 500 L
Impeller: M40e, 4 blades, 16.5 in diameter, Di/Dt*: 0.34, 40° pitch, 15° off center
Film: ASI PL-01026/01077
A, B (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 120 in 1/8 in × 1/4 in C-Flex 374, 
plugged, pinch clamp
C, D, F (liquid additions): 18 in of 1/2 in × 3/4 in C-Flex 374 terminated with female Kleenpak connector, pinch clamp
E (headspace gas): pressure sensor, CFVTV0.2-33A filter (Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated 
with instant tube fitting
G (liquid addition): 120 in of 1/2 in × 3/4 in C-Flex 374, plugged, pinch clamp
H (sample lines): 12 in of 1/8 in × 1/4 in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
I, J, K, L (probe ports): female Kleenpak port for probe connection
M (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
N (drain): 36 in of 3/4 in × 1 in C-Flex 374 terminated with ReadyMate connector
O (vent filter): KA3V002PV1G filter (Pall), Y with 36 in of 3/4 in × 1 in C-Flex 374 terminated 
with ReadyMate connector
Sparge 1 to 8: 20 µm sintered disk, all ports combined to 120 in of 1/2 in × 3/4 in C-Flex 374 to KA2V002PV1G 
filter (Pall), pinch clamp, 1-1/2” TC at filter inlet
888-0081-C
* Impeller diameter to bioreactor bag diameter
† Resistance temperature detectors
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XDR-2000 PRO FLEX
Minimum volume: 400 L; nominal volume: 2000 L; headspace volume: 500 L
Impeller: M40e, 4 blades, 16.5 in diameter, Di/Dt*: 0.34, 40° pitch, 15° off center
Film: ASI PL-01026/01077
A, B (liquid additions): 3 in of 1/4 in × 7/16 in C-Flex 374 reduced to 120 in 1/8 in × 1/4 in C-Flex 374, 
plugged, pinch clamp
C, D, F (liquid additions): 18 in of 1/2 in × 3/4 in C-Flex 374 terminated with ReadyMate connector, pinch clamp
E (headspace gas): pressure sensor, CFVTV0.2-33A filter (Meissner), 3 in of 1/4 in × 7/16 in C-Flex 374 terminated 
with instant tube fitting
G (liquid addition): 120 in of 1/2 in × 3/4 in C-Flex 374, ReadyMate conector, pinch clamp
H (sample lines): 12 in of 1/8 in × 1/4 in C-Flex 374 terminated with female luer sampling port, pinch clamp (× 2)
I, J, K, L (probe ports): female Kleenpak port for probe connection
M (RTD† thermowell): 1/4 in barb with dip tube for RTD† connection
N (Sparge-T): 2 mm drilled hole Sparge-T
O (drain): 36 in of 1 in × 1 3/8” in C-Flex 374 terminated with ReadyMate connector
P (vent filter): KA3V002PV1G filter (Pall), Y with 36 in of ¾ in × 1” C-Flex 374 terminated 
with ReadyMate Connector
Sparge 1 to 8: 20 µm sintered disk, all ports combined to 120 in of 1/2 in × 3/4 in C-Flex 374 to KA2V002PV1G 
filter (Pall), pinch clamp, 1-1/2” TC at filter inlet
888-0081-F
* Impeller diameter to bioreactor bag diameter
† Resistance temperature detectors
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Opticap  XL and XLT capsule filters eliminate the time
and expense associated with assembling, cleaning, and
validating stainless steel housings.
Opticap  XL and XLT Disposable Capsule Filters with
Millipore Express  SHF 0.2 μm Hydrophilic Membrane
®
®
®
Request More
Information
Overview Specifications Ordering Information Supporting Documentation Related Product & Applications
Specifications (Autoclavable Capsules)
Opticap XL3 Opticap XL5 Opticap XL10
Filtration Area 0.16 m² 0.29 m² 0.54 m²
Materials of Construction
Filter Polyethersulfone (PES) Polyethersulfone (PES) Polyethersulfone (PES)
Film Edge Polypropylene Polypropylene Polypropylene
Supports Polypropylene Polypropylene Polypropylene
Structural
Components
Polypropylene/Polysulfone Polypropylene/Polysulfone Polypropylene/Polysulfone
Vent O­ring Silicone (SI) Silicone (SI) Silicone (SI)
Vent/Drain 1/4 in. hose barb with double silicone O­ring seal
Maximum
Differential
Pressure, bar
(psid)
Forward: 6.9 bar (100 psid) intermittent @ 25 °C; 5.5 bar (80 psid) @ 25 °C; 1.0 bar (15 psid) @ 80 °C. Reverse: 2.1 bar (30 psid) @ 25 °C,
intermittent
Bubble Point ≥4000 mbar (58 psig) air with water
Air Diffusion ≤9.1 mL/min @ 2.8 bar (40 psig) in water ≤16.4 mL/min @ 2.75 bar (40 psig) in water ≤30 mL/min @ 2.75 bar (40 psig) in water
Bacterial
Retention
Quantitative retention of 10  CFU/cm  Brevundimonas diminuta (ATCC  19146) per ASTM  F838­83 methodology
Bacterial
Endotoxins
Aqueous extraction contains ≤0.25 EU/mL as determined by the Limulus Amebocyte Lysate (LAL) Test
Specifications
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Good
Manufacturing
Practices
These products are manufactured in a facility which adheres to FDA Good Manufacturing Practices.
Non­Fiber
Releasing
Component materials meet the "non­fiber releasing" criteria as defined in 21 CFR 210.3 (b) (6).
Indirect Food
Additive
All component materials meet the FDA Indirect Food Additive requirements cited in 21 CFR 177­182.
Typical Clean Water Flow Rate vs Pressure Drop (Autoclavable Capsules)
Opticap  XL 3 Capsule Filters with 0.2 µm
Millipore Express  SHF Membrane  
Opticap  XL 5 Capsule Filters with 0.2 µm
Millipore Express  SHF Membrane  
Opticap  XL 10 Capsule Filters with 0.2 µm
Millipore Express  SHF Membrane
Opticap  XLT 10 Capsule Filters with 0.2 µm
Millipore Express  SHF Membrane  
Opticap  XLT 20 Capsule Filters with 0.2 µm
Millipore Express  SHF Membrane  
Opticap  XLT 30 Capsule Filters with 0.2 µm
Millipore Express  SHF Membrane
Specifications (Sterile and Gamma Compatible Capsules)
Opticap XL 150 Opticap XL 300 Opticap XL 600
Filtration Area 220 cm² 480 cm² 970 cm²
Materials of Construction
Filter Polyethersulfone (PES) Polyethersulfone (PES) Polyethersulfone (PES)
Supports Polyethylene Polyethylene Polyethylene
Structural
Components
Gamma stable polypropylene/Polysulfone Gamma stable polypropylene/Polysulfone Gamma stable polypropylene/Polysulfone
Vent O­ring Silicone (SI) Silicone (SI) Silicone (SI)
Vent/Drain 1/4 in. Hose Barb with double O­ring seal 1/4 in. Hose Barb with double O­ring seal 1/4 in. Hose Barb with double O­ring seal
Maximum
Differential
Pressure, bar
(psid)
Forward: 6.9 bar (100 psid) intermittent @ 25 °C; 5.5 bar (80 psid) @ 25 °C; 1.0 bar (15 psid) @ 80 °C. Reverse: 2.1 bar (30 psid) @ 25 °C,
intermittent
Bubble Point ≥4000 mbar (58 psig) air with water
Air Diffusion ≤1.4 mL/min @ 2.75 bar (40 psig) in water ≤2.8 mL/min @ 2.8 bar (40 psig) in water ≤5.8 mL/min @ 2.8 bar (40 psig) in water
Bacterial
Retention
Quantitative retention of 10  CFU/cm  Brevundimonas diminuta (ATCC  19146) per ASTM  F838­83 methodology
Bacterial
Endotoxins
Aqueous extraction contains ≤0.25 EU/mL as determined by the Limulus Amebocyte Lysate (LAL) Test
®
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TOC/Conductivity
at 25 °C
Gamma sterilized filters meet the WFI
requirements of USP <643> for Total
Organic Carbon and USP <645> for Water
Conductivity after a WFI flush of: 2 liter
Gamma sterilized filters meet the WFI
requirements of USP <643> for Total
Organic Carbon and USP <645> for Water
Conductivity after a WFI flush of: 2.5 liters
Gamma sterilized filters meet the WFI
requirements of USP <643> for Total Organic
Carbon and USP <645> for Water
Conductivity after a WFI water flush of:
3 liters
Oxidizable
Substances
Will meet the USP Oxidizable Substances
Test requirements after a water flush of
≥1 L
Will meet the USP Oxidizable Substances
Test requirements after a water flush of ≥1 L
Will meet the USP Oxidizable Substances
Test requirements after a water flush of ≥1 L
Sterilization
Gamma
compatible
capsules
Gamma compatible to 45 kGy; 3 autoclave cycles of 60 min @ 123 °C; not in­line steam sterilizable
Sterile capsules 3 autoclave cycles of 60 min @ 123 °C; not in­line steam sterilizable
Sterility Sterile capsules meet current USP and AAMI guidelines for sterility utilizing a validated sterilization cycle
Component
Material Toxicity
Component materials meet the criteria of the USP <88> Reactivity Test for Class VI Plastics. These products meet the requirements of the
USP <88> Safety Test, utilizing a 0.9% sodium chloride extraction.
USP Toxicity Non­toxic per MEM elution ISO  10993­5
Good
Manufacturing
Practices
These products are manufactured in a facility which adheres to FDA Good Manufacturing Practices.
Non­Particle
Releasing
Passes USP test for particulates in injectables.
Non­Fiber
Releasing
Component materials meet the "non­fiber releasing" criteria as defined in 21 CFR 210.3 (b) (6).
Indirect Food
Additive
All component materials meet the FDA Indirect Food Additive requirements cited in 21 CFR 177­182.
Opticap XLT10 Opticap XLT20 Opticap XLT30
Filtration Area 0.57 m² 1.14 m² 1.71 m²
Materials of Construction
Filter Polyethersulfone (PES) Polyethersulfone (PES) Polyethersulfone (PES)
Film Edge Polyethylene Polyethylene Polyethylene
Supports Polyester Polyester Polyester
Structural
Components
Gamma stable polypropylene/Polysulfone Gamma stable polypropylene/Polysulfone Gamma stable polypropylene/Polysulfone
Vent O­ring Silicone (SI) Silicone (SI) Silicone (SI)
Vent/Drain 1/4 in. Hose Barb with double O­ring seal
Maximum
Differential
Pressure, bar
(psid)
Forward: 6.9 bar (100 psid) intermittent @ 25 °C; 5.5 bar (80 psid) @ 25 °C; 1.0 bar (15 psid) @ 80 °C. Reverse: 2.1 bar (30 psid) @ 25 °C,
intermittent
Bubble Point ≥4000 mbar (58 psig) air with water
Air Diffusion ≤32.7 mL/min @ 2.75 bar (40 psig) in water ≤65.5 mL/min @ 2.75 bar (40 psig) in water ≤98.2 mL/min @ 2.75 bar (40 psig) in water
Bacterial
Retention
Quantitative retention of 10  CFU/cm  Brevundimonas diminuta (ATCC  19146) per ASTM  F838­83 methodology
Bacterial
Endotoxins
Aqueous extraction contains ≤0.25 EU/mL as determined by the Limulus Amebocyte Lysate (LAL) Test
®
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TOC/Conductivity Autoclaved filter meets the WFI
requirements of USP <643> for Total
Organic Carbon and USP <645> for Water
Conductivity after a WFI water flush of: 11
liters at 25 °C
Autoclaved filter meets the WFI
requirements of USP <643> for Total
Organic Carbon and USP <645> for Water
Conductivity after a WFI water flush of: 22
liters at 25 °C
Autoclaved filter meets the WFI
requirements of USP <643> for Total
Organic Carbon and USP <645> for Water
Conductivity after a WFI water flush of: 33
liters at 25 °C
Oxidizable
Substances
Will meet the USP Oxidizable Substances
Test requirements after a water flush of
≥1.5 L
Will meet the USP Oxidizable Substances
Test requirements after a water flush of ≥3 L
Will meet the USP Oxidizable Substances
Test requirements after a water flush of
≥4.5 L
Sterilization
Gamma
compatible
capsules
Gamma compatible to 45 kGy; 3 autoclave cycles of 60 min @ 123 °C; not in­line steam sterilizable
Sterile capsules 3 autoclave cycles of 60 min @ 123 °C; not in­line steam sterilizable
Sterility Sterile
Component
Material Toxicity
Component materials meet the criteria of the USP <88> Reactivity Test for Class VI Plastics. These products meet the requirements of the
USP <88> Safety Test, utilizing a 0.9% sodium chloride extraction.
USP Toxicity Non­toxic per MEM elution ISO  10993­5
Good
Manufacturing
Practices
These products are manufactured in a facility which adheres to FDA Good Manufacturing Practices.
Non­Fiber
Releasing
Component materials meet the "non­fiber releasing" criteria as defined in 21 CFR 210.3 (b) (6).
Indirect Food
Additive
All component materials meet the FDA Indirect Food Additive requirements cited in 21 CFR 177­182.
Typical Clean Water Flow Rate vs Pressure Drop (Sterile and Gamma Compatible Capsules)
Opticap  XL 150 Capsule Filters with 0.2 µm
Millipore Express  SHF Membrane  
Opticap  XL 300 Capsule Filters with 0.2 µm
Millipore Express  SHF Membrane  
Opticap  XL 600 Capsule Filters with 0.2 µm
Millipore Express  SHF Membrane
Opticap  XL 3 Capsule Filters with 0.2 µm
Millipore Express  SHF Membrane  
Opticap  XL 5 Capsule Filters with 0.2 µm
Millipore Express  SHF Membrane  
Opticap  XL 10 Capsule Filters with 0.2 µm
Millipore Express  SHF Membrane
®
®
®
®
®
®
®
®
®
®
®
®
®
4/16/2018 Opticap® XL and XLT Disposable Capsule Filters with Millipore Express® SHF 0.2&nbsp;μm Hydrophilic Membrane - Millipore Express SHF
http://www.emdmillipore.com/US/en/product/Opticap-XL-and-XLT-Disposable-Capsule-Filters-with-Millipore-Express-SHF-0.2nbspm-Hydrophilic-Membrane,MM_NF-C9127?Cata
Opticap  XLT 10 Capsule Filters with 0.2 µm
Millipore Express  SHF Membrane  
Opticap  XLT 20 Capsule Filters with 0.2 µm
Millipore Express  SHF Membrane  
Opticap  XLT 30 Capsule Filters with 0.2 µm
Millipore Express  SHF Membrane
®
®
®
®
®
®
Opticap  XL and XLT Disposable
Capsule Filters with Millipore
Express  SHF 0.2 μm
Hydrophilic Membrane
Opticap  XL and XLT capsule
filters eliminate the time and
expense associated with
assembling, cleaning, and
validating stainless steel housings.
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®
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Research. Development. Production.
We are a leading supplier to the global Life
Science industry: solutions and services for
research, development and production of
biotechnology and pharmaceutical drug
therapies.
EMD Group   Imprint   Terms of Use   Privacy Statement   Conditions of Sale   
© 2018 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved. 
The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the US and Canada.
Opticap  Gamma
Compatible XL 3
Millipore
Express  SHC...
®
®
Opticap  XL4
Durapore
0.22 µm 9/16 in.
HB/HB
®
®
Opticap  XL5
Durapore
0.22 µm 1­1/2 in.
TC/TC
®
®
Tubing Application  
Guide
Pushing the Boundaries of 
Peristaltic Pump Technology 
with Unique Formulations 
® Tubing Application Guide
ColeParmer.com
BioPharm Plus Tubing
Longer life (up to five times) and lower spallation compared  
to other platinum silicone tubing. Ultra-smooth inner surface.  
Biocompatible for sensitive applications. Autoclavable.  
Meets FDA, USP Class VI, and EP standards, and exceeds  
3A sanitary standards. Max temp: 450°F (232°C).  
 
•  Excellent pumping accuracy for high repeatability 
and consistent performance over time
•  Smooth inner bore results in less  
particle entrapment
• Low spallation maintains purity of fluid
•  No leachable additives or plasticizers to  
impart taste or contamination
• Sterilize to maintain system sterility
• Tolerates high-pressure applications
•  Ultra-low spallation maintains fluid purity and 
extends the life of filters 
•  Low permeability provides barrier to chemicals 
that damage tubing
•  Tolerates continuous-pressure applications  
up to 40 psi (2.7 bar)
•  Long tubing life means time and  
cost savings
C-FLEX® Tubing 
Excellent biocompatibility; contains no toxic materials.  
Heat sealable and weldable. Autoclavable. Meets FDA and  
USP Class VI standards. Max temp: 275° F (135°C).  
•  Combines the biocompatibility of silicone with 
chemical resistance of Tygon®, but with longer 
pumping life
•  Nonpyrogenic, noncytotoxic, and nonhemolytic 
properties maintain purity and sterility of fluids
•  Low protein binding ensures minimal  
degradation or loss of sample
•  Chemically resistant to acids and bases  
for longer tubing life
Pharmaceuticals   S Drug Discovery 
PharmaPure® Tubing
Nontoxic and nonhemolytic, excellent biocompatibility. Longest  
pumping life of any high-performance formulation; low extractability.  
Autoclavable. Meets FDA, EP,  and USP Class VI standards.  
Max temp: 275°F (135°C). 
Biopharmaceuticals   S Nutraceuticals 
 Pharmaceutical   S Life Science   S Electronics   S Semiconductor 
Applications: filtration; fermentation; dispensing solutions and media.
Applications: biopharmaceutical processing and storage; botanical production.
Applications: sterile filling; filtration; transfer of cell media.
eExclusiveMast
erflex
®
eExclusiveMast
erflex
®
ColeParmer.com
Chem-Durance™ Tubing
Best combination of pumping life and chemical resistance.  
Excellent durability. Plasticizer-free inner liner provides low  
spallation. Autoclavable. Meets FDA standards.  
Max temp: 165°F (74°C).  
•  Chemical-resistant inner liner allows use  
with harsh chemicals
• Low spallation maintains purity of fluid
•  Flexible outer jacket dissipates heat  
generated from rollers for longer tubing life
•  Hydrophobic, smooth-bore inner liner means  
negligible absorption of fluids or leachables
Viton® Tubing
Resistant to corrosives, solvents, and oils at elevated  
temperatures. Low gas permeability.  
Max temp: 400°F (205°C). 
•  Exclusive Masterflex® formulation—highest 
fluorine content of any Viton for enhanced 
chemical compatibility
•  Tolerates some of the harshest chemicals used 
in the semiconductor industry
•  Resistant to corrosive solvents and  
aliphatic and aromatic hydrocarbons
•  Ultra-low gas permeability maintains  
integrity of fluid
Tygon® Chemical Tubing
Best chemical resistance of any Tygon formulation. Compatible  
with many popular solvents. Autoclavable. Complies with FDA 21  
CFR 177.2600 criteria. Max temp: 135°F (57°C).  
•  Plasticizer- and oil-free to ensure accurate 
results from analytical tests; does not yield 
taste into fluids
• Clear tubing for easy flow monitoring
• Sterilize to maintain system sterility
•  Low gas permeability and extractability  
maintains integrity of fluid
•  Very good chemical compatibility affords  
longer tubing life
Applications: transfer of sensitive fluids; ink and solvent production.
Applications: disinfectant transfer; dispensing of food additives.
Applications: transfer harsh chemicals through process line.
Chemical   S Printing   S Automotive 
Chemical   S Pharmaceutical   S Food & Beverage 
Chemical   S Manufacturing   S Semiconductor 
eExclusiveMast
erflex
®
eExclusiveMast
erflex
®
FREE TECHNICAL  
APPLICATIONS ASSISTANCE!
In the United Kingdom
Free phone: 0500-345-300
Phone: 020-8574-7556
Fax: 020-8574-7543
www.coleparmer.co.uk
International customers  
Call 847-549-7600 to reach our  
International Sales Department  
or contact your local dealer.
In the U.S.  
625 E. Bunker Court
Vernon Hills, IL 60061
Call toll-free 800-323-4340
Phone: 847-549-7600
Fax: 847-247-2929
www.coleparmer.com
In Canada  
Call toll-free 800-363-5900
Phone: 514-355-6100
Fax: 514-355-7119
www.coleparmer.ca
In India
Phone: 91-22-6716-2222
Fax: 91-22-6716-2211
www.coleparmer.in
ColeParmer.com1759
PTFE Tubing 
The only peristaltic-compatible PTFE tubing available!
Excellent fluid purity, chemical resistance, and very low gas permeability.  
Autoclavable. Meets FDA and USP Class VI standards. Max temp: 500°F (260°C).  
GLOSSARY
Cytotoxic—having a toxic effect on cells  
Hemolytic—causing the destruction of red blood cells 
Leachables—chemicals released from tubing that may 
contaminate fluid being pumped 
Pyrogenic—showing measurable traces of bacterial endotoxins 
Spallation—the generation of particles from the inner  
bore of the tubing
•  Chemically inert; offering the best chemical 
resistance of any pump tubing
•  Rigid tubing structure provides tolerance for 
high-pressure applications up to 100 psi (6.8 bar)
•  Inert fluoropolymer will not leach into or absorb 
out of fluid being pumped
MASTERFLEX® RESOURCES ONLINE
Pump system selection:  
Masterflex.com/pumpconfigurator 
Tubing compatibility:  
Masterflex.com/mflexChem
Peristaltic pump applications:  
Masterflex.com/pumpSolutions
 Electronics   S Semiconductor   S Industrial   S Chemical   S Food & Beverage 
 Pharmaceutical   S Water  S Wastewater 
Applications: vulcanization; feeding and metering of aggressive chemicals; dispensing of fruit extracts and flavoring.
High-Pressure PharMed® BPT  
and High-Pressure Norprene® Tubing
High-Pressure PharMed BPT: Over 10,000 hours of tubing life. Heat sealable,  
bondable, and autoclavable. Resists ozone and UV radiation. Meets FDA and  
USP Class VI standards. NSF-listed. Max temp: 270°F (135°C).  
High-Pressure Norprene: Up to 10,000 hours tubing life. Resists heat, ozone,  
acids, and alkalis. Heat sealable, non-aging, non-oxidizing, and autoclavable.  
Best choice for pressure/vacuum applications. Max temp: 270°F (135°C).  
•  Thick-walled tubing withstands pressures up to 
100 psi (6.8 bar) with precise, repeatable flow
•  Noncytotoxic and nonhemolytic properties make 
PharMed BPT ideal for tissue and cell culture work
•  Chemical-resistant Norprene handles a variety 
of chemicals and solutions
Applications: sterile filtration; chemical injection.
eExclusiveMast
erflex
®
4/16/2018 Corning® Erlenmeyer bafﬂed cell culture ﬂasks 250 mL Erlenmeyer Flask w/ Vent Cap, polycarbonate, sterile, 50/cs | Sigma-Aldrich
https://www.sigmaaldrich.com/catalog/product/sigma/cls431407?lang=en&region=US&cm_sp=Insite-_-prodRecCold_xorders-_-prodRecCold2-1 1/4
USA Home   CLS431407 ­ Corning® Erlenmeyer baffled cell culture flasks
SDS SIMILAR PRODUCTS
CLS431407 SIGMA
Corning® Erlenmeyer baffled cell culture flasks
250 mL Erlenmeyer Flask w/ Vent Cap, polycarbonate, sterile, 50/cs
Synonym: Corning Erlenmeyer flasks, baffled cell culture flasks, cell culture flasks, conical flasks, plastic Erlenmeyer
flasks, shaker flasks
 eCl@ss 32040501
 
4/16/2018 Corning® Erlenmeyer bafﬂed cell culture ﬂasks 250 mL Erlenmeyer Flask w/ Vent Cap, polycarbonate, sterile, 50/cs | Sigma-Aldrich
https://www.sigmaaldrich.com/catalog/product/sigma/cls431407?lang=en&region=US&cm_sp=Insite-_-prodRecCold_xorders-_-prodRecCold2-1 2/4
Description
General description
Corning® Erlenmeyer Baffled Cell Culture Flasks
  
Corning baffled bottom Erlenmeyer flasks are sterile, disposable and are ideal for all shaker culture applications as well as liquid handling and storage. Like all
Corning flasks, the flasks are certified nonpyrogenic and sterile. The 125 mL through 1 L Erlenmeyer flasks are available with standard two­position plug seal
caps or filtered vent caps. The 2 L and 3 L flasks are available with vent caps.
  
Features and Benefits:
  
More Robust
 • Polycarbonate construction: USP Class VI material provides excellent optical clarity and mechanical strength
 • Unlike PETG, flasks will not collapse when autoclaving media or sanitizing waste
 • Unlike glass, flasks will not break when dropped
  
More Reliable
 • RNase­ and DNase­free
 • Molded­in­graduations for accuracy
 • Vent cap option for continuous gas exchange while ensuring sterility and preventing leakage
 • Individual packaged and radiation sterilized
 • All flasks have the highest Sterility Assurance Level (SAL) of 10­6
 • Certified nonpyrogenic
 • Made from optically clear polycarbonate
 • Ideal for shaker culture applications
 • Vent caps available for applications requiring sterile gas exchange
 • Sterilized by gamma radiation and certified nonpyrogenic
  
Note: Erlenmeyer flasks can be used with Corning LSE™ orbital shaker
Legal Information
Corning is a registered trademark of Corning, Inc.
LSE is a trademark of Corning, Inc.
Properties
Related Categories Corning, Corning Erlenmeyer Flasks and Fernbach Flasks,
Polycarbonate, Corning Flasks, Corning LSE Equipment,
Corning LSE Shakers & Vortexers,
More...
material   polycarbonate flask
  polypropylene cap (Easy­Grip vent)
  wide­mouth
sterility   sterile; γ­irradiated
feature   disposable
  graduations 25 mL
  graduations
packaging   pack of 1
  case of 50
mfr. no.   Corning, 431407
flask capacity   250 mL
neck diam.   25 mL
suitability   suitable for (ideal for all shaker culture
applications as well as liquid handling and
storage)
Show Fewer Properties 
Price and Availability
SKU­Pack Size Availability   Price(USD) Quantity
CLS431407­50EA   641.70
4/16/2018 Corning LSE Low Speed Orbital Shaker Low speed orbital shaker:BioPharmaceutical
https://www.ﬁshersci.com/shop/products/corning-lse-low-speed-orbital-shaker-low-speed-orbital-shaker/10320813 1/2
Ć  Our pricing TZTtem iT unavailaCle. You are viewing liTt price. 
PleaTe call 1-800-766-7000 to place Zour order or trZ our Tite again later.
Corning™ L4&™ Low 4peed
OrCital 4haker 
Ideal for Ttaining and deTtaining fragile gelT,
waThing ClotT and general mixing applicationT
Manufacturer:  Corning™ 6780FP
Catalog No. 10-320-813
$1,363.68 / CaTe 
DeTcription
Gentle motion preventT foaming of liquidT
Analog control with eaTZ-turn knoCT
19mm orCit for Clotting, gel Ttaining and general mixing
4peed can Ce Tet from 3 to 60rpm
Timer can Ce Tet for up to 2 hourT or for continuouT operation
4afe for cold room and incuCator uTe
120V, 50/60Hz
ThiT product(T) reTideT on a FiTher 4cienti c G4A or VA contract. If Zou are viewing thiT page aT a nonregiTtered uTer, the price(T)
diTplaZed iT LiTt Price. To view Zour G4A or VA contract pricing, log in uTing Zour account numCer, or Cecome a regiTtered uTer CZ
contacting one of our CuTtomer 4ervice teamT. You can alTo view Zour contract price CZ Tearching for thiT item(T) on G4A
Advantage. To place an order, contact FiTher 4cienti c CuTtomer 4ervice.
4peci cationT
Model 6780-FP
OrCit 1.9cm
Length (&ngliTh) &xterior 10 in.
Plug TZpe U4
Height (&ngliTh) 6 in.
TZpe OrCital Thaker
4peed Range 3 to 60rpm
Hertz 50/60Hz
Length (Metric) &xterior 25.5cm
Voltage 120V
Height (Metric) 16cm
Width (&ngliTh) 12.5 in.
4/16/2018 Corning LSE Low Speed Orbital Shaker Low speed orbital shaker:BioPharmaceutical
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Width (Metric) 32cm
&lectrical RequirementT 120V 50/60Hz
Controller TZpe Analog
SPECIFICATIONS AND 
ORDERING INFORMATION
© 2015 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries.
See how Thermo Scientific C02 incubators provide optimal cell growth. 
Learn more at www.thermoscientific.com/co2incubators
BRCO2FORMA3 0115
Australia +61 39757 4300
Austria +43 1 801 40 0
Belgium +32 53 73 42 41
China +800 810 5118 or  
+400 650 5118  
France +33 2 2803 2180
Germany national toll free  0800 1 536 376 
Germany international +49 6184 90 6000
India toll free 1800 22 8374 
India +91 22 6716 2200
Italy +39 02 95059 552
Japan +81 3 5826 1616
Netherlands +31 76 579 55 55
New Zealand +64 9 980 6700
Nordic/Baltic/CIS countries 
+358 9 3291 0200
Russia +7 812 703 42 15
Spain/Portugal +34 93 223 09 18
Switzerland +41 44 454 12 22
UK/Ireland +44 870 609 9203
USA/Canada +1 866 984 3766
Other Asian countries +852 2885 4613 
Countries not listed +49 6184 90 6000
All units are UL Listed to United States and Canadian requirements and bear the CE Mark.
*50°C (122°F) on Model 4120 (4121), 45°C (113°F) on Models 4130 (4131) and 4140 (4141).
**Truncated
Construction
Water Jacket Volume 11.7 gal. (43.5 liters)
Interior Volume 6.5 cu. ft. (184.1 liters)
Interior Type 304, mirror finish, stainless steel
Exterior 18 gauge, cold-rolled steel, powder coated
Outer Door Gasket Four-sided, molded, magnetic vinyl
Inner Door Gasket Removable, cleanable, feather-edged, silicone 
Electrical
4110/4120/4130/4140       115V, 50/60 Hz, 3.6 FLA (operating range 90–125V)
4111/4121/4131/4141        230V, 50/60 Hz, 2.0 FLA (operating range 180–250V)
Circuit Breaker/ 6 Amps/2 Pole
Power Switch
Convenience Receptacle 75 Watts max. (one per chamber)
Plug 115V: NEMA 5-15P Plug
230V: CEE 7/7 Plug
Alarm Contacts Power interruption; deviation of temp, CO2, O2, 
RH; customer connections through jack on back of unit
Data Outputs (opt.) USB (standard), 4–20 milliamp (optional)
Dimensions
Exterior 26.0"W x 39.5"H x 25.0 USB Port (standard), 4-20 ma
(optional)"F-B (66.0cm x 100.3cm x 63.5cm)
Interior 21.3"W x 26.8"H x 20.0"F-B
(54.1cm x 68.1cm x 50.8cm)
Weight
Net 265 lb (120.2 kg)
Net Operational 365 lb (165.6 kg)
Shipping (Motor) 324 lb (147.0 kg)
Specifications
Temperature
Control ±0.1°C
Range 5°C above ambient to 55°C (131°F)*
Uniformity ±0.2°C @ 37°C (98.6°F)**
Tracking Alarm +/-1°C 
Temperature Safety
Sensor Precision thermistor
Controller Independent analog electronic
Setability 0.1°C
CO2/O2
CO2/O2 Control Better than ±0.1%
CO2 Range 0–20%
O2 Range 1–20%
Inlet Pressure 15 PSIG (1.0 bar)
CO2 Sensor T/C or IR
O2 Sensor Fuel cell 
Readability & Setability 0.1%
Tracking Alarm +/-1%
Humidity
RH Ambient to 95% @ 37°C (98.6°F)
Humidity Pan 3.2 qt. (3.0 liters) standard
Display (opt.) In 1% increments
Fittings
Fill Port 3/8" hose (barbed)
Drain Port 1/4" hose (barbed)
Access Port 1.3" (3.3cm) with removable silicone plug with filter
CO2 Inlet 1/4" hose (barbed)
Unit Heat Load
115V/230V 344 BTUH (100 Watt)
Orderimg Information
OC.oN .taC 2 O2 Voltage
511oNC/T
032oNC/T
511oNRI
032oNRI
511seYC/T
032seYC/T
IR
IR
Yes
Yes
115
230
L US®C U
4110
4111
4120
4121
4130
4131
4140
4141
Shelves
Dimensions 18.5" x 18.5" (47.0cm x 47.0cm)
Construction Stainless steel, perforated
Surface Area 2.4 sq. ft. (0.2 sq. m)
Max. per Chamber 40.8 sq. ft. (3.8 sq. m)
Standard, Maximum 4, 17
Thermo Scientific Forma Series 3
Water Jacketed CO2 Incubator
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Thermo Scientiﬁc Nalgene
Cryogenic Storage Boxes for
Locator™ and Locator Plus Systems
 Email This Page   Print Page
Request A Customer Account
DESCRIPTION
Obtain a comprehensive solution when plastic is preferred to
ﬁberboard. Thermo Scientiﬁc™ Nalgene™ Cryogenic Storage Boxes
for Locator™ and Locator Plus Systems ﬁt in Thermo Scientiﬁc
stainless-steel, ultra-low temperature freezer racks.
Please Enter Your Order Info
Filter by:   
PRODUCT DETAIL
PRODUCT AVAILABILITY: Did you know you can view a product's availability right on the product page?
Simply enter the quantity you want to purchase and the current availability will appear below the item.

 

 CLEAR FILTERS
5149D15
Mfr. No.  CS509X3
Description
Ampule Box, 25-Place For Locator 8
List Price/Quantity Total
$723.86 /CS
(80/CS)
0
$0.00
5149D25 List Price/Quantity Total
Avail. Qty
4/16/2018 Cryogenic Storage Boxes for Locator™ and Locator Plus Systems
https://www.thomassci.com/Laboratory-Supplies/Cryogenic-Storage-Containers/_/Cryoboxes-for-Locator-Systems 2/3
$0.00 (0 Items)
ADD TO FREQUENT BUY LIST
You must be logged in to add items to a list. Please log in here.
Write A Review
Rating (required)
Comments (required)
Mfr. No.  CS509X4
Description
Ampule Box, 81-Place For Locator 4
List Price/Quantity Total
$556.87 /CS
(40/CS)
0
$0.00
5149D35
Mfr. No.  CS509X5
Description
Ampule Box, 81-Place For Locator Jr
List Price/Quantity Total
$276.88 /CS
(20/CS)
0
$0.00
1187N35
Mfr. No.  CS509X10
Description
4" Vial Box for 5mL Nalgene Vials, 81
vials/box
List Price/Quantity Total
$40.85 /EA
(1/EA)
0
$0.00
1187N36
Mfr. No.  CS509X24
Description
2" Vial Box for 1 & 1.5mL Nalgene Vials, 100
vials/box
List Price/Quantity Total
$159.70 /CS
(10/CS)
0
$0.00
ADD TO SHOPPING CART
QF150S
Quaternary Diaphragm Pumps
Multiple-Use – Biotech/Biopharma
Spec Sheet QF150S 
Effective: October 2014
Replaces: NEW
Features
• 4-piston technology
• Includes control panel
• Gentle product treatment
• No particle generation
• Low pulsation
• Linear flow characteristic
• Hygienic design
• Self-priming
• Safe dry-run operation
• Also available as single-use version
Applications
• Filtration systems (TFF, etc.)
• Chromatography systems
• Feeding pump
• Virus filtration
• Sterile filtration
QF150S Standard Motor
Flow Rate Maximum:
Eccentric Shaft 5° 180 l/h (48 gph)
Flow Rate Minimum:
Eccentric Shaft 5° 1  l/h (0.26 gph)
Pressure:
Temperature of Fluid < 40° C (104° F) 6 bar (87 psi)
Temperature of Fluid > 40° C (104° F) 4 bar (58 psi)
Maximum Temperature:
Fluid 80° C (176° F)
CIP 90° C (194° F)
SIP 130° C (260° F)
Autoclave 130° C (260° F)
Suction Lift Dry at 3000 rpm:
Eccentric Shaft 5° 2 - 3 m (6.6 - 9.8 ft)
Volume Specifications:
Approximated Volume per 
Revolution at Free Output 1.2 ml
Filling Volume Without Connectors 15 ml
Connection Specification (Standard):
Connectors 1/4" TC
Position of Connectors Inline
Number of Flow Directions 4
QF150S Standard Motor
Product Wetted Materials (Standard):
Pump Housing SS316L
Valve Plate SS316L
Diaphragms TPE
Valves EPDM
O-rings EPDM
Certificates/Proofs (Optional):
Elastomere (product wetted) USP <88> Cl. VI; FDA21CFR177;  BSE/TSE Safe
Stainless Steel Parts (product wetted) 3.1; Surface Roughness; Ferrite Content
Motor (Standard):
Rated speed 3000 min-1 (50 Hz)
Voltage 230/115 V
Power 0.05 KW
Pump Dimension with Motor and Housing:                               
Length 280.5 mm (11.04")
Width 115 mm (4.53")
Height 184 mm (7.24")
Pump Weight with Motor and Housing:
8.4 kg (19 lb.)
Technical Data
Other connection specifications, materials and motors available on request.
Distributed by:
© 2014 ALMATECQF150S
ALMATEC Maschinenbau GmbH
Carl-Friedrich-Gauß-Str. 5
47475 Kamp-Lintfort, Germany
O: +49/2842/961-0, F: +49/2842/961-40
www.quattroflow.com
info@almatec.de
Almatec reserves the right to modify the information and illustrations contained in this document
without prior notice. This is a non-contractual document. 
Performance Charts
Accessories
Power Box
• Plug & Play installation
• Protects system and pump from overpressure
• Configurable pressure switch setpoint
• Reset button for pump reset
• To be used with pressure switch (also available)
QF1200S
Quaternary Diaphragm Pumps
Multiple-Use – Biotech/Biopharma
Spec Sheet QF1200S 
Effective: October 2014
Replaces: NEW
Features
• 4-piston technology
• Gentle product treatment
• No particle generation
• Low pulsation
• Linear flow characteristic
• Hygienic design
• Self-priming
• Safe dry-run operation
• Also available as single-use version
Applications
• Filtration systems (TFF, etc.)
• Chromatography systems
• Feeding pump
• Virus filtration
• Sterile filtration
QF1200S Standard Motor
Flow Rate Maximum:
Eccentric Shaft 3° 800 l/h (211 gph)
Eccentric Shaft 5° 1,200 l/h (317 gph)
Flow Rate Minimum*:
Eccentric Shaft 3° 10  l/h (2.64 gph)
Eccentric Shaft 5° 20  l/h (5.3 gph)
Pressure:
Temperature of Fluid < 40° C (104° F) 6 bar (87 psi)
Temperature of Fluid > 40° C (104° F) 4 bar (58 psi)
Maximum Temperature:
Fluid 80° C (176° F)
CIP 90° C (194° F)
SIP 130° C (260° F)
Autoclave 130° C (260° F)
Pump Speed Range:
rpm 30 - 2,400
Suction Lift Dry at 1800 rpm:
Eccentric Shaft 3° 2.5 - 3 m (8.2-9.8 ft)
Eccentric Shaft 5° 4 - 4.5 m (13.1-14.7 ft)
Volume Specifications:
Approximated Volume per 
Revolution at Free Output
9.6 ml (5°)
5.8 ml (3°)
Filling Volume Without Connectors 75 ml
QF1200S Standard Motor
Connection Specification (Standard):
Connectors 3/4" TC
Position of Connectors Inline
Number of Flow Directions 4
Product Wetted Materials (Standard):
Pump Housing SS316L
Valve Plate SS316L
Diaphragms TPE
Valves EPDM
O-rings EPDM
Certificates/Proofs (Optional):
Elastomere (product wetted) USP <88> Cl. VI; FDA21CFR177;  BSE/TSE Safe
Stainless Steel Parts (product wetted) 3.1; Surface Roughness; Ferrite Content
Motor (Standard):
Rated speed 1375 min-1 (50 Hz)
Voltage 230/400 V
Power 0.37 KW
Pump Dimension with Motor and Housing:                               
Length 487 mm (19.17")
Width 159 mm (6.26")
Height 210 mm (8.27")
Pump Weight with Motor and Housing:
24 kg (53 lb.)
Technical Data
Other connection specifications, materials and motors available on request.
*  When using pump with control box: 20 l/h (5.28 gph) and 40 l/h (10.6 gph)
Distributed by:
© 2014 ALMATECQF1200S
ALMATEC Maschinenbau GmbH
Carl-Friedrich-Gauß-Str. 5
47475 Kamp-Lintfort, Germany
O: +49/2842/961-0, F: +49/2842/961-40
www.quattroflow.com
info@almatec.de
Almatec reserves the right to modify the information and illustrations contained in this document
without prior notice. This is a non-contractual document. 
Performance Charts
Accessories
Eccentric Shaft: 3º
Eccentric Shaft: 5º
Control Box
• Variable speed controller with 
integrated touch pad for manual 
speed control
• Configurable for remote  
speed control with 4-20 mA  
analogue input
• 230V / 50 Hz or 115 V / 60 Hz
• Hygienic 1.4301 housing, IP 54 
• Easy plug & play installation
Power Box
• Plug & Play installation
• Protects system and pump from 
overpressure
• Configurable pressure switch 
setpoint
• Reset button for pump reset
• To be used with pressure switch 
(also available)
Diaphragm Sensor
• Sensor installed in ring  
drive unit
• Detection of all liquids
• Signal output to a controller,  
if diaphragm is ruptured
Depending on the selected motor/frequency drive combination, the motor frequency and the resulting pump speed might differ.
825 series hygienic pump
FEATURES
800 series
Watson-Marlow Bredel
• Flow rates up to 575 gph (36 L/min) at 50 psi (3.5 bar) continuous pressure 
• Clean-in-place and steam-in-place sterilization at full velocity with no bypass
required
• Ideal for viscous or shear sensitive products
• Bioprene or STA-PURE tube certified to USP Class VI and FDA approved with
hygienic stainless steel connectors
• Bioprene tubing available in two hardnesses for pressures up to 30 psi (2 bar)
and 50 psi (3.5 bar). STA-PURE tubing is rated for pressures up to
50 psi (3.5 bar)
• Pumpheads to accept B5 output flange-mounted gear motors in a range of
single and three phase fixed and electronic variable speeds
• Hinged door with only two captive bolts makes tube inspection and change
extremely simple and safe
• Explosion proof version available
• Options include stainless steel pushbar and swivel caster set for mobile
applications and a wide variety of connectors
PERFORMANCE
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rpm
Speed Flow rate Flow rate Fitted Motor Power
(rpm) (gph) (L/min) (hp) 
30 157 10 0.75
56 293 18 1.0
84 439 28 1.5
101 528 33 2.0 
For variable speed units and other gearing or build options, please contact your local representative, or the Watson-Marlow Bredel Applications Engineering department. 
All flow rates shown were obtained pumping water at 68°F with zero suction and delivery heads.
Watson-Marlow, Bioprene and Marprene are trademarks of Watson-Marlow Limited. 
Disclaimer: The information contained in this document is believed to be correct but Watson-Marlow Limited accepts
no liability for any errors it contains, and reserves the right to alter specifications without notice. LoadSure is a
trademark of Watson-Marlow Limited. ® Chem-Sure and ® STA-PURE are registered trademarks of W.L Gore &
Associates Inc. Please state the product code when ordering pumps and tubing. 
SPECIFICATIONS MATERIALS OF CONSTRUCTION
DRAWINGS
Watson-Marlow Bredel Pumps 
37 Upton Technology Park
Wilmington, MA 01887
Tel: 800 282 8823  Fax: 978 658 0041 
www.watson-marlow.com  support@watson-marlow.com
Bredel
PUMPS
ORDER INFORMATION
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Environment Temperature 40°F to 104°F
Fluid Temperature -32°F to 175°F
Max Operating Speed 109 rpm
Max Pressure 50 psi continuous (3.5 Bar)
Suction Pressure Up to 28 ft water
Pump weight Dependant upon drive. Nominally 250 lbs
Control ratio Dependant upon VFD selection
Noise < 75dB(A) at 1m 
Supply 230/460/575 3ph 60Hz, 115/230 1ph 60Hz
Door Switch 50 Watt, 240VAC (not suitable for XP 
environments)
Power Up to 2 hp 
Component Material
Pumphead body Aluminum alloy with epoxy polyester 
powder coat finish
Pumphead door Aluminum alloy with epoxy polyester 
powder coat finish
Pumphead rotor hub Aluminum alloy with epoxy polyester 
powder coat finish
Rotor rollers Stainless steel 316
Support frame Stainless steel 304
Door fixings Stainless steel 304
Motor fixings Zinc plated high tensile steel bolts, 
stainless steel nuts and washers
Frame fixings Stainless steel 304
Element and Connector product codes
Description Sanitary Description Partcode
Bioprene TM hose 088.0250.E0M 1" Tri-clamp, 316SS 089.0250.00T
Bioprene TH hose 088.0250.E0H 1" Tri-clamp, PVDF 089.0250.00K
Sta-pure hose 089.0250.000 1" Male Cam & Groove, 316SS 089.0250.00Q
Length dependant on selection of gearbox and motor
D
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! Ideal for particle and
microorganism removal
! Excellent resistance to 
thermal and hydraulic stress 
! Validated to withstand multiple
sterilization cycles
! Scalable — from bench-top 
to full-scale production
! Wide selection of
configurations to meet 
your process needs
Â
Durapore hydrophobic membrane cartridges and capsules are sterilizing-grade
filters that provide sterility assurance, high flow rates and high throughput. They
are used for sterile tank and gas venting, as well as for the filtration of liquids in
small and large volume systems. Durapore 0.22 µm hydrophobic polyvinylidene
fluoride (PVDF) membrane reliably eliminates contaminants and microorganisms
in sterilizing applications, even at high pH.
Broad Chemical Compatibility,
Low Extractables
Contributing to clean manufacturing
processes, Durapore filters are made
of just two materials—PVDF membrane
and polypropylene support structure
—this ensures broad chemical
compatibility and low gravimetric
extractables. 
Regulatory Compliance
Filters with hydrophobic Durapore
0.22 µm membrane are designed,
developed, and manufactured in
accordance with a Quality Manage-
ment System approved by an accred-
ited registering body to an ISO® 9000
Quality Systems Standard and are
shipped with a Certificate of Quality.
Each Opticap® XL capsule and
Durapore cartridge filter is integrity
tested during manufacturing and is
supported with a comprehensive
Validation Guide for compliance 
with regulatory requirements. 
For traceability and easy identifi-
cation, each filter is labeled with the
product name and identifying
characteristics.
Multiple Formats Available
Sterilizing-grade hydrophobic
Durapore membranes are available 
in three formats and multiple configu-
rations that vary by filtration surface
area and type of inlet/outlet
connection.
Sterilizing-grade 
Durapore® 0.22 µm
Hydrophobic Filters
Reliable filters for the sterile filtration 
of gases and liquids
Membrane Types
• Durapore 0.22 µm hydrophobic
Filter Formats
• Opticap XL disposable capsule filters
• Optiseal® cartridge filters 
• Cartridge filters
 
2From process
development 
to full-scale
production,
Millipore 
has the right
solution for you!
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Opticap XL Disposable Capsule Filters 
Opticap XL Filters 
Opticap XL disposable capsule filters
with hydrophobic Durapore membrane
are available in multiple filtration
areas, providing an optimal choice for
every application. Each Opticap XL
capsule is integrity tested during the
manufacturing process. The Opticap
XL capsule patented design allows
unparalleled thermal and hydraulic
stress resistance in a disposable filter,
resulting in reliability, high confidence
in the sterility process, and improved
cleanliness. The unique capsule
design with pleated hydrophobic
Durapore membrane minimizes hold-up
volume and reduces production losses.
Convenient and Easy to Use
Opticap XL capsule filters eliminate the
time and expense associated with
assembling, cleaning, and validating
stainless steel housings. Adjustable,
easy-to-turn
upstream vents 
and drain valves
with O-ring seals
allow easy process
control. Other ease-
of-use features include flow direction
arrows and ribbed housing for easy
gripping, even with gloved-hands. 
The Right Size
A wide range of filtration areas is
available to fit all of your application
needs, and to allow easy scale-up of
your small volume filtration steps to
larger, full-scale filtration processes.
The Right Connections
Self-contained, disposable Opticap XL
capsule filters are supplied with a
choice of inlet and outlet connections
to optimize your filtration process.
Connections include hose barb,
fractional sanitary flange, and
sanitary flange, which provide the
highest flow rate.
3Optiseal Cartridge Filters
Optiseal Filters
Featuring a unique cartridge-to-housing
sealing mechanism and pleated mem-
brane configuration, these Durapore
0.22 µm hydrophobic cartridges offer
maximum sterility assurance. Each
cartridge filter is integrity tested during
the manufacturing process.
Cartridge Filters
Cartridge Filters
Hydrophobic Durapore cartridge filters
provide high throughput and minimal
differential pressure. Cartridges are
robust, resilient, and designed to
withstand multiple steam-in-place
cycles. Each cartridge filter is integrity
tested during the manufacturing
process.
Durapore cartridge filters are
available in five cartridge lengths,
from five to thirty inches, and provide
a full range of filtration areas to suit
every size system. Three connection
options are offered for easy adapta-
tion to existing housings.
4Opticap XL 5 Opticap XL 10
Nominal Dimensions
Maximum length: 21.6 cm (8.5 in.) 33.5 cm (13.2 in.)
Body diameter: 10.7 cm (4.2 in.) 10.7 cm (4.2 in.)
Vent to vent diameter: 14.5 cm (5.7 in.) 14.5 cm (5.7 in.)
Filtration Area 0.35 m2 (3.7 ft2) 0.69 m2 (7.4 ft2)
Materials of Construction
Filter membrane: Hydrophobic PVDF
Film edge: Polypropylene
Supports: Polypropylene
Structural components*: Polypropylene
Vent O-rings: Silicone
Vent/Drain ª in. hose barb with double O-ring seal
Maximum Inlet Pressure 5.5 bar (80 psi) at 23 °C
2.8 bar (40 psi) at 60 °C
1.0 bar (15 psi) at 80 °C
Maximum Differential Pressure
Forward: 5.5 bar (80 psid) at ambient temperature, 1.0 bar (15 psid) at 80 °C
Reverse: 3.4 bar (50 psid) at ambient temperature
Bubble Point at 23 °C ≥ 1170 mbar (17.0 psig) nitrogen > 1240 mbar (18.0 psig) nitrogen
with 70/30 IPA/water with 60/40 IPA/water
Nitrogen Diffusion Through a water wet membrane at ambient room temperature at 1720 mbar (25 psig) nitrogen:
≤ 5 cc/min ≤ 10 cc/min
Bacterial Endotoxin Aqueous extraction contains < 0.5 EU/mL as determined by the Limulus Amebocyte Lysate (LAL) Test.
Bacterial Retention Quantitative retention of 107 CFU/cm2 Brevundimonas diminuta ATCC® 19146 per ASTM® methodology.
Sterilization May be autoclaved for 20 cycles of 30 minutes at 126 °C.
Good Manufacturing Practices These products are manufactured in a Millipore facility which adheres to FDA Good Manufacturing Practices.
Non-Fiber Releasing Durapore membrane meets the criteria for a “non-fiber releasing” filter as defined in 21 CFR 210.3 (b) (6).
Component Material Toxicity Component materials were tested and meet the criteria of USP <88> Reactivity Tests for Class VI Plastics. 
Durapore filters meet the requirements of the USP <88> Safety Test.
European Pressure Equipment Millipore Corporation certifies that this product complies with the European Pressure Equipment Directive,
Directive 97/23/EC of 29 May 1997. This product has been classified under Article 3 § 3 of the Pressure Vessel 
Directive. It has been designed and manufactured in accordance with sound engineering practice to ensure safe 
use. In compliance with Article 3 § 3 of this Pressure Equipment Directive, this product does not bear the CE mark.
*Cage, core, end caps, and capsule housing
Specifications
5Optiseal Filters 5-inch Cartridge Per 10-inch Cartridge
Nominal Dimensions
Maximum length: 12.0 cm (4.7 in.) 12.5 cm (5 in.) 25 cm (10 in.)
Outside diameter: 6.9 cm (2.7 in.) 6.9 cm (2.7 in.) 6.9 cm (2.7 in.)
Filtration Area 0.18 m2 (1.9 ft2) — 0.7 m2 (7.4 ft2)
Materials of Construction
Filter membrane: Hydrophobic PVDF Hydrophobic PVDF
Supports: Polypropylene Polypropylene
O-rings: Silicone Silicone
Connections Double 2-123 O-ring Code 7 (2-226) O-ring with locking tab and spear
Code 5 (2-222) O-ring with spear
Code 0 (2-222) O-ring 
Maximum Differential Pressure
Forward: 5.5 bar (80 psid) at 25 °C; 3.5 bar (50 psid) at 80 °C; 0.35 bar (5 psid) at 135 °C
Reverse: 3.4 bar (50 psid) at 25 °C
Bubble Point at 23 °C ≥ 2000 mbar (29 psig) in water ≥ 2000 mbar (29 psig) in water
≥ 1240 mbar (18 psig) in 60/40 IPA/water ≥ 1240 mbar (18 psig) in 60/40 IPA/water
≥ 1170 mbar (17 psig) in 70/30 IPA/water ≥ 1170 mbar (17 psig) in 70/30 IPA/water
≥ 1170 mbar (17 psig) in 100 IPA
Nitrogen Diffusion At 1.0 bar (15 psig) in 60/40 IPA/water at 23 °C: At 1.7 bar (25 psig) in water at 23 °C:
≤ 2 cc/min ≤ 5.0 mL/min ≤ 10.0 mL/min
At 1.7 bar (25 psig) in water at 23 °C: 
≤ 5.0 cc/min
Bacterial Endotoxin < 0.5 EU/mL as determined by the Limulus Amebocyte Lysate (LAL) Test.
Bacterial Retention Quantitative retention of Brevundimonas diminuta (ATCC 19146) following ASTM F838-83 methodology 
at a minimum challenge level of 107 CFU/cm2.
Sterilization 30 steam-in-place cycles of 30 min at 135 °C; 30 steam-in-place cycles at 30 min at 126 °C; 
10 autoclave cycles of 30 min at 126 °C. 30 autoclave cycles of 60 min at 126 °C.
Specifications
6Typical Air Flow Rate and Pressure Drop 
Typical Liquid Flow Rate and Pressure Drop 
Opticap XL 5 Capsule with Hydrophobic
Durapore 0.22 µm Membrane, FF Fitting*
Opticap XL 5 Capsule With 0.22 µm
Phobic Durapore Media — FF Fitting
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Opticap XL 5 Capsule with Hydrophobic
Durapore 0.22 µm Membrane
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Opticap XL 10 Capsule with Hydrophobic
Durapore 0.22 µm Membrane
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Opticap XL 10 Capsule with Hydrophobic
Durapore 0.22 µm Membrane, FF Fitting*
Opticap XL 10 Capsule With 0.22 µm
Phobic Durapore Media — FF Fitting
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Opticap XL 10 Capsule with Hydrophobic
Durapore 0.22 µm Membrane, HH Fitting*
Opticap XL 10 Capsule With 0.22 µm
Phobic Durapore Media — HH Fitting
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Opticap XL 5 Capsule with Hydrophobic
Durapore 0.22 µm Membrane, HH Fitting*
Opticap XL 5 Capsule With 0.22 µm
Phobic Durapore Media — HH Fitting
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Opticap XL 5 Capsule with Hydrophobic
Durapore 0.22 µm Membrane, TT Fitting*
Opticap XL 5 Capsule With 0.22 µm
Phobic Durapore Media — TT Fitting
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Opticap XL 10 Capsule with Hydrophobic
Durapore 0.22 µm Membrane, TT Fitting*
Opticap XL 10 Capsule With 0.22 µm
Phobic Durapore Media — TT Fitting
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Optiseal Cartridge with 0.22 µm
Hydrophobic Durapore Membrane
Optiseal Cartridges
with Durapore 0.22µm
Hydrophobic Filters (LAGB)
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10-inch Cartridge with 0.22 µm
Hydrophobic Durapore Membrane
10-inch Cartridge with 0.22 µm
Phobic Durapore Media
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10-inch Cartridge with 0.22 µm
Hydrophobic Durapore Membrane
CVGB 01T P3 Liquid
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*Opticap XL Capsule Connection Types
TT = 38 mm (1∞ in.) sanitary flange inlet and outlet; FF = 19 mm (º in.) sanitary flange inlet and outlet; HH = 14 mm (9/16 in.)  hose barb inlet and outlet
Ordering Information
Device Connections Qty/Pk Catalogue No.
Opticap XL 5 Capsules 38 mm (1∞ in.) sanitary flange inlet and outlet 1/pk KVGB A05 TT1
19 mm (º in.) sanitary flange inlet and outlet 1/pk KVGB A05 FF1
14 mm ( 9/16 in.) hose barb inlet and outlet 1/pk KVGB A05 HH1
Opticap XL 10 Capsules 38 mm (1∞ in.) sanitary flange inlet and outlet 1/pk KVGB A10 TT1
19 mm (º in.) sanitary flange inlet and outlet 1/pk KVGB A10 FF1
14 mm ( 9/16 in.) hose barb inlet and outlet 1/pk KVGB A10 HH1
Optiseal Cartridges Double 2-123 O-ring 6/pk LAGB 04T P6
5-inch Cartridges Code 7 (2-226) O-ring with locking tab 1/pk CVGB 75S 01
10-inch Cartridges Code 7 (2-226) O-ring with locking tab and spear 3/pk CVGB 71T P3
Code 5 (2-222) O-ring with spear 3/pk CVGB 51T P3
Code 0 (2-222) O-ring 3/pk CVGB 01T P3
20-inch Cartridges Code 7 (2-226) O-ring with locking tab and spear 3/pk CVGB 72T P3
Code 5 (2-222) O-ring with spear 3/pk CVGB 52T P3
Code 0 (2-222) O-ring 3/pk CVGB 02T P3
30-inch Cartridge Code 7 (2-226) O-ring with locking tab and spear 3/pk CVGB 73T P3
Code 5 (2-222) O-ring with spear 3/pk CVGB 53T P3
Code 0 (2-222) O-ring 3/pk CVGB 03T P3
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ÂMillipore, Durapore, Opticap and Optiseal are registered trademarks of Millipore Corporation.
Discover the More in Millipore is a trademark of Millipore Corporation.
ISO is a registered trademark of the International Organization for Standardization.
ASTM is a registered trademark of American Society for Testing and Materials.
ATCC is a registered trademark of American Type Culture Collection. 
Lit. No. DS8932EN00   Rev. B 1/06    06-011
© 2006 Millipore Corporation, Billerica, MA 01821 U.S.A. All rights reserved.
To Place an Order or Receive Technical Assistance
For additional information call your nearest Millipore office:
In the U.S. and Canada, call toll-free 1-800-MILLIPORE (1-800-645-5476)
In the U.S., Canada and Puerto Rico, fax orders to
1-800-MILLIFX (1-800-645-5439)
Outside of North America contact your local office.
To find the office nearest you visit www.millipore.com/offices.
Internet: www.millipore.com
Technical Service: www.millipore.com/techservice
Discover the More in Millipore™
In every application, every step and every scale, count on Millipore to be
everywhere for you—from monoclonals to vaccines, from clinical through 
pilot to full-scale manufacturing. Our technologies are used by most of the
world’s major biopharmaceutical companies. But we deliver more than
advanced separation, purification, sterilization and quality control products.
With Millipore, you get services to optimize and validate your processes,
comprehensive resources to streamline and enhance your operation, 
unmatched know how forged from 50 years’ experience—
and solutions that integrate it all. For higher yields, improved process 
economics and faster speed to market, discover the more in Millipore.
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Silent Oil Free Air Compressor
Model GA­84
Power 3200W
Note:Powerful Air Compressor
Powerful Dental Air Compressor (piston type)
Model No.: GA­84
Brand: Greeloy (made in Shanghai, China)
 
Specification:
Power: 3200W (4pcs 800W motor)
Volt./Hz: 110~240V    50~60Hz
Speed: 1400/1750 r.p.m
Air Flow: 620L/min at 0Bar
Noise Level: 56dB
Max Pressure: 8Bar
Restart Pressure: 5Bar
Tank Capacity: 120L
Weight: 94/125kg
Product Size: 1105*450*645mm
 
Remark: 
All Greeloy air compressors, can be with air dryer system & silent cabinet.
 
Advantages:
※ Super silent. 
Low working noise, create a quiet working environment.
※ Low vibration.
With special rubberfeet, reduce vibration during operation.
※ Pure air flow.
Oil free design, no lubrication oil needed during operation.
※ Core technology.
Diamond hardness cylinder ensure durable working performance.
※ Fashion and durable design.
Compact structure, light weight. Under normal situation, can be used for more than 20000hours.
※ Use safety.
With multiple self protection system, if here will be abnormal with pressure, current or voltage, the motor would cut o
※ Easy operation.
Quite simple operation, connect to power supply, then no need any more maintenance, just drainage regularly.
※ Low energy consumption.
Full automatic design, automatic stop and restart control, low consumption.
※ High precision filtration.
With double filters, ensure high precision of outlet air flow. 
※ Tank inside has done anti­rust treatment.
Ensure pure outlet air flow for medical equipments. 
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Bio-Pharm
UltraFlowTM: Powerful CIP in 
a Compact, Portable Design.
The Sani-Matic UltraFlow is a 
self-contained, compact and portable  
Clean-In-Place (CIP) System programmed  
to accommodate a variety of recirculated 
CIP applications. Designed for critical 
cleaning, the UltraFlow meets cGMP  
and ASME-BPE standards.
UltraFlow 110 UltraFlow 45
sanimatic.com
Advantages
•  Small Footprint. Space-saving design for installations with limited floor space. Fits through standard 
doorways with ease.
•  Wide Operating Range. The systems range from 2–45 gpm and 5–110 gpm and are able to clean small  
and large applications
•  Self-Cleaning. Self-cleans without extra steps, and eliminates cross-contamination.
•  Portable. Positioned on low-friction casters for easy movement between process suites. No expensive 
supply and return line installation required.
•  Water & Chemical Savings. The high-turbulent flow rate and low water requirements for operation  
reduce the amount of water and chemicals needed for a complete clean. 
•  Low Outlets? No Problem. Returns solutions with entrained air to accommodate vessels with low  
and restricted outlets. 
Standard
• Operation and maintenance manuals
• Recommended spare parts list
• Instrument list
• Instrumentation calibration procedures
• Performance data
• Material certificates
• Weld qualification and inspection records
• Inspection test results, reports and certificates
• Component catalog cut sheets
• As-built assembly drawings
• As-built process and instrumentation diagrams
• As-built electrical drawings
• PLC and HMI application files
Optional
• Functional Specifications (FS)
• Configuration Specification (CS)
• Factory Acceptance Test (FAT)
• Site Acceptance Test (SAT) 
• Installation and Operation Qualification (IQ/OQ)
• Traceability matrix
• ISA data sheets
• Cleaning and passivation report
• Digital weld video record (Borescope)
• Printer
• Hydrostatic test certificate
• ASME data for heat exchanger
• Riboflavin coverage test
Documentation
Air Separation 
Chamber
The Sani-Matic UltraFlow needs a mere 6 gallons of water  
to operate vs. conventional CIP Systems, which must maintain  
a significant quantity of water in the supply tank to prevent 
pump cavitation.
UltraFlow Schematic
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UltraFlow 110
•  74" L x 33" W x 80" H (height may vary  
with options)
• Operating range of 5–110 gpm @ 60 psi
• Electric or steam heat
• For process tank diameters up to 10'
•  For process line diameters up to 3"
•  Mass flow meter
Standard for Both Models
•  Wetted surface: 316L stainless steel, 25 Ra 
Non-wetted surface: 304 stainless steel, 32 Ra
•  UL listed, 304 stainless steel, NEMA 4X enclosure
• Allen-Bradley CompactLogix 
• Allen-Bradley PanelView Plus HMI
• Ethernet communication
•  40 customizable cleaning cycle programs
•  Eductor return system
Optional for Both Models
•  15 Ra Electropolish (EP) finish
• Allen-Bradley PanelView Plus 1000
• Printer
• Stainless steel motor
•  Shell and tube heater
•  Air blow manifold
•  Chemical reservoir low level switches
•  One chemical delivery system (standard offers two)
•  One water supply valve (standard offers two)
• CIP supply routing valves
•  Water connection bleed valves
•  Sample valve
•  A single centrifugal CIP supply pump
•  Modulating diaphragm control valves to set cleaning circuit 
flow rates and to control the rate of discharge to drain
•  Two chemical delivery systems comprised of pneumatic 
diaphragm pumps, removable chemical reservoirs
•  Chemical conductivity, proof of rinse conductivity
•  Supply and return temperature sensors
•  Electric flow-through heater
•  Discharge pressure gauge
•  Vent filter assembly
•  Pressure transmitter
•  Mass or turbine flow meter alternate
•  Fixed position leveling feet
•  Frame weld finish upgrade
•  Sanitary flex hose package
•  Piping insulation
•  Fixed position seismic zone calculations
•  Passivation
•  Spare parts budget
•  Larger electric heater
•  Sani-Matic Start-up Services
UltraFlow 45
•  68" L x 24" W x 74" H (height may vary  
with options)
• Operating range of 2–45 gpm @ 50 psi
• Electric or steam heat
• For process tank diameters up to 4.5'
•  For process line diameters up to 2"
•  Turbine flow meter
Features
UltraFlow 45
• Instrument Air ½" NPT, 10 scfm @ 90 psi
• Water Supply Two 1" tri-clamps, WFI, DI, potable 
≤ 2 gpm @ 25 psi, 20°–80° C
• Drain 2" tri-clamp (programmable to meet app)
• Dry Weight 900 lbs (approximate)
•  Electrical Power 
(with electric heat)
12 kW, 27 amps (standard) or 24 kW, 43 
amps (optional) @ 460 VAC, 3 Ph, 60 Hz
•  Electrical Power 
(with steam heat)
11 amps @ 460 VAC, 3 Ph, 60 Hz
• Plant Stream ¾" flange, 195 lbs/hr @ 50 psi
• Plant Condensate ½" flange
• CIP Supply 1 ½" tri-clamp, 2–45 gpm @ 50 psi
• CIP Return 2" tri-clamp, 2–45 gpm @ 8.5' of head  
@ 80° C
• Vent/Overflow 2" tri-clamp
UltraFlow 110
• Instrument Air ½" NPT, 10 scfm @ 90 psi
• Water Supply Two 1" tri-clamps, WFI, DI, potable  
≤ 2 gpm @ 25 psi, 20°–80° C
• Drain 3" tri-clamp (programmable to meet app)
• Dry Weight 1,400 lbs (approximate)
•  Electrical Power 
(with electric heat)
15 kW, 50 amps (standard) or 30 kW, 68 
amps (optional) @ 460 VAC, 3 Ph, 60 Hz
•  Electrical Power 
(with steam heat)
27 amps @ 460 VAC, 3 Ph, 60 Hz
• Plant Stream 1 ½" flange, 540 lbs/hr @ 50 psi
• Plant Condensate 1" flange
• CIP Supply 2" tri-clamp, 5–110 gpm @ 60 psi
• CIP Return 3" tri-clamp, 5–110 gpm @ 11' of head  
@ 80° C
• Vent/Overflow 2" tri-clamp
Operating Requirements
Sani-Matic, Inc.           1915 S. Stoughton Rd., Madison, WI 53716           (p) 800-356-3300           (f) 608-222-5348            
sanimatic.com
Cleaning Confidence.
Repeatable results you can count on every time you clean your process parts and equipment.  
That’s Cleaning Confidence from Sani-Matic.
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T4U™ 4erieT -86°C Upright Ultra-
Low Temperature FreezerT
&nTure ultimate protection and optimum
capacitZ for Zour moTt critical TampleT with
T4U™ 4erieT −86°C Upright Ultra-Low
Temperature FreezerT.
#rand:  Thermo 4cienti c T4U700V
Code : N&W
Additional DetailT : Weight : 411.00000kg
Product Code. 15694394
£14392.07 / &ach
 
QuantitZ   
Call for lateTt availaCilitZ 
+44 (0)1509 555 500
DeTcription
Choice of  ve capacitieT maximize Tample Ttorage while minimizing the freezer'T phZTical Tpace inTide the laC
High-performance mode provideT the tighteTt temperature uniformitZ and peak variation†—for moTt applicationT, energZ-
TavingT mode o erT excellent temperature control, pluT up to 15% TavingT on energZ uTage compared to high performance
mode
IncreaTeT the internal capacitZ of 2 inch vialT over previouT generation freezerT—gain up to 76% more capacitZ in the Tame
footprint†— with 1mL CrZ#ank tuCeT
Five TizeT accommodate anZ Tize laC, featuring the induTtrZ'T leading capacitZ per footprint Tpeci cationT‡
Monitor the freezer'T health 24/7 and acceTT a detailed event log
OCtain a record, TimplZ download a report of the current event log to a portaCle drive
&nvironmentallZ-friendlZ, CFC/HCFC free refrigerantT
High-e ciencZ compreTTorT o er exceptional performance and reliaCilitZ
#razed plate heat exchanger for more e cient heat tranTfer—induction Crazed jointT to reduce leak potential and improve
reliaCilitZ
Power management TZTtem protectT againTt a wide range of voltage variation and iT eaTilZ acceTTiCle through the touch-
Tcreen diTplaZ
Remote alarm contactT compatiCle with external alarm and monitoring TZTtemT
Two rear acceTT, 1in. (25mm) portT allow for the uTe of inexpedient proCeT or inTtrumentation
4tore up to 15 ZearT worth of temperature and event data on our on-Coard computer
 UTe the new U4# port to download freezer temperature and event log data, or freezer TettingT from one freezer to another
ProvideT protection againTt duTt on the condenTer, which can cauTe reduced refrigeration performance and increaTed riTk to
TampleT
4tore up to 278 lCT. of TampleT (depending on freezer model) on our reinforced, TtainleTT Tteel Thelving
4×7 heated gaTket provideT four touchpointT of TecuritZ and Teven zoneT of protection, maximizing caCinet temperature and
eliminating froTt Cuild-up
Four polZTtZrene inTulated inner doorT help maintain caCinet temperature during openingT and feature emCedded rare earth
magnetT, eliminating expoTed latcheT or magnetT
4everal optional featureT including LN2 and CO  Cack-up TZTtem, chart recorder, TtainleTT Tteel inventorZ racking TolutionT,
and handT-free locking option
† Compared to energZ-TavingT and high-prformance modeT.
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‡ #aTed on internal performance data; Data on  le MaZ 2011
4peci cationT
Amperage 9.5A
Hertz 50Hz
InTulation Vacuum Panel and
Water #lown Foam
4hipping Weight (Metric) 432kg
#ackup 4ZTtemT CO2 or LN2 Optional
AcceTT 4ecuritZ KeZLock 4tandard,
Padlock CompatiCle,
KeZ Card Optional
Certi cationT/Compliance cULuT, C& liTted
DeTcription CapacitZ: 33.5 cu.  .
(948.7L); HoldT 700
CoxeT; 230V/50Hz
DimenTionT (L x W x H)
&xterior
37.6 x 49.2 x 78 in. (96
x 125 x 198cm)
Plug TZpe &uropean
TZpe Ultra Low Freezer,
Upright
DoorT 4ingle
&lectrical RequirementT 230V 50Hz
Health Monitoring On 4creen, Log File
Inner DoorT 4
Line Voltage Indicator Line voltage and
#uck/#ooTt
On-#oard Datalogging 4tandard
DiTplaZ Touch 4creenLCD
HoldT 700 CoxeT
4helveT 3
Vial CapacitZ 70,000 x 2mL
CapacitZ (Metric) 4helf 432kg
Chart Recorder 7-daZ Ink or InkleTT
(Optional)
Data OutputT R4-485, 4-20mA, drZ
contactT - Ttandard
CapacitZ (Metric) 949L
DimenTionT (D x W x H)
Interior
28.3 x 40 x 51.2 in. (72
x 102 x 130cm)
Temperature Range −50° to −86°C
Voltage 230V
Door Opening RecoverZ 39 min.
&nergZ UTage 18.5/21.8kW-hr/daZ
Footprint (Metric) 1.19 Tq. meterT
Interior Painted 4teel -
4tandard, 4tainleTT-
Tteel - Optional
Operating ModeT High Performance or
&nergZ & ciencZ
Peak Variation at -80C +2.2/-5.5°C
4mart View CompatiCilitZ 4mart-Vue CompatiCle
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RegulatorZ ApprovalT C&
4etpoint 4ecuritZ 4tandard - Individual
uTer nameT and
paTTwordT
Vial to Footprint Ratio
(Metric)
58.824 vialT/cu. m
Warm up Time -80 C to
-50C
241 min.
Water Cooled Optional
Product Line Thermo 4cienti c
Vial to &nergZ Ratio 1.31 wattT/100mL vialT
(Cox)
Voltage CompenTation #uck/#ooTt
Weight (Metric) 432kg
WarrantZ WarrantZ varieT CZ
countrZ, pleaTe contact
uT for detailT
InTtrument & &quipment 4erviceT
Product Code #rand DeTcription Price QuantitZ &
AvailaCilitZ
 
15410842
 
UnitZ LaC 4erviceT™ UnitZ #aTic
Plan Cold 4torage Group 2
UnitZ LaC 4erviceT™ 
UL4_#A4IC_C4-2
UnitZ #aTic Plan
Cold 4torage
group 2
£298.00  
&ach
&Ttimated
4hipment
date  
from
4upplier
11-05-
2018
15420822
 
UnitZ LaC 4erviceT™ UnitZ &xt
WarrantZ Cold 4torage Group 2
UnitZ LaC 4erviceT™ 
UL4_&XT_WTY_C4-2
UnitZ &xt WarrantZ
Cold 4torage
group 2
£557.00  
&ach
&Ttimated
4hipment
date  
from
4upplier
30-04-
2018
15430852
 
UnitZ LaC 4erviceT™ UnitZ Full
Plan Cold 4torage Group 2
UnitZ LaC 4erviceT™ 
UL4_FULL_C4-2
UnitZ Full Plan
Cold 4torage
group 2
£1418.00
&ach
&Ttimated
4hipment
date  
from
4upplier
30-04-
2018
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• Heat Water and Water/Glycol 
Solutions	to	300˚F	(150˚C)
• 50 - 800 kW
• 240 V, 480 V and 600 V, 3 -Phase, 
60 Hz
• Compact Footprint for 
Installation
• 150# Welded Steel Construction
• Long Life 0.475 in. (12.1 mm) 
dia. Copper Sheath Heating 
Elements
• High Temperature Centrifugal 
Pump	-	rated	to	300˚F	(150˚C)
• Electronic Digital Temperature 
and Process Control
• Discharge Pressure Gauge
• UL NEMA 12 Electrical Enclosure 
Complete with Contactors, 
Temperature Safety Limit, 
Transformers and Pilot Light(s)
• External Cold Expansion Tank 
(Optional)
• External Heat Exchanger 
(Optional)
MWS
Water and Water/Glycol 
System
Description
Chromalox MWS - Mid-Size Water/Glycol 
System - is engineered to operate to 300˚F 
(150˚C) with either water or water/glycol 
fluids. Its electric heating core assures 
responsive and precise temperature control 
in a space saving package. The system is 
suitable for a large range of heating needs 
with a compact design. The MWS operates in 
a closed loop system using a cold expansion 
tank (optional).
Applications
Chromalox MWS system is great for applica-
tions such as reactors, evaporators, dryers, 
platen presses, heat excangers, roll heating, or 
any jacketed kettles / vessels / tanks. 
Hot water systems can be used in a variety of 
industries such as chemical, plastics, cosmet-
ics, automotive, rubber, refining, pharmaceuti-
cal, non-woven / textiles/ fibers, aerospace, or 
any other industrial market.   
     
Construction
Chromalox MWS systems are ruggedly 
constructed for industrial applications. The 
heavy-duty, steel support base features chan-
nel grooves for forklift transport. The heater 
chamber is fully welded and houses Chro-
malox brand, long-lasting heating elements. 
The panel is fully UL-listed and assembled 
in-house. The pump is air-cooled with a 
mechanical seal, rated to 300˚F (150˚C). The 
final assembly is fully-shop tested prior to 
shipment.
WARNING — In hazardous areas, pipe sur-
faces could achieve temperatures high enough 
to cause auto-ignition of the hazardous mate-
rial present. Consult Article 500 of the National 
Electric Code for further information on the 
maximum allowable temperature for a specific 
application.
Packaged Systems
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MWS
Water and Water/Glycol 
System (cont’d.)
Standard Features Benefits
Electronic Process Control ........................................................................ Precise process control
Element Overtemperature Protection ........................ Protect elements and fluid from overheating
Air-Cooled Mechanical Seal ..................................................................No external cooling needed
Insulated Heating Chamber ........................................Maximize efficiency by minimizing heat loss
Discharge Pressure Gauge ..................................................Confirm pump operating performance
Compact Footprint ......................................................................................... Space saving design
Fully Pre-wired & Tested .......................................................................... Ready to operate on site
Centrifugal Pump .............................................................................Minimize piping configuration
Temperature rating to 300˚F (150˚C) .......................................................Covers most applications
150# ANSI Flange Connection ........................................................... Easy fit up to installed piping
Start / Stop buttons with Motor Starter ............................................... Complete operating system
Pilot Lights for Power, Heater, & Pump ................................ Visual indication of system operation
Options
• Electronic Solid State (SCR) Trim Power 
Control
• Strainer
• Powder Coated or Stainless Steel Side 
Coverings
• Dedicated Fill Connection
• NEMA 4 or 4X (Stainless) Construction
• Class 1, Div 2 Hazardous Area Rating (with 
purge)
• Panel Disconnect Switch
• Heater On/Off Switch
• Suction Pressure Guage
• Inlet / Outlet 150# Gate Valves
• Drain / Bleed Values
• Digital Overtemperature Controller
• Relief Valve
• ASME Design & Certified, Section VIII, for 
100 psi (7 bar) at 300˚F (150˚C)
• High Flow Pump (300 GPM, 450-800 kW 
only)
• Heat Exchanger (shipped loose for customer 
installation)
• Expansion Tank (shipped loose for customer 
installation)
• Liquid Level Switch for Expansion Tank
H
DW
H
D
W
MWS 50-250 kW Unit
(Front View)
MWS 300-600 kW Unit
(Rear View)
Unit Proportions       
Unit
Size
Weight
(Lbs.)
Width
(In.)
Depth
(In.)
Height
(In.)
Flow 
Rate1
GPM
Pressure1
TDH
Motor
HP
Inlet/Outlet
Connection
System 
Capacity 
(Gal.)
50 - 150 kW 900 36 42 96 60 100 3 2", 150# 25
175 - 250 kW 1400 36 42 96 120 100 5 3", 150# 35
300 - 400 kW 2000 48 54 96 200 100 10 3", 150# 55
450 - 600 kW 2600 48 54 96 2002 1002 102 3", 150#2 65
650 - 800 kW 3600 61 54 99 2002 1002 102 3", 150#2 85
1 Refer to Pump Graph in instruction manual for full operating range.
2 Option for 300 GPM 15 HP pump with 4", 150# inlet/outlet.
Packaged Systems
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MWS Mid-Size Water and Water Glycol System
 Code Unit Temperature Rating1
 300 300˚F (150˚C)
 Code Kilowatts
 50 50 kW 150 150 kW 300 300 kW 550 500 kW
 75 75 kW 175 175 kW 350 350 kW 600 600 kW
 100 100 kW 200 200 kW 400 400 kW 800 800 kW
 125 125 kW 250 250 kW 500 500 kW
 Code Enclosure Types
 E1 General Purpose
 E4 Moisture Resistant
 E4X Moisture / Corrosion Resistant (Stainless Steel)
 E4NP Class 1, Div 2 rating - Nitrogen Purge (by customer)
 Code Option
 (Blank) No Options
 ST SCR Trim 
 SR Strainer2 
 GV I/O Gate Valves2 
 FC Dedicated Fill Connection2 
 DB Drain / Bleed Valves 
 PD Panel Disconnect 
 HW Heater On/Off Switch
 SG Suction Pressure Guage
 DT Digital Overtemp Control
 SV Safety Relief Valve - 125psi
 PC Power Coated Skins
 SS Stainless Skins
 AE ASME Designed & Certified
 HF 300 GPM Pump3
 XX Custom Feature
 Code Voltage
 240 240 V (only available for 50 and 75 kW units)
 480 480 V
 600 600 V
 Code Phase
 3P Three-Phase
 Code Kilowatts
 150 kW
MWS - 300 - 150P - E4 GV 480V 3P 150kW Typical Model No.
Example of Final Model Description: MWS-300-150P-E4GV 480V 1-3P 150kW
1 Unit operating temperature based on 104°F (40°C) max. ambient, indoor invironment
2 When ordering more than one of these options, some items will be shipped loose to avoid 
damage during shipment. Simple assembly will be required for installation.
3 300 GPM option comes with 15 HP motor and 4", 150# inlet/outlet connections.
Ordering Information
To Order — Complete the Model Number  
using the Matrix provided.
MWS
Water and Water/Glycol 
System (cont’d.)
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 WFIS 3-250  3 2.140 2.000 2.900 1.300 270 130 1.095 800
 WFIS 3-500 3 2.105 1.900 2.875 960 500 235 2.030 1.000
 WFIS 4-500 4 2.500 1.900 2.875 960 500 190 1.185 1.200
 WFIS 4-750 4 2.910 2.100 3.100 1.100 775 295 1.835 1.350
 WFIS 4-1250 4 3.040 2.230 3.090 1.180 1.200 460 2.840 1.500
 WFIS 5-500 5 2.915 1.900 2.875 960 500 165 650 2.100
 WFIS 5-750 5 3.420 2.100 3.070 1.100 775 255 1.005 2.300
 WFIS 5-1250 5 3.590 2.230 3.090 1.180 1.200 390 1.555 2.500
 WFIS 5-2000 5 3.700 2.400 3.550 1.500 2.075 680 2.690 3.000
 WFIS 5-3000 5 4.200 2.685 3.830 1.500 3.065 1.000 3.970 3.400
 WFIS 5-4500 5 4.400 2.950 3.975 1.600 4.585 1.500 5.940 3.800
 WFIS 6-2000 6 4.270 2.400 3.550 1.500 2.075 605 1.150 4.200
 WFIS 6-3000 6 4.880 2.980 3.830 1.500 3.065 890 1.695 4.700
 WFIS 6-4500 6 5.315 2.950 3.975 1.548 4.585  1.335 2.540 5.200
 WFIS 6-6500 6 5.900 3.080 4.420 1.630 6.535 1.900 3.615 5.800
 WFIS 6-9000 6 6.900 3.080 4.420 1.800 9.060 2.635 5.015 6.500
 WFIS 6-12000 6 6.675 3.170 4.500 2.100 12.640 3.680 11.665 7.200
 WFIS 7-3000 7 5.560 2.980 3.830 1.500 3.065 815 0 6.000
 WFIS 7-4500 7 6.050 2.950 3.975 1.550 4.585 1.220 0 7.400
 WFIS 7-6500 7 6.710 3.080 4.420 1.630 6.535 1.740 0 8.800
 WFIS 7-9000 7 7.510 3.080 4.420 1.800 9.060 2.410 0 10.300
 WFIS 7-12000 7 7.700 3.170 4.500 2.400 12.645 3.365 0 12.500
MODEL
No. of
effects
Overall dimmensions Main Utilities
Approx.
Weight
Kg
Width 
(W)
mm
Height 
(H1)
mm
Height 
(H2)
mm
Depth 
(D)
mm
Distillate 
output
l/h
Heating steam
@ 8 bar
kg/h
Cooling water
(25-50º C)
l/h
Water For Injection Stills
WFIS
DTS PRE-HEATER
DTS HEAT EXCHANGER
PLANT STEAM HEATED 
COLUMN
PURE STEAM HEATED 
COLUMN
CONDENSER
Feed water (PW) is pre-heated by means of two DTS heat exchangers, which use 
respectively the heat of the pure steam and distillate water outlet and the plant steam 
outlet. The first column of the CS water still is equal to our CPS steam generators, heated 
also with plant steam. 
The pure steam produced in the first column is used as the heating medium for the next 
one, so it condenses and turns into WFI. Simultaneously, the partial amount of non-
evaporated water goes to the next column, so it is also partially evaporated as pure steam 
and used as heating energy for the next column. 
Here, the pure steam also condenses (resulting in WFI distillate) and it is transferred by 
pressure to the successive columns. 
• Feed water conductivity monitoring
• Pure steam take from the first column
• Elevated WFIS condenser
• Hot standby mode
• Sanitisation/Sterilization of the separator columns and WFIS condensers
• Protective mesh guarding
• On-line TOC monitoring device
• WFI storage and distribution skid.
H2
W
H1*
D
* WFIS OUTLET
Technical data
Options and accessories
The control system is based on a 
PLC wire operator supervision via a 
user-friendly touch-screen HMI with 
the following menu:
• Mimics of the equipment, showing 
the operational state in real time
• Process parameters (temperature, 
pressure and conductivity)
• Setting up of parameters
• Alarm information
• Start-up and alarm recognition.
Options include: paper or electronic 
chart recorder for pure steam 
conductivity, temperature, extra 
feed water conductivity meter, on-
line TOC monitoring, etc. 
Control system
Operating  principle
BR-WFI-EN-1110
Telstar Puretech reserves the right to improvements and specifications changes without notice.
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ISO 9001: Certified Company
WFIS  
Water For Injection Stills
A choice of quality 
Telstar Puretech Multiple Effect Water for Injection Stills are designed and 
constructed to produce pyrogen-free sterile water (WFI) in full compliance 
with cGMP guidelines as per FDA and EMEA requirements. 
Engineering and manufacturing practices follow ISO 9001 procedures, 
ASME BPE criteria, GAMP guidelines, etc. Design and construction meets 
the most stringent Regulations and Codes from Europe, USA and others 
concerning safety and pressure vessels. 
To ensure the equipment meets your requirements, we work in partnership 
with you and a dedicated team follows your order as a unique project. We 
develop specific Quality Plans (DQ, IQ and OQ) and undertake factory 
acceptance testing (FAT) to give assurance, performance and quality.
WFI applications 
WFI water for injection, as defined in the Ph Eur and the USP, is used 
for the preparation of medicines for injectable administration, where 
water is used as a vehicle (water for injections in bulk), to disolve or 
dilute substances or preparations for injectable administration before use 
(sterile water for injections). According to the Ph. Eur water for injections 
can only be produced by distillation, of drinking water or purified water.
Compact and Modular 
The unit and all its components such as feed water pump, 
pre-heater and condensers are mounted on a stainless steel 
AISI 304 skid. 
All parts in contact with the media are made of stainless steel 
AISI 316L, insulated with mineral wool (asbestos-free material) 
with external cladding made of stainless steel AISI 304. Inner 
surfaces are polished to Ra ≤ 0.64 µm and electro polishing is 
an available option. 
Hygienic design: Including clamp connections, orbital welding 
techniques for tubing and components, minimisation of dead 
legs and proper piping slopes for self-drainability, double tube 
sheet construction in first column, condenser and pre-heaters, 
diaphragm valves for distillate/reject, etc.
Simple and Efficient Design 
The lower part of the column consists of a double tube sheet shell 
heat exchanger with a large central pipe surrounded by a bundle of 
peripheral seamless pipes. This arrangement produces a natural fluid 
circulation: ascendant inside the peripheral pipes and descendant 
inside the central one. Steam flows up very slowly but droplets cannot 
reach the top of the column as they fall down simply by gravity. Thus, 
impurities such as particles and pyrogens contained in the droplets 
are dragged down towards the bottom of the column where they are 
automatically blown down. Pure steam from the first column serves 
as heating energy in the next column where it condenses as WFI. 
This can be reproduced several times, so called multiple effects, up 
to 7 columns. The more effects we install, the less heating energy and 
cooling water required.
Ease of Maintenance and Installation 
The heat exchangers are totally accessible and no internal elements 
are located within the column. This makes inspection much easier than 
other designs, with long pipes or internal heat exchangers.
The replacement of column gaskets can be done easily and quick, 
without needing to dismantle the column, which removes the need for 
very high technical areas in order to take off any internal part.  
Heat exchanger pipes are always totally immersed in water, so there is 
a very low tendency to build up scale inside the tubes. Moreover, as 
they are shorter than other designs, they are less stressed by vibrations 
and risk of corrosion is significantly reduced.
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 WFIS 3-250  3 2.140 2.000 2.900 1.300 270 130 1.095 800
 WFIS 3-500 3 2.105 1.900 2.875 960 500 235 2.030 1.000
 WFIS 4-500 4 2.500 1.900 2.875 960 500 190 1.185 1.200
 WFIS 4-750 4 2.910 2.100 3.100 1.100 775 295 1.835 1.350
 WFIS 4-1250 4 3.040 2.230 3.090 1.180 1.200 460 2.840 1.500
 WFIS 5-500 5 2.915 1.900 2.875 960 500 165 650 2.100
 WFIS 5-750 5 3.420 2.100 3.070 1.100 775 255 1.005 2.300
 WFIS 5-1250 5 3.590 2.230 3.090 1.180 1.200 390 1.555 2.500
 WFIS 5-2000 5 3.700 2.400 3.550 1.500 2.075 680 2.690 3.000
 WFIS 5-3000 5 4.200 2.685 3.830 1.500 3.065 1.000 3.970 3.400
 WFIS 5-4500 5 4.400 2.950 3.975 1.600 4.585 1.500 5.940 3.800
 WFIS 6-2000 6 4.270 2.400 3.550 1.500 2.075 605 1.150 4.200
 WFIS 6-3000 6 4.880 2.980 3.830 1.500 3.065 890 1.695 4.700
 WFIS 6-4500 6 5.315 2.950 3.975 1.548 4.585  1.335 2.540 5.200
 WFIS 6-6500 6 5.900 3.080 4.420 1.630 6.535 1.900 3.615 5.800
 WFIS 6-9000 6 6.900 3.080 4.420 1.800 9.060 2.635 5.015 6.500
 WFIS 6-12000 6 6.675 3.170 4.500 2.100 12.640 3.680 11.665 7.200
 WFIS 7-3000 7 5.560 2.980 3.830 1.500 3.065 815 0 6.000
 WFIS 7-4500 7 6.050 2.950 3.975 1.550 4.585 1.220 0 7.400
 WFIS 7-6500 7 6.710 3.080 4.420 1.630 6.535 1.740 0 8.800
 WFIS 7-9000 7 7.510 3.080 4.420 1.800 9.060 2.410 0 10.300
 WFIS 7-12000 7 7.700 3.170 4.500 2.400 12.645 3.365 0 12.500
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Width 
(W)
mm
Height 
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mm
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mm
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Heating steam
@ 8 bar
kg/h
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l/h
Water For Injection Stills
WFIS
DTS PRE-HEATER
DTS HEAT EXCHANGER
PLANT STEAM HEATED 
COLUMN
PURE STEAM HEATED 
COLUMN
CONDENSER
Feed water (PW) is pre-heated by means of two DTS heat exchangers, which use 
respectively the heat of the pure steam and distillate water outlet and the plant steam 
outlet. The first column of the CS water still is equal to our CPS steam generators, heated 
also with plant steam. 
The pure steam produced in the first column is used as the heating medium for the next 
one, so it condenses and turns into WFI. Simultaneously, the partial amount of non-
evaporated water goes to the next column, so it is also partially evaporated as pure steam 
and used as heating energy for the next column. 
Here, the pure steam also condenses (resulting in WFI distillate) and it is transferred by 
pressure to the successive columns. 
• Feed water conductivity monitoring
• Pure steam take from the first column
• Elevated WFIS condenser
• Hot standby mode
• Sanitisation/Sterilization of the separator columns and WFIS condensers
• Protective mesh guarding
• On-line TOC monitoring device
• WFI storage and distribution skid.
H2
W
H1*
D
* WFIS OUTLET
Technical data
Options and accessories
The control system is based on a 
PLC wire operator supervision via a 
user-friendly touch-screen HMI with 
the following menu:
• Mimics of the equipment, showing 
the operational state in real time
• Process parameters (temperature, 
pressure and conductivity)
• Setting up of parameters
• Alarm information
• Start-up and alarm recognition.
Options include: paper or electronic 
chart recorder for pure steam 
conductivity, temperature, extra 
feed water conductivity meter, on-
line TOC monitoring, etc. 
Control system
Operating  principle
BR-WFI-EN-1110
Telstar Puretech reserves the right to improvements and specifications changes without notice.
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Millistak+® Pod disposable  
depth filter system
Innovative, High-Performance Pod Filters are 
ideal for Primary and Secondary Clarification 
in Lab, Pilot and Process-Scale Applications.
Data Sheet
Millistak+® depth filter media is offered 
in a scalable, disposable format, the Pod 
Filter System. Accommodating applications 
from lab to pilot to process scale, the Pod 
format offers greater flexibility because of 
its unique modular and 100% disposable 
design. 
The Millistak+® Pod system is ideal for a wide variety 
of primary and secondary clarification applications, 
including cell cultures, yeast and E. coli lysates post 
centrifuge, E. coli refolds, media, vaccines, plasma 
proteins and sera.
Millistak+® Pod filters are available in three distinct 
series of media grades in order to meet your specific 
application needs. Millistak+® DE, CE and HC media 
deliver optimal performance through a gradient density 
matrix as well as positive surface charge properties.
Benefits
•  Low hold-up volume for greater product yield
•  Broad range of media types offered in single and 
multilayer products
•  Millistak+® HC dual-action media improves 
prefiltration and compresses clarification
•  Flexible, modular format offers scalability from  
5 to 12,000 liters or more
•  Patented disposable design eliminates need for 
housing, CIP or cleaning validation 
•  Self-contained Pod filters protect operators from 
exposure to biohazards
•  Robust construction is easy to use and set up
•  Smaller footprint facilitates use in tight spaces
EMD Millipore Corp. is a subsidiary of Merck KGaA, Darmstadt, Germany
Linear Scalability
The innovative Pod filter system consists of eight filter sizes 
and two expandable holders. No matter what size Pod filter 
you choose, the same flow path and configuration ensures  
a linearly scalable solution from bench to process scale. 
 
Easy to Use 
With the compact, modular design of our Pod system,  
you can increase productivity and shorten cycle times.
Installation and set-up of the Pod system is simple and 
straightforward. The unique design of the disposable 
adapters and disposable manifolds makes it easy to connect 
the Pod filters to the rest of the unit operations in the 
process. The self-contained and disposable nature of the 
system protects operators from exposure to biohazards and 
eliminates maintenance as well as cleaning validation 
requirements. 
 
Configurations
•   µPod® filter — 23 cm2
•   Lab scale Pod filter — 0.027 m2, 0.054 m2
•   Millistak+® DE and CE media — 0.11 m2,  
0.77 m2, or 1.4 m2 filtration area.
•   Millistak+® HC media — 0.11 m2, 0.55 m2, or 
1.1 m2 filtration area.
•   Process scale holder — accepts from five to ten Pod filters 
per rack. Up to three racks can be stacked for process 
flexibility.
•   Pilot scale holder — accommodates up to two full size 
Pod filters for configurations from 0.11 m2 to 2.8 m2 
depending on media type. An optional accessory kit 
expands capacity to five full scale Pod filters.
•   Disposable adapters — connect Pod filters to process 
piping, creating disposable flow path. 
•   Disposable diverter plates — enable more than one media 
grade on a single rack
Millistak+® Depth Filter Media
Available in three media series, the proven filtration 
performance of Millistak+® filter media in the Pod format 
provides greater flexibility and reduced cycle times. 
Millistak+® Pod filters incorporate multiple graded-density 
layers and adsorptive, positively-charged filter media. 
Composed of select grade cellulose fiber and diatomaceous 
earth, the Millistak+® DE series not only improves the 
manufacturing process, but also increases contaminant 
holding. In addition, the Millistak+® CE series consists of 
single layer media with cellulose fibers that are suitable for 
coarse filtration applications.
Millistak+® HC series improves productivity by combining 
multiple media grades into one device enabling compression 
of multiple filtration stages downstream of the bioreactor.
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Millistak+® grades with diatomaceous earth 
Millistak+® grades with diatomaceous earth and cellulose
Millistak+® grades with cellulose only
Millistak+® grades with activated carbon
CE15
CE20
CE25
CE30
CE35
CE40
CE45
CE50
DE25
DE35
DE30
DE40
DE45
DE50
DE55
DE60
DE65
DE70
DE75
C0HC
D0HC
BIHC
AIHC
X0HC
F0HC
Nominal Micron Rating (µm)
CR40
Single Layer Millistak+® CE & DE Media Millistak+® HC Media (non X0HC) Millistak+® X0HC/F0HC Media
Conductivity 1.52 - 1.94 µS/cm post autoclave (1 cycle of 
60 minutes at 123 ºC) and pure water flush 
of 5 L/ft2 (50 L/m2) of media surface area
3.64 - 10.5 µS/cm post autoclave (1 cycle of 
60 minutes at 123 ºC) and pure water flush 
of 10 L/ft2 (100 L/m2) of media surface area
19.34 - 53.2 µS/cm (X0HC) and  
21.4 - 42.7 µS/cm (F0HC) post autoclave  
(1 cycle of 60 minutes at 123 ºC) and  
pure water flush of 10 L/ft2 (100 L/m2) of 
media surface area
NVR Gravimetric 
Extractables
Not Tested 420 - 750 mg/f2 (process scale) and  
630 - 1251 mg/m2  (lab-scale) per 24 hour 
static soak in pure water (type 1 DI water) 
post autoclave (1 cycle of 60 minutes at  
123 ºC) and pure water flush of 10 L/ft2  
(100 L/m2) of media surface area
Not Tested
TOC 910 - 1800 ppb post autoclave (1 cycle of  
60 minutes at 123 ºC) and pure water flush 
of 5 L/ft2 (50 L/m2) of media surface area
720 - 4600 ppb post autoclave (1 cycle of  
60 minutes at 123 ºC) and pure water flush 
of 10 L/ft2 (100 L/m2) of media surface area
1200 - 2800 ppb (X0HC) and 460 - 3200 ppb 
(F0HC) post autoclave (1 cycle of 60 minutes 
at 123 ºC) and pure water flush of 10 L/ft2 
(100 L/m2) of media surface area
Metals  
(mg/ft2 Media)
 
DE Series
 
CE Series
 
A1HC Series
 
X0HC Series F0HC Series
Sodium ≤ 11.5 ≤ 9.91 ≤ 38.2 ≤ 14.02 ≤17.313
Calcium ≤0.050 ≤ 1.46 ≤ 7.30 ≤ 9.60 ≤5.170
Potassium ≤0.351 ≤ 0.042 ≤ 1.18 ≤ 0.82 ≤0.439
Magnesium ≤ 0.129 ≤ 0.662 ≤ 2.31 ≤ 3.905 ≤1.464
Iron ≤ 0.042 ≤ 0.042 ≤ 0.090 < 0.001* <0.041
Lead ≤ 0.0004 ≤ 0.0004 <0.001 <0.001* <0.001
Aluminum ≤ 0.025 ≤ 0.059 ≤ 0.141 ≤ 0.084 ≤0.021
Titanium <0.001* <0.001* ≤0.019 ≤ 0.04 <0.001
Chromium ≤0.001 0.0003 ≤0.003 ≤0.001 <0.001
Manganese ≤0.001 ≤0.001 ≤ 0.487 ≤ 0.425 ≤0.370
Cobalt ≤0.0002 0.0002 ≤0.002 ≤0.001 ≤0.002
Nickel ≤0.001 ≤ 0.0004 ≤0.013 ≤ 0.013 ≤0.022
Copper ≤0.003 ≤ 0.0004 ≤ 0.167 ≤ 0.009 ≤0.019
Zinc ≤0.002 ≤ 0.003 ≤0.112 ≤ 0.046 ≤0.052
Mercury ≤ 0.0004 ≤ 0.0004 <0.001* <0.001* <0.001
Arsenic ≤0.003 ≤ 0.002 ≤ 0.011 ≤ 0.009 ≤0.004
*Pilot and process scale only
Typical Extractables
Pilot Scale:  
HC: 0.11 - 5.5 m2 
DE or CE: 0.11 - 7.1 m2
Lab Scale:  
HC, DE, CE: 270 - 540 cm2
Small Scale:  
HC, DE, CE: 23 cm2
Process Scale: 
HC: 5.5 - 33 m2 
DE or CE: 7.1 - 43 m2
Surface Area
23 cm2  
(HC, CE and DE media)
1.2 ft2 (0.11 m2) 
(HC, CE and DE media)
5.9 ft2 (0.55 m2) 
(HC media)
8.3 ft2 (0.77 m2) 
(CE and DE media)
11.8 ft2 (1.1 m2) 
(HC media)
Materials of Construction 
Filter Media: 
Filter Membrane: 
Pod Housings: 
Adapters: 
Gaskets and Plugs:
Cellulose fibers with inorganic filter aid (CE Media contains cellulose only)
Mixed esters of cellulose (grades A1HC and B1HC only)
Glass Filled Polypropylene
Glass Filled Polypropylene*
Thermo Plastic Elastomer (TPE)*
Inlet, Vent and Outlet 
Connections Female Luer Flat seal
Pod Dimensions
 Length:
 Height:
 Thickness:  
3.5 in. (8.9 cm)
2.6 in. (6.6 cm)
1.6 in. (4.1 cm)
24.2 in. (62 cm)
12.5 in. (32 cm)
1.2 in. (3 cm)
24.2 in. (62 cm)
12.5 in. (32 cm)
2.8 in. (7.1 cm) 
24.2 in. (62 cm) 
12.5 in. (32 cm) 
3.1 in. (7.9 cm) 
24.2 in. (62 cm)
12.5 in. (32 cm)
4.8 in. (12.2 cm)
Maximum Operating 
Pressure 50 psig (3.5 bar) at ≤40° C 50 psig (3.5 bar) at 25 °C; 15 psig (1.0 bar) at 80° C
Maximum Differential 
Pressure
 Forward:
  
 Reverse:
 
30 psid (2.1 bar) at  
40 °C
15 psid (1.0 bar) at  
40 °C
 
 
30 psid (2.1 bar) at 25° C; 15 psid (1.0 bar) at 80° C
 
30 psid (2.1 bar) at 25° C
Sterilization 2 cycles of 60 minutes  
at 123° C 1 cycle of 60 minutes at 123° C
Indirect Food Additive All components meet the FDA indirect food requirements cited in 21 CFR 177-182.
Toxicity  All component materials meet the requirements of the current USP <88> biological reactivity test for class VI plastics.
Bacterial Endotoxin  < 0.25 EU/mL as determined by the Limulus Amebocyte Lysate (LAL) test.
CE Pressure
Equipment Directive
 This filter has been designed and manufactured according to the essential requirements of the Pressure.
 Equipment Directive 97/23/EC. Only 0.77 m2, 1.1 m2 and 1.4 m2 filters carry the CE mark.*
* Pilot and process scale only.
Millistak+® Pod Filter Specifications
Surface Area
15.4 ft2 (1.4 m2)  
(CE and DE media) 0.29 ft2 (0.027 m2) 0.58 ft2 (0.054 m2)
Materials of Construction
 Filter Media:
 Filter Membrane:
 Pod Housings:
 Adapters:
 Gaskets and Plugs: 
Cellulose fibers with inorganic filter aid (CE Media contains cellulose only)
Mixed esters of cellulose (grades A1HC and B1HC only)
Glass Filled Polypropylene
Glass Filled Polypropylene*
Thermo Plastic Elastomer (TPE)*
Pod Dimensions
 Length:
 Height:
 Thickness:  
24.2 in. (62 cm) 
12.5 in. (32 cm)
5.0 in. (12.7 cm) 
8.5 in. (22 cm) 
5.3 in. (14 cm) 
2.9 in. (7.9 cm) 
8.5 in. (22 cm)
5.3 in. (14 cm)
3.7 in. (9.4 cm)
Maximum Operating Pressure  
50 psig (3.5 bar) at 25 °C; 15 psig (1.0 bar) at 80 °C
 
30 psig (3.5 bar) at  37 °C
Maximum Differential Pressure
 Forward:
 Reverse: 
 
30 psid (2.1 bar) at 25 °C; 15 psid (1.0 bar) at 80 °C
30 psid (2.1 bar) at 25 °C
 
30 psid (2.1 bar) at 4-37 °C
30 psid (2.1 bar) at 37 °C
Sterilization May be autoclaved for 1 cycle of 60 minutes at 123 °C 2 cycles of 60 minutes at 123 °C
Indirect Food Additive All components meet the FDA indirect food requirements cited in 21 CFR 177-182.
Toxicity  All component materials meet the requirements of the current USP <88> biological reactivity test for class VI plastics.
Bacterial Endotoxin  < 0.25 EU/mL as determined by the Limulus Amebocyte Lysate (LAL) test.
CE Pressure
Equipment Directive
 This filter has been designed and manufactured according to the essential requirements of the Pressure
 Equipment Directive 97/23/EC. Only 0.77 m2, 1.1 m2 and 1.4 m2 filters carry the CE mark.
* Pilot and process scale only.
Millistak+® Pod Filter Specifications
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Millistak+® CE Series
Media Type/Grade
Water Flow Rate  
L/min/m2 at 10 psid, 23° C
CE15 3054.9 - 5611.5
CE20 2082.6 - 3825.5
CE25 1425.8 - 2619.1
CE30 974.1 - 1789.3
CE35 665.5 - 1222.4
CE40 454.6 - 835.1
CE45 310.6 - 570.5
CE50 212.2 - 389.8
Millistak+® DE Series 
Media Type/Grade
Water Flow Rate   
L/min/m2 at 10 psid, 23° C
DE25 1425.8 - 2619.1
DE30 974.1 - 1789.3
DE35 665.5 - 1222.4
DE40 454.6 - 835.1
DE45 310.6 - 570.5
DE50 212.2 - 389.8
DE55 145.0 - 266.3
DE60 99.0 - 181.9
DE65 67.7 - 124.3
DE70 46.2 - 84.9
DE75 31.6 - 58.0
Media Grade Application Characteristics Media Construction
Single-layer CE* Cellulose CE15 to 50
Single-layer DE* Cellulose + inorganic filter aid DE 25 to 75
Triple-layer A1HC Post-TFF (Prostak™ system) clarification fluids Tightest media combination with an additional membrane 
layer to protect downstream membrane filters
DE60 + DE75 + RW01 
Triple-layer B1HC Post-centrifuge or settled permeate containing 
cellular particulate
A more open first layer withan additional membrane  
layer to protect downstream membrane filters
DE50 + DE75 + RW01
Double-layer C0HC Perfusion bioreactor fluid Two layers of a more open DE media DE30 + DE60
Double-layer D0HC Primary clarification directly out of the bioreactor A more open CE layer and DE media combination CE25 + DE40
Double-layer X0HC Secondary clarification of bioreactor harvests, 
primarily for cell cultures
Two DE layers. Provides sterile filter protection without  
an RW01 membrane
IM75 + IM83
Double-layer F0HC Secondary clarification of pretreated harvest by  
acid precipitation or flocculation, E. coli and yeast
Two DE layers. Provides sterile filter protection without  
an RW01 membrane
DE60 + IM75
*For clarification of serum, plasma, vaccines, cell culture or other fluids, choice of media grade should be based on small-scale trials.
Choose the Right Media
Millistak+® HC Series
Media Type/Grade
Water Flow Rate  
L/min/m2 at 10 psid, 23° C
A1HC
DE60 99.0 - 181.9
DE75 31.6 - 58.0
B1HC
DE50 212.2 - 389.8
DE75 31.6 - 58.0
C0HC
DE30 974.1 - 1789.3
DE60 99.0 - 181.9
D0HC
CE25 1425.8 - 2619.1
DE40 454.6 - 835.1
F0HC
DE60 99.0 - 181.9
IM75 39.1 - 54.6
X0HC
IM75 39.1 - 54.6
IM83 21.2 - 27.7
Water Flow Rates
Size 
027 = 0.027 m2 
054 = 0.054 m2 
Connection 
H = 1/4 in. (6 mm) 
Hose Barb 
Package Quantity 
1 = 1/pack
Ordering Information
Lab Scale Pod Filter
Millistak+®  
M H 1
A1HC
B1HC
C0HC
D0HC
F0HC
X0HC
CE15
CE20
CE25 
CE30
CE35 
CE40
CE45
CE50 
DE25
DE30
DE35
DE40
DE45
DE50
DE55
DE60
DE65
DE70
DE75
Size  
01 = 0.11 m2
07 = 0.77 m2
13 = 1.4 m2
Single Layer Process Scale Pod Filter
Millistak+®
M
CE15
CE20
CE25
CE30
CE35 
CE40
CE45
CE50 
DE25
DE30
DE35
DE40
DE45
DE50
DE55
DE60
DE65
DE70
DE75
Size 
01 = 0.11 m2
05 = 0.55 m2
10 = 1.1 m2
Package Quantity 
1 = 1/pack
Package Quantity 
1 = 1/pack
Connection 
FS = Flat seal
Connection 
FS = Flat seal
Multi Layer Process Scale Pod Filter
Millistak+®
 
M
F
F
S
S
1
1
A1HC
B1HC
C0HC
D0HC
X0HC
F0HC
Size  
23C = 23 cm2
Connection  
L = Luer Fitting
Package Quantity 
3 = 3/pack
µPod® Filter
Millistak+®
µPod® Filter Accessories
µPod® Tubing Kit Catalogue No. MTUBEKITL1
Gauge 0 - 60 psi and Connection Fittings Catalogue No. XXPXLGAGE
M 3L2 3 C
A1HC    
B1HC
C0HC
D0HC
F0HC
X0HC
CE15
CE20
CE25
CE30 
CE35    
CE40
CE45
CE50
DE25
DE30
DE35
DE40
DE45
DE50 
DE55   
DE60
DE65
DE70
DE75
Media Type and grade
Media Type and grade
Media Type and grade
Media Type and grade
Pilot and Process scale pods require a pod holder. Lab scale pods and µPod® filters do not require a holder.  
Please contact your local sales representative for more information.
EMD Millipore, the M logo, Millistak+ and µPod are registered trademarks of Merck KGaA, Darmstadt, Germany.
Prostak is a trademark of Merck KGaA, Darmstadt, Germany.  Lit No. DS0217EN00  Vers. 9.0    DP-SBU-11-04134   
07/2016    © 2016 EMD Millipore Corporation. All rights reserved.
www.emdmillipore.com/millistak
To place an order or receive
technical assistance
In the U.S. and Canada, call toll-free 
1(800)-645-5476
For other countries across Europe, call
+44 (0) 115 943 0840
For other countries across Europe and the world, 
please visit www.emdmillipore.com/offices
For Technical Service, please visit 
www.emdmillipore.com/techservice
Hardware for Pod disposable 
depth filter systems
Innovative, high-performance Pods are ideal  
for primary and secondary clarification in lab,  
pilot and process-scale applications.
Data Sheet
Millistak+® and Clarisolve® depth filter media are offered 
in a scalable, disposable format, the Pod Filter System. 
Accommodating applications from lab to pilot to process 
scale, the Pod format offers greater flexibility because of 
its unique modular design. 
The Pod system is ideal for a wide variety of primary 
and secondary clarification applications, including cell 
cultures, yeast and E. coli lysates post centrifuge, E. coli 
refolds, media, vaccines, plasma proteins and sera.
The system’s modular design allows users to operate the 
system with as few as one at pilot scale and as many 
as 30 Pod filters installed at the process scale. These 
options make it easy to configure a system for a specific 
application, and conveniently reconfigure it as process 
capacity requirements scale-up or down.
Benefits
•  Modular format offers scalability from 5 to  
12,000 liters or more
•  Optional 100% disposable flow path eliminates 
need for housing, CIP, cleaning validation
•  Robust construction is easy to use and set up
•  Increase your installed surface area by 6x within  
the same footprint
EMD Millipore is a division of Merck KGaA, Darmstadt, Germany.
Linear Scalability
The innovative Pod filter system consists of seven filter 
sizes and two expandable holders. No matter what size 
Pod filter you choose, the same flow path and configura-
tion ensures a linearly scalable solution from bench to 
process scale.
Easy to Use 
With the compact, modular design of our Pod  
system, you can increase productivity and shorten  
cycle times.
Installation and set-up of the Pod system is simple and 
straightforward. The unique design of the disposable 
adapters makes it easy to connect the Pods to the process 
piping. The self-contained and disposable nature of the 
system protects operators from exposure to biohazards 
and eliminates maintenance as well as cleaning validation 
requirements.
Configurations
•   Pilot scale holder — accommodates up to two full 
size Pods. An optional accessory kit expands capacity 
to 5 full scale Pods. Total surface area is dependent on 
media grade.
•   Process scale holder — accepts from five to ten  
Pods per rack. Up to three racks can be stacked for 
process flexibility. Total surface area is dependent  
on media grade. 
•   Disposable adapters — connect Pods to process  
piping, creating disposable flow path. 
•   Disposable diverter plates — enable more than one 
media grade on a single rack
•   Disposable feed and filtrate manifolds —  
make your flow path 100% disposable by replacing 
the stainless steel manifolds with disposable versions. 
Available for 1, 2, and 3 rack process scale holders.
Pod Holder Specifications*
Surface Area Pilot Scale Process Scale
Materials of construction
 Manifold
 Diverter plate
 End plates
N/A
Polypropylene
304 stainless steel
 
316 L stainless steel
Polypropylene
304 stainless steel
All metal surfaces in contact with process fluids N/A 316 L stainless steel
Manifold surface finish, internal N/A Electropolished, Ra <0.5 µm (<20 micro-inches)
End plate clamp and guide rods 17–4 PH steel 17–4 PH steel
All other metal surfaces 304 stainless steel 304 stainless steel
TC gaskets Thermoplastic Elastomer (TPE) Thermoplastic Elastomer (TPE)
TC clamp 304 stainless steel 2 piece clamp 304 stainless steel 2-piece clamp
Performance properties Capable of supporting and sealing pod filters up to 50 psig maximum operating pressure at 25 °C.  
Inlet and outlet connection to the pods and vents are via disposable adapters.
Maximum differential pressure
 Forward
 Reverse
 
50 psid (3.5 bar) at 25 °C; 15 psid (1.0 bar) at 80 °C
30 psid (2.1 bar) at 25 °C
Regulatory information Sealing materials and plastics in contact with the product meet USP <88> biological reactivity test for 
Class VI plastics and are Title 21 CFR 177.2600 and 177.1550 compliant.
Pod Disposable Manifold Specifications*
Pod Disposable Manifold Specifications
Materials of construction
 Polypropylene
 Double braided silicon tubing
 Silicone gaskets
 Glass filled nylon clamps
Max. operating pressure: 50 psi
Hot water sanitization: 1 cycle of 80 °C for 30 minutes
Toxicity: Component materials comply with the requirements of USP <88> biological reactivity tests for 
Class IV plastics
The Pod pilot scale holder 
supports your process as 
you scale up.
*No holder required for lab scale pod
Ordering Information
Description Qty/Pk Catalogue No.
Pilot Scale Holder
For pod configurations from 1 to 2 filters 1 MP0DPIL0T
Pilot holder expansion kit allows for pod configurations up to 5 filters 1 MP0DPIL0TX
Process Scale Holders
1-rack holder; for 5 to 10 filters; Gemü® valves 1 MP0DSYS1A
1-rack holder; for 5 to 10 filters; ITT valves 1 MP0DSYS1B
1-rack holder; for 5 to 10 filters; no valves 1 MP0DSYS1N
1-rack expansion kit; for 5 to 10 filters; no valves or casters 1 MP0DSYS1X
2-rack holder; for 5 to 20 filters; Gemü® valves 1 MP0DSYS2A
2-rack holder; for 5 to 20 filters; ITT valves 1 MP0DSYS2B
3-rack holder; for 5 to 30 filters; Gemü® valves 1 MP0DSYS3A
3-rack holder; for 5 to 30 filters; ITT valves 1 MP0DSYS3B
Holder Replacement Parts*
Hydraulic pump MP0DHYPUMP
Hydraulic system pressure gauge MP0DHYGAGE
Hydraulic fluid MP0DHFLUID
Clamp insert MP0DINSERT
1.5 in. TC stainless steel clamp for use with MP0DINSERT YY2004045
Clamp rod knob MP0DCRKN0B
Clamp rod for 2 filters MP0DCR0D02
Clamp rod for 5 filters MP0DCR0D05
Clamp rod for 10 filters MP0DCR0D10
Manifold elbow, 90 °C, 1.5 in. 316 stainless steel MP0DSSELB0
Manifold tee, 1.5 in. 316 stainless steel MP0DSSTEE
Manifold spool, 1 in. x 6.60 in. L MP0DMANSPH
Manifold spool, 1.5 in. x 13.16 in. L MP0DMANSPV
Manifold bracket assembly MP0DMANBRK
Replacement diaphragm for 1 in. Gemü® MPODVALVEA MPODVLVADIA
Replacement diaphragm for 1 in. ITT MPODVALVEB MPODVLVBDIA
Holder Accessories*
1-rack Disposable feed and filtrate manifold MP0DDSPMAN1
2-rack Disposable feed and filtrate manifold MP0DDSPMAN2
3-rack Disposable feed and filtrate manifold MP0DDSPMAN3
Disposable adapter kit** 3 through adapters, 3 blind adapters 1 MP0DADAPT
Disposable adapter kit** 6 through adapters, required if using MP0DDIVERTR 1 MP0DADPTF
1.5 in. TC sanitary gauge, 0–4 bar (0–60 psi) 1 MP0D60PSIG
1.5 in. TC EPDM gasket 10 HGTC150EP
1.5 in. TC stainless steel clamp 1 YY2004045
Diaphragm valve, 1 in. Gemü® 1 MP0DVALVEA
Diaphragm valve, 1 in. ITT 1 MP0DVALVEB
Disposable diverter plate 10 MP0DDIVERTR
Pod pilot holder handle 1 MP0DPLTHNDL
End Plate Replacement Kit
This kit replaces the bronze bushings with linear ball bearings to facilitate movement of the end plate.  
The kits come with one end plate, new guide rods and associated hardware.
Pod Retrofit Kit for MP0DPILOT MP0DRET1
Pod Retrofit Kit for MP0DPILOT with extension rods MP0DRET2
Pod Retrofit Kit for process scale holders MP0DRET3
*Consult your sales associate for replacement part and accessory availability. 
**The disposable adapter kit must be ordered with individual Pod filters in order to install the Pod filter in the holder.
www.emdmillipore.com
To Place an Order or Receive 
Technical Assistance
In the U.S. and Canada, call toll-free 
1(800)-645-5476
For other countries across Europe, call
+44 (0) 115 943 0840
For other countries across Europe and the world, 
please visit www.emdmillipore.com/offices
For Technical Service, please visit 
www.emdmillipore.com/techservice
EMD Millipore, the M mark, Millistak+ and Clarisolve are registered  
trademarks of Merck KGaA, Darmstadt, Germany. 
Gemü is a registered trademark of Gebroder Müller Apparatebau GmbH & Co.
Lit No. DS3388EN00   Rev. B   06/2014    DP SBU-11-04244   Printed in the U.S.A. 
©2014 EMD Millipore Corporation, Billerica, MA 01821 U.S.A.   All rights reserved.
Data file 18-1138-92 AF Process columns
gelifesciences.com
Chromaflow™ columns
Chromaflow columns are a family of convenient to use, 
process-scale columns. A patented nozzle in the top and 
bottom of the column allows packing, unpacking, and 
cleaning when fully assembled, that is with the lid in place. 
Chromaflow columns simplify chromatographic procedures 
and offer:
• convenience
• saving of labor
• reproducibility
• contained packing
• scalability
General column description
Chromaflow low-pressure columns (Fig 1) are available in 
a choice of dimensions and materials. The complete range 
offers inner diameters (i.d.) from 300 to 2000 mm (Table 1), 
with column tubes manufactured from cast acrylic (Fig 1). All 
dimensions are available with variable bed heights, providing 
a wide variety of bed volumes. All columns are pressure rated 
for operation at 3 bar.
Chromaflow columns incorporate a patented, pack-in-place 
nozzle (Fig 2) through which process liquids enter and exit. 
Manual or automated versions of the nozzles are available. 
The automated nozzle is controlled from the packing station 
or the nozzle control unit. The nozzle has three positions to 
facilitate the different aspects of column operation: packing, 
operation, unpacking and cleaning. In addition to this pack-
in-place functionality, the nozzle also contains the process 
liquid flow path to provide a consolidated solution to the 
process stream handling.
Bed supports are available in 316L stainless steel or 
polyethylene. The multilayer, woven stainless steel bed 
supports have very high chemical resistance and longevity 
for use in applications where salt concentrations are low and 
pH is above 5. Polyethylene bed supports are recommended 
Fig 1. A Chromaflow column, 2000 mm i.d.
Fig 2. The Chromaflow nozzle that enables packing in place in a fully 
assembled column (GE Healthcare patent).
for applications with low pH and high salt concentrations. 
All other wetted parts in columns with polyethylene bed 
supports are manufactured from plastic or noncorrodible 
materials for use in low pH /high salt applications.
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The construction materials include 316L stainless steel, 
acrylic, polypropylene, polyethylene, PEEK 450 G, EPDM rubber 
and FEP encapsulated silicone. These materials have high 
chemical resistance to the liquids typically used in process 
chromatography (Table 2). Furthermore, all polymeric materials 
are approved according to USP class VI tests for toxicity.
As an option, a dedicated packing station is available for 
Chromaflow columns. The packing station speeds up the 
packing procedure by eliminating the more time-consuming, 
manual maneuvers (Fig 3). 
Comprehensive documentation is delivered with each column 
and includes a User manual, a Maintenance manual, assembly 
drawings, a full spare part list, materials certificates etc.
A Validation Support File containing information on column 
component composition, materials of construction and 
toxicity studies is also available.
Convenient and labor saving
Once the column is assembled and the lid in place, no 
lifting gear is required for packing, operation, unpacking or 
cleaning-in-place (CIP). This means that a single operator can 
perform all column operations, thereby reducing labor costs 
and increasing convenience in large-scale operations.
Reproducibility
Packing with the lid in place allows the packing parameters 
to be easily set and fixed. Manual operation is minimized and 
standard operating procedures can be followed, helping to 
give reproducible column packing and results.
Contained packing
Improved safety is another advantage of the Chromaflow 
column concept. Because all the column operations are 
performed in a “closed system” environment, there is less 
Fig 3. Packing Chromaflow columns with the dedicated packing station is 
convenient and simple.
risk of the operator coming into contact with hazardous 
chemicals and of the target product being exposed to 
contamination. In this way, overall safety and hygienic 
operation are improved.
Principle of operation
The column has a three-position nozzle located in the center 
of the top and bottom bed support. These three positions 
enable packing, unpacking, operation and cleaning to be 
performed without any adjustments to the assembled 
column, that is the lid remains in place.
Flow profiles from the two nozzles are identical. Packing 
direction will depend on the characteristics of the media and 
packing method used. The three positions are illustrated in 
Figure 4.
Fig 4. The three positions of the Chromaflow nozzle showing 
packing from the top.
Packing position
The bottom nozzle is extended part of 
the way (mid position) into the column. 
The top nozzle is fully retracted. Slurry 
enters the column via the bottom nozzle 
and excess liquid exits via the top mobile 
phase outlet. After packing, the slurry 
lines are isolated from the mobile phase 
and can be cleaned independently from 
the rest of the column.
Running position
The bottom and top nozzles are 
retracted. Mobile phase enters the 
column directly into an annulus, 
immediately behind the bed support. 
The annulus is cut through at an angle to 
ensure that linear flow is kept constant 
during distribution of the mobile phase 
across the bed.
Unpacking position
In this position, both bottom and 
top nozzles are fully extended into 
the column thereby exposing a third 
passage through which medium leaves 
the column.
Cleaning solution can be pumped 
through the nozzles and sprayed into the 
column. In this way the column is easily 
and effectively cleaned without exposing 
the interior or the medium to the 
environment, and without dismantling 
the column.
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Table 1. Weights, volumes and dimensions for variable bed height Chromaflow columns
 Max operating Volume Column overall Weight, Footprint
Description pressure (bar) (L) height (mm) dry (kg) (mm × mm)
Chromaflow column 400/100-300* 3 12.6–37.8 1568 230 700 × 700
Chromaflow column 600/100-300 3 28.3–84.9 1568 375 800 × 800
Chromaflow column 800/100-300 3 50.3–150.9 1572 610 1000 × 1000
Chromaflow column 1000/100-300 3 78.5–235.5 1573 930 1200 × 1200
Chromaflow column 1200/100-300 3 113.1–339.3 
Chromaflow column 1400/100-300 3 153.9–461.7  
Chromaflow column 1600/100-300 3 201.1–603.3  
Chromaflow column 1800/100-300 3 254.5–763.5  
Chromaflow column 2000/100-300 3 314.2–942.6
* The first figure in the column name indicates the inner diameter and the second figure indicates stroke length.
Table 2. Major components and their composition
  In contact with  
Component Material process stream
Column tube Acrylic or stainless steel 316L Yes 
Column lids Stainless steel 316L No 
Distributor Polypropylene Yes 
Bed support Stainless steel 316L or polyethylene Yes 
Chromaflow nozzle Polypropylene, stainless steel 316L, PEEK 450 G Yes 
Seals EPDM or FEP encapsulated silicone Yes 
Stand Stainless steel 316 No 
EPDM = ethylene propylene diene, FEP = fluoroethenepropene, PEEK = polyetherether ketone
Scalability
Chromaflow columns are available in a wide range of 
dimensions, all designed and constructed around the 
same design principle. Standard range columns come in 
dimensions from 400 to 1000 mm, for more information 
about columns and dimensions, see Ordering information.
Scaling up a chromatographic process from small to larger 
diameters is easily performed with maintained reproducibility, 
safety and convenience.
Column dimensions
A selection of Chromaflow columns in the range 400 to 
2000 mm i.d. are presented in Table 1. The adapter stroke 
length is a standard 200 mm. Variable bed heights are 
available in the ranges 100 to 300 mm, 200 to 400 mm and 
300 to 500 mm.
Chromaflow 400 SFP columns
Chromaflow 400 SFP (small flow path) columns are specially 
designed for low-flow applications. The dimensions in the 
mobile phase have been optimized to reduce dead volumes 
to a minimum and the area behind the nozzle tip has also 
been reduced.
Column materials and their chemical 
resistance
Table 2 lists the major components of Chromaflow columns 
in contact with process fluids (wetted parts) and Table 3 lists 
the chemical resistance of materials using data compiled 
from several published sources. It is important to note that 
columns with stainless steel bed supports and other stainless 
steel wetted components must be appropriately maintained 
when exposed to NaCl. Since salt can be corrosive to 
stainless steel over time, it is recommended that residual 
salt is removed by rinsing columns with at least five column 
volumes (CV) of clean water.
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Table 3. Chemical resistance of materials used in Chromaflow columns (60 days)
Chemical Acrylic SS 316L EPDM FEP PEEK 450 G PE PP 
Acetic acid 1.7 M + + + + + + + 
EtOH 20% 1 + + + + + + + 
EtOH 40% – + + + + (+) + 
Ethylene glycol 50% + + + + + + + 
Formaldehyde 1.7 M + + + + + + +
Formic acid 10% (+) + + + + + + 
Glycerol 100% + + + + + + + 
Hydrochloric acid 0.1 M + – + + + + + 
Isopropyl alcohol 30% – + + + + (+) + 
Nitric acid 0.1 M + + + + + (+) + 
Phosphoric acid 25% + (+) + + + + + 
Sodium chloride 0.5 M + +2 + + + + + 
Sodium hydroxide 2 M3 + + + + + + + 
Trifluoroacetic acid 0.1% (+) + + + + + + 
Triton™ X-100 100% + + + + + + + 
Urea 8 M + + + + + + + 
+ Resistant    (+) Limited resistance     – Not recommended
1 Do not expose acrylic to concentrations of ethanol greater than 20%. Do not exceed the following parameters during storage: 5 yr, 23°C, 0.5 bar g.
2 NaCl can cause corrosion on stainless steel at pH <5. Do not use NaCl in storage solutions. Rinse with at least 5 CV of clean water after use with NaCl.
3 Maximum exposure 4 h.
SS=stainless steel, EPDM=ethylene propylene diene, FEP=fluoroethenepropene, PEEK=polyetherether ketone, PE=polyethylene, PP=polypropylene.
Sanitizing Chromaflow columns
The design of Chromaflow columns facilitates cleaning-in-
place. Below is a recommended cleaning protocol suitable for 
most applications.
1. Circulate 1.5 CV of 20% acetic acid at a low flow velocity 
(60 cm/h) for 15 min, upward flow. Then reverse the flow 
for 15 min.
2. Repeat this procedure with 1.0 M NaOH.
3. Following step 2, slowly circulate 1.0 M NaOH in the 
column for 60 min.
4. Re-equilibrate the column with a storing or starting buffer.
Chromaflow Packing stations
Chromaflow Packing stations make column priming and 
packing a simple operation, reducing the operator’s time 
to a minimum. The packing stations consist of a control 
panel with pumps and valves fitted underneath (Fig 5). 
Valves and diaphragm pumps are actuated pneumatically 
from the control panel. As they are brought into operation 
indicators on the control panel display the relevant flow 
paths. For operation, packing stations only require a supply of 
compressed air. To select an appropriate packing station for 
your column and media, refer to Tables 4 and 5.
Fig 5. Chromaflow Packing station Pack 100.
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What else do I need?
The column
The columns are supplied ready for use and are equipped 
with adjustable feet. Castors can be ordered separately for 
columns up to 1000 mm in diameter.
Isolating the column after packing 
We recommend using sanitary stainless steel valves (of the 
appropriate inner diameter) on the mobile phase to prevent 
contamination of the packed bed. For storage purposes, blind 
flanges with a clamp and gasket can be used to seal off the 
column.
Connecting the column to your system and 
packing station
Clamps and gaskets of suitable size are required to connect 
the sanitary flanged inlet/outlet to either valves or tubing of 
the same type. Preflanged tubing is also available.
Table 4. Specifications of Chromaflow packing stations
  Pump flow Req. air Inlet piping/ TC Weight, Size
  capacity supply outlet i.d. connections dry W × H × D
Designation* Pump (L/min) (m3/min) (mm) (mm) (kg) (mm)
Pack 50 Tapflo™ T53 10–50 0.5 22.1/22.1 50.5 115 810 × 1175 × 
715 
Pack 100 Tapflo T103 30–100 1.0 34.8/22.1 50.5 130 810 × 1175 × 715
* Packing stations, Pack 200 and Pack 400 with pump flow capacities of 60 to 200 l/min and 100 to 400 l/min are available as custom orders.
Table 5. Approximate packing flow rates for different media at two different bed heights
Column 
diameter (mm) 400 600 800 1000
Bed height (mm) 150 300 150 300 150 300 150 300
Flow cm/h L/min cm/h L/min cm/h L/min cm/h L/min cm/h L/min cm/h L/min cm/h L/min cm/h L/min
Sepharose™
Fast Flow media   500     11    250    5.5   500   24   250   12   500     42   250   21   500      66   250   33
Sepharose
Big Beads media  1600     34 1200  25 1600   75 1200   57 1600   134 1200 101 1600   209 1200 157
Assembly or disassembly of the column
An adequate sized wrench is needed for assembly or 
disassembly of the column. A hoist is needed to remove the 
adapter or top lid from the column.
Spare parts to keep on site
It is recommended that nozzle seals, column seals, and 
column bed support kits are kept as spare parts. 
Useful accessories
Safety valve: Precalibrated valve which releases pressure if 
the calibrated value is exceeded. Recommended to install on 
the mobile phase inlet if no other pressure sensor is included 
in the chromatography system. The T-junction, clamps and 
gaskets must be ordered separately.
Pressure sensor: The sensor is installed inline, preferably 
on the mobile phase inlet. Clamps and gaskets have to be 
ordered separately.
6  18-1138-92 AF
Chromaflow columns  Bed support  Bed support  Bed support 
with acrylic tubes  10 mm SS sinter  20 mm SS sinter  20 mm PE sinter 
I.d. 400 mm Man. nozzle    
Stroke length 100-300  18-1150-40  18-1159-40  18-1161-40 
Stroke length 200-400  18-1157-42  18-1159-42  18-1161-42 
Stroke length 300-500  18-1157-44  18-1159-44  18-1161-44 
I.d. 400 mm Auto. nozzle    
Stroke length 100-300  18-1157-41  18-1159-41  18-1161-41 
Stroke length 200-400  18-1157-43  18-1159-43  18-1161-43 
Stroke length 300-500  18-1157-45  18-1159-45  18-1161-45 
I.d. 400 mm SFP* Man. nozzle    
Stroke length 100-300  18-1170-53  18-1176-12  11-0011-85 
Stroke length 200-400  11-0011-80  11-0011-83  11-0011-86 
Stroke length 300-500  11-0011-82  11-0011-84  11-0011-87 
I.d. 400 mm SFP Auto. nozzle    
Stroke length 100-300  11-0011-89  11-0011-91  11-0011-94 
Stroke length 200-400  11-0011-88  11-0011-92  11-0011-95 
Stroke length 300-500  11-0011-90  11-0011-93  11-0011-96 
I.d. 600 mm Man. nozzle    
Stroke length 100-300  18-1150-60  18-1159-60  18-1161-60 
Stroke length 200-400  18-1157-62  18-1159-62  18-1161-62 
Stroke length 300-500  18-1157-64  18-1159-64  18-1161-64 
I.d. 600 mm Auto. nozzle    
Stroke length 100-300  18-1157-61  18-1159-61  18-1161-61 
Stroke length 200-400  18-1157-63  18-1159-63  18-1161-63 
Stroke length 300-500  18-1157-65  18-1159-65  18-1161-65 
I.d. 800 mm Man. nozzle    
Stroke length 100-300  18-1150-80  18-1159-80  18-1161-80 
Stroke length 200-400  18-1157-82  18-1159-82  18-1161-82 
Stroke length 300-500  18-1157-84  18-1159-84  18-1161-84 
I.d. 800 mm Auto. nozzle    
Stroke length 100-300  18-1157-81  18-1159-81  18-1161-81 
Stroke length 200-400  18-1157-83  18-1159-83  18-1161-83 
Stroke length 300-500  18-1157-85  18-1159-85  18-1161-85 
I.d. 1000 mm Man. nozzle    
Stroke length 100-300  18-1150-10  18-1160-10  18-1162-10 
Stroke length 200-400  18-1158-12  18-1160-12  18-1162-12 
Stroke length 300-500  18-1158-14  18-1160-14  18-1162-14 
I.d. 1000 mm Auto. nozzle    
Stroke length 100-300  18-1158-11  18-1160-11  18-1162-11 
Stroke length 200-400  18-1158-13  18-1160-13  18-1162-13 
Stroke length 300-500  18-1158-15  18-1160-15  18-1162-15 
For column specifications other than listed in the table, please contact your local GE Healthcare representative. 
* SFP = Small Flow Path on mobile phase, only available on 400 mm i.d. columns. 
Ordering information
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Packing stations
 Min Max
 (L/min) (L/min) Code number
Pack 50   10   50 18-1163-74
Pack 100   30 100 18-1162-08
Pack 200   60 200 Custom order
Pack 400 100 400 Custom order
Accessories
Designation Code number
Valves
4 port 2 way, i.d. 10 mm, 25 mm TC 18-1012-56
4 port 4 way, i.d. 10 mm, 25 mm TC 18-1012-57
3 port 2 way, i.d. 15 mm, 25 mm TC 44-5499-90
4 port 4 way, i.d. 20 mm, 51 mm TC 44-2302-01
3 port 2 way, i.d. 22 mm, 51 mm TC 44-1583-01
3 port 2 way, i.d. 35 mm, 51 mm TC 44-5494-65
Valve sealing washer 18-1128-69
Fits 10 mm 2- and 4-way valves
PVC tubing with sanitary fitting 25 mm TC 
i.d. 10 mm, 900 mm 18-1012-62
i.d. 10 mm, 1400 mm 18-1012-63
i.d. 10 mm, 1700 mm  18-1012-64
i.d. 10 mm, 2000 mm  18-1012-87
i.d. 14 mm, 750 mm  18-1027-28
i.d. 14 mm, 1800 mm 18-1027-29
PVC tubing with sanitary fitting 51 mm TC 
i.d. 22 mm, 900 mm  44-1616-09
i.d. 22 mm, 1400 mm  44-1616-08
i.d. 22 mm, 2000 mm 44-1616-07
i.d. 22 mm, 4000 mm 44-1616-06
Clamp gasket 
25 mm i.d., 10 mm 18-1035-79
25 mm i.d., 12 mm 18-0200-00
51 mm i.d., 22 mm 44-7133-01
51 mm i.d., 38 mm 44-0515-01
Clamp 25 mm 18-1001-31
Clamp 51 mm 44-7134-01
Blind flange 25 mm incl. gasket 18-1001-25
Blind flange 51 mm incl. gasket 44-7135-01
Safety valve, 3 bar, 51 mm TC 18-5738-01
Safety valve, 5 bar, 51 mm TC 44-5498-97
T-junction i.d., 10 mm, 2×25 mm TC, 1×51 mm TC 18-1003-63
Castors, assembly kit 400-600 18-1171-51
Castors, assembly kit 800-1000 18-1171-52
The kit contains a complete set of wheels, fasteners and adapters for a column.
Pressure sensor i.d. 10 mm, 25 mm TC 44-0507-02
Pressure sensor i.d. 22 mm, 51 mm TC 44-0507-03
Designation Code number
Media stirrers
Media stirrer, 80 cm 18-1149-80
Media stirrer, 150 cm 18-1149-81
Connectors
i.d. 10, 25 mm TC-3/4″-20 UNF threaded 18-1012-68
i.d. 10, 25 mm TC-i.d. 14, 51 mm TC 18-1027-25
i.d. 14, 51 mm TC-i.d. 22, 51 mm TC 18-1027-26
Chromaflow Nozzle control unit 18-1164-61
Chromaflow Nozzle pipings 
Chromaflow Nozzle piping 400 1/2”  18-1172-01 
Chromaflow Nozzle piping 400 3/4”  18-1172-00 
Chromaflow Nozzle piping 400 1”  18-1171-99 
Chromaflow Nozzle piping 600 1/2”  18-1172-06 
Chromaflow Nozzle piping 600 3/4”  18-1172-05 
Chromaflow Nozzle piping 600 1”  18-1172-04 
Chromaflow Nozzle piping 800 1/2”  18-1171-94 
Chromaflow Nozzle piping 800 3/4”  18-1171-93 
Chromaflow Nozzle piping 800 1”  18-1171-92 
Chromaflow Nozzle piping 1000 1/2”  18-1172-09 
Chromaflow Nozzle piping 1000 3/4”  18-1172-08 
Chromaflow Nozzle piping 1000 1”  18-1172-07
GE and GE monogram are trademarks of General Electric Company.
Chromaflow and Sepharose are trademarks of General Electric Company 
or one of its subsidiaries.
Triton is a trademark of Union Carbide Chemicals and Plastics Co.  
Tapflo is a trademark of Tapflow AB.
All other third party trademarks are the property of their respective owner.
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Cogent® Process-Scale  
Tangential Flow Filtration System
A fully-automated, configurable, TFF system suited  
for manufacturing of biopharmaceuticals and  
cGMP process-scale applications
Data Sheet
The fully automated Cogent® TFF system is  
designed to separate and purify monoclonal  
antibodies, vaccines, plasma, and therapeutic  
proteins. It is ideally suited for both pilot and  
production scale applications, thereby  
supporting rapid scale up from small to large  
scale operations.
Benefiting from our leading bioprocess  
knowledge and engineering expertise,  
the Cogent® Process Scale System is the  
culmination of 25 years of custom system  
design and incorporates many unique,  
innovative and intelligent design features.  
This system has a very low hold-up volume  
for maximum volume concentration and  
optimal product recovery, thus enhancing 
process performance. 
Benefits:
•  Modular standard options allow the unique system  
configuration that best matches process  
requirements while minimizingupfront investment.
•  Full process automation eases the consistent  
production of preclinical and clinical scale  
quantities of high-value drug products to 
cGMP standard.
•  Optimized design and component integration of 
NovAseptic® valves and TFF cassette holders result  
in a low minimum working volume and ensure 
maximum product recovery. 
•  Designed to maximize TFF performances in  
fed-batch, concentration, total recycle or  
single pass mode.
•  Comprehensive services ensure rapid  
implementation and optimized performance.
EMD Millipore is a division of Merck KGaA, Darmstadt, Germany
2Configure your system according to your process needs…
Option 7: Filtrate  
conductivity
Measurement of a wide 
range of products (WFI, 
buffer solutions, protein 
solutions) or post CIP  
flushing monitoring
Option 1: Tank  
(50, 100, 200L) 
Jacketed for  
temperature regulation 
Option 10: Retentate pH 
In-process monitoring of 
product pH
Option 9: Retentate  
conductivity 
In-process monitoring of 
product conductivity
Option 18: Retentate  
and Filtrate NovaSeptum®  
Sampling port 
In-process sterile sampling 
of product
Option 19: Spray ball valve  
Tank cleaning using the 
spray ball
Option 2: Mini loop 
Minimizes the recirculation  
volume to reach high 
concentration and minimal 
product volume
Option 13: Tank Outlet 
Level Switch 
Allows to stop the feed 
pump when air reaches this 
sensor. E.g: In Mini loop 
concentration mode, detects 
the end of the step (tank 
fully empty).
Option 12: Tank  
NovAseptic® GMP mixer
Ensures product  
homogeneity, specially  
important during  
diafiltration step. Aseptic  
design, minimized shearing 
1
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3...and build a consistent user experience
Option 3: Transfer Pump 
Transfer of product / buffers 
into the feed tank from  
any other tank. Allows  
fed-batch mode, and  
diafiltration.Option 8: Filtrate pH 
pH monitoring during 
cleaning and sanitization 
procedures
Option 11: Filtrate UV 
In-process monitoring of 
protein content in filtrate 
during ultrafiltration
Options 16/17: Filtrate  
Mass / Magnetic flowmeter 
Filtrate flow and total 
volume monitoring in  
diafiltration mode
Options 14/15: 
Process Scale Holder  
Can be configured either 
with manual or hydraulic 
closure. Hydraulic closure 
can be done with a hand 
pump or with an automated 
hydraulic box. 
Options 4/5: Feed Magnetic 
/ Mass Flowmeter 
Feed flow monitoring
Option 6: Transfer Inlet 
Manifold 
Allows connecting several 
inlets to the transfer pump 
head (product/WFI/CIP) 
at the same time, avoiding 
many connections /  
disconnections
11
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4Total Process Control  
and Connectivity
The Cogent® Process Scale system is easily controlled  
via the Common Control Platform® (CCP®) software, a 
powerful, intuitive and graphical software that provides  
real-time monitoring and total in-depth control of  
your TFF process.
Using robust PCs, PLCs, and SCADA® technology, it  
meets the most stringent standards for connectivity,  
reliability and ease of use. 
NovAseptic® GMP mixer
Embedded NovAseptic® Valves, 
Mixer and Connectors
Engineered for optimal performance, reliability, durability 
and ease of maintenance. 
The design and development of each component is based 
on more than 20 years’ experience, focused on aseptic 
application. This is why we choose to call it ‘‘Aseptic by 
Design.” 
Benefits:
•  Create process operations using the recipe  
editor, monitor or control the process in the  
home screen, and create reports for the batch  
using the configurable report generator
•  Developed under GAMP guidelines and FDA 21  
CFR Part 11 compliance-ready, including audit  
trails and electronic signatures for verification
•  Sensor combinations can be adapted to process 
requirements allowing the maximum confidence 
in process monitoring
•  Utilities to connect all of your separation  
unit operations to a central network or  
DCS (e.g. Delta V)
•  Used on multiple unit operations CCP® software 
provides one familiar interface to simplify  
software management and reduce learning curves 
Benefits:
•  Comply with cGMP Design Qualification criteria  
for aseptic processing
•  NovAseptic® connector ensures no dead legs  
and maximum product recovery with zero hold  
up volume.
•  Comply with the most stringent cleaning and  
sterilization requirements
•  Mixer is clean running and is suitable for  
general mixing, heat transfer and shear  
sensitive applications.
•  Reduced bioburden
•  Lower cost of maintenance
•  Diamond coated mixer bearings ensure   
long life and optimum performance.
•  Ability to mix the “last drop”, ensures  
complete product recovery 
5Unparalleled Ultrafiltration
Plug and Play
The Pellicon® Process-scale Holder is uniquely designed 
to reduce the time required to install and remove  
TFF cassettes at production scale while keeping the  
flow path unchanged.
The holder can be configured with a manual or hydraulic 
closure. Hydraulic closure can be done with a hand pump 
or with an automated hydraulic box which allows local  
or distant control. 
Biomax® membrane
Pellicon® 3 cassettes with Biomax® membranes are  
designed for the filtration of therapeutic proteins, 
albumin, hormones, vaccines and growth factors. These 
advanced, high-performance cassettes are ideal for 
today’s processes that require higher operating pressures, 
temperatures and higher caustic cleaning regimes. 
Ultracel® membrane
Pellicon® 3 Cassettes with Ultracel® membrane are the 
device of choice for today’s higher titer therapeutic  
antibodies as well as the more demanding filtration  
processes that require low protein fouling. The new  
D screen is optimized for applications that require  
higher viscosity and concentration applications.
Benefits:
•  Compact footprint
•  TFF cassettes can be installed/removed quickly
•  Easy to vent and fully drainable, maximizes  
product recovery
•  Easy retrofit from manual to hydraulic closure
•  Flow path unchanged, minimizes future  
re-qualification and validation effort in  
new process applications 
Benefits:
•  Robust, void-free membranes for optimum  
product recovery and performance consistency 
•  All thermoplastic design, protective end cap and  
integrated gasket provides great process  
consistency and ease of use
•  Predictable and fast process scalability from lab  
to production scale
•  Robust product design ideally suited to filtration 
processes with higher operating pressures,  
temperatures and caustic cleaning regimes
•  Automated manufacturing delivers unbeatable  
performance consistency and reliability
•  Proven process expertise and technical support  
to partner with you from development to  
full scale manufacturing
•  Optimized flow path for higher flux and resolution 
separation capability
Air Integrity Test 
In order to ensure that the cassettes have been installed properly and has not sustained any damage during  
storage and handling, we recommend integrity testing prior to startup and after each post use cleaning.  
Air Integrity Test accessories consist of a set of air pressure regulators and fittings including assembly procedure  
to guarantee an easy plug and play solution.
Pellicon® 3 Ultrafiltration Cassettes 
The tangential flow filtration cassette of choice for demanding filtration processes requiring unbeatable performance 
consistency. For use in applications including: monoclonal antibodies, recombinant and non-recombinant proteins, 
albumin, hormones, vaccines, and growth factors. 
6Provantage® Bioprocess  
Consulting Services  
Provantage® Bioprocess Consulting Services leverage 
our core expertise, products, services and technology 
in downstream production to help solve your business 
problem or challenge. Our commitment to your project 
outcomes and timelines is managed with our stage gate 
approach and a dedicated project manager.  
Application Expertise
Our Biomanufacturing Sciences Network (BSN) is a global 
team of over 85 engineers, scientists and technology 
specialists who provide expertise and peer-to-peer  
support in process development and manufacturing. 
We act as an extension of your team, helping you to 
minimize potential risk and streamline your operations. 
With over 3,000 client engagements, our toolkit of best 
practices will ensure your project is delivered on time  
and within budget.  
Design and Implement
From lab-scale to pilot and manufacturing facility  
start-up, EMD Millipore is a partner of choice for  
providing consultative expertise on current best  
practices to integrate device, hardware and process 
technology, and process automation. We can provide 
consultative evaluations for TFF optimization and  
operating strategies. 
Develop
With our 35+ year history manufacturing and  
implementing TFF technologies, EMD Millipore  
application specialists develop reproducible,  
scalable and robust TFF processes that meet your  
specific requirements and your required scale. 
Optimize
Starting with a comprehensive technical assessment and 
characterization of your existing TFF step, EMD Millipore 
application specialists can recommend and implement 
TFF enhancements that use best-practice operating 
conditions and state of the art processes to deliver an 
optimized and validatable TFF process at your targeted 
scale, in a timely manner.  
Transfer
During the lifecycle of a biopharmaceutical, technical 
transfers occur at various stages: from research to  
clinical development to commercial manufacturing,  
and from one manufacturing facility to another.  
EMD Millipore leverages experienced technical staff, 
strong project management, and good documentation 
practices on both sides throughout the course of transfer 
activities to ensure a robust and successful transfer. 
Troubleshoot
EMD Millipore has extensive experience in troubleshoot-
ing and investigating manufacturing, method and 
process development issues. Our experienced team  
works together collectively with your technical project 
team to identify the root cause and to develop a robust, 
acceptable path forward.
High
Performance
Products
Applications and 
Best in Class
Integration
Knowledge
Global
Facilities and
Resources 
Optimize
Troubleshoot
SupplyDevelop
TransferDesign
7Provantage® implementation  
services
In the biopharmaceutical industry, implementing new  
equipment with respect to Quality rules and guidelines  
can be challenging. To help you stay ahead in today’s  
demanding and competitive production environment,  
SAT  and IQ/OQ Operator training CCP® Software Design CCP® Software Training Support for PQ
Qualification package GMP • • •
Single Molecule cGMP package • • • •
Full cGMP package • • • • •
our Provantage® Services group provides unparalleled  
support for implementation of the Cogent® Process  
Scale System. With a wide range of comprehensive  
packages to meet your unique manufacturing  
requirements, resulting in peace of mind and  
maximum operational flexibility. 
Provantage® Lab Services  
Establishing an effective cleaning and sanitization plan 
for equipment used is a fundamental cGMP requirement 
necessary to assure the quality and consistency of your 
drug substance. Effective and consistent membrane 
cleaning and sanitization after each process cycle is  
the single most important factor in maintaining  
system performance.
Cleaning and sanitization after every cycle removes 
residual foulants and contaminants from the membrane, 
preventing batch-to-batch carry over, maintaining 
optimal performance and maximizing the useful life of 
the filter cassettes.
Effectiveness is measured by the ability to control and 
eliminate microbial contamination, and to remove  
process foulants to restore membrane performance  
such that consistent flux and separation are achieved 
batch after batch.
Our Provantage® TFF Cleaning Services can help you 
develop cleaning and sanitization procedures that  
assure the safety and purity of your product and  
maximize the useful life of your TFF cassettes.
Multiple Process
& Cleaning Cycles
Look for Consistent &
Reproducible Results
Analyze Trends for
Corrective Action
? Process Flux
? Pressure Profiles
? Retention
? Product Yield
? Cleaning 
? Chemical Usage
? Cycle Times
? Pressure Profiles
TOC Residuals in
Permeate and
Retentate Flush Water
Reproducible NWP 
within 20% of 
Pre-Process NWP
Process Run to
Concentrate Protein
Cleaning
Regime
Critical
Flush
NWP
Measurement
Benefits:
•  Qualify your system with our IQ/OQ service  
protocols and use our qualified Field Service  
Engineers with years of product experience to  
ensure your system functions as specified in  
cGMP environments
•  Train your operators with an interactive,  
hands-on courses for either system operation,  
or advanced CCP® software recipe creation  
training by certified trainers
•  Get the support of our experienced  
Biomanufacturing Engineers during your  
Process Performance Qualification
•  Maintain your system with annual preventive  
maintenance by qualified Field Service Engineers 
to ensure the lifetime of the system and  
ultimately reduce your capital expenditures 
EMD Millipore, the M logo, Provantage, Biomax, Ultracel, Pellicon, Common Control 
Platform, CCP, Cogent, and the M mark are registered trademarks of Merck KGaA, 
Darmstadt, Germany.  NovAseptic is a registered trademark of Millipore AB.  
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©2015 EMD Millipore Corporation, Billerica, MA 01821 U.S.A. All rights reserved.
www.emdmillipore.com/offices
To place an order or receive
technical assistance
In the U.S. and Canada, call toll-free 1-800-645-5476
For other countries across Europe and the world, 
please visit: www.emdmillipore.com/offices
For Technical Service, please visit: 
www.emdmillipore.com/techservice
Typical Applications
Concentration, desalting or buffer
exchange of:
• Protein solutions
• Polysaccharide solutions
• Virus suspensions
Harvest, washing or clarification of:
• Cell cultures and lysates
• Colloidal suspensions
• Viral cultures
Superior TFF Performance
For research, process development,
scale-up and production, Pellicon 2
filters and holders offer the following
benefits:
Consistent High Flux and High
Product Recovery
Millipore’s Biomax® polyethersulfone
and Ultracel® PLC-composite regen-
erated cellulose membranes have 
void-free structures that guard against
leakage of solutes through microdefects
normally associated with voids
beneath the thin skins of conventional
UF membranes (Figures1and 2).
These void-free membranes are
more permeable, resulting in high-flux
with equivalent or superior product
retention (Figure 3). These void-free
membranes provide the advantages 
of fast, high yield processing and
smaller systems.
The long established Durapore®
hydrophilic PVDF microfiltration mem-
brane is well known for its exceptional
combination of high flux, low protein
binding and high product recoveries.
Pellicon 2 Filters 
and Holders
High-performance tangential flow filters 
for biopharmaceutical process development,
scale-up/scale-down and concentration/
purification/cell harvesting applications
®
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! Leading-edge void-free
membranes to match virtually
any separation challenge
! Short flow path for higher
flux and higher resolution
separation capability 
! Choice of flow channel
configuration providing
process optimization
capability
! Predictable, fast, scale-up
! True linear scalability from
laboratory size modules to
industrial assemblies for
processing thousands of liters 
Figure 1. Void-free Biomax 10 modified
polyethersulfone membrane
Figure 2. Conventional 10 kD polyether-
sulfone membrane with sub-surface voids
2Easy, Reliable Linear Scale-Up from
the Lab to the Production Plant 
Pellicon 2 Mini filters scale-up easily
and reliably from the laboratory to the
production plant (Figures 4 and 5).
By ensuring every flow channel has
the same length, height and turbulence
promoter as well as flow direction and
materials of construction, we maintain
the same ultrafilter/microfilter perfor-
mance at all scales. Thus, rapid and
reliable translation of processes from
lab to manufacturing scale is easily
achieved. 
Linear Scale-Up
Mini filters (0.1 m2/1.1 ft2) and holders
are designed for laboratory ultrafiltra-
tion/microfiltration of 100 mL to10 L
volumes, yet scale up linearly to
Pellicon 2 Cassette (0.5 m2/5.4 ft2)
and Maxi (2.5 m2/26.9 ft2) filters
used in the pilot or manufacturing
plant to process volumes from one liter
to thousands of liters.
Thus, whether you operate 0.1 m2
or 100 m2 of installed area, every
Pellicon 2 filter operates with the same
pressure drop, flow velocity and con-
centration profile for true, rapid and
simple linear scale-up.
Pellicon 2 Filters Proof of Performance
1.7 2.7 4.5 7.4 12.2 20.1 33.1
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
90.00
100.00
BSA Concentration in %
Fl
ux
 - 
L/
m
2 h
Conventional cassette
with 10kD modified
polyethersulfone membrane
Pellicon 2 cassette with
Biomax-10 membrane
and type “A” screen
Improved Flux
Feed pressure: 5.6 bar/80 psi
Retentate pressure: 2.1 bar/30 psi
Temperature: 10 – 13.5 °C
Initial volume 28 L
Final volume: 2 L
Conclusion
Pellicon 2 filters with Biomax membranes provide up
to two-times the process flux of conventional
cassettes resulting in faster processing and smaller
systems.
Figure 3. Flux versus BSA concentration
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Figure 4. Feed to retentate pressure drop
versus average crossflow on a10% BSA
solution
Linear Scalability
Temperature: 8 °C
Feed to retentate pressure drop: 2.8 bar/40 psi
Conclusion
(Figures 4 and 5) Pellicon 2 family of cassette filters
scale linearly from 0.1 to 0.5 to 2.5 m2 (1.1 to 5.4
to 26.9 ft2) sizes for rapid, accurate and safe
process scale-up and transfer.
Figure 5. Flux versus average transmem-
brane pressure on a 10% BSA solution.
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Conclusion
The void-free structure of Biomax membranes is
demonstrated by low, linear air diffusion values. This
performance ensures better process reliability and
safety and better product retention for higher yields.
Figure 6. Integrity test comparison-air flow
through wetted cassettes
Greater Process Reliability and
Reproducibility
The combination of defect-free 
membranes with Millipore’s highly 
reliable manufacturing processes,
offers greater consistency of process
parameters.
The high quality of Millipore’s 
ultrafiltration membranes is further
ensured by our pioneering multiple-
solute mixed-dextran retention profile
test. Unlike the single solute protein
retention test, Millipore’s retention 
profile test measures and ensures
reproducible retention performance 
of our UF membranes over the entire
range of molecular weights retained
by the membrane, not ¡ust at one or
two molecular weights.
Low Product Loss
Pellicon 2 filters have a low minimum
working volume – as low as 175 mL
of retentate volume per square meter 
of membrane area. This low retentate
volume permits high concentration 
factors to be reached with low starting
volumes and maximizes the recovery
of small sample volumes.
To prevent product loss, Pellicon 2 
filters are 100% tested in manufacturing
to ensure that every filter is integral.
In addition, Biomax and Ultracel
membranes are exposed to a new
high-pressure integrity test that provides
greater sensitivity. The integrity test
procedure and specifications are 
supplied so users can confirm integrity
at high pressure when the filter is
installed (Figure 6). 
Biocompatibility
All wetted parts have been tested and
meet the requirements of the USP
Class VI biological test for plastics.
Superior Filter Quality
Pellicon cassettes are subjected to a
complete array of quality control
release tests.
A Certificate of Quality is included
with every cassette.
Each casette is identified with a
unique serial number.
Validatable
Since 1973, Pellicon filters and 
systems have been successfully used
for development and scale-up of
processes for manufacturing injectable
protein and polysaccharide drugs, in
the serum fractionation, biotechnology,
vaccine and pharmaceutical 
industries.
Pellicon 2 filters and systems were
developed based upon Millipore’s
experience serving these applications,
and are supported by an extensive
Validation Support Data Package
proving performance claims and
demonstrating the suitability of these
filters for drug manufacturing in 
validated processes. This package is
available upon request.
Millipore can further assist your 
validation efforts through:
• Design and fabrication of standard
and custom turnkey TFF systems for
drug manufacturing facilities
• Installation and operational
qualification services for these
systems
• Validation support services for
tangential flow filter use in drug
manufacturing processes.
• Training on TFF process scale-up,
optimization and development.
4A Choice of Feed Channel Screens
For optimal performance in a range 
of applications Pellicon 2 filters
incorporate three types of 
feed-channel screens:
• Type A screen (tight screen) is
optimized to operate Biomax
membranes with maximum flux with
low-viscosity solutions.
• Type C screen (coarse screen) is
optimized to operate PLC series
membranes with maximum flux. 
The Type C screen is also
available with Biomax-50,100,
300, 500 and Biomax 1000
membranes for concentration and
diafiltration of viscous solutions.
• Type V screen (open channel) is
optimized for very viscous solutions
or solutions with higher levels of
suspended solids.
Normalized Recirculation Rates
Parameter Unit Typical ∆P
Screen Type A         C         V
Recirculation Rate L/min/m2 4/6      5/35
Differential Pressure bar/psi 1.4/20 0.4/6
Screen Selection Guidelines
Solution Type Screen Type
Dilute protein solution or low viscosity solutions A screen  
(MAbs, interferons) (tight screen)
Concentrated protein solutions or high viscosity solutions C screen 
(IgG, biopolymers) (course screen)
High viscosity solutions (polysaccharides, V screen
certain microfiltration or clarification applications) (loose screen)
For More Detailed Information
Request literature number P17512 –
User Guide for Pellicon Filters.
Specifications
Temperature Range
Mini, Cassette and Maxi: 
4 to 50 °C
Maximum Forward Transmembrane Pressure
Device Size (m2) Biomax Ultracel
0.1 6.8 bar (100 psi) Max 6.8 bar (100 psi) Max
0.5 6.8 bar (100 psi) at 30 °C 3.4 bar (50 psi) at 30 °C
2.5 6.8 bar (100 psi) at 30 °C 3.4 bar (50 psi) at 30 °C
Maximum Reverse Transmembrane Pressure
Device Size (m2) Biomax Ultracel
0.1 0.33 bar (5 psi) 0.33 bar (5 psi)
0.5 0.33 bar (5 psi) 0.33 bar (5 psi)
2.5 0.33 bar (5 psi) 0.33 bar (5 psi)
Prefiltration Required
Mini, Cassette and Maxi:
100 µm
Dimensions
Device Width Length Thickness
Mini 5.6 cm 21 cm 1.5 cm (V screen-2.16 cm)
Cassette 17.8 cm 21 cm 1.5 cm (V screen-2.16 cm)
Maxi 17.8 cm 21 cm 7.6 cm (V screen-9.0 cm)
 
5Membrane Selection Guideline
Membrane Type Materials Benefits
Biomax Modified polyethersulfone Highest flux ultrafiltration membrane
Excellent chemical resistance
Void-free structure for higher yield and reliability
Ultracel PLC Regenerated cellulose Extremely low protein binding hydrophilic membrane
(ideal for protein solutions <20 g/L)
PLC membranes are composite Highest product recovery and improved performance
membranes cast on a microporous with difficult to process streams (antifoams, lipids,
substrate for defect-free membranes protein transmission applications)
with superior adhesion.
Brings higher resolution, improved
yields and superior back-pressure
resistance
Durapore Hydrophilic PVDF Very hydrophilic microporous membrane for cell 
harvest or clarification applications
Pellicon 2 Membrane Selection Chart
Approximate Molecular Weight Membrane NMWL (kD) Membrane pH
(range of solutes retained >99%, kD) or Microns Material Range
High Flux Biomax Membranes – Void-free for Higher Yield and Reliability
12 – 25 (growth factors, hormones) Biomax-5 5 modified polyethersulfone 1 – 14
25 – 50 (growth factors, hormones) Biomax-8 8 modified polyethersulfone 1 – 14
50 –100 (albumin, hemoglobin) Biomax-10 10 modified polyethersulfone 1 – 14
100 –140 (enzymes) Biomax-30 30 modified polyethersulfone 1 – 14
140 – 300 (IgG’s) Biomax-50 50 modified polyethersulfone 1 – 14
300 – 500 (small viruses and antigens) Biomax-100 100 modified polyethersulfone 1 – 14
>500 (IgM’s, large viruses) Biomax-300 300 modified polyethersulfone 1 – 14
>0.03 µm (large viruses, colloids, particulates) Biomax-500 500 modified polyethersulfone 1 – 14
>0.03 µm (large viruses, cells, colloids, particulates) Biomax-1000 1000 modified polyethersulfone 1 – 14
Ultracel PLC Series – for High Recoveries
8 –18 (proinsulin, hematopoetic factors) PLCCC 5 regenerated cellulose 2 – 13
18 – 60 (hemoglobin, enzymes) PLCGC 10 regenerated cellulose 2 – 13
60 – 200 (monoclonal IgG’s) PLCTK 30 regenerated cellulose 2 – 13
200 – 500 (small viruses, viral antigens) PLCHK 100 regenerated cellulose 2 – 13
>500 (large viruses, IgM’s) PLCMK 300 regenerated cellulose 2 – 13
>0.03 µm (large viruses, cells, colloids, particulates) PLCXK 1000 regenerated cellulose 2 – 13
Durapore Membranes – for Microporous Applications
Clarify cell lysates and protein solutions, VVPP 0.1 µm hydrophilic PVDF 2 – 11
clarify viral cultures
Harvest & wash colloidal suspensions, bacterial cells; GVPP 0.22 µm hydrophilic PVDF 2 – 11
clarify protein solutions and viral cultures
Harvest & wash colloidal suspensions, cell & viral HVMP 0.45 µm hydrophilic PVDF 2 – 11
cultures, clarify protein solutions & viral cultures
Harvest cell cultures or colloidal suspensions DVPP 0.65 µm hydrophilic PVDF 2 – 11
 
Ordering Information
Pellicon 2 Filters
Filters with A Screens (Tight Screen) Filters with Type C Screens (Coarse Screen)
Membrane 0.1 m2/1.1 ft2 0.5 m2/5.4 ft2 2.5 m2/26.9 ft2 0.1 m2/1.1 ft2 0.5 m2/5.4 ft2 2.5 m2/26.9 ft2
Biomax Series – Modified Polyethersulfone
Biomax 5 P2B0 05A 01 P2B0 05A 05 P2B0 05A 25 + + +
Biomax 8 P2B0 08A 01 P2B0 08A 05 P2B0 08A 25 + + +
Biomax 10 P2B0 10A 01 P2B0 10A 05 P2B0 10A 25 + + +
Biomax 30 P2B0 30A 01 P2B0 30A 05 P2B0 30A 25 + + +
Biomax 50 P2B0 50A 01 P2B0 50A 05 P2B0 50A 25 P2B0 50C 01 P2B0 50C 05 P2B0 50C 25
Biomax 100 P2B1 00A 01 P2B1 00A 05 P2B1 00A 25 P2B1 00C 01 P2B1 00C 05 P2B1 00C 25
Biomax 300 + + + P2B3 00C 01 P2B3 00C 05 P2B3 00C 25
Biomax 500 + + + P2B5 00C 01 P2B5 00C 05 P2B5 00C 25
Biomax 1000 + + + P2B0 1MC 01 P2B0 1MC 05 P2B0 1MC 25
Ultracel PLC Series – Regenerated Cellulose, Composite Construction
5 kD NA NA NA P2C0 05C 01 P2C0 05C 05 P2C0 05C 25
10 kD NA NA NA P2C0 10C 01 P2C0 10C 05 P2C0 10C 25
30 kD NA NA NA P2C0 30C 01 P2C0 30C 05 P2C0 30C 25
100 kD NA NA NA P2C1 00C 01 P2C1 00C 05 P2C1 00C 25
300 kD NA NA NA P2C3 00C 01 P2C3 00C 05 P2C3 00C 25
1000 kD NA NA NA P2C0 1MC 01 P2C0 1MC 05 P2C0 1MC 25
Durapore – Hydrophilic PVDF
0.1 µm + + + P2VV PPC 01 P2VV PPC 05 P2VV PPC 25
0.22 µm + + + P2GV PPC 01 P2GV PPC 05 P2GV PPC 25
0.45 µm + + + P2HV MPC 01 P2HV MPC 05 P2HV MPC 25
0.65 µm + + + P2DV PPC 01 P2DV PPC 05 P2DV PPC 25
6
Each Pellicon filter is packed one per box and includes Operating Instructions. A Certificate of Quality is included in every box. 
Silicone intercassette gaskets are required for use with Pellicon 2 filters. Two gaskets are packed in the box with every Pellicon 2 filter.
+     = On request (custom order)
NA  = not available
Filters with V Screens (Loose Screen)
0.1 m2/1.1 ft2 0.5 m2/5.4 ft2 2.0 m2/21.5 ft2
P2B0 05V 01 P2B0 05V 05 P2B0 05V 20
P2B0 08V 01 P2B0 08V 05 P2B0 08V 20
P2B0 10V 01 P2B0 10V 05 P2B0 10V 20
P2B0 30V 01 P2B0 30V 05 P2B0 30V 20
P2B0 50V 01 P2B0 50V 05 P2B0 50V 20
P2B 100V 01 P2B1 00V 05 P2B1 00V 20
P2B3 00V 01 P2B3 00V 05 P2B3 00V 20
P2B5 00V 01 P2B5 00V 05 P2B5 00V 20
P2B0 1MV 01 P2B0 1MV 05 P2B0 1MV 20
P2C0 05V 01 P2C005V 05 P2C0 05V 20
P2C0 10V 01 P2C0 10V 05 P2C0 10V 20
P2C0 30V 01 P2C0 30V 05 P2C0 30V 20
P2C1 00V 01 P2C1 00V 05 P2C1 00V 20
P2C3 00V 01 P2C3 00V 05 P2C3 00V 20
P2C0 1MV 01 P2C0 1MV 05 P2C01MV 20
P2VV PPV 01 P2VV PPV 05 P2VV PPV 20
P2GV PPV 01 P2GV PPV 05 P2GV PPV 20
P2HV MPV 01 P2HV MPV 05 P2HV MPV 20
P2DV PPV 01 P2DV PPV 05 P2DV PPV 20
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Pellicon 2 Mini Holder
Pellicon 2 Mini holder operates one to
three Mini filters in parallel for total
areas of 0.1 to 0.3 m2 (1.1 – 3.3 ft2).
This sanitary holder is tightened with a
small torque wrench to compress the
filters between a manifold plate that
conveys fluids in and out of the filters
and an end plate that seals the filters
together. The Mini holder is designed
for process development and small
volume pharmaceutical manufacturing.
Materials of Construction
Manifold and End Plates:
316 L stainless steel
Base, Tie Rods, Spacers and Washers:
304 stainless steel
Feet:
Thermoplastic rubber
Gaskets:
Silicone
Nuts:
Silicone bronze
Separator Plates
An optional separator plate allows
processing simultaneously with up to
three 0.1 m2/1.1 ft2 cassettes to 
determine the best molecular weight
cut-off in a single study on the same
feed material.
Connections
All manifold connections are standard
∞-inch sanitary clamp type.
Operating Parameters
Temperature Range:
4 to 50 °C. The Mini holder can 
be autoclaved without filters 
installed. The filters themselves
cannot be autoclaved.
Maximum Pressure: 
6.8 bar
Dimensions
Height: 260 mm; Width: 114 mm
Length: 140 mm; Weight: 5 kg
Holder Manifold Volume:
Feed plus retentate: 5.3 mL 
Permeate:              6.4 mL
To Place an Order or Receive
Technical Assistance
For additional information call your
nearest Millipore office:
In the U.S. and Canada, 
call toll-free 1-800-MILLIPORE 
(1-800-645-5476)
In the U.S., Canada and Puerto Rico,
fax orders to 1-800-MILLIFX
(1-800-645-5439)
Outside of North America contact your
local office. To find the office nearest
you visit www.millipore.com/offices.
Internet: www.millipore.com
Technical Service:
www.millipore.com/techservice
Â
Stainless Steel Pellicon Holder
XX42P0080
The stainless steel Pellicon filter holder,
designed for sanitary applications, can
be used alone or to expand existing
cassette ultrafiltration (CUF) systems or
to replace existing holders.
It requires only to be connected to
an existing sanitary pump and piping
for tangential flow microporous filtration
or ultrafiltration. 
It can accomodate up to 5 m2/55 ft2
filter area as shipped with long tie
rods or 0.5 to 2.5 m2 (5.4 – 26.9 ft2)
with accessory short tie rods.
Materials of Construction
Wetted Surfaces:
316 L stainless steel  
Non-wetted Surfaces:
Silicon bronze nuts
Dimensions
Length: 28 cm; Width:19 cm
Height: 25 cm
Operating Parameters
Operating Temperature Range:
4 to 50 °C. The Pellicon holder can 
be autoclaved without pressure 
gauges and filters; holder with 
gauges cannot be steamed. 
Pellicon filters cannot be steamed 
or autoclaved.
Connections
Sanitary º" TC connections; 
1∞" TC connections for gauges.
Shipping Weight
24 kg
Process-scale Pellicon Holder
The Pellicon Process-scale Holder is a
unique innovation for production scale
Pellicon systems. This holder, vertically
mounted, can hold up to 80 m2/880 ft2
of membrane area.
Benefits
• Extremely compact footprint
• Easy to change cassettes
• Easy to vent and fully drain
• Simple connections
• Up to 4 levels. Can be easily
extended in levels for simple
membrane area expansion
• Each level up to 20 m2/220 ft2
• Uses standard and Maxi Cassettes
• Can be adapted for series or
parallel configurations
• Simplifies pipework connection
• Hydraulic closure systems are
available for the stainless-steel
Pellicon holder and the 
process-scale Pellicon holder. These
systems are convenient, reliable and
easy to use to enable rapid and
repeatable loading operation and
storage of Pellicon 2 cassettes.
Materials of Construction
Manifold segment, fitting blocks and
end plate 316 L stainless steel; tie
rods 304 and 304 L stainless steel.
Ordering Information
Pellicon 2 Filter Holders
Description Catalogue No.
Pellicon 2 Mini filter holder XX42 PMI NI
Pressure gauges XX42 PSG 01L
One diaphragm-protected digital pressure gauge,
0 – 7 bar, º-inch fittings
Pressure gauge adapters XX42 PM0 01
Fitting kit XX42 PFK 01
Contains all tees, clamps, gaskets and a valve to connect 
tubing and pressure gauges to the Pellicon 2 Mini holder
Pellicon filter holder (for cassettes and Maxi filters) XX42 P00 80
Pellicon 2 double thick gasket PSSP 2XC10
Pellicon Process-scale holder support and plate XX42 SSP LT
Pellicon Process-scale holder On request
A Typical Pellicon Production
Processing System
Millipore supplies a range of standard
and custom engineered systems. These
systems can contain from 1 m2/11 ft2 to
several hunded m2 of membrane area,
with Clean-in-Place (CIP) or Steam-in-
Place (SIP) integrated as appropriate.
Systems can also be supplied with
integrated process vessels in manual
or fully automatic versions.
All systems are designed, 
engineered and manufactured in 
ISO® 9001 registered facilities, and
are supplied with extensive validation
data support packages.
Please contact us to discuss your
specific application and process
requirements.
Pellicon XL Devices for Process
Development
For process development of volumes
from 50 mL to 1 liter, Millipore offers
Pellicon XL devices. This small volume
TFF filter is designed for true scalability
by providing the same flow path,
channel length, and channel height as
the Pellicon 2 cassettes. Based on
proven TFF membrane technology,
Pellicon XL devices ensure reliable,
consistent and predictable 
performance.
Millipore, Biomax, Durapore, Pellicon and Ultracel are
registered trademarks of Millipore Corporation.
ISO is a registered trademark of the International
Organization of Standardization.
Lit. No. DS1210EN00   Rev. A  10/04   
Printed in U.S.A.   04-324 
Copyright 2003, 2004 Millipore Corporation
Billerica, MA 01821 U.S.A. All rights reserved.
 
Data file 11-0025-76 AG Ion exchange chromatography
Capto™ S, Capto Q, and Capto DEAE
Fig 1. Pressure/flow curve for Capto S compared to Q Sepharose™ Fast Flow. 
Running conditions: AxiChrom™ 1000 for Capto S, Chromaflow™ 1000 for 
Q Sepharose Fast Flow, 20 cm packed bed, with water at 20ºC. The pressure 
includes pressure drop from the bed and the column. System/tubing pressure 
is excluded.
Capto S, Capto Q and Capto DEAE are, respectively, strong cation, 
strong anion and weak anion exchange media for packed 
bed chromatography that increase speed and throughput 
in capture and intermediate purification. They combine high 
capacity with high flow velocity and low backpressure to 
reduce process cycle times and increase productivity. As 
BioProcess™ media, the Capto range meets the demands of 
large-scale biopharmaceutical manufacturers by:
• Raising productivity with high dynamic binding capacity  
at high flow
• Reducing process time with high volume throughput
• Cost-effective processing with smaller unit operations
Chromatography media characteristics
High throughput in downstream purification requires separation 
media that combine mechanical strength of the matrix with 
a pore structure that allows fast mass transfer and high 
capacity for target molecules. Capto media are based on 
a highly rigid agarose base matrix that offers outstanding 
pressure/flow properties, optimized pore structure, and very 
high chemical stability to support CIP procedures. Capto 
media are intended for general use in large-scale bioprocess 
operations. The basic characteristics of Capto S, Capto Q, and 
Capto DEAE are summarized in Table 1.
High flow and low backpressure in  
large-scale columns
High flow velocities allow increased productivity of large-scale 
bioprocessing operations and processing of larger volumes 
in one working shift. Shorter cycle times also reduce exposure 
of the target protein to proteases. Typical flow velocities for 
Capto media in a 1 m diameter column with 20 cm bed height 
are over 700 cm/h, with a backpressure below 3 bar. 
Figure 1 compares the pressure/flow performance of Capto 
with Sepharose 6 Fast Flow in a representative large-scale  
situation with a 1 m column that gives negligible wall support. 
imagination at work
Although the bead and pore sizes are similar between 
the two matrices, the pressure/flow properties of Capto 
are significantly better. This is a result of the exceptional 
mechanical stability of the Capto base matrix.
Anion and cation exchangers with  
fast mass transfer and high dynamic 
binding capacities
For ion exchange, Capto S uses a sulfonate group, Capto Q 
uses a quartenary amine group and Capto DEAE uses a 
diethylaminoethyl group. The groups are linked to a high flow  
agarose base matrix modified with a dextran surface extender 
which further increases capacities and mass transfer 
properties. Fast mass transfer ensures high dynamic binding 
capacity over a wide range of residence times. High binding 
capacity also contributes to shortening the overall processing 
time as the total number of cycles may be reduced. The 
dynamic binding capacities of Capto S, Capto Q and Capto 
DEAE at different residence times are shown in Figure 2.
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Fig 2. Dynamic binding capacity as a function of residence time for: A) Capto Q and bovine serum albumin (BSA), B) Capto S and α-chymotrypsin, 
C) Capto DEAE and amyloglucosidase. For Sepharose Fast Flow media, residence times below 2 min are not possible in large-scale columns.
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1
  d50v is the median particle size of the cumulative volume distribution.
2  Dynamic binding capacity at 10% breakthrough as measured at a residence time of 1 min, 600 cm/h in a Tricorn™ 5/100 column with 10 cm bed height, in a 30 mM sodium phosphate buffer, pH 6.8.
3 Dynamic binding capacity at 10% breakthrough as measured at a residence time of 1 minute, 600 cm/h in a Tricorn 5/100 column with 10 cm bed height in a 50 mM Tris-HCl buffer, pH 8.0.
4  Short term pH: pH interval that the medium can be subjected to, for cleaning- or sanitization-in-place (accumulated 90–300 h at room temperature) without significant change in function.
 Working pH: pH interval where the medium binds protein as intended or is needed for elution, without adverse long-term effect.
 Long term pH: pH interval where the medium can be operated without significant change in function.
5  Low temperatures can decrease capacity of Capto S and Capto DEAE.
6 No significant change in ionic capacity and carbon content after 1 week storage in 1 M NaOH at 40°C.
Table 1. Characteristics of Capto S, Capto Q, and Capto DEAE
 Capto S Capto Q Capto DEAE
Matrix highly cross-linked agarose with dextran surface extender 
Ion exchange type strong cation, S strong anion, Q weak anion, DEAE
Charged group -SO3
- -N+(CH3)3 -N+H(CH2CH3)2
Total ionic capacity 0.11 to 0.14 mmol Na+/mL medium 0.16 to 0.22 mmol Cl-/mL medium  0.29 to 0.35 mmol Cl-/mL medium
Particle size1 90 µm (d50v) 90 µm (d50v) 90 µm (d50v)
Flow velocity  at least 700 cm/h in a 1 m diameter column with 20 cm bed height at 20 °C using process buffers with the 
same viscosity as water at < 3 bar (0.3 MPa)
Dynamic binding capacity > 120 mg lysozyme/mL medium2 > 100 mg BSA/mL medium3 > 90 mg ovalbumin/mL medium3
pH stability4
short term 3 to 14 2 to 14 2 to 14 
working 4 to 12 2 to 12 2 to 9 
long term 4 to 12 2 to 12 2 to 12
Working temperature5 4°C to 30°C 4°C to 30°C 4°C to 30°C
Chemical stability  all commonly used aqueous buffers, 1 M acetic acid, 1 M NaOH6, 8 M urea, 6 M guanidine hydrochloride, 
30% isopropanol and 70% ethanol
Storage 20% ethanol + 0.2 M NaAc  20% ethanol 20% ethanol
Avoid oxidizing agents, oxidizing agents,  oxidizing agents,  
 cationic detergents anionic detergents anionic detergents
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Fig 3. The highly rigid Capto base matrix allows a much larger window of 
operation (area below the curves) at large-scale than Sepharose 6 Fast 
Flow. This is particularly true at bed heights of 20-30 cm and above. Data 
correspond to a 1 m diameter column, at 20oC and viscosity of water. Red and 
blue curves correspond to pressure limits of 1.3 and 3 bar, respectively. Green 
contours give the residence time in the column in minutes.  
Fig 4. The separation ability of Capto Q for GFP compared to Q Sepharose 
Fast Flow and Q Sepharose XL media in 1 ml prepacked HiTrap columns.
0 5 10 15 20 25 30  35   
A280
A490
Capto Q
Q Sepharose XL
Q Sepharose Fast Flow
Columns: HiTrap™ Capto Q, 1 mL
Columns:
 
HiTrap™ Capto Q, 1 mL
HiTrap Q XL, 1 mL
HiTrap Q FF, 1 mL 
Sample: GFP in E. coli homogenate
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A large window of operation also allows flexibility even if the 
viscosity of the feed is high. Doubling viscosity halves the 
operational velocity. For a feedstock with a viscosity of 2 cP 
at a bed height of 30 cm, the flow velocity of Capto is 235 cm/h 
compared to 80 cm/h for Sepharose 6 Fast Flow.
Figure 3 also shows contours of the residence time in the 
column. A long residence time allows for better utilization of the  
full equilibrium capacity. It is possible to increase the residence 
time by either decreasing the flow velocity, or increasing the 
column bed height. For Capto, increasing bed heights assures 
longer residence times even under high flow conditions.
Selectivity
The charged groups of the S, Q and DEAE ligands used in 
Capto media are identical to the charged groups used in  
many other ion exchange media. However, minor differences 
in selectivity can occur between media having the same 
ligand as illustrated in Figures 4 and 5. This is due to differences 
in base matrix, ligand density and surface extenders.
Rigid media for cost-effective purification
The rigidity of Capto products allows improved process 
economics. Capto media characteristics allow a wider working 
range of flow velocities, bed heights and sample viscosities, 
all of which affect processing costs in a positive way. High 
flow velocities increase volume throughput and reduce 
process time, longer bed heights means smaller equipment 
and reduced footprint, and high flow processing of viscous 
samples means less dilution and shorter cycle times.
The available degree of freedom in process design for a medium 
can be illustrated as its “window of operation”. Figure 3 shows 
schematically the ranges for key operating variables for 
Capto IEX and Sepharose 6 Fast Flow. Given a maximum allowed 
pressure, it predicts the allowable combinations of column 
bed heights and operating velocities. The pressure limits, 
shown as blue and red curves, are based on a 1 m diameter 
column and calculated from 20 cm bed height and maximum 
operating velocities of 700 and 250 cm/h, respectively. At 
this point, the pressure is 3 bar for Capto and 1.3 bar for 
Sepharose 6 Fast Flow. For Sepharose 6 Fast Flow, 1.3 bar 
represents the highest recommended operating pressure 
for this medium at this scale. For Capto, 3 bar corresponds 
to the maximum pressure for many low-pressure systems; 
the medium as such can normally be run to the maximum 
pressure rating of low and medium pressure columns.
The size of the area below the pressure limit curves represents 
the window of operation, or the available operating range 
for the respective medium. As shown in Figure 3, this is 
significantly larger for Capto than for Sepharose 6 Fast Flow 
based media, especially when bed heights increase to  
20-30 cm or more. At these bed heights, Capto can still be 
run at flow velocities of 300-400 cm/h or more. Thus, the high 
mechanical stability of Capto allows practical and  
cost-effective use of smaller diameter columns.
4       11-0025-76 AG
0 5 10 15 20 25 30  mL
3500
2500
1500
500
0
3500
2500
1500
500
0
3500
2500
1500
500
0
A280
Capto S
SP Sepharose Fast Flow
Columns: HiTrap Capto S, 1 mL
HiTrap SP XL, 1 mL
HiTrap SP FF, 1 mL
Sample: α-chymotrypsin in E. coli homogenate
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Flow: 1 mL/min (156 cm/h)
Gradient: 0% to 100% elution buffer, 10 CV
System: ÄKTAexplorer 100
SP Sepharose XL
Fig 5. The separation ability of Capto S for α-chymotrypsin compared to 
SP Sepharose Fast Flow and SP Sepharose XL media in 1 mL prepacked 
HiTrap columns.
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Fig 6. Titration curve of Capto DEAE.
Fig 7. The selectivity difference between Capto Q and Capto DEAE at pH 6 
exemplified by separation of a mixture containing three proteins and some 
breakdown products.
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Elution buffer: 20 mM piperazine, 1 M NaCl,  pH 6.0
Flow rate:  150 cm/h
Gradient:  0% to 80% elution buffer, 32 CV
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Fig 8. Elution conductivity as a function of pH for a set of model proteins on A) 
Capto Q, where only the change in surface charge of the proteins influences the 
elution position B) Capto DEAE, where both the change in surface charge of the  
proteins and the changed charge of the ligand determine the elution behavior. 
Capto Q vs Capto DEAE
In addition to the difference in working pH range, the anion 
exchangers Capto Q and Capto DEAE also differ in selectivity.  
This difference, which is mainly pH dependent, is illustrated 
in Figures 7 and 8. Which product to chose depends on the 
individual application and what should be achieved during 
the separation. However the general recommendation is to 
start by evaluating the strong ion exchanger (Capto Q) since 
its function is less dependent on pH. 
Strong vs weak ion exchangers
Strong ion exchangers like Capto S and Capto Q maintain 
their charge (and thus their function) over a wide pH range 
whereas with weak ion exchangers the degree of dissociation 
and thus ion exchange capacity varies with pH. Capto DEAE, 
although predominantly a weak anion exchanger, can not be 
fully discharged by raising the pH due to a minor content of 
quaternarized amine groups (Fig 6). It is therefore, possible to 
use DEAE media at higher pH values for separations of highly 
charged species as nucleotides, for example.
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Applications
Recent developments in upstream processing have resulted 
in larger feed volumes and increased protein expression 
levels. The combination of high volume throughput and high 
capacity makes Capto media the optimal choice for processing 
large amounts of protein in a fast and efficient way. As ion 
exchangers, their behavior can be easily controlled and 
application areas predicted by buffer choice and pI of the 
target proteins. Note that to reach the full potential of media 
where the design includes dextran, close attention must be 
paid to pH, conductivity, and other loading conditions. If this is 
done, very high capacities can be reached. 
Note that the DEAE ligand has buffering properties. Therefore, 
a greater volume or concentration of equilibration buffer may 
be reqired for titration of the DEAE ligand in comparison to 
the non-titrateable Q ligand.
Improved productivity based on high flow features
Scale-up modelling and productivity calculations based on 
experimental data at small and pilot scale indicate that it is 
possible to capture and recover >100 kg of green fluorescent 
protein (GFP) from an Escherichia coli homogenate in 24 h 
using Capto Q in a 1.6 m i.d. column at 20 cm bed height 
(equivalent to 400 L of medium). Assuming the same process 
conditions, using Q Sepharose Fast Flow would require a 3 m 
i.d. column or 1400 L medium (in practice, this means three 
separate columns would be needed). This example supports 
the argument that Capto Q is being particularly suitable for 
high throughput and high productivity capture purification.  
For further details see Application note 11-0026-20.
Similar calculations indicate that it is possible to capture and 
recover >100 kg of α-chymotrypsin from E. coli homogenate 
in 24 hours with Capto S in a 0.8 m i.d. column at 20 cm bed 
height (equivalent to 100 L of medium). Assuming the same 
process cycle conditions, using SP Sepharose Fast Flow would 
require a 1.2 m i.d. column at 20 cm bed height (equivalent 
to 250 L medium). This example also indicates that Capto S 
is suitable for high throughput and high productivity capture 
purification. For further details see Application note 28-4078-15.
Process cycle times and productivity data for both examples 
are summarized in Table 3. Similar improvement in 
productivity is obtained with Capto DEAE compared to DEAE 
Sepharose Fast Flow.
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Fig 9. Screening for optimal binding conditions (pH, ionic strength and 
incubation time) for amyloglucosidase on Capto DEAE by batch uptake 
methodology using 96-well filter plates. Note that incubation time using 
this methodology is not equivalent to residence time in the column; typical 
residence times can be seen in Fig 2c.
Operation
Fast method development
In order to find the most suitable chromatography media 
and/or process conditions, screening and optimization 
should be performed. Time and sample can be saved in 
the early stages of development by using small-scale 
formats. PreDictor™ 96-well filter plates and Assist software 
may be used for initial screening of process conditions 
such as, pH and conductivity (Fig 9). ÄKTA™ avant – with 
Design of Experiment (DoE) functionality - or ÄKTAexplorer 
chromatography systems together with prepacked columns, 
such as HiScreen™ and HiTrap columns, can be used for 
further optimization and verification of the operating conditions. 
Target protein  Cycle time   Productivity Media volume for 
and medium (min) (kg/h, m3) 100 kg/24 h (L)
GFP  
Capto Q 91 11 400
Q Sepharose Fast Flow 190 3 1400
α-chymotrypsin   
Capto S 131 53 80
SP Sepharose Fast Flow 229 17 250
amyloglucosidase
Capto DEAE† 197 37 114
DEAE Sepharose Fast Flow† 306 12 353
† Productivity calculations based on pure protein
Table 3. Results from scale-up modelling and productivity calculations for 
Capto Q, Capto S, and Capto DEAE as described in the text
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Column: Tricorn 5/100 (bed height 9.7 cm, CV=1.9 mL)
Medium: Capto S
Sample: α-chymotrypsin in E. coli homogenate, 
 4 mg/mL–50 mL
Start buffer: 50 mM NaAc, pH 4.8
Elution buffer: 50 mM NaAc, 1 M NaCl, pH 4.8
Flow rate:  285 cm/h
Gradient: 0%–100% 0 CV, 100% 5 CV
System: ÄKTAexplorer 100
Residence time: 2 min
Column: XK 16/40 (bed height 20.7 cm, CV= 41.5 mL) 
Medium: Capto S
Sample: α-chymotrypsin in E. coli homogenate,
 4 mg/mL–1040 mL
Start buffer: 50 mM NaAc, pH 4.8
Elution buffer: 50 mM NaAc, 1 M NaCl, pH 4.8
Flow rate: 624 cm/h
Gradient: 0%–100% 0 CV, 100% 5 CV
System: ÄKTAexplorer 100
Residence time: 2 min
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C) Column: AxiChrom 50 (bed height 22 cm, CV= 431 mL)
Medium: Capto S
Sample: α-chymotrypsin in E. coli homogenate,
 4 mg/mL–10.8 L 
Start buffer:  50 mM NaAc, pH 4.8
Elution buffer: 50 mM NaAc, 1 M NaCl, pH 4.8
Flow rate: 645 cm/h
Gradient: 0%–100% 0 CV, 100% 5 CV
System: ÄKTApilot™
Residence time: 2 min
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Fig 10. A 200-fold scale up using (A) Tricorn 5/100, (B) XK 16/40 and, 
(C) AxiChrom columns.
UNICORN™ software on ÄKTA systems makes it simple to transfer 
the optimized method to a production scale process system. 
For more information about method development and 
optimization, consult the handbooks, “High-throughput process 
development with PreDictor plates“ and ”Ion Exchange 
Chromatography & Chromatofocusing: Principles and Methods”.
Fully scalable
Capto media belong to the BioProcess range of media 
that are developed and supported for production-scale 
chromatography. This includes validated manufacturing 
methods, secure supply and Regulatory Support Files (RSF) 
to assist process validation and submission to regulatory 
authorities.
Scale-up is typically done by keeping bed height and flow 
velocity constant, while increasing column bed diameter and 
flow rate. However, since optimization is preferentially done 
with small column volumes (to save sample and buffer), some 
parameters such as the dynamic binding capacity may be 
optimized using shorter bed heights than those being used in 
the final scale. As long as the residence time is constant, the 
binding capacity for the target molecule remains the same. 
Other factors, like clearance of critical impurities, may change 
when column bed height is changed and should be validated 
using the final bed height.
To utilize the full potential of Capto media, we recommend 
bed heights of 20 cm and higher at large scale. 
A scale-up experiment was conducted for Capto S (Fig 10) 
using an optimized process for α-chymotrypsin with a 
constant residence time of 2 min. From Tricorn 5/100 the bed 
height was doubled to 20 cm in a XK 16/40 column  
(CV 40 mL). From the XK 16/40 column further scale up was 
conducted on an AxiChrom™ 50 (CV 400 mL) by increasing 
bed diameter to give a 200-fold scale up. 
Cleaning and sanitization
Cleaning-in-place (CIP) is a cleaning procedure that removes 
contaminants such as lipids, precipitates, or denatured 
proteins that may remain in the packed column after 
regeneration. Regular CIP also prevents the build-up of these 
contaminants in the media bed and helps to maintain the 
capacity, flow properties and general performance of the media.
A specific CIP protocol should be designed for each process 
according to the type of contaminants present. The frequency 
of CIP depends of the nature and the condition of the starting 
material, but one CIP cycle is generally recommended every 
1 to 5 separation cycles. For some contaminants a more 
rigorous CIP procedure can be required for Capto DEAE than 
for Capto S and Capto Q, see instruction manual.
All Capto media withstand all standard CIP solutions (e.g.  
1 M NaOH, 2 M NaCl or 70% ethanol) or combinations thereof.
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Ordering information
All Capto media are available as bulk media and in 
several pre-packed formats, including PreDictor 96-well 
filter plates, PreDictor RoboColumn™, HiTrap, HiScreen, 
and ReadyToProcess columns. Please contact your local 
GE Healthcare representative for additional information.
Product Pack size Code no.  
Capto S 25 mL 17-5441-10
Capto S 100 mL 17-5441-01
Capto S 1 L 17-5441-03
Capto S 5 L 17-5441-04
Capto S 10 L 17-5441-05
Capto S 60 L 17-5441-60
Capto Q 25 mL 17-5316-10
Capto Q 100 mL 17-5316-02 
Capto Q 1 L 17-5316-03
Capto Q 5 L 17-5316-04
Capto Q 10 L 17-5316-05
Capto Q 60 L 17-5316-60
Capto DEAE 25 mL 17-5443-10
Capto DEAE 100 mL 17-5443-01
Capto DEAE 1 L 17-5443-03
Capto DEAE 5 L 17-5443-04
Capto DEAE 10 L 17-5443-05
Capto DEAE 60 L 17-5443-60
Prepacked formats
HiTrap Capto S 5 × 1 mL 17-5441-22
HiTrap Capto S 5 × 5 mL 17-5441-23
HiTrap Capto Q 5 × 1 mL 11-0013-02
HiTrap Capto Q 5 × 5 mL 11-0013-03
HiTrap Capto DEAE 5 × 1 mL 28-9165-37   
HiTrap Capto DEAE 5 × 5 mL 28-9165-40 
PreDictor AIEX screening, 20 µL 4 × 96-well filter plates 28-9432-89
PreDictor AIEX screening, 2 µL/6 µL 4 × 96-well filter plates 28-9432-88
PreDictor CIEX screening 20 µL 4 × 96-well filter plates 28-9432-91
PreDictor CIEX screening 2 µL/6 µL 4 × 96-well filter plates 28-9432-90
PreDictor Capto DEAE, 2 µL 4 × 96-well filter plates 28-9258-11
PreDictor Capto DEAE, 20 µL 4 × 96-well filter plates 28-9258-12
PreDictor Capto DEAE, 50 µL 4 × 96-well filter plates 28-9258-13
PreDictor Capto DEAE Isotherm 4 × 96-well filter plates 28-9432-80
PreDictor Capto Q, 2 µL 4 × 96-well filter plates 28-9257-73
PreDictor Capto Q, 20 µL 4 × 96-well filter plates 28-9258-06
PreDictor Capto Q, 50 µL 4 × 96-well filter plates 28-9258-07
PreDictor Capto Q Isotherm 4 × 96-well filter plates 28-9432-78
PreDictor Capto S, 2 µL 4 × 96-well filter plates 28-9258-08
PreDictor Capto S, 20 µL 4 × 96-well filter plates 28-9258-09
PreDictor Capto S, 50 µL 4 × 96-well filter plates 28-9258-10
PreDictor Capto S Isotherm 4 × 96-well filter plates 28-9432-79
Equipment
Capto media can be used together with most equipment 
available for chromatography from lab scale to production 
scale. Due to the high rigidity of the medium, packing 
procedures are slightly different compared to Sepharose 6 
Fast Flow based media. In process-scale, the preferred 
packing technique for Capto media is axial compression. 
Using AxiChrom columns, with Intelligent Packing and pre-set 
packing methods for all Capto media, is the most optimal and 
fastest approach. Appropriate columns from GE Healthcare 
are shown in Table 4. For details on packing lab-scale 
columns, see Instruction manuals, and for packing process-
scale columns see Application notes.
All Capto media is also available in the ReadyToProcess™ 
platform, with pre-packed, pre-qualified and pre-sanitized 
ReadyToProcess columns ranging in size from 1-20 L.
Table 4. Appropriate columns
Column family range Inner diameter (mm)
Lab scale:
Tricorn 5, 10
HiScale™ 16, 26, 50
Pilot and production scale:
AxiChrom 50 – 1000
BPG 100 – 300†
Chromaflow 400 – 800‡
† The pressure rating of BPG 450 is too low to use it with Capto media.
‡ Larger pack stations might be required at larger diameters.
Storage
Capto S
Store unused media and prepacked columns at 4°C to 30°C in 
20% in ethanol and 0.2 M sodium acetate.
Capto Q and Capto DEAE
Store unused media and prepacked columns at 4°C to 30°C in 
20% in ethanol.
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Product Pack size Code no.  
PreDictor RoboColumn  
Capto Q, 200 µl 
One row of eight 
columns
28-9860-72
PreDictor RoboColumn  
Capto Q, 600 µl 
One row of eight 
columns 
28-9861-75
PreDictor RoboColumn  
Capto S, 200 µl 
One row of eight 
columns 
28-9860-81
PreDictor RoboColumn  
Capto S, 600 µl 
One row of eight 
columns 
28-9861-76
PreDictor RoboColumn  
Capto DEAE, 200 µl 
One row of eight 
columns 
28-9860-82
PreDictor RoboColumn  
Capto DEAE, 600 µl 
One row of eight 
columns 
28-9861-77
HiScreen Capto DEAE 1 × 4.7 mL 28-9269-82
HiScreen Capto Q 1 × 4.7 mL 28-9269-78
HiScreen Capto S 1 × 4.7 mL 28-9269-79
ReadyToProcess Capto Q 2.5 L 28-9017-23
ReadyToProcess Capto Q 10 L 28-9017-24
ReadyToProcess Capto Q 1 L 28-9510-90
ReadyToProcess Capto Q 20 L 28-9017-25
ReadyToProcess Capto S 20 L 28-9017-31
ReadyToProcess Capto S 2.5 L 28-9017-29
ReadyToProcess Capto S 10 L 28-9017-30
ReadyToProcess Capto S 1 L 28-9510-93
Related literature Code no.  
Data files
PreDictor 96-well filter plates and Assist software 28-9258-39
PreDictor RoboColumn 28-9886-34
HiScreen prepacked columns 28-9305-81
ReadyToProcess columns 28-9159-87
BPG columns 18-1115-23
Chromaflow columns 18-1138-92
AxiChrom columns 28-9290-41
Application notes
Capture of Green Fluorescent Protein on Capto Q 11-0026-20
Methods for packing Capto S and Capto Q in  
production scale columns
28-9259-32
High productivity capture of α-chymotrypsin 
on Capto S cation exchanger
28-4078-15
Screening and optimization of loading  
conditions on Capto S
28-4078-16
Screening of loading conditions on Capto S using  
a new high-throughput format, PreDictor plates 
28-9258-40
Capto S cation exchanger for post-Protein A  
purification of monoclonal antibodies
28-4078-17
Process-scale purification of monoclonal  
antibodies – polishing using Capto Q
28-9037-16
Purification of a monoclonal antibody using  
ReadyToProcess columns
28-9198-56
Use of Capto ViralQ for the removal of genomic  
DNA from influenza virus produced in MDCK cells
28-9769-69
Two-step purification of monoclonal IgG1 from 
CHO cell culture supernatant
28-9078-92
Handbooks
High-throughput process development with  
PreDictor plates, principles and methods
28-9403-58
Ion Exchange Chromatography & Chromatofocusing: 
Principles and Methods
11-0004-21
Product Information
Sartopore® 2 0.2 µm
Scalability
Sartopore® 2 0.2 µm filter elements are available in a broad range 
of sizes and formats to provide linear scale-up from R&D to  
process scale. The wide range of membrane areas from 150 cm2  
to 1.8 m2 per filter element guarantees greatest flexibility and 
most economic filter sizing.
Applications
– Therapeutics 
– Biological Fluids
– Ophthalmic solutions
– Injectables
– Media 
– SVPs, LVPs
– Antibiotics
– WFI
– Buffers
– Chemicals
– Cleaning and sanitizing agents
– Bulk pharmaceutical products
High-Performance and broad compatibility
Sartopore® 2 filter elements feature a unique hydrophilic hetero-
geneous double layer design of a 0.45 µm pre-filter and 0.2 µm 
final filter membrane with an exceptionally high throughput and 
flow-rate. In addition to its outstanding performance, the Poly-
ethersulfone membrane gives Sartopore® 2 0.2 µm broad chemical 
compatibility, including a pH-range from pH 1 to pH 14, and  
a high thermal resistance. 
Industry standard for sterile-grade liquid filters
Sartopore® 2 0.2 µm filters are fully validated as sterilizing grade 
filter elements according to current ASTM F-838 guidelines.  
Each individual element is integrity tested by diffusion and  
bubble point test prior to release, assuring absolute reliability. 
Sartopore® 2 filter elements are designed, developed and  
manufactured in accordance with an ISO 9001 certified Quality 
Management System. The Validation and Extractables Guide are 
available for compliance with regulatory requirements.
Sartopore® 2 0.2 µm
Sterilizing Grade Filter Elements  
–  Industry standard of high-performance  
liquid sterile filters
–  Unique hydrophilic heterogeneous double layer  
Polyethersulfone membrane
–  Exceptional high throughput and excellent  
flowrates at low pressure drops
–  High thermal resistance and broad chemical  
compatibility 
Technical Data
Available Sizes Filtration Area Max. Diffusion at 2.5 bar | 36 psi
[ml/min]
Min. Bubble Point 
[bar | psi]
Cartridges, T-Style MaxiCaps® | MaxiCaps® | Gamma MaxiCaps®
Size 0.5 (Only Cartridge) 0.3 m2 | 3.2 ft2 10 3.2 | 46
Size 1 0.6 m2 | 6.5 ft2 18 3.2 | 46
Size 2 1.2 m2 | 12.9 ft2 36 3.2 | 46
Size 3 1.8 m2 | 19.4 ft2 54 3.2 | 46
Mini Cartridges | MidiCaps® | Gamma MidiCaps®
Size 7 0.05 m2 | 0.5 ft2 4 3.2 | 46
Size 8 0.1 m2 | 1.1 ft2 5 3.2 | 46
Size 9 0.2 m2 | 2.2 ft2 7 3.2 | 46
Size 0 (Only MidiCaps®  
& Gamma MidiCaps®)
0.45 m2 | 4.8 ft2 14 3.2 | 46
Capsules | Gamma Capsules
Size 4 0.015 m2 | 0.16 ft2 1 3.2 | 46
Size 5 0.03 m2 | 0.32 ft2 2 3.2 | 46
Materials
Prefilter Membrane 
Polyethersulfone, asymmetric
Endfilter Membrane    
Polyethersulfone, asymmetric   
Support Fleece     
Polypropylene    
(In-Line Steam sterilizable & autoclavable)
Polyester 
(γ-irradiatable or γ-irradiatable | autoclavable)
Core
Polypropylene 
Pore Size Combination
0.45 µm + 0.2 µm
Max. Allowable Differential Pressure
Mini Cartridges |Cartridges
5 bar | 72.5 psi at 20°C
2 bar | 29 psi at 80°C
T-Style MaxiCaps® | MaxiCaps® | Gamma MaxiCaps® | MidiCaps® | Gamma MidiCaps®
5 bar | 72.5 psi at 20°C
3 bar | 43.5 psi at 50°C
Capsules | Gamma Capsules 
4 bar | 58 psi at 20°C
2 bar | 29 psi at 50°C
Max. Allowable Back Pressure
2 bar | 29 psi at 20°C  
(for all elements)
End Caps
Polypropylene
Capsule Housing
Polypropylene 
O-Ring
Silicone
(other materials on request)
Filling Bell
Polycarbonate
Sartopore® 2 0.2 µm 3
Regulatory Compliance
– Each individual element is tested for integrity by Bubble Point and Diffusion test
– Fully validated as sterilizing grade filters according to ASTM current F-838 guidelines
– Designed, developed and manufactured in accordance with an ISO 9001 certified Quality Management System
– Meet or exceed the requirements for WFI quality standards set by the current USP
– Non pyrogenic according to USP Bacterial Endotoxins
– USP Plastic Class VI Test
– Non fiber releasing according to 21 CFR
Sterilization
Mini Cartridges, Cartridges
In-Line Steam Sterilization
134 °C, 0.3 bar, 20 min. 
Min. 25 Sterilization Cycles
or
Autoclaving
134°C, 2 bar, 30 min
Min. 25 Sterilization Cycles
MaxiCaps®, MidiCaps® & Capsules
Autoclaving
134°C, 2 bar, 30 min
Min. 25 Sterilization Cycles (MidiCaps® & MaxiCaps®)
Min. 5 Sterilization Cycles (Capsules)
Gamma MaxiCaps®, Gamma MidiCaps® & Gamma Capsules
Gamma Irradiation
< 50 kGy
1 Sterilization Cycle
T-Style MaxiCaps®
Autoclaving
134°C, 2 bar, 30 min
Min. 5 Sterilization Cycles
or
Gamma Irradiation
< 50 kGy
1 Sterilization Cycle
Technical References
Validation Guide SPK5802-e
Extractables Guide  SPK5731-e
Performance
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Water Flow Rates for Standard Cartridges
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Total Throughput Comparison
10″ Cartridge format
Water Flow Rates for T-Style MaxiCaps®
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Ordering Information
544 15 07 H
Mini Cartridge
Filter Size
7: 0.05 m2 | 0.5 ft2 
8: 0.1 m2 | 1.1 ft2
9: 0.2 m2 | 2.2 ft2
Adapter
15: Bayonet adapter with o-ring
18: Plug Adapter with double o-ring
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Packing Size
B: box of 5
544 25 07 H
Cartridge
Filter Size
0: 0.3 m2 | 3.2 ft2 (5“)
1: 0.6 m2 | 6.5 ft2 (10“)
2: 1.2 m2 | 12.9 ft2 (20“)
3: 1.8 m2 | 19.4 ft2 (30“)
Adapter
21: double open end with flat gaskets
25: 2 Flange Bayonet adapter with 226 double o-ring
27: Bayonet adapter with 222 double o-ring
28: 3 Flange Bayonet adapter with 222 double o-ring
(Standard with silicone o-ring optional with EPDM o-ring. Example: 5442507H1---E)
(Standard with silicone o-ring optional with EPDM o-ring. Example: 5441507H7---E--B)
T-Style MaxiCaps® 
Filter Size
1: 0.6 m2 | 6.5 ft2 (10“)
2: 1.2 m2 | 12.9 ft2 (20“)
3: 1.8 m2 | 19.4 ft2 (30“)
 
Connector Outlet
S: 1½“ Tri-Clamp 50 mm 
O: ½“ single stepped hose barb
Y: 1“ single stepped hose barb
Sterilization
G-: γ-irradiatable  
and autoclavable
G-544 83 07 H
Connector Inlet
S: 1½“ Tri-Clamp 50 mm 
O: ½“ single stepped hose barb
Y: 1“ single stepped hose barb
544 73 07 H
MaxiCaps® | Gamma MaxiCaps® 
Filter Size
1: 0.6 m2 | 6.5 ft2 (10“)
2: 1.2 m2 | 12.9 ft2 (20“)
3: 1.8 m2 | 19.4 ft2 (30“)
Connector Inlet
S: 1½“ Tri-Clamp 50 mm 
O: ½“ single stepped hose barb
F: ¾“ Tri-Clamp 25 mm
 
Sterilization
G-: γ-irradiatable
--: autoclavable
(Optional with vent valve design for connection of integrity tester. Example: 5447307H1--SSIT)
Connector Outlet
S: 1½“ Tri-Clamp 50 mm 
O: ½“ single stepped hose barb
F: ¾“ Tri-Clamp 25 mm
 
544 53 07 H
MidiCaps® | Gamma MidiCaps®
Filter Size
7: 0.05 m2 | 0.5 ft2 
8: 0.1 m2 | 1.1 ft2
9: 0.2 m2 | 2.2 ft2
0: 0.45 m2 | 4.8 ft2
Connector Inlet
S: 1½“ Tri-Clamp 50 mm 
O: ½“ single stepped hose barb
F: ¾“ Tri-Clamp 25 mm 
H:  ¼“ multiple stepped hose barb 
(only size 7 with filling bell)
Sterilization
G-: γ-irradiatable
--: autoclavable
Packing Size
A: box of 4 (size 7,8,9)
V: box of 2 (size 0)
Connector Outlet
S: 1½“ Tri-Clamp 50 mm 
O: ½“ single stepped hose barb
F: ¾“ Tri-Clamp 25 mm 
H:  ¼“ multiple stepped hose barb 
(only size 7 with filling bell)
--
B544 13 07 H
Capsules | Gamma Capsules
Filter Size
4: 0.015 m2 | 0.16 ft2
5: 0.03 m2 | 0.32 ft2
Connector Inlet
S: ¾“ Tri-Clamp 25 mm
O:  ¼“ multiple stepped  
hose barb
Packing Size
B: box of 5
Sterilization
G-: γ-irradiatable
--: autoclavable
Connector Outlet
S: ¾“ Tri-Clamp 25 mm
O:  ¼“ multiple stepped  
hose barb
--
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Check the availability of your desired configuration with 
your Sartorius sales representative or online at:
POROS™ HIC Resins: Ethyl, Benzyl, and Benzyl Ultra
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Product information
Product description
POROS
™
 Hydrophobic Interaction Chromatography (HIC) resins are
rigid, 50-µL polymeric resins with a range of hydrophobic
functionalities for the purification of antibody fragments, antibody
drug conjugates (ADCs), recombinant proteins, viruses, and other
biomolecules. The resin backbone consists of crosslinked poly(styrene-
divinylbenzene) with a unique pore structure that provides rapid
mass transport and enables enhanced productivity. The particle
surface is coated with a novel polymer coating, which is then further
derivatized with a range of hydrophobic ligands for flexible
purification process design.
POROS
™
 HIC resins are suitable for bind/elute and flow‑through
applications at lower salt concentrations. These resins have superior
resolution capability, high capacity, and differentiating selectivity for a
range of biomolecules, and this performance is independent of flow
rate.
Storage
Store resins at 2– 30°C. Do not freeze.
Specifications
Table 1   Ligands, hydrophobicity, and applications
Resin Ligand Relative
hydrophobicity
[1]
Application
Ethyl Novel ethyl Low Bind/elute mode to bind
moderately to strongly
hydrophobic molecules.
Benzyl Low-density
benzyl/
aromatic
Moderate Bind/elute or flow‑through
mode depending on the
hydrophobicity of the
molecule.
Benzyl
Ultra
High-density
benzyl/
aromatic
High Flow-through mode in lower
salt concentration to bind
impurities such as
aggregates.
[1] Hydrophobicity results are based on lysozyme gradient elution. Column size: 
0.66 cmD × 20 cmL; 1.7-M ammonium sulfate, 50-mM sodium phosphate pH 7.0; 
Gradient elution: 1.7-M ammonium sulfate/50 mM sodium phosphate pH 7.0 to 
50‑mM sodium phosphate pH 7.0 over 10 column volumes; Flow rate: 100 cm/hr.
Table 2   Characteristics and stability
Characteristic Description
Support matrix Crosslinked poly(styrene-divinylbenzene)
Shipping solution 18% ethanol
Average particle size 50 µm
Mechanical
resistance
100 bar (1450 psi, 10 MPa)
pH range 1–14
Ionic strength range 0 to 5 M, all common salts
Buffer additives All common agents, including 1 M sodium
hydroxide, 8 M urea, 6 M guanidine hydrochloride,
ethylene glycol, and detergents
Salts Ammonium sulfate, sodium sulfate, sodium
chloride, sodium acetate, sodium citrate and other
common salts
IMPORTANT! POROS™ Benzyl and POROS™ Benzyl
Ultra are designed for use with lower salt
concentration than traditional HIC resins. With
some molecules, high salt concentration can cause
poor recovery due to a strong interaction between
the target and the ligand.
Solvents Water, 0–100% alcohol, acetonitrile, 1 to 2 M acids
(for example, acetic, hydrochloric, phosphoric),
other common organic solvents
Do not expose to strong oxidizers (such as
hypochlorite), oxidizing acids (such as nitric), strong
reducing agents (such as sulfite), acetone, or benzyl
alcohol.
Shrinkage/swelling <1% from 1–100% solvent
Operating
temperature
2– 30°C
Do not freeze
POROS
™
 HIC resins can be operated at high linear flow rates with a
pressure drop that allows use with conventional low-pressure
chromatography columns and systems. POROS
™
 HIC resins have
linear and predictable pressure flow responses as column diameter
increases (Figure 1 and Figure 2).
USER GUIDE
Product usage: See "Ordering information" on page 5.
Fig. 1  Pressure-flow properties of POROS™ Ethyl resin—20-cm bed
height
Fig. 2  Pressure-flow properties of POROS™ Benzyl Ultra resin—20-cm
bed height
Pack and qualify the column
Packing guidelines
• Resins are supplied in 18% ethanol. For column packing, exchange
the shipping solution with water to remove the ethanol.
• Resins are mechanically rigid and incompressible and can be
packed effectively in low-pressure glass columns and in
high-pressure stainless steel columns. The lack of wall support
with increasing column diameter has minimal impact on
chromatography performance because the beads support
themselves, allowing for flexible column packing approaches and
consistent and robust results. Columns can be packed with
traditional flow pack, axial compression, or pack-in-place/stall
pack packing methods.
• Standard 10–23 µm screens (frits) can be used.
Prepare slurry: lab-scale columns (£ 100 mL)
Buffer‑exchange using a 0.2–0.45 µm bottle‑top filter or sintered-glass
filter:
1. Transfer the required volume of resin slurry to the top of a
bottle‑top filter.
2. Apply vacuum to remove the shipping solution.
3. Resuspend the resin cake to the starting resin slurry volume with
water. Mix with a plastic or rubber spatula. Do not grind the resin
bed or tear the filter membrane.
4. Repeat the vacuum and resuspension steps for a total of three
exchanges.
5. Resuspend the exchanged resin to the original slurry
concentration, then proceed with column packing.
6. Verify that the slurry concentration is 50–70% (see “Determine the
slurry concentration“ on page 2).
7. If needed, adjust the slurry concentration to 50–70%.
Prepare slurry: lab-scale and larger scale columns
(> 100 mL)
Buffer‑exchange using repeated gravity settling:
1. Allow the resin to settle in the shipping container. Settling
requires > 8 hours because the density of the resin is
approximately that of water.
2. Carefully decant the supernatant. Do not disturb the bed.
Some particles/turbidity may be present in the decant as beads
slough off the settled bed or come loose from the carboy side
walls. This is not problematic.
3. Replace the supernatant with the same volume of the desired
packing solution.
4. Replace the supernatant with the same volume of water.
5. Resuspend the resin by gentle agitation, then allow the resin to
settle by gravity.
6. Repeat steps 1 to 4 two to three times to thoroughly exchange into
water.
7. Verify that the slurry concentration is 50–70% (see “Determine the
slurry concentration“ on page 2).
8. If needed, adjust the slurry concentration to 50–70%.
Determine the slurry concentration
1. Separate the slurry using either of the following methods.
• Gravity settling—Add 100 mL of slurry in water to a 100-mL
graduated cylinder, then allow to settle for >72 hours.
Note: The time that POROS™ HIC resins take to gravity settle
can be inconsistent due to hydrophobicity. We recommend
using the centrifugation method for faster, more consistent
results.
• Centrifugation—Add 10 mL of slurry in water to three (3)
15-mL conical tubes. Centrifuge at 3,000 rpm for 10 minutes at
20°C with the brake off. Remove the tubes from the centrifuge
and allow the tubes to sit for 5 minutes before determining the
concentration.
2. Calculate the concentration: Volume of resin/total volume in the
graduated cylinder or conical tube.
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Pack the column
When you adjust the flow rate to form the bed, you may observe some
turbidity in the eluent as packing starts. Turbidity will clear as packing
proceeds and 1–2 bed volumes of packing buffer pass through the
column.
1. Determine the required slurry volume:
Example for a POROS™ Ethyl 40 cmD × 20 cmL 25-L column using
slurry with a 50% slurry ratio:
25 L / 0.56 × 1.06 = 47.3 L slurry required
The 1.06 packing factor above accounts for the difference in bed
volume between a centrifuged bed in water and a 3-bar pressure-
packed bed. Use a 1.12 packing factor for POROS™ Benzyl and
POROS™ Benzyl Ultra.
2. Ensure that the column outlet is closed and plumbed directly to
waste. Do not connect the column outlet to the chromatography
system. Plumbing into the system creates backpressure that fights
against the inlet pressure trying to settle the bed and pack the
column.
3. Ensure that the column is level and locked in place before starting
the pack.
4. Deliver the required slurry volume to the column by hand or with
a diaphragm pump, as dictated by your equipment and the
intended packing procedure. Use a squirt bottle containing
packing solution to remove any residual resin from the column
wall.
POROS™ resin beads have a skeletal density similar to the density
of water and do not settle rapidly. Do not allow the resin to
gravity‑settle in the column before packing.
5. With the column inlet line connected to the system and the
bottom outlet closed, bring the primed top flow adapter to 1–2 cm
from the slurry level, then tighten the O-ring. Do not push up the
resin and over the O-ring. Change the top valve to force the air
and liquid out the top of the adapter and to waste using the
bypass line. Continue to lower the adapter slowly to remove the
bubbles from the top of the column. Do not allow large air
bubbles between the top adaptor and the top of the resin slurry.
6. Change the valve back to flow through the system on the top,
then open the column bottom.
7. Increase the flow rate to the maximum or desired flow rate and
pressure obtainable with the equipment used.
8. After the bed is formed, bring the adapter into contact with the
top of the bed without pushing the resin over the O-ring by
closing the column outlet and displacing liquid through the top of
the adapter to waste through the bypass line.
POROS™ resin does not shrink or swell, so an open headspace is
not recommended.
9. Flow at the packing flow rate again for 1–2 CVs, taking note of
the bed height at the desired pressure. Adjust the adapter again
to the noted bed height by displacing the liquid through the top
of the adapter and to waste.
10. After the column is packed, flow 2–3 CVs of packing solution
through the packed bed at the operating flow rate to stabilize the
bed.
The flow rate used should generate no more than 80% of the final
packing pressure.
11. If you will reverse the flow of the column during operation,
condition the column in upflow:
• Flow 2–3 CVs in upflow at the operating flow rate.
• Flow 2–3 CVs in downflow at the operating flow rate, then
adjust the adapter if needed.
• Flow 2 CVs after you adjust the adapter.
Qualify the column
To qualify the integrity of a packed column, determine HETP (height
equivalent to a theoretical plate) and asymmetry using a non-binding
analyte (a “plug”).
Recommended column qualification conditions
Condition Recommendation
Flow rate 50 cm/hour
Equilibration buffer Water
Plug solution 0.5 M sodium chloride
Plug volume 1% of column volume
Guidelines for qualification
• Ensure uniform column plumbing:
– Avoid using reducers to connect different tubing sizes.
– Minimize and keep consistent the column tubing lengths
between the plug solution to the column inlet and the column
outlet to the detector(s).
• Equilibrate with at least 4 CVs of equilibration buffer before
injection.
Setting specifications
Qualification results depend on several factors, including the:
• Solutions and method used
• Scale
• Column hardware
• Chromatography system
After you define a column qualification procedure for a specific
system (column plus chromatography system), base the qualification
acceptance criteria on historical values and ranges instead of
theoretical qualification results. Performing the column qualification
method consistently and reproducibly is critical to obtaining
meaningful results.
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Chromatography condition optimization
General guidelines
Standardized conditions or platform-type evaluations are not
recommended. Different HIC resins that are operated with the same
process conditions can yield variable results.
When optimizing conditions:
• Test different loading and elution conditions to evaluate static
binding capacity and yield based on the target molecule
characteristics and process challenges.
• Limit static binding load incubation time to 15 minutes.
• Optimize the chromatography step for peak separation: Use
conditions that remove some of the bound impurities during the
flow‑through/wash phase and that retain other bound impurities
until elution during the strip and cleaning-in-place (CIP) steps.
• Use buffer salts and reagents of the highest purity.
• Filter (0.22 or 0.45 µm) all buffers, solutions, and load before use.
Resin selection guidelines
• If the hydrophobicity of the target molecule is unknown:
– Run a small-scale bind/elute gradient separation on POROS™
Benzyl resin to determine the elution conductivity of the target
molecule, contaminants, and impurities.
– Optimize conditions on POROS™ Benzyl Ultra resin (higher
hydrophobicity) or POROS™ Ethyl resin (lower
hydrophobicity).
– If needed, continue to optimize conditions on POROS™ Benzyl
resin (mid-range hydrophobicity).
• If the target molecule is hydrophobic, optimize conditions on
POROS™ Ethyl resin or on POROS™ Benzyl with lower salt
concentration.
• For flow‑through applications where the target molecule is less
hydrophobic, optimize conditions on POROS™ Benzyl or POROS™
Benzyl Ultra with lower salt concentration.
After you select the resin, continue to optimize other process
conditions.
Binding capacity and loading condition screening guidelines
Perform high-throughput static binding capacity testing in spin
columns or in a 96-well plate to screen POROS™ HIC resin. Optimize
loading conditions as needed.
Note: A 96-well high-throughput protocol is available on request. This
protocol can be used to evaluate static binding capacity and to screen
several resins and loading conditions per resin in a single 96-well
plate.
Bind/elute chromatography optimization guidelines
Binding conditions guidelines
• Salt and salt concentration — POROS
™
 HIC resins are designed to
use less lyotropic salts and to bind at lower concentrations than
traditional HIC resins with similar functional groups (Table 3).
Table 3    Typical salts used in hydrophobic interaction
chromatography in order of decreasing lyotropic ("salting out")
effect and increasing chaotropic ("salting in") effect
Effect Anionic salts Cationic salts
Most lyotropic C6H5O7 3– NH4 +
PO4 3– Rb+
SO4 2– K+
CH3COO– Na+
Cl- Cs+
Br– Li+
NO3 – Mg2+
CIO4 – Ca2+
Most chaotropic I– Ba2+
Note the following:
– You can perform initial binding experiments with lower salt
concentrations than are typically used for HIC chromatography.
For example, you can start with 25%, 50% and 75% of the
salting out concentration, instead of the typical 10–15% lower
than the salting out concentration.
– The optimized ionic salt concentration for the salts listed above
can differ from ammonium sulfate, which has been traditionally
used for HIC chromatography.
– Different salts can provide different selectivity.
Optimize the salt concentration for the target molecule by using a
"salting out" experiment: increase the ionic strength of the loading
buffer until the sample precipitates. Alternatively, you can
measure increasing optical density of the loading buffer to detect
aggregation (~350 nm, but this value may differ with each salt).
Salts that are commonly used to perform salting out experiments
are ammonium sulfate, sodium chloride, sodium citrate, sodium
sulfate, and sodium acetate.
• Buffer system—Buffer systems are not as critical for HIC processes
as they are for ion-exchange chromatography steps. Citrate,
acetate, Bis-Tris propane, HEPES, MES, sodium phosphate,
succinate, and Tris are commonly used.
The buffer system is typically dictated by the upstream
purification step. When selecting the upstream buffer system,
consider molecule stability in the buffer, binding optimization, and
buffering capacity.
• pH—pH is not typically critical for HIC processes, but it can affect
the binding strength and selectivity. Because pH effects are
unpredictable on HIC, test a few pH values over the stability range
of the target molecule.
• Flow rate—The target operating flow rate is flexible. Start
optimization at 4-minute residence time (300 cm/hr in a 20-cmL
column).
• Temperature—Temperature can significantly impact HIC
performance. Perform all optimization at the final intended
process temperature.
Elution conditions guidelines
Start elution optimization with a gradient elution. Most often, after
elution performance is determined, you can implement a step elution.
• Salt gradient—To determine where the target molecule and
contaminants/ impurities elute, start with a 20-CV gradient from
high salt to buffer only. To do so, assay fractions across the peaks
(~1/10 CV). Based on this information, the process can be further
optimized.
• Dynamic binding capacity (DBC)—Assess separation as a
function of DBC. The maximum DBC depends on several factors,
including sample solubility, column selectivity, buffer pH, and
loading buffer conductivity.
• Bed height—Initial screening can be run with shorter bed heights
and a constant residence time. Use the final desired bed height for
scale up development (typically 15 cm to 30 cm).
Flow-through chromatography optimization guidelines
An optional flow‑through step can be used remove trace product and
process-related impurities such as aggregates from the target
molecule. You can add the flow‑through step as the second or third
chromatography step for polishing in a downstream process. Different
target molecules have different degrees of hydrophobicity and other
biophysical characteristics. Therefore, it is essential to optimize the
process conditions to achieve the desired aggregate clearance and
recovery of the target molecule.
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Loading conditions guidelines
• Initial study —Perform an initial study using a decreasing salt
gradient in bind/elute mode:
– Load approximately 1 mg of protein per 1 ml of resin at 0.5–
1.0 M sodium chloride (or other preferred salt), then elute using
a gradient over 10 column volumes (CVs) in a buffered solution
to determine aggregates, impurities, and target molecule
elution profiles.
– Use the elution conductivity at peak maximum to determine the
highest approximate salt concentration that is required to
remove impurities, but that allows the target molecule to flow
through (Figure 3).
Start flow-through
optimization at
~7 mS/cm
Fig. 3  Example screening chromatogram to obtain the ideal low
salt condition for flow-through conditions. Process screening
for a monoclonal antibody using POROS™ Benzyl Ultra resin in
flow-through mode. Gradient: High conductivity to low
conductivity using sodium citrate. Based on this chromatogram,
the resin was further optimized in flow-through mode at low
salt conditions starting at 7 mS/cm.
• Buffer system—Buffer systems are not as critical for HIC processes
as they are for ion-exchange chromatography steps. Citrate,
acetate, Bis-Tris propane, HEPES, MES, sodium phosphate,
succinate, and Tris are commonly used.
The buffer system is typically dictated by the upstream
purification step. When selecting the upstream buffer system,
consider molecule stability in the buffer, binding optimization, and
buffering capacity.
• pH—pH is not typically critical for HIC processes, but it can affect
the binding strength and selectivity. Because pH effects are
unpredictable on HIC, test a few pH values over the stability range
of the target molecule.
• Flow rate—The target operating flow rate is flexible. Good
impurity binding has been demonstrated at flow rates up to
600 cm/hour on a 20 cmL column (1.6-minute residence time).
• Temperature—Temperature can significantly impact HIC
performance. Perform all optimization at the final intended
process temperature.
• Dynamic binding capacity (DBC)—A conservative starting point
for DBC determination is 100–250 mg of the target molecule per
mL of resin. Determine the DBC for each impurity by using
breakthrough analysis under the desired load pH and conductivity
conditions.
• Bed height—A bed height of 15 cm to 30 cm can be used for this
step.
Resin cleaning and storage
Resin cleaning guidelines
• POROS
™
 resins can tolerate harsh cleaning conditions that allow
acceptable column life.
• Clean the resin with 3 to 5 CVs of water followed by 3 to 5 CVs of
1 M NaOH.
• For more stringent cleaning, use 20% ethanol/1 M acetic acid.
• Other solutions may be required for column cleaning if the resin is
used for capture chromatography.
• Degas more viscous solutions such as 1 M acetic acid or
20% ethanol before use on the column to avoid gassing out during
operation.
Note: Low-level gassing out does not impact column performance.
Store the resin
Store the resin in 20% ethanol or 0.1 M NaOH at 2–30°C.
Ordering information
Table 4   POROS™ HIC bulk resins
Resin Cat. No. Amount Product usage
Ethyl A32552 10,000 mL Pharmaceutical Grade Reagent. For
Manufacturing and Laboratory Use
Only.
A32553 5,000 mL
A32554 1,000 mL
A32555 250 mL For Research Use Only. Not for use
in diagnostic procedures.A32556 50 mL
A32557 25 mL
Benzyl A32558 10,000 mL Pharmaceutical Grade Reagent. For
Manufacturing and Laboratory Use
Only.
A32559 5,000 mL
A32560 1,000 mL
A32561 250 mL For Research Use Only. Not for use
in diagnostic procedures.A32562 50 mL
A32563 25 mL
Benzyl
Ultra
A32564 10,000 mL Pharmaceutical Grade Reagent. For
Manufacturing and Laboratory Use
Only.
A32565 5,000 mL
A32566 1,000 mL
A32567 250 mL For Research Use Only. Not for use
in diagnostic procedures.A32568 50 mL
A32569 25 mL
Support
For service and technical support, go to thermofisher.com/poros or
call toll-free in US: 1.800.831.6844.
For the latest service and support information at all locations, or to
obtain Certificates of Analysis or Safety Data Sheets (SDSs; also known
as MSDSs), go to thermofisher.com/support, or contact you local
Thermo Fisher Scientific representative.
Limited product warranty
Life Technologies Corporation and/or its affiliate(s) warrant their
products as set forth in the Life Technologies' General Terms and
Conditions of Sale found on Life Technologies' website at 
www.thermofisher.com/us/en/home/global/terms-and-
conditions.html. If you have any questions, please contact Life
Technologies at www.thermofisher.com/support.
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Virus Clearance
required as protection for the Virosart® CPV membrane. The optimum 
pre - filter - final filter ratio has to be identified during development 
of the process step. 
Product Benefits
Virosart® CPV provides highest virus safety to the biopharmaceutical 
product.  Based on the unique double layer 20 nm PES membrane, 
Virosart® CPV provides excellent flow rates and superior capacity.  
This filter retains more than 4 log10 of small non-enveloped viruses 
(e.g. PPV, MVM) and more than 6 log10 of large enveloped viruses 
(e.g. MuLV). This filter offers highest virus safety over the entire flow 
decay profile independent of operating pressure or pressure pauses.
Scalability
Scale down work is realised using the Virosart® CPV Minisart (5 cm2 
capsule) to enable filtration work for flow and capacity studies as 
well as for optimizing the final pre - filter - final filter ration. These  
elements, available as IT tested devices are also used for reliable 
scale-down work within GLP virus spiking studies. Scale up studies  
as well as small scale production are performed using Virosart® CPV 
capsule and|or MidiCaps® (180 cm2 | 2.000 cm2) to reliably scale up 
into larger scale manufacturing. Large scale manufacturing is oper-
ated with Virosart® CPV MaxiCaps® or cartridges. Typical batch sizes 
of products subject to virus  filtration with Virosart® CPV MaxiCaps® 
and cartridges are > 50 liter. 
Description
Virus filtration with Virosart® is an integral part of the orthogonal 
virus clearance technology platform of Sartorius Stedim Biotech.  
This orthogonal technology platform features virus filtration, virus 
inactivation and virus adsorption. The Virosart® product ranges  
includes three different virus retentive membranes, in order to  
provide the best solution for every application. 
Virosart® CPV targets the removal of both small non-enveloped  
viruses (20 nm) e.g. PPV, MVM and larger enveloped viruses  
(> 50 nm) e.g. MuLV from a biopharmaceutical feed stream.
Application & Positioning of Virosart® CPV
The main applications for Virosart® CPV for virus filtration are  
monoclonal antibodies (Mab), antibody fragments (Fab) or small  
recombinant proteins (<150kD). Virosart® CPV is used at the end  
of the purification process for virus filtration of the biopharmaceuti-
cal product. At this stage the purity of the biopharmaceutical  
product is the highest and virus filter blockage due to contaminants 
(DNA, CHOP, aggregates & lipoproteins) is the lowest.
Even if these contaminants should be removed during the polishing 
process of the target molecule, small amounts might be sufficient  
to cause premature blockage of the final virus filter. To prevent this,  
an efficient pre-filtration step, such as the Virosart® Max, might be 
Virosart® CPV MaxiCaps® and Cartridges
The virus filter for the robust and  
efficient removal of all viruses
Virosart® CPV is a well established virus retentive filter 
within the monoclonal antibody market. The unique  
assymmetric PES membrane structure provides highest 
virus retention under all circumstances independent  
from operation pressure or pressure pauses.  
 
Product Information
Specifications
Materials
Membrane Double layer polyethersulfone
Support Fleece Polypropylene
Core Polypropylene
End Caps Polypropylene
Capsule Housing Polypropylene
Pore Size 
CPV (20 nm nominal)
Available Sizes | Filtration Area
MaxiCaps®
Size 1 0.7 m2 | 7 ft2
Size 2 1.4 m2 | 14 ft2
Size 3 2.1 m2 | 21 ft2
Standard Filter Cartridges
Size 1 0.7 m2 | 7 ft2
Size 2 1.4 m2 | 14 ft2
Size 3 2.1 m2 | 21 ft2
Available Connectors 
Sanitary for MaxiCaps® & code 7 for cartridges
Operating Parameters
In the direction of filtration At 20°C   max. 5.0 bar | 72.5 psi 
At 121°C max. 0.2 bar | 2.9 psi
In the reversed direction  
of filtration
At 20°C   max. 0.2 bar | 2.9 psi
Extractables
Virosart® CPV filters meet, or exceed the requirements for  
WFI quality standards set by the USP 26
Non-pyrogenic according to USP Bacterial Endotoxins
Passes USP Plastics Class VI Test
Non-fiber releasing according to 21 CFR
Sterilization
Steaming (Virosart® CPV cartridges only!): 
121°C @ 1 bar | 14.5 psi for 30 min
up to 2 cycles
Autoclaving: 
121°C @ 1 bar | 14.5 psi for 30 min 
up to 2 cycles
No In-Line Steam Sterilization of MaxiCaps®!
Technical References
Validation Guide:   SPK5754-e | 85030-522-02
Extractable Guide:  SPK5773-e | 85034-536-47
Virus Information Guide:  SPK5752-e | 85030-521-91
Technical Data
Integrity Testing
Virosart® CPV filters are tested for integrity using a water based  
integrity test, e.g. based on the Sartocheck® technology of Sartorius 
Stedim Biotech. Virosart® CPV filters have been validated for 4 log10 
removal of small non-enveloped viruses using bacteriophage PP7  
as the model virus. Validation data is shown in the validation guide 
of Virosart® CPV. 
Quality Control
Each individual Virosart® CPV filter is autoclaved and integrity  
tested during manufacture assuring highest product reliability. 
Documentation
Virosart® CPV filters are designed, developed and manufactured  
in accordance with a ISO 9001 certified Quality Management  
System. A Validation Guide is available for compliance with  
regulatory requirements.
Virus Clearance
0 14.6 29.2
0
500
1000
1500
210
800 - 1,400 mL/min
Pressure [bar]
Fl
ow
 [m
L/
m
in
]
Pressure [psi]
0 14.6 29.2
0
1000
2000
3000
210
1,600 - 2,800 mL/min
Pressure [bar]
Fl
ow
 [m
L/
m
in
]
Pressure [psi]
Characteristic Water Flow Rates for Virosart® CPV  
10“ Standard Filter Cartridges & 10” MaxiCaps®
Characteristic Water Flow Rates for Virosart® CPV  
20” Standard Filter Cartridges & 20” MaxiCaps®
0 14.6 29.2
0
1500
3000
4500
210
2,400 - 4,200 mL/min
Pressure [bar]
Fl
ow
 [m
L/
m
in
]
Pressure [psi]
Characteristic Water Flow Rates for Virosart® CPV  
30” Standard Filter Cartridges & 30” MaxiCaps®
3
Ordering Information Virosart® CPV Standard Filter Cartridges
545 25 28 V1   Explanation
 Virosart® CPV, double layer
 Adapter
 25: S-adapter top,  
 locking bayonet adapter  
 with double O-ring bottom
 Pore Size
 28:  PPV retentive,  
20 nm filter membrane
 Height Filtration Area
 V1: 10“ 0.7 m2|7 ft2
 V2: 20“ 1.4 m2|14 ft2
 V3: 30“ 2.1 m2|21 ft2
Ordering Information Virosart® CPV MaxiCaps®
545 73 28 V1 -- SS  Explanation
 Virosart® CPV, double layer
 Capsule Design
 13: Old MaxiCaps® design 
 73: New MaxiCaps® desgin
 Pore Size
 28:  PPV retentive,  
20 nm filter membrane
 Height Filtration Area
 V1: 10“ 0.7 m2|7 ft2
 V2: 20“ 1.4 m2|14 ft2
 V3: 30“ 2.1 m2|21 ft2
 Adapter
 SS Sanitary inlet – and outlet  
 adapter
Ordering Information
Sales and Service Contacts
For further contacts, visit www.sartorius-stedim.com
Europe
Germany
Sartorius Stedim Biotech GmbH
August-Spindler-Strasse 11
37079 Goettingen
Phone +49.551.308.0
Fax +49.551.308.3289
Sartorius Stedim Systems GmbH
Robert-Bosch-Strasse 5 – 7 
34302 Guxhagen
Phone +49.5665.407.0
Fax +49.5665.407.2200
France
Sartorius Stedim FMT S.A.S.
ZI des Paluds
Avenue de Jouques – CS 91051
13781 Aubagne Cedex
Phone +33.442.845600
Fax +33.442.845619
Sartorius Stedim France SAS
ZI des Paluds
Avenue de Jouques – CS 71058
13781 Aubagne Cedex 
Phone +33.442.845600
Fax +33.442.846545
Austria
Sartorius Stedim Austria GmbH
Modecenterstrasse 22
1030 Vienna
Phone +43.1.7965763.18
Fax +43.1.796576344
Belgium
Sartorius Stedim Belgium N.V.
Rue Colonel Bourg 105
1030 Bruxelles
Phone +32.2.756.06.80
Fax +32.2.756.06.81
Hungary
Sartorius Stedim Hungária Kft.
Kagyló u. 5
2092 Budakeszi
Phone +36.23.457.227
Fax +36.23.457.147
Italy
Sartorius Stedim Italy S.p.A.
Via dell’Antella, 76/A
50012 Antella-Bagno a Ripoli (FI)
Phone +39.055.63.40.41
Fax +39.055.63.40.526
 
Netherlands
Sartorius Stedim Netherlands B.V.
Phone +31.30.60.25.080
Fax +31.30.60.25.099
filtratie.nederland@sartorius-stedim.com
Poland
Sartorius Stedim Poland Sp. z o.o.
ul. Wrzesinska 70
62-025 Kostrzyn
Phone +48.61.647.38.40
Fax +48.61.879.25.04
Russian Federation
LLC “Sartorius Stedim RUS”
Uralskaya str. 4, Lit. B
199155 St. Petersburg
Phone +7.812.327.53.27
Fax +7.812.327.53.23
Spain
Sartorius Stedim Spain, S.A.U.
Avda. de la Industria, 32
Edificio PAYMA
28108 Alcobendas (Madrid)
Phone +34.902.110.935
Fax +34.91.358.96.23
Switzerland
Sartorius Stedim Switzerland AG
Ringstrasse 24 a
8317 Tagelswangen
Phone +41.52.354.36.36
Fax +41.52.354.36.46
U.K.
Sartorius Stedim UK Ltd.
Longmead Business Centre
Blenheim Road, Epsom
Surrey KT19 9 QQ
Phone +44.1372.737159
Fax +44.1372.726171
Ukraine
LLC “Biohit”
Post Box 440 “B”
01001 Kiev, Ukraine
Phone +380.44.411.4918
Fax +380.50.623.3162
Americas
USA
Sartorius Stedim North America Inc.
5 Orville Drive, Suite 200
Bohemia, NY 11716
Toll-Free +1.800.368.7178
Fax +1.631.254.4253
Argentina
Sartorius Argentina S.A. 
Int. A. Ávalos 4251 
B1605ECS Munro 
Buenos Aires 
Phone +54.11.4721.0505 
Fax +54.11.4762.2333 
Brazil
Sartorius do Brasil Ltda 
Avenida Senador Vergueiro 2962 
São Bernardo do Campo 
CEP 09600-000 - SP- Brasil
Phone +55.11.4362.8900
Fax +55.11.4362.8901
Mexico
Sartorius de México S.A. de C.V.
Circuito Circunvalación Poniente 
No. 149
Ciudad Satélite
53100, Estado de México
México
Phone +52.5555.62.1102
Fax +52.5555.62.2942
Asia|Pacific
Australia
Sartorius Stedim Australia Pty. Ltd.
Unit 5, 7-11 Rodeo Drive
Dandenong South Vic 3175
Phone +61.3.8762.1800
Fax +61.3.8762.1828
China
Sartorius Stedim Biotech (Beijing) Co. Ltd.
No. 33 Yu’an Road
Airport Industrial Park Zone B
Shunyi District, Beijing 101300
Phone +86.10.80426516
Fax +86.10.80426580
Sartorius Stedim (Shanghai) 
Trading Co., Ltd.
3rd Floor, North Wing, Tower 1
No. 4560 Jinke Road
Zhangjiang Hi-Tech Park 
Pudong District
Shanghai 201210, P.R. China
Phone +86.21.6878.2300
Fax +86.21.6878.2882
Sartorius Stedim Biotech (Beijing) Co. Ltd.
Guangzhou Representative Office
Unit K, Building 23
Huihua Commerce & Trade Building
No. 80 Xianlie Middle Road
Guangzhou 510070
Phone +86.20.37618687 | 37618651
Fax +86.20.37619051
 
India
Sartorius Stedim India Pvt. Ltd.
#69/2-69/3, NH 48, Jakkasandra
Nelamangala Tq
562 123 Bangalore, India
Phone +91.80.4350.5250
Fax +91.80.4350.5253
Japan
Sartorius Stedim Japan K.K.
4th Fl., Daiwa Shinagawa North Bldg.
8-11, Kita-Shinagawa 1-chome
Shinagawa-ku, Tokyo, 140-0001 Japan
Phone +81.3.4331.4300
Fax +81.3.4331.4301
Malaysia
Sartorius Stedim Malaysia Sdn. Bhd.
Lot L3-E-3B, Enterprise 4
Technology Park Malaysia
Bukit Jalil
57000 Kuala Lumpur, Malaysia
Phone +60.3.8996.0622
Fax +60.3.8996.0755
Singapore
Sartorius Stedim Singapore Pte. Ltd.
1 Science Park Road, 
The Capricorn, #05-08A,
Singapore Science Park II
Singapore 117528
Phone +65.6872.3966
Fax +65.6778.2494
South Korea
Sartorius Korea Biotech Co., Ltd.
8th Floor, Solid Space B/D, 
PanGyoYeok-Ro 220, BunDang-Gu
SeongNam-Si, GyeongGi-Do, 463-400
Phone +82.31.622.5700
Fax +82.31.622.5799
www.sartorius-stedim.com Spe
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Material Safety Data Sheet
Sodium hydroxide, Pellets, Reagent ACS MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium hydroxide, Pellets, Reagent ACS
Catalog Codes: SLS4090
CAS#: 1310-73-2
RTECS: WB4900000
TSCA: TSCA 8(b) inventory: Sodium hydroxide
CI#: Not available.
Synonym:   Caustic Soda
Chemical Name: Sodium Hydroxide
Chemical Formula: NaOH
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Sodium hydroxide 1310-73-2 100
Toxicological Data on Ingredients: Sodium hydroxide LD50: Not available. LC50: Not available.
Section 3: Hazards Identification
Potential Acute Health Effects:
Very hazardous in case of skin contact (corrosive, irritant, permeator), of eye contact (irritant, corrosive), of ingestion,
of inhalation. The amount of tissue damage depends on length of contact. Eye contact can result in corneal damage or
blindness. Skin contact can produce inflammation and blistering. Inhalation of dust will produce irritation to gastro-intestinal or
respiratory tract, characterized by burning, sneezing and coughing. Severe over-exposure can produce lung damage, choking,
unconsciousness or death. Inflammation of the eye is characterized by redness, watering, and itching. Skin inflammation is
characterized by itching, scaling, reddening, or, occasionally, blistering.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available. The substance is toxic to lungs. Repeated or prolonged exposure to the
substance can produce target organs damage. Repeated exposure of the eyes to a low level of dust can produce eye irritation.
Repeated skin exposure can produce local skin destruction, or dermatitis. Repeated inhalation of dust can produce varying
degree of respiratory irritation or lung damage.
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Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention immediately.
Skin Contact:
In case of contact, immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing
and shoes. Cover the irritated skin with an emollient. Cold water may be used.Wash clothing before reuse. Thoroughly clean
shoes before reuse. Get medical attention immediately.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek medical attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention immediately.
Serious Inhalation:
Evacuate the victim to a safe area as soon as possible. Loosen tight clothing such as a collar, tie, belt or waistband. If
breathing is difficult, administer oxygen. If the victim is not breathing, perform mouth-to-mouth resuscitation. WARNING: It may
be hazardous to the person providing aid to give mouth-to-mouth resuscitation when the inhaled material is toxic, infectious or
corrosive. Seek immediate medical attention.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. If large quantities of this material are swallowed, call a physician immediately. Loosen tight clothing such as a collar,
tie, belt or waistband.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: of metals
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available. Slightly explosive in presence of heat.
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards:
sodium hydroxide + zinc metal dust causes ignition of the latter. Under proper conditions of temperature, pressure and state
of division, it can ignite or react violently with acetaldehyde, ally alcohol, allyl chloride, benzene-1,4-diol, chlorine trifluoride,
1,2 dichlorethylene, nitroethane, nitromethane, nitroparaffins, nitropropane, cinnamaldehyde, 2,2-dichloro-3,3-dimethylbutane.
Sodium hydroxide in contact with water may generate enough heat to ignite adjacent combustible materials. Phosphorous
boiled with NaOH yields mixed phosphines which may ignite spontanously in air. sodium hydroxide and cinnamaldehyde +
heat may cause ignition. Reaction with certain metals releases flammable and explosive hydrogen gas.
Special Remarks on Explosion Hazards:
Sodium hydroxide reacts to form explosive products with ammonia + silver nitrate. Benzene extract of allyl benzenesulfonate
prepared from allyl alcohol, and benzene sulfonyl chloride in presence of aquesous sodium hydroxide, under vacuum
distillation, residue darkened and exploded. Sodium Hydroxde + impure tetrahydrofuran, which can contain peroxides, can
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cause serious explosions. Dry mixtures of sodium hydroxide and sodium tetrahydroborate liberate hydrogen explosively at
230-270 deg. C. Sodium Hydroxide reacts with sodium salt of trichlorophenol + methyl alcohol + trichlorobenzene + heat to
cause an explosion.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. If necessary: Neutralize the residue with
a dilute solution of acetic acid.
Large Spill:
Corrosive solid. Stop leak if without risk. Do not get water inside container. Do not touch spilled material. Use water spray
to reduce vapors. Prevent entry into sewers, basements or confined areas; dike if needed. Call for assistance on disposal.
Neutralize the residue with a dilute solution of acetic acid. Be careful that the product is not present at a concentration level
above TLV. Check TLV on the MSDS and with local authorities.
Section 7: Handling and Storage
Precautions:
Keep container dry. Do not breathe dust. Never add water to this product. In case of insufficient ventilation, wear suitable
respiratory equipment. If you feel unwell, seek medical attention and show the label when possible. Avoid contact with skin
and eyes. Keep away from incompatibles such as oxidizing agents, reducing agents, metals, acids, alkalis, moisture.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area. Do not store above 23°C (73.4°F).
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection:
Splash goggles. Synthetic apron. Vapor and dust respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Vapor and dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to
avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling
this product.
Exposure Limits:
CEIL: 2 from ACGIH (TLV) [United States] [1995] Consult local authorities for acceptable exposure limits.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid.
Odor: Odorless.
Taste: Not available.
Molecular Weight: 40 g/mole
Color: White.
pH (1% soln/water): 13.5 [Basic.]
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Boiling Point: 1388°C (2530.4°F)
Melting Point: 323°C (613.4°F)
Critical Temperature: Not available.
Specific Gravity: 2.13 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility: Easily soluble in cold water.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Not available.
Incompatibility with various substances:
Highly reactive with metals. Reactive with oxidizing agents, reducing agents, acids, alkalis, moisture.
Corrosivity: Not available.
Special Remarks on Reactivity:
Hygroscopic. Much heat is evolved when solid material is dissolved in water. Therefore cold water and caution must be
used for this process. Sodium hydroxide solution and octanol + diborane during a work-up of a reaction mixture of oxime
and diborane in tetrahyrofuran is very exothermic, a mild explosion being noted on one occassion. Reactive with water,
acids, acid chlorides, strong bases, strong oxidizing agents, strong reducing agents, flammable liquids, organic halogens,
metals (i.e aluminum, tin, zinc), nitromethane, glacial acetic acid, acetic anhydride, acrolein, chlorohydrin, chlorosulfonic acid,
ethylene cyanohydrin, glyoxal, hydrochloric acid, sulfuric acid, hydrosulfuric acid, nitric acid, oleum, propiolactone, acylonitrile,
phorosous pentoxide, chloroethanol, chloroform-methanol, tetrahydroborate, cyanogen azide, 1,2,4,5 tetrachlorobenzene,
cinnamaldehyde. Reacts with formaldehyde hydroxide to yield formic acid, and hydrogen.
Special Remarks on Corrosivity: Very caustic to aluminum and other metals in presence of moisture.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Absorbed through skin. Dermal contact. Eye contact. Inhalation. Ingestion.
Toxicity to Animals:
LD50: Not available. LC50: Not available.
Chronic Effects on Humans: Causes damage to the following organs: lungs.
Other Toxic Effects on Humans:
Extremely hazardous in case of inhalation (lung corrosive). Very hazardous in case of skin contact (corrosive, irritant,
permeator), of eye contact (corrosive), of ingestion, .
Special Remarks on Toxicity to Animals:
p. 5
Lowest Published Lethal Dose: LDL [Rabbit] - Route: Oral; Dose: 500 mg/kg
Special Remarks on Chronic Effects on Humans: May affect genetic material (mutagenic). Investigation as a mutagen
(cytogenetic analysis), but no data available.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: May be harmful if absorbed through skin. Causes severe skin irritation and burns. May
cause deep penetrating ulcers of the skin. Eyes: Causes severe eye irritation and burns. May cause chemical conjunctivitis
and corneal damage. Inhalation: Harmful if inhaled. Causes severe irritation of the respiratory tract and mucous membranes
with coughing, burns, breathing difficulty, and possible coma. Irritation may lead the chemical pneumonitis and pulmonary
edema. Causes chemical burns to the respiratory tract and mucous membranes. Ingestion: May be fatal if swallowed. May
cause severe and permanent damage to the digestive tract. Causes severe gastrointestinal tract irritation and burns. May
cause perforation of the digestive tract. Causes severe pain, nausea, vomiting, diarrhea, and shock. May cause corrosion and
permanent destruction of the esophagus and digestive tract.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.
Section 14: Transport Information
DOT Classification: Class 8: Corrosive material
Identification: : Sodium hydroxide, solid UNNA: 1823 PG: II
Special Provisions for Transport: Not available.
Section 15: Other Regulatory Information
Federal and State Regulations:
Illinois toxic substances disclosure to employee act: Sodium hydroxide Illinois chemical safety act: Sodium hydroxide New
York release reporting list: Sodium hydroxide Rhode Island RTK hazardous substances: Sodium hydroxide Pennsylvania
RTK: Sodium hydroxide Minnesota: Sodium hydroxide Massachusetts RTK: Sodium hydroxide New Jersey: Sodium hydroxide
Louisiana spill reporting: Sodium hydroxide California Director's List of Hazardous Substances: Sodium hydroxide TSCA 8(b)
inventory: Sodium hydroxide CERCLA: Hazardous substances.: Sodium hydroxide: 1000 lbs. (453.6 kg)
Other Regulations:
OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200). EINECS: This product is on the
European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): CLASS E: Corrosive solid.
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DSCL (EEC):
HMIS (U.S.A.):
Health Hazard: 3
Fire Hazard: 0
Reactivity: 2
Personal Protection: j
National Fire Protection Association (U.S.A.):
Health: 3
Flammability: 0
Reactivity: 1
Specific hazard:
Protective Equipment:
Gloves. Synthetic apron. Vapor and dust respirator. Be sure to use an approved/certified respirator or equivalent. Wear
appropriate respirator when ventilation is inadequate. Splash goggles.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/09/2005 06:32 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Material Safety Data Sheet
Sodium Hydroxide, 50% MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium Hydroxide, 50%
Catalog Codes: SLS3127, SLS4549
CAS#: Mixture.
RTECS: Not applicable.
TSCA: TSCA 8(b) inventory: Sodium hydroxide; Water
CI#: Not applicable.
Synonym:   Sodium Hydroxide, 50% Solution
Chemical Name: Not applicable.
Chemical Formula: Not applicable.
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Sodium hydroxide 1310-73-2 50
Water 7732-18-5 50
Toxicological Data on Ingredients: Sodium hydroxide LD50: Not available. LC50: Not available.
Section 3: Hazards Identification
Potential Acute Health Effects:
Very hazardous in case of skin contact (corrosive, irritant, permeator), of eye contact (irritant, corrosive), of ingestion, . Slightly
hazardous in case of inhalation (lung sensitizer). Liquid or spray mist may produce tissue damage particularly on mucous
membranes of eyes, mouth and respiratory tract. Skin contact may produce burns. Inhalation of the spray mist may produce
severe irritation of respiratory tract, characterized by coughing, choking, or shortness of breath. Severe over-exposure can
result in death. Inflammation of the eye is characterized by redness, watering, and itching. Skin inflammation is characterized
by itching, scaling, reddening, or, occasionally, blistering.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available. The substance is toxic to lungs. Repeated or prolonged exposure to the
substance can produce target organs damage. Repeated or prolonged contact with spray mist may produce chronic eye
irritation and severe skin irritation. Repeated or prolonged exposure to spray mist may produce respiratory tract irritation
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leading to frequent attacks of bronchial infection. Repeated exposure to a highly toxic material may produce general
deterioration of health by an accumulation in one or many human organs.
Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. Immediately flush eyes with running water for at least 15 minutes, keeping eyelids
open. Cold water may be used. Get medical attention immediately. Finish by rinsing thoroughly with running water to avoid a
possible infection.
Skin Contact:
In case of contact, immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing
and shoes. Cover the irritated skin with an emollient. Cold water may be used.Wash clothing before reuse. Thoroughly clean
shoes before reuse. Get medical attention immediately.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek immediate medical
attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention immediately.
Serious Inhalation:
Evacuate the victim to a safe area as soon as possible. Loosen tight clothing such as a collar, tie, belt or waistband. If
breathing is difficult, administer oxygen. If the victim is not breathing, perform mouth-to-mouth resuscitation. Seek medical
attention.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an
unconscious person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention immediately.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: Not applicable.
Explosion Hazards in Presence of Various Substances: Non-explosive in presence of open flames and sparks, of shocks.
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards:
Sodium hydroxide reacts to form explosive products with ammonia + silver nitrate. Benzene extract of allyl benzenesulfonate
prepared from allyl alcohol, and benzene sulfonyl chloride in presence of aquesous sodium hydroxide, under vacuum
distillation, residue darkened and exploded. Sodium Hydroxde + impure tetrahydrofuran, which can contain peroxides, can
cause serious explosions. Dry mixtures of sodium hydroxide and sodium tetrahydroborate liberate hydrogen explosively at
230-270 deg. C. Sodium Hydroxide reacts with sodium salt of trichlorophenol + methyl alcohol + trichlorobenzene + heat to
cause an explosion. (Sodium hydroxide)
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Section 6: Accidental Release Measures
Small Spill:
Dilute with water and mop up, or absorb with an inert dry material and place in an appropriate waste disposal container. If
necessary: Neutralize the residue with a dilute solution of acetic acid.
Large Spill:
Corrosive liquid. Poisonous liquid. Stop leak if without risk. Absorb with DRY earth, sand or other non-combustible material.
Do not get water inside container. Do not touch spilled material. Use water spray curtain to divert vapor drift. Use water spray
to reduce vapors. Prevent entry into sewers, basements or confined areas; dike if needed. Call for assistance on disposal.
Neutralize the residue with a dilute solution of acetic acid. Be careful that the product is not present at a concentration level
above TLV. Check TLV on the MSDS and with local authorities.
Section 7: Handling and Storage
Precautions:
Do not ingest. Do not breathe gas/fumes/ vapor/spray. Never add water to this product. In case of insufficient ventilation,
wear suitable respiratory equipment. If ingested, seek medical advice immediately and show the container or the label. Avoid
contact with skin and eyes. Keep away from incompatibles such as oxidizing agents, reducing agents, metals, acids, alkalis,
moisture.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area.
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Provide exhaust ventilation or other engineering controls to keep the airborne concentrations of vapors below their respective
threshold limit value.
Personal Protection:
Face shield. Full suit. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Gloves. Boots.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Vapor respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits:
Sodium hydroxide STEL: 2 (mg/m3) from ACGIH (TLV) [United States] TWA: 2 CEIL: 2 (mg/m3) from OSHA (PEL) [United
States] CEIL: 2 (mg/m3) from NIOSHConsult local authorities for acceptable exposure limits.
Section 9: Physical and Chemical Properties
Physical state and appearance: Liquid.
Odor: Odorless.
Taste: Alkaline. Bitter. (Strong.)
Molecular Weight: Not applicable.
Color: Clear Colorless.
pH (1% soln/water): Basic.
Boiling Point: 140°C (284°F)
Melting Point: 12°C (53.6°F)
Critical Temperature: Not available.
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Specific Gravity: 1.53 (Water = 1)
Vapor Pressure: The highest known value is 2.3 kPa (@ 20°C) (Water).
Vapor Density: The highest known value is 0.62 (Air = 1) (Water).
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility: Easily soluble in cold water.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Excess heat, incompatible materials, water/moisture
Incompatibility with various substances:
Reactive with oxidizing agents, reducing agents, metals, acids, alkalis. Slightly reactive with water
Corrosivity:
Extremely corrosive in presence of aluminum, brass. Corrosive in presence of copper, of stainless steel(304), of stainless
steel(316). Non-corrosive in presence of glass.
Special Remarks on Reactivity:
Hygroscopic. Much heat is evolved when solid material is dissolved in water. Therefore cold water and caution must be
used for this process. Generates considerable heat when a sodium hydroxide solution is mixed with an acid Sodium
hydroxide solution and octanol + diborane during a work-up of a reaction mixture of oxime and diborane in tetrahyrofuran
is very exothermic, a mild explosion being noted on one occassion. Reactive with water, acids (mineral, non-oxidizing, e.g.
hydrochloric, hydrofluoric acid, muriatic acid, phosphoric), acids (mineral, oxidizing e.g. chromic acid, hypochlorous acid, nitric
acid, sulfuric acid), acids (organic e.g. acetic acid, benzoic acid, formic acid, methanoic acid, oxalic acid), aldehydes (e.g.
acetaldehyde, acrolein, chloral hydrate, foraldehyde), carbamates (e.g. carbanolate, carbofuran), esters (e.g. butyl acetate,
ethyl acetate, propyl formate), halogenated organics (dibromoethane, hexachlorobenzene, methyl chloride, trichloroethylene),
isocyanates (e.g. methyl isocyanate), ketones (acetone, acetophenone, MEK, MIBK), acid chlorides, strong bases, strong
oxidizing agents, strong reducing agents, flammable liquids, powdered metals and metals (i.e aluminum, tin, zinc, hafnium,
raney nickel), metals (alkali and alkaline e.g. cesium, potassium, sodium), metal compounds (toxic e.g. berylium, lead
acetate, nickel carbonyl, tetraethyl lead), mitrides (e.g. potassium nitride, sodium nitride), nitriles (e.g. acetonitrile, methyl
cyanide), nitro compounds (organic e.g. nitrobenzene, nitromethane), acetic anhydride, hydroquinone, chlorohydrin,
chlorosulfonic acid, ethylene cyanohydrin, glyoxal, hydrosulfuric acid, oleum, propiolactone, acylonitrile, phorosous pentoxide,
chloroethanol, chloroform-methanol, tetrahydroborate, cyanogen azide, 1,2,4,5 tetrachlorobenzene, cinnamaldehyde. Reacts
with formaldehyde hydroxide to yield formic acid, and hydrogen. (Sodium hydroxide)
Special Remarks on Corrosivity: Very caustic to aluminum and other metals in presence of moisture.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Absorbed through skin. Dermal contact. Eye contact. Inhalation.
Toxicity to Animals:
LD50: Not available. LC50: Not available.
Chronic Effects on Humans: Not available.
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Other Toxic Effects on Humans:
Extremely hazardous in case of inhalation (lung corrosive). Very hazardous in case of skin contact (corrosive, irritant,
permeator), of eye contact (corrosive), of ingestion, .
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: Investigation as a mutagen (cytogenetic analysis), but no data available.
(Sodium hydroxide)
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: May be harmful if absorbed through skin. Causes severe skin irritation and burns. May
cause deep penetrating ulcers of the skin. Eyes: Causes severe eye irritation and burns. May cause chemical conjunctivitis
and corneal damage. Inhalation: Harmful if inhaled. Causes severe irritation of the respiratory tract and mucous membranes
with coughing, burns, breathing difficulty, and possible coma. Irritation may lead the chemical pneumonitis and pulmonary
edema. Causes chemical burns to the respiratory tract and mucous membranes. Ingestion: May be fatal if swallowed. May
cause severe and permanent damage to the digestive tract. Causes
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The products of degradation are less toxic than the product itself.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.
Section 14: Transport Information
DOT Classification: Class 8: Corrosive material
Identification: : Sodium hydroxide, solution (Sodium hydroxide) UNNA: UN1824 PG: II
Special Provisions for Transport: Not available.
Section 15: Other Regulatory Information
Federal and State Regulations:
Illinois toxic substances disclosure to employee act: Sodium hydroxide Illinois chemical safety act: Sodium hydroxide New
York release reporting list: Sodium hydroxide Rhode Island RTK hazardous substances: Sodium hydroxide Pennsylvania
RTK: Sodium hydroxide Minnesota: Sodium hydroxide Massachusetts RTK: Sodium hydroxide New Jersey: Sodium hydroxide
Louisiana spill reporting: Sodium hydroxide TSCA 8(b) inventory: Sodium hydroxide; Water CERCLA: Hazardous substances.:
Sodium hydroxide: 1000 lbs. (453.6 kg);
Other Regulations: OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200).
Other Classifications:
WHMIS (Canada):
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CLASS D-2A: Material causing other toxic effects (VERY TOXIC). CLASS E: Corrosive liquid.
DSCL (EEC):
HMIS (U.S.A.):
Health Hazard: 3
Fire Hazard: 0
Reactivity: 1
Personal Protection:
National Fire Protection Association (U.S.A.):
Health: 3
Flammability: 0
Reactivity: 1
Specific hazard:
Protective Equipment:
Gloves. Full suit. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Wear appropriate respirator
when ventilation is inadequate. Face shield.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/09/2005 06:32 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Material Safety Data Sheet
Sodium chloride MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium chloride
Catalog Codes: SLS3262, SLS1045, SLS3889, SLS1669,
SLS3091
CAS#: 7647-14-5
RTECS: VZ4725000
TSCA: TSCA 8(b) inventory: Sodium chloride
CI#: Not applicable.
Synonym:   Salt; Sea Salt
Chemical Name: Sodium chloride
Chemical Formula: NaCl
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Sodium chloride 7647-14-5 100
Toxicological Data on Ingredients: Sodium chloride: ORAL (LD50): Acute: 3000 mg/kg [Rat.]. 4000 mg/kg [Mouse].
DERMAL (LD50): Acute: &gt;10000 mg/kg [Rabbit]. DUST (LC50): Acute: &gt;42000 mg/m 1 hours [Rat].
Section 3: Hazards Identification
Potential Acute Health Effects: Slightly hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of
inhalation.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells. Mutagenic for
bacteria and/or yeast. TERATOGENIC EFFECTS: Not available. DEVELOPMENTAL TOXICITY: Not available. Repeated or
prolonged exposure is not known to aggravate medical condition.
Section 4: First Aid Measures
Eye Contact:
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Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention.
Skin Contact:
Wash with soap and water. Cover the irritated skin with an emollient. Get medical attention if irritation develops. Cold water
may be used.
Serious Skin Contact: Not available.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention if symptoms appear.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if symptoms appear.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: Not applicable.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available.
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards: When heated to decomposition it emits toxic fumes.
Special Remarks on Explosion Hazards:
Electrolysis of sodium chloride in presence of nitrogenous compounds to produce chlorine may lead to formation of explosive
nitrogen trichloride. Potentially explosive reaction with dichloromaleic anhydride + urea.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by spreading water on
the contaminated surface and dispose of according to local and regional authority requirements.
Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water on the
contaminated surface and allow to evacuate through the sanitary system.
Section 7: Handling and Storage
Precautions:
Keep locked up.. Do not ingest. Do not breathe dust. Avoid contact with eyes. Wear suitable protective clothing. If ingested,
seek medical advice immediately and show the container or the label. Keep away from incompatibles such as oxidizing
agents, acids.
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Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area. Hygroscopic
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection:
Splash goggles. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Solid crystalline powder.)
Odor: Slight.
Taste: Saline.
Molecular Weight: 58.44 g/mole
Color: White.
pH (1% soln/water): 7 [Neutral.]
Boiling Point: 1413°C (2575.4°F)
Melting Point: 801°C (1473.8°F)
Critical Temperature: Not available.
Specific Gravity: 2.165 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility:
Easily soluble in cold water, hot water. Soluble in glycerol, and ammonia. Very slightly soluble in alcohol. Insoluble in
Hydrochloric Acid.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
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Instability Temperature: Not available.
Conditions of Instability: Incompatible materials, high temperatures.
Incompatibility with various substances: Reactive with oxidizing agents, metals, acids.
Corrosivity: Not considered to be corrosive for metals and glass.
Special Remarks on Reactivity:
Hygroscopic. Reacts with most nonnoble metals such as iron or steel, building materials (such as cement) Sodium chloride is
rapidly attacked by bromine trifluoride. Violent reaction with lithium.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Inhalation. Ingestion.
Toxicity to Animals:
WARNING: THE LC50 VALUES HEREUNDER ARE ESTIMATED ON THE BASIS OF A 4-HOUR EXPOSURE. Acute oral
toxicity (LD50): 3000 mg/kg [Rat.]. Acute dermal toxicity (LD50): >10000 mg/kg [Rabbit]. Acute toxicity of the dust (LC50):
>42000 mg/m3 1 hours [Rat].
Chronic Effects on Humans: MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells. Mutagenic for bacteria and/
or yeast.
Other Toxic Effects on Humans: Slightly hazardous in case of skin contact (irritant), of ingestion, of inhalation.
Special Remarks on Toxicity to Animals: Lowest Published Lethal Dose (LDL) [Man] - Route: Oral; Dose: 1000 mg/kg
Special Remarks on Chronic Effects on Humans:
Causes adverse reproductive effects in humans (fetotoxicity, abortion, ) by intraplacental route. High intake of sodium chloride,
whether from occupational exposure or in the diet, may increase risk of TOXEMIA OF PREGNANCY in susceptible women
(Bishop, 1978). Hypertonic sodium chloride solutions have been used to induce abortion in late pregnancy by direct infusion
into the uterus (Brown et al, 1972), but this route of administration is not relevant to occupational exposures. May cause
adverse reproductive effects and birth defects in animals, particularly rats and mice (fetotoxicity, abortion, musculoskeletal
abnormalities, and maternal effects (effects on ovaries, fallopian tubes) by oral, intraperitoneal, intraplacental, intrauterine,
parenteral, and subcutaneous routes. While sodium chloride has been used as a negative control n some reproductive
studies, it has also been used as an example that almost any chemical can cause birth defects in experimental animals
if studied under the right conditions (Nishimura & Miyamoto, 1969). In experimental animals, sodium chloride has caused
delayed effects on newborns, has been fetotoxic, and has caused birth defects and abortions in rats and mice (RTECS, 1997).
May affect genetic material (mutagenic)
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: May cause skin irritation. Eyes: Causes eye irritation. Ingestion: Ingestion of large
quantities can irritate the stomach (as in overuse of salt tablets) with nausea and vomiting. May affect behavior (muscle
spasicity/contraction, somnolence), sense organs, metabolism, and cardiovascular system. Continued exposure may
produce dehydration, internal organ congestion, and coma. Inhalation: Material is irritating to mucous membranes and upper
respiratory tract.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
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Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: Sodium chloride
Other Regulations: EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
R40- Possible risks of irreversible effects. S24/25- Avoid contact with skin and eyes.
HMIS (U.S.A.):
Health Hazard: 1
Fire Hazard: 0
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 1
Flammability: 0
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Splash goggles.
Section 16: Other Information
References:
-Hawley, G.G.. The Condensed Chemical Dictionary, 11e ed., New York N.Y., Van Nostrand Reinold, 1987. -SAX, N.I.
Dangerous Properties of Indutrial Materials. Toronto, Van Nostrand Reinold, 6e ed. 1984. -The Sigma-Aldrich Library of
Chemical Safety Data, Edition II.
Other Special Considerations: Not available.
Created: 10/11/2005 12:33 PM
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Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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SECTION: 1. Product and company identification 
 
1.1. Product identifier 
Product form : Substance 
Name : Nitrogen, refrigerated liquid 
CAS No : 7727-37-9 
Formula : N2 
Other means of identification : Nitrogen (cryogenic liquid), Nitrogen, Medipure Liquid Nitrogen 
 
1.2. Relevant identified uses of the substance or mixture and uses advised against 
Use of the substance/mixture : Medical applications 
Industrial use 
Food applications 
 
1.3. Details of the supplier of the safety data sheet 
Praxair, Inc. 
10 Riverview Drive 
Danbury, CT 06810-6268 - USA 
T 1-800-772-9247 (1-800-PRAXAIR) - F 1-716-879-2146 
www.praxair.com 
 
1.4. Emergency telephone number 
Emergency number : Onsite Emergency: 1-800-645-4633 
 
 
CHEMTREC, 24hr/day 7days/week  
— Within USA: 1-800-424-9300, Outside USA: 001-703-527-3887  
(collect calls accepted, Contract 17729) 
 
SECTION 2: Hazard identification 
 
2.1. Classification of the substance or mixture 
GHS-US classification 
Refrigerated liquefied gas H281  
  
 
 
2.2. Label elements 
GHS-US labeling 
Hazard pictograms (GHS-US) : 
 
GHS04 
     
Signal word (GHS-US) : WARNING 
Hazard statements (GHS-US) : H281 - CONTAINS REFRIGERATED GAS; MAY CAUSE CRYOGENIC BURNS OR INJURY 
OSHA-H01 - MAY DISPLACE OXYGEN AND CAUSE RAPID SUFFOCATION 
Precautionary statements (GHS-US) : P202 - Do not handle until all safety precautions have been read and understood 
P271+P403 - Use and store only outdoors or in a well-ventilated place 
P282 - Wear cold insulating gloves/face shield/eye protection. cold insulating gloves, face 
shield, eye protection 
CGA-PG05 - Use a back flow preventive device in the piping 
CGA-PG24 - DO NOT change or force fit connections 
CGA-PG06 - Close valve after each use and when empty 
CGA-PG23 - Always keep container in upright position 
 
 
2.3. Other hazards 
Other hazards not contributing to the : Asphyxiant in high concentrations 
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classification Contact with liquid may cause cold burns/frostbite. 
2.4. Unknown acute toxicity (GHS US) 
No data available 
SECTION 3: Composition/Information on ingredients 
 
3.1. Substance 
 
 
Name Product identifier % 
Nitrogen, refrigerated liquid 
(Main constituent) 
(CAS No) 7727-37-9  100 
 
 
3.2. Mixture 
Not applicable 
SECTION 4: First aid measures 
 
4.1. Description of first aid measures 
First-aid measures after inhalation : Remove victim to uncontaminated area wearing self contained breathing apparatus. Keep 
victim warm and rested. Call a doctor. Apply artificial respiration if breathing stopped. 
First-aid measures after skin contact : The liquid may cause frostbite. For exposure to liquid, immediately warm frostbite area with 
warm water not to exceed 105°F (41°C).  Water temperature should be tolerable to normal 
skin.  Maintain skin warming for at least 15 minutes or until normal coloring and sensation have 
returned to the affected area. In case of massive exposure, remove clothing while showering 
with warm water. Seek medical evaluation and treatment as soon as possible. 
First-aid measures after eye contact : Immediately flush eyes thoroughly with water for at least 15 minutes. Hold the eyelids open and 
away from the eyeballs to ensure that all surfaces are flushed thoroughly.  Contact an 
ophthalmologist immediately.. Get immediate medical attention. 
First-aid measures after ingestion : Ingestion is not considered a potential route of exposure. 
 
4.2. Most important symptoms and effects, both acute and delayed 
No additional information available 
 
4.3. Indication of any immediate medical attention and special treatment needed 
None. 
SECTION 5: Firefighting measures 
 
5.1. Extinguishing media 
Suitable extinguishing media : Use extinguishing media appropriate for surrounding fire. 
 
5.2. Special hazards arising from the substance or mixture 
Reactivity : No reactivity hazard other than the effects described in sub-sections below. 
 
5.3. Advice for firefighters 
Firefighting instructions : DANGER! Extremely cold liquid and gas under pressure.  Take care not to direct spray onto 
vents on top of container.   Do not discharge sprays directly into liquid; cryogenic liquid can 
freeze water rapidly 
 
Evacuate all personnel from the danger area.  Use self-contained breathing apparatus (SCBA) 
and protective clothing.  Immediately cool containers with water from maximum distance. Stop 
flow of gas if safe to do so, while continuing cooling water spray.  Remove ignition sources if 
safe to do so. Remove containers from area of fire if safe to do so.  On-site fire brigades must 
comply with OSHA 29 CFR 1910.156 and applicable standards under 29 CFR 1910 Subpart 
L—Fire Protection. 
Protection during firefighting : Compressed gas: asphyxiant. Suffocation hazard by lack of oxygen. 
Special protective equipment for fire fighters : Use self-contained breathing apparatus. Standard protective clothing and equipment (Self 
Contained Breathing Apparatus) for fire fighters. 
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Specific methods : Use fire control measures appropriate for the surrounding fire. Exposure to fire and heat 
radiation may cause gas containers to rupture. Cool endangered containers with water spray jet 
from a protected position. Prevent water used in emergency cases from entering sewers and 
drainage systems 
 
Exposure to fire may cause containers to rupture/explode 
 
Stop flow of product if safe to do so 
 
Use water spray or fog to knock down fire fumes if possible 
 
If leaking do not spray water onto container. Water surrounding area (from protected position) 
to contain fire. 
Other information : Cryogenic liquid causes severe frostbite, a burn-like injury. Heat of fire can build pressure in a 
closed container and cause it to rupture.  Venting vapors may obscure visibility. Air will 
condense on surfaces such as vaporizers or piping exposed to liquid or cold gas.  Nitrogen, 
which has a lower boiling point than oxygen, evaporates first, leaving an oxygen-enriched 
condensate 
 
Containers are equipped with a pressure relief device. (Exceptions may exist where authorized 
by DOT.). 
SECTION 6: Accidental release measures 
 
6.1. Personal precautions, protective equipment and emergency procedures 
General measures : Evacuate area. Ensure adequate air ventilation. Wear self-contained breathing apparatus when 
entering area unless atmosphere is proven to be safe. Prevent from entering sewers, 
basements and workpits, or any place where its accumulation can be dangerous. Stop leak if 
safe to do so. 
6.1.1. For non-emergency personnel 
No additional information available 
6.1.2. For emergency responders 
No additional information available 
 
6.2. Environmental precautions 
Try to stop release. 
 
6.3. Methods and material for containment and cleaning up 
No additional information available 
 
6.4. Reference to other sections 
See also sections 8 and 13. 
SECTION 7: Handling and storage 
 
7.1. Precautions for safe handling 
Precautions for safe handling : Wear leather safety gloves and safety shoes when handling cylinders.  Protect cylinders from 
physical damage; do not drag, roll, slide or drop.  While moving cylinder, always keep in place 
removable valve cover.  Never attempt to lift a cylinder by its cap; the cap is intended solely to 
protect the valve.  When moving cylinders, even for short distances, use a cart (trolley, hand 
truck, etc.) designed to transport cylinders.  Never insert an object (e.g, wrench, screwdriver, 
pry bar) into cap openings; doing so may damage the valve and cause a leak.  Use an 
adjustable strap wrench to remove over-tight or rusted caps.  Slowly open the valve.  If the 
valve is hard to open, discontinue use and contact your supplier.  Close the container valve 
after each use; keep closed even when empty.  Never apply flame or localized heat directly to 
any part of the container.  High temperatures may damage the container and could cause the 
pressure relief device to fail prematurely, venting the container contents.  For other precautions 
in using this product, see section 16. 
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7.2. Conditions for safe storage, including any incompatibilities 
Storage conditions : Store in a cool, well-ventilated place. Store and use with adequate ventilation. Store only where 
temperature will not exceed 125°F (52°C). Firmly secure containers upright to keep them from 
falling or being knocked over. Install valve protection cap, if provided, firmly in place by hand. 
Store full and empty containers separately. Use a first-in, first-out inventory system to prevent 
storing full containers for long periods 
 
OTHER PRECAUTIONS FOR HANDLING, STORAGE, AND USE: When handling product 
under pressure, use piping and equipment adequately designed to withstand the pressures to 
be encountered. Never work on a pressurized system. Use a back flow preventive device in the 
piping. Gases can cause rapid suffocation because of oxygen deficiency; store and use with 
adequate ventilation. If a leak occurs, close the container valve and blow down the system in a 
safe and environmentally correct manner in compliance with all international, federal/national, 
state/provincial, and local laws; then repair the leak. Never place a container where it may 
become part of an electrical circuit. 
 
7.3. Specific end use(s) 
None. 
SECTION 8: Exposure controls/personal protection 
 
8.1. Control parameters 
Nitrogen, refrigerated liquid (7727-37-9) 
ACGIH Not established 
USA OSHA Not established 
 
 
8.2. Exposure controls 
Appropriate engineering controls : Oxygen detectors should be used when asphyxiating gases may be released. Systems under 
pressure should be regularly checked for leakages. Provide adequate general and local 
exhaust ventilation. Consider work permit system e.g. for maintenance activities. 
Hand protection : Wear working gloves when handling gas containers. 
Eye protection : Wear safety glasses with side shields. Wear goggles and a face shield when transfilling or 
breaking transfer connections. 
Respiratory protection : Self contained breathing apparatus (SCBA) or positive pressure airline with mask are to be 
used in oxygen-deficient atmospheres. 
Thermal hazard protection : Wear cold insulating gloves. Wear cold insulating gloves when transfilling or breaking transfer 
connections. 
Environmental exposure controls : None necessary. 
Other information : Wear safety shoes while handling containers. 
SECTION 9: Physical and chemical properties 
 
9.1. Information on basic physical and chemical properties 
Physical state : Gas 
  
Appearance : Colorless liquid. 
Molecular mass : 28 g/mol 
Color : Colorless liquid. 
  
Odor : No odor warning properties. 
  
Odor threshold : No data available 
  
pH : Not applicable. 
  
Relative evaporation rate (butyl acetate=1) : No data available 
  
Relative evaporation rate (ether=1) : Not applicable. 
Melting point : -210 °C 
  
Freezing point : No data available 
  
Boiling point : -195.8 °C 
  
Flash point : No data available 
  
Critical temperature : -149.9 °C 
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Auto-ignition temperature : Not applicable. 
  
Decomposition temperature : No data available 
  
Flammability (solid, gas) : No data available 
  
Vapor pressure : Not applicable. 
  
Critical pressure : 3390 kPa 
Relative vapor density at 20 °C : No data available 
  
Relative density : 0.8 
  
Density : 808.5 kg/m³ Liquid density at boiling point and 1 atm 
Relative gas density : 0.97 
Solubility : Water: 20 mg/l 
  
Log Pow : Not applicable. 
  
Log Kow : Not applicable. 
  
Viscosity, kinematic : Not applicable. 
  
Viscosity, dynamic : Not applicable. 
  
Explosive properties : Not applicable. 
  
Oxidizing properties : None. 
  
Explosion limits : No data available 
  
 
9.2. Other information 
Gas group : Refrigerated liquefied gas 
Additional information : Gas/vapor heavier than air. May accumulate in confined spaces, particularly at or below ground 
level 
SECTION 10: Stability and reactivity 
 
10.1. Reactivity 
No reactivity hazard other than the effects described in sub-sections below. 
 
10.2. Chemical stability 
Stable under normal conditions. 
 
10.3. Possibility of hazardous reactions 
None. 
 
10.4. Conditions to avoid 
Avoid high temperatures, exposure to Lithium (Li), Neodymium (Nd), Titanium (Ti), Magnesium. 
 
10.5. Incompatible materials 
None. 
 
10.6. Hazardous decomposition products 
Under certain conditions, nitrogen can react violently with lithium, neodymium, titanium (above 
1472°F/800°C), and magnesium to form nitrides.  At high temperature, it can also combine with 
oxygen and hydrogen. 
SECTION 11: Toxicological information 
 
11.1. Information on toxicological effects 
 
Acute toxicity : Not classified 
 
 
Skin corrosion/irritation : Not classified 
pH: Not applicable. 
Serious eye damage/irritation : Not classified 
pH: Not applicable. 
Respiratory or skin sensitization : Not classified 
Germ cell mutagenicity : Not classified 
Carcinogenicity : Not classified 
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Reproductive toxicity : Not classified 
Specific target organ toxicity (single exposure) : Not classified 
 
 
Specific target organ toxicity (repeated 
exposure) 
: Not classified 
 
 
Aspiration hazard : Not classified 
SECTION 12: Ecological information 
 
12.1. Toxicity 
Ecology - general : No ecological damage caused by this product. 
 
 
 
12.2. Persistence and degradability 
Nitrogen, refrigerated liquid (7727-37-9) 
Persistence and degradability No ecological damage caused by this product. 
 
 
12.3. Bioaccumulative potential 
Nitrogen, refrigerated liquid (7727-37-9) 
Log Pow Not applicable. 
Log Kow Not applicable. 
Bioaccumulative potential No ecological damage caused by this product. 
 
 
12.4. Mobility in soil 
Nitrogen, refrigerated liquid (7727-37-9) 
Mobility in soil No data available. 
Ecology - soil No ecological damage caused by this product. 
 
 
 
12.5. Other adverse effects 
Other adverse effects : Can cause frost damage to vegetation. 
Effect on ozone layer : None 
 
Effect on the global warming : No known effects from this product 
 
SECTION 13: Disposal considerations 
 
13.1. Waste treatment methods 
Waste disposal recommendations : Dispose of contents/container in accordance with local/regional/national/international 
regulations.  Contact supplier for any special requirements. 
SECTION 14: Transport information 
 
In accordance with DOT 
Transport document description : UN1977 Nitrogen, refrigerated liquid (cryogenic liquid), 2.2  
UN-No.(DOT) : UN1977 
Proper Shipping Name (DOT) : Nitrogen, refrigerated liquid 
cryogenic liquid 
Class (DOT) : 2.2 - Class 2.2 - Non-flammable compressed gas 49 CFR 173.115 
Hazard labels (DOT) : 2.2 - Non-flammable gas 
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DOT Special Provisions (49 CFR 172.102) : 345 - “Nitrogen, refrigerated liquid (cryogenic liquid), UN1977” transported in open cryogenic 
receptacles with a maximum capacity of 1 L are not subject to the requirements of this 
subchapter. The receptacles must be constructed with glass double walls having the space 
between the walls vacuum insulated and each receptacle must be transported in an outer 
packaging with sufficient cushioning and absorbent materials to protect the receptacle from 
damage 
346 - “Nitrogen, refrigerated liquid (cryogenic liquid), UN1977” transported in accordance with 
the requirements for open cryogenic receptacles in §173.320 and this special provision are not 
subject to any other requirements of this subchapter. The receptacle must contain no 
hazardous materials other than the liquid nitrogen which must be fully absorbed in a porous 
material in the receptacle 
T75 - When portable tank instruction T75 is referenced in Column (7) of the 172.101 Table, the 
applicable refrigerated liquefied gases are authorized to be transported in portable tanks in 
accordance with the requirements of 178.277 of this subchapter 
TP5 - For a portable tank used for the transport of flammable refrigerated liquefied gases or 
refrigerated liquefied oxygen, the maximum rate at which the portable tank may be filled must 
not exceed the liquid flow capacity of the primary pressure relief system rated at a pressure not 
exceeding 120 percent of the portable tank's design pressure. For portable tanks used for the 
transport of refrigerated liquefied helium and refrigerated liquefied atmospheric gas (except 
oxygen), the maximum rate at which the tank is filled must not exceed the liquid flow capacity of 
the pressure relief device rated at 130 percent of the portable tank's design pressure. Except 
for a portable tank containing refrigerated liquefied helium, a portable tank shall have an outage 
of at least two percent below the inlet of the pressure relief device or pressure control valve, 
under conditions of incipient opening, with the portable tank in a level attitude. No outage is 
required for helium 
 
Additional information 
Emergency Response Guide (ERG) Number : 121 (UN1066);120 (UN1977) 
Other information : No supplementary information available. 
 
Special transport precautions : Avoid transport on vehicles where the load space is not separated from the driver's 
compartment. Ensure vehicle driver is aware of the potential hazards of the load and knows 
what to do in the event of an accident or an emergency. Before transporting product containers: 
- Ensure there is adequate ventilation. - Ensure that containers are firmly secured. - Ensure 
cylinder valve is closed and not leaking. - Ensure valve outlet cap nut or plug (where provided) 
is correctly fitted. - Ensure valve protection device (where provided) is correctly fitted. 
 
 
Transport by sea 
UN-No. (IMDG) : 1977 
Proper Shipping Name (IMDG) : NITROGEN, REFRIGERATED LIQUID 
Class (IMDG) : 2.2 - Non-flammable, non-toxic gases 
MFAG-No : 120 
Air transport 
UN-No. (IATA) : 1977 
Proper Shipping Name (IATA) : NITROGEN, REFRIGERATED LIQUID 
Class (IATA) : 2 
Civil Aeronautics Law : Gases under pressure/Gases nonflammable nontoxic under pressure 
SECTION 15: Regulatory information 
 
15.1. US Federal regulations 
Nitrogen, refrigerated liquid (7727-37-9) 
Listed on the United States TSCA (Toxic Substances Control Act) inventory 
SARA Section 311/312 Hazard Classes Immediate (acute) health hazard 
Sudden release of pressure hazard 
All components of this product are listed on the Toxic Substances Control Act (TSCA) 
inventory. 
 
 
 
 
 Nitrogen, refrigerated liquid 
Safety Data Sheet P-4630  
This SDS conforms to U.S. Code of Federal Regulations 29 CFR 1910.1200, Hazard Communication. 
Date of issue: 01/01/1979 Revision date: 10/21/2016  Supersedes: 10/03/2014  
 
 
EN (English US) SDS ID: P-4630  8/9 
This document is only controlled while on the Praxair, Inc. website and a copy of this controlled version is available for download. Praxair cannot assure the integrity or 
accuracy of any version of this document after it has been downloaded or removed from our website. 
 
This product or mixture does not contain a toxic chemical or chemicals in excess 
of the applicable de minimis concentration as specified in 40 CFR §372.38(a) 
subject to the reporting requirements of section 313 of Title III of the Superfund 
Amendments and Reauthorization Act of 1986 and 40 CFR Part 372. 
 
 
 
 
 
15.2. International regulations 
CANADA 
 
Nitrogen, refrigerated liquid (7727-37-9) 
Listed on the Canadian DSL (Domestic Substances List) 
 
  
 
EU-Regulations 
 
Nitrogen, refrigerated liquid (7727-37-9) 
Listed on the EEC inventory EINECS (European Inventory of Existing Commercial Chemical Substances) 
 
 
15.2.2. National regulations 
Nitrogen, refrigerated liquid (7727-37-9) 
Listed on the AICS (Australian Inventory of Chemical Substances) 
Listed on IECSC (Inventory of Existing Chemical Substances Produced or Imported in China) 
Listed on the Korean ECL (Existing Chemicals List) 
Listed on NZIoC (New Zealand Inventory of Chemicals)  
Listed on PICCS (Philippines Inventory of Chemicals and Chemical Substances) 
Listed on INSQ (Mexican National Inventory of Chemical Substances) 
 
 
15.3. US State regulations 
Nitrogen, refrigerated liquid(7727-37-9) 
U.S. - California - Proposition 65 - Carcinogens List No 
U.S. - California - Proposition 65 - Developmental 
Toxicity 
No 
U.S. - California - Proposition 65 - Reproductive 
Toxicity - Female 
No 
U.S. - California - Proposition 65 - Reproductive 
Toxicity - Male 
No 
State or local regulations    U.S. - Massachusetts - Right To Know List 
U.S. - New Jersey - Right to Know Hazardous Substance List 
U.S. - Pennsylvania - RTK (Right to Know) List 
 
 California Proposition 65 - This product does not contain any substances known to the state of California to cause cancer, 
developmental and/or reproductive harm 
  
 
 Nitrogen, refrigerated liquid 
Safety Data Sheet P-4630  
This SDS conforms to U.S. Code of Federal Regulations 29 CFR 1910.1200, Hazard Communication. 
Date of issue: 01/01/1979 Revision date: 10/21/2016  Supersedes: 10/03/2014  
 
 
EN (English US) SDS ID: P-4630  9/9 
This document is only controlled while on the Praxair, Inc. website and a copy of this controlled version is available for download. Praxair cannot assure the integrity or 
accuracy of any version of this document after it has been downloaded or removed from our website. 
 
SECTION 16: Other information 
 
Other information : When you mix two or more chemicals, you can create additional, unexpected hazards.  Obtain 
and evaluate the safety information for each component before you produce the mixture.  
Consult an industrial hygienist or other trained person when you evaluate the end product.  
Before using any plastics, confirm their compatibility with this product 
 
Praxair asks users of this product to study this SDS and become aware of the product hazards 
and safety information.  To promote safe use of this product, a user should (1) notify 
employees, agents, and contractors of the information in this SDS and of any other known 
product hazards and safety information, (2) furnish this information to each purchaser of the 
product, and (3) ask each purchaser to notify its employees and customers of the product 
hazards and safety information 
 
The opinions expressed herein are those of qualified experts within Praxair, Inc.  We believe 
that the information contained herein is current as of the date of this Safety Data Sheet.  Since 
the use of this information and the conditions of use are not within the control of Praxair, Inc, it 
is the user's obligation to determine the conditions of safe use of the product 
 
Praxair SDSs are furnished on sale or delivery by Praxair or the independent distributors and 
suppliers who package and sell our products. To obtain current SDSs for these products, 
contact your Praxair sales representative, local distributor, or supplier, or download from 
www.praxair.com.  If you have questions regarding Praxair SDSs, would like the document 
number and date of the latest SDS, or would like the names of the Praxair suppliers in your 
area, phone or write the Praxair Call Center (Phone: 1-800-PRAXAIR/1-800-772-9247; 
Address: Praxair Call Center, Praxair, Inc, P.O. Box 44, Tonawanda, NY 14151-0044) 
 
PRAXAIR and the Flowing Airstream design are trademarks or registered trademarks of Praxair 
Technology, Inc. in the United States and/or other countries. 
 
 
NFPA health hazard : 3 - Short exposure could cause serious temporary or 
residual injury even though prompt medical attention was 
given. 
 
NFPA fire hazard : 0 - Materials that will not burn. 
NFPA reactivity : 0 - Normally stable, even under fire exposure conditions, 
and are not reactive with water. 
NFPA specific hazard : SA - This denotes gases which are simple asphyxiants. 
 
 
HMIS III Rating 
  
Health : 3 Serious Hazard - Major injury likely unless prompt action is taken and medical treatment is 
given 
Flammability : 0 Minimal Hazard 
Physical : 2 Moderate Hazard 
 
SDS US (GHS HazCom 2012) - Praxair 
 
This information is based on our current knowledge and is intended to describe the product for the purposes of health, safety and environmental requirements only. It should not therefore be construed as 
guaranteeing any specific property of the product. 
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Material Safety Data Sheet
Hydrochloric acid MSDS
Section 1: Chemical Product and Company Identification
Product Name: Hydrochloric acid
Catalog Codes: SLH1462, SLH3154
CAS#: Mixture.
RTECS: MW4025000
TSCA: TSCA 8(b) inventory: Hydrochloric acid
CI#: Not applicable.
Synonym:   Hydrochloric Acid; Muriatic Acid
Chemical Name: Not applicable.
Chemical Formula: Not applicable.
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Hydrogen chloride 7647-01-0 20-38
Water 7732-18-5 62-80
Toxicological Data on Ingredients: Hydrogen chloride: GAS (LC50): Acute: 4701 ppm 0.5 hours [Rat].
Section 3: Hazards Identification
Potential Acute Health Effects:
Very hazardous in case of skin contact (corrosive, irritant, permeator), of eye contact (irritant, corrosive), of ingestion, . Slightly
hazardous in case of inhalation (lung sensitizer). Non-corrosive for lungs. Liquid or spray mist may produce tissue damage
particularly on mucous membranes of eyes, mouth and respiratory tract. Skin contact may produce burns. Inhalation of the
spray mist may produce severe irritation of respiratory tract, characterized by coughing, choking, or shortness of breath.
Severe over-exposure can result in death. Inflammation of the eye is characterized by redness, watering, and itching. Skin
inflammation is characterized by itching, scaling, reddening, or, occasionally, blistering.
Potential Chronic Health Effects:
Slightly hazardous in case of skin contact (sensitizer). CARCINOGENIC EFFECTS: Classified 3 (Not classifiable for
human.) by IARC [Hydrochloric acid]. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available. The substance may be toxic to kidneys, liver, mucous membranes, upper
respiratory tract, skin, eyes, Circulatory System, teeth. Repeated or prolonged exposure to the substance can produce target
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organs damage. Repeated or prolonged contact with spray mist may produce chronic eye irritation and severe skin irritation.
Repeated or prolonged exposure to spray mist may produce respiratory tract irritation leading to frequent attacks of bronchial
infection. Repeated exposure to a highly toxic material may produce general deterioration of health by an accumulation in one
or many human organs.
Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention immediately.
Skin Contact:
In case of contact, immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing
and shoes. Cover the irritated skin with an emollient. Cold water may be used.Wash clothing before reuse. Thoroughly clean
shoes before reuse. Get medical attention immediately.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek immediate medical
attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention immediately.
Serious Inhalation:
Evacuate the victim to a safe area as soon as possible. Loosen tight clothing such as a collar, tie, belt or waistband. If
breathing is difficult, administer oxygen. If the victim is not breathing, perform mouth-to-mouth resuscitation. WARNING: It may
be hazardous to the person providing aid to give mouth-to-mouth resuscitation when the inhaled material is toxic, infectious or
corrosive. Seek immediate medical attention.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an
unconscious person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention immediately.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: of metals
Explosion Hazards in Presence of Various Substances: Non-explosive in presence of open flames and sparks, of shocks.
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards:
Non combustible. Calcium carbide reacts with hydrogen chloride gas with incandescence. Uranium phosphide reacts with
hydrochloric acid to release spontaneously flammable phosphine. Rubidium acetylene carbides burns with slightly warm
hydrochloric acid. Lithium silicide in contact with hydrogen chloride becomes incandescent. When dilute hydrochloric acid is
used, gas spontaneously flammable in air is evolved. Magnesium boride treated with concentrated hydrochloric acid produces
spontaneously flammble gas. Cesium acetylene carbide burns hydrogen chloride gas. Cesium carbide ignites in contact with
hydrochloric acid unless acid is dilute. Reacts with most metals to produce flammable Hydrodgen gas.
Special Remarks on Explosion Hazards:
p. 3
Hydrogen chloride in contact with the following can cause an explosion, ignition on contact, or other violent/vigorous reaction:
Acetic anhydride AgClO + CCl4 Alcohols + hydrogen cyanide, Aluminum Aluminum-titanium alloys (with HCl vapor), 2-Amino
ethanol, Ammonium hydroxide, Calcium carbide Ca3P2 Chlorine + dinitroanilines (evolves gas), Chlorosulfonic acid Cesium
carbide Cesium acetylene carbide, 1,1-Difluoroethylene Ethylene diamine Ethylene imine, Fluorine, HClO4 Hexalithium
disilicide H2SO4 Metal acetylides or carbides, Magnesium boride, Mercuric sulfate, Oleum, Potassium permanganate,
beta-Propiolactone Propylene oxide Rubidium carbide, Rubidium, acetylene carbide Sodium (with aqueous HCl), Sodium
hydroxide Sodium tetraselenium, Sulfonic acid, Tetraselenium tetranitride, U3P4 , Vinyl acetate. Silver perchlorate with carbon
tetrachloride in the presence of hydrochloric acid produces trichloromethyl perchlorate which detonates at 40 deg. C.
Section 6: Accidental Release Measures
Small Spill:
Dilute with water and mop up, or absorb with an inert dry material and place in an appropriate waste disposal container. If
necessary: Neutralize the residue with a dilute solution of sodium carbonate.
Large Spill:
Corrosive liquid. Poisonous liquid. Stop leak if without risk. Absorb with DRY earth, sand or other non-combustible material.
Do not get water inside container. Do not touch spilled material. Use water spray curtain to divert vapor drift. Use water spray
to reduce vapors. Prevent entry into sewers, basements or confined areas; dike if needed. Call for assistance on disposal.
Neutralize the residue with a dilute solution of sodium carbonate. Be careful that the product is not present at a concentration
level above TLV. Check TLV on the MSDS and with local authorities.
Section 7: Handling and Storage
Precautions:
Keep locked up.. Keep container dry. Do not ingest. Do not breathe gas/fumes/ vapor/spray. Never add water to this product.
In case of insufficient ventilation, wear suitable respiratory equipment. If ingested, seek medical advice immediately and show
the container or the label. Avoid contact with skin and eyes. Keep away from incompatibles such as oxidizing agents, organic
materials, metals, alkalis, moisture. May corrode metallic surfaces. Store in a metallic or coated fiberboard drum using a strong
polyethylene inner package.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area.
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Provide exhaust ventilation or other engineering controls to keep the airborne concentrations of vapors below their respective
threshold limit value. Ensure that eyewash stations and safety showers are proximal to the work-station location.
Personal Protection:
Face shield. Full suit. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Gloves. Boots.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Vapor respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits:
CEIL: 5 (ppm) from OSHA (PEL) [United States] CEIL: 7 (mg/m3) from OSHA (PEL) [United States] CEIL: 5 from NIOSH
CEIL: 7 (mg/m3) from NIOSH TWA: 1 STEL: 5 (ppm) [United Kingdom (UK)] TWA: 2 STEL: 8 (mg/m3) [United Kingdom
(UK)]Consult local authorities for acceptable exposure limits.
Section 9: Physical and Chemical Properties
Physical state and appearance: Liquid.
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Odor: Pungent. Irritating (Strong.)
Taste: Not available.
Molecular Weight: Not applicable.
Color: Colorless to light yellow.
pH (1% soln/water): Acidic.
Boiling Point:
108.58 C @ 760 mm Hg (for 20.22% HCl in water) 83 C @ 760 mm Hg (for 31% HCl in water) 50.5 C (for 37% HCl in water)
Melting Point:
-62.25°C (-80°F) (20.69% HCl in water) -46.2 C (31.24% HCl in water) -25.4 C (39.17% HCl in water)
Critical Temperature: Not available.
Specific Gravity:
1.1- 1.19 (Water = 1) 1.10 (20%and 22% HCl solutions) 1.12 (24% HCl solution) 1.15 (29.57% HCl solution) 1.16 (32% HCl
solution) 1.19 (37% and 38%HCl solutions)
Vapor Pressure: 16 kPa (@ 20°C) average
Vapor Density: 1.267 (Air = 1)
Volatility: Not available.
Odor Threshold: 0.25 to 10 ppm
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water, diethyl ether.
Solubility: Soluble in cold water, hot water, diethyl ether.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Incompatible materials, water
Incompatibility with various substances:
Highly reactive with metals. Reactive with oxidizing agents, organic materials, alkalis, water.
Corrosivity:
Extremely corrosive in presence of aluminum, of copper, of stainless steel(304), of stainless steel(316). Non-corrosive in
presence of glass.
Special Remarks on Reactivity:
Reacts with water especially when water is added to the product. Absorption of gaseous hydrogen chloride on mercuric
sulfate becomes violent @ 125 deg. C. Sodium reacts very violently with gaseous hydrogen chloride. Calcium phosphide
and hydrochloric acid undergo very energetic reaction. It reacts with oxidizers releasing chlorine gas. Incompatible with,
alkali metals, carbides, borides, metal oxides, vinyl acetate, acetylides, sulphides, phosphides, cyanides, carbonates. Reacts
with most metals to produce flammable Hydrogen gas. Reacts violently (moderate reaction with heat of evolution) with
water especially when water is added to the product. Isolate hydrogen chloride from heat, direct sunlight, alkalies (reacts
vigorously), organic materials, and oxidizers (especially nitric acid and chlorates), amines, metals, copper and alloys (e.g.
brass), hydroxides, zinc (galvanized materials), lithium silicide (incandescence), sulfuric acid(increase in temperature and
pressure) Hydrogen chloride gas is emitted when this product is in contact with sulfuric acid. Adsorption of Hydrochloric Acid
onto silicon dioxide results in exothmeric reaction. Hydrogen chloride causes aldehydes and epoxides to violently polymerize.
Hydrogen chloride or Hydrochloric Acid in contact with the folloiwng can cause explosion or ignition on contact or
Special Remarks on Corrosivity:
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Highly corrosive. Incompatible with copper and copper alloys. It attacks nearly all metals (mercury, gold, platinium, tantalum,
silver, and certain alloys are exceptions). It is one of the most corrosive of the nonoxidizing acids in contact with copper alloys.
No corrosivity data on zinc, steel. Severe Corrosive effect on brass and bronze
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Absorbed through skin. Dermal contact. Eye contact. Inhalation.
Toxicity to Animals:
Acute oral toxicity (LD50): 900 mg/kg [Rabbit]. Acute toxicity of the vapor (LC50): 1108 ppm, 1 hours [Mouse]. Acute toxicity of
the vapor (LC50): 3124 ppm, 1 hours [Rat].
Chronic Effects on Humans:
CARCINOGENIC EFFECTS: Classified 3 (Not classifiable for human.) by IARC [Hydrochloric acid]. May cause damage to the
following organs: kidneys, liver, mucous membranes, upper respiratory tract, skin, eyes, Circulatory System, teeth.
Other Toxic Effects on Humans:
Very hazardous in case of skin contact (corrosive, irritant, permeator), of ingestion, . Hazardous in case of eye contact
(corrosive), of inhalation (lung corrosive).
Special Remarks on Toxicity to Animals:
Lowest Published Lethal Doses (LDL/LCL) LDL [Man] -Route: Oral; 2857 ug/kg LCL [Human] - Route: Inhalation; Dose: 1300
ppm/30M LCL [Rabbit] - Route: Inhalation; Dose: 4413 ppm/30M
Special Remarks on Chronic Effects on Humans:
May cause adverse reproductive effects (fetoxicity). May affect genetic material.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: Corrosive. Causes severe skin irritation and burns. Eyes: Corrosive. Causes severe
eye irritation/conjuntivitis, burns, corneal necrosis. Inhalation: May be fatal if inhaled. Material is extremely destructive to
tissue of the mucous membranes and upper respiratory tract. Inhalation of hydrochloric acid fumes produces nose, throat,
and larryngeal burning, and irritation, pain and inflammation, coughing, sneezing, choking sensation, hoarseness, laryngeal
spasms, upper respiratory tract edema, chest pains, as well has headache, and palpitations. Inhalation of high concentrations
can result in corrosive burns, necrosis of bronchial epithelium, constriction of the larynx and bronchi, nasospetal perforation,
glottal closure,  occur, particularly if exposure is prolonged. May affect the liver. Ingestion: May be fatal if swallowed. Causes
irritation and burning, ulceration, or perforation of the gastrointestinal tract and resultant peritonitis, gastric hemorrhage and
infection. Can also cause nausea, vomitting (with "coffee ground" emesis), diarrhea, thirst, difficulty swallowing, salivation,
chills, fever, uneasiness, shock, strictures and stenosis (esophogeal, gastric, pyloric). May affect behavior (excitement), the
cardiovascular system (weak rapid pulse, tachycardia), respiration (shallow respiration), and urinary system (kidneys- renal
failure, nephritis). Acute exposure via inhalation or ingestion can also cause erosion of tooth enamel. Chronic Potential Health
Effects: dyspnea, bronchitis. Chemical pneumonitis and pulmonary edema can also
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The products of degradation are less toxic than the product itself.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
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Waste must be disposed of in accordance with federal, state and local environmental control regulations.
Section 14: Transport Information
DOT Classification: Class 8: Corrosive material
Identification: : Hydrochloric acid, solution UNNA: 1789 PG: II
Special Provisions for Transport: Not available.
Section 15: Other Regulatory Information
Federal and State Regulations:
Connecticut hazardous material survey.: Hydrochloric acid Illinois toxic substances disclosure to employee act: Hydrochloric
acid Illinois chemical safety act: Hydrochloric acid New York release reporting list: Hydrochloric acid Rhode Island RTK
hazardous substances: Hydrochloric acid Pennsylvania RTK: Hydrochloric acid Minnesota: Hydrochloric acid Massachusetts
RTK: Hydrochloric acid Massachusetts spill list: Hydrochloric acid New Jersey: Hydrochloric acid New Jersey spill list:
Hydrochloric acid Louisiana RTK reporting list: Hydrochloric acid Louisiana spill reporting: Hydrochloric acid California
Director's List of Hazardous Substances: Hydrochloric acid TSCA 8(b) inventory: Hydrochloric acid TSCA 4(a) proposed test
rules: Hydrochloric acid SARA 302/304/311/312 extremely hazardous substances: Hydrochloric acid SARA 313 toxic chemical
notification and release reporting: Hydrochloric acid CERCLA: Hazardous substances.: Hydrochloric acid: 5000 lbs. (2268 kg)
Other Regulations:
OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200). EINECS: This product is on the
European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada):
CLASS D-2A: Material causing other toxic effects (VERY TOXIC). CLASS E: Corrosive liquid.
DSCL (EEC):
R34- Causes burns. R37- Irritating to respiratory system. S26- In case of contact with eyes, rinse immediately with plenty of
water and seek medical advice. S45- In case of accident or if you feel unwell, seek medical advice immediately (show the label
where possible).
HMIS (U.S.A.):
Health Hazard: 3
Fire Hazard: 0
Reactivity: 1
Personal Protection:
National Fire Protection Association (U.S.A.):
Health: 3
Flammability: 0
Reactivity: 1
Specific hazard:
Protective Equipment:
Gloves. Full suit. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Wear appropriate respirator
when ventilation is inadequate. Face shield.
Section 16: Other Information
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References:
-Hawley, G.G.. The Condensed Chemical Dictionary, 11e ed., New York N.Y., Van Nostrand Reinold, 1987. -SAX, N.I.
Dangerous Properties of Indutrial Materials. Toronto, Van Nostrand Reinold, 6e ed. 1984. -The Sigma-Aldrich Library of
Chemical Safety Data, Edition II. -Guide de la loi et du règlement sur le transport des marchandises dangeureuses au canada.
Centre de conformité internatinal Ltée. 1986.
Other Special Considerations: Not available.
Created: 10/09/2005 05:45 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Material Safety Data Sheet for Cell Cultures 
(Biosafety Level 1) 
 
 
1. Product Identification 
 
Name of cell line: CHO (CLS order no. 603479) 
Designation: Chinese Hamster Ovary cell line, permanent cell line 
 
 
2. Company Identification 
 
CLS Cell Lines Service GmbH 
Dr. Eckener-Str. 8 
D-69214 Eppelheim 
Germany 
 
Emergency phone number: +49 (0)6221 700799 
 
3. Composition / Ingredients 
 
Unit: cryovial; frozen liquid 
 
Hazardous Ingredient(s)  CAS no.  Percentage EC no. 
Dimethyl Sulfoxide 67-68-5 10 200-664-3 
 
Non-Hazardous Ingredient(s)    Percentage 
DMEM, supplemented for freezing  60-80 
FBS (Fetal Bovine Serum)  10-20 
Cells  1 
 
4. Hazards Identification 
 
Hamster source cell line 
Categorized as non-infectious and non-toxic 
 
5. First Aid Measures 
 
Skin contact: 
Wash off immediately with plenty of water and soap. 
Eye contact: 
Flush eyes immediately with water for 10-15 minutes. 
Ingestion: 
If the material was swallowed, rinse the mouth with water. 
 
6. Accidental Release Measures 
 
Use personal protective equipment 
Do not flush into surface water. 
Clean contaminated surface thoroughly. Autoclave before disposal into appropriated containers. 
 
 
CLS Cell Lines Service GmbH, Dr. Eckener-Straße 8, 69214 Eppelheim, Germany 
TEL: +49(0)6221 700799 FAX +49(0)6221 700717 info@clsgmbh.de  www.clsgmbh.de 
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7. Handling and storage 
Handling: 
Open only under a sterile workbench. Wear protective equipment. Handle as if containing infectious 
material. 
Storage:  
Keep the cryovial at -150°C (freezer) or at -196°C (liquid nitrogen vapour phase). 
 
8. Personal Protection 
 
Hygienic measures 
Avoid the contact with skin, eyes and clothing. Keep away from food and drinks. Wash hands 
immediately after handling the product.  
 
Normally, no respiratory protective equipment is required. 
 
Use protective gloves and safety goggles and wear a lab coat while handling the product. 
 
9. Physical and Chemical Properties / Reactivity  
 
Form: 
Liquid 
 
DMSO is stable. It is incompatible with a very wide range of materials, including acid chlorides, 
strong acids, strong oxidizing agents, strong reducing agents, phosphorus halides, moisture, copper 
wool + trichloroacetic acid, hygroscopic. 
 
10. Toxicological Information 
 
Not hazardous according to Directive 67/548/EC. 
 
Toxicity data for DMSO: 
 
ORL-RAT LD50 14500 mg kg-1  ORL-MAM LD50 21400 mg kg-1  
IVN-MAN TDLO 686 mg kg-1  IPR-RAT LD50 8200 mg kg-1  
IVN-MUS LD50 3100 mg kg-1  ORL-BWD LD50 100 mg kg-1  
IVN-DOG LD50 2500 mg kg 
 
11. Transportation Information 
 
Non-hazardous for air, sea and road freight. 
 
12. General Information 
 
Recommended use: 
For in vitro research use only. 
 
Disclaimer: 
The information provided in the present Material Safety Data Sheet is believed to be correct at the 
date of publication. No guarantee is given for its accuracy or completeness, but is intended as 
guidance only. Biological material may be hazardous and should be used with caution. 
CLS Cell Lines Service GmbH shall not be held liable for any damage resulting from handling or from 
contact with the product.  
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SAFETY DATA SHEET
Creation Date  30-Apr-2010 Revision Date  17-Jan-2018 Revision Number  4
1. Identification
Product Name Sodium hypochlorite
Cat No. : SS290-1;  SS290-4;  SS290-4LC
Synonyms No information available
Recommended Use Laboratory chemicals.
Uses advised against Not for food, drug, pesticide or biocidal product use
Details of the supplier of the safety data sheet 
Emergency Telephone Number 
CHEMTRECÒ, Inside the USA: 800-424-9300
CHEMTRECÒ, Outside the USA: 001-703-527-3887
2. Hazard(s) identification
Classification 
This chemical is considered hazardous by the 2012 OSHA Hazard Communication Standard (29 CFR 1910.1200)
Label Elements  
Signal Word
Danger
Hazard Statements
May be corrosive to metals
Causes severe skin burns and eye damage
May cause respiratory irritation
Company 
Fisher Scientific
One Reagent Lane
Fair Lawn, NJ 07410
Tel: (201) 796-7100
Skin Corrosion/irritation Category 2
Serious Eye Damage/Eye Irritation Category 1
Specific target organ toxicity (single exposure) Category 3
Target Organs -  Respiratory system.
Corrosive to metals
______________________________________________________________________________________________
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Sodium hypochlorite Revision Date  17-Jan-2018
Precautionary Statements
Prevention
Wash face, hands and any exposed skin thoroughly after handling
Wear protective gloves/protective clothing/eye protection/face protection
Avoid breathing dust/fume/gas/mist/vapors/spray
Use only outdoors or in a well-ventilated area
Keep only in original container
Inhalation
IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
Call a POISON CENTER or doctor/physician if you feel unwell
Skin
IF ON SKIN: Wash with plenty of soap and water
If skin irritation occurs: Get medical advice/attention
Take off contaminated clothing and wash before reuse
Eyes
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing
Immediately call a POISON CENTER or doctor/physician
Spills
Absorb spillage to prevent material damage
Storage
Store in a well-ventilated place. Keep container tightly closed
Store locked up
Store in corrosive resistant polypropylene container with a resistant inliner
Store in a dry place
Disposal
Dispose of contents/container to an approved waste disposal plant
Hazards not otherwise classified (HNOC)  
Toxic to aquatic life with long lasting effects
Contact with acids liberates toxic gas
3. Composition/Information on Ingredients
Component CAS-No Weight %
Water 7732-18-5 94-96
Sodium hypochlorite 7681-52-9 4-6
4. First-aid measures
General Advice Immediate medical attention is required. Show this safety data sheet to the doctor in
attendance.
Eye Contact Rinse immediately with plenty of water, also under the eyelids, for at least 15 minutes.
Immediate medical attention is required. Keep eye wide open while rinsing.
Skin Contact Wash off immediately with plenty of water for at least 15 minutes. Remove and wash
contaminated clothing before re-use. Call a physician immediately.
Inhalation If breathing is difficult, give oxygen. Do not use mouth-to-mouth method if victim ingested or
inhaled the substance; give artificial respiration with the aid of a pocket mask equipped with
a one-way valve or other proper respiratory medical device. Remove from exposure, lie
down. Call a physician immediately.
Ingestion Do not induce vomiting. Never give anything by mouth to an unconscious person. Clean
mouth with water. Call a physician immediately.
Most important symptoms and Causes eye burns. Causes burns by all exposure routes. .  Product is a corrosive material.
______________________________________________________________________________________________
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effects Use of gastric lavage or emesis is contraindicated.  Possible perforation of stomach or
esophagus should be investigated: Ingestion causes severe swelling, severe damage to the
delicate tissue and danger of perforation
Notes to Physician Treat symptomatically
5. Fire-fighting measures
Suitable Extinguishing Media CO 2, dry chemical, dry sand, alcohol-resistant foam.
Unsuitable Extinguishing Media No information available
Flash Point Not applicable
Method - No information available
Autoignition Temperature No information available
Explosion Limits
Upper No data available
Lower No data available
Sensitivity to Mechanical Impact No information available
Sensitivity to Static Discharge No information available
Specific Hazards Arising from the Chemical
Thermal decomposition can lead to release of irritating gases and vapors. The product causes burns of eyes, skin and mucous
membranes. Do not allow run-off from fire fighting to enter drains or water courses.
Hazardous Combustion Products
Hydrogen chloride gas Sodium oxides Thermal decomposition can lead to release of irritating gases and vapors
Protective Equipment and Precautions for Firefighters
As in any fire, wear self-contained breathing apparatus pressure-demand, MSHA/NIOSH (approved or equivalent) and full
protective gear. Thermal decomposition can lead to release of irritating gases and vapors.
NFPA  
6. Accidental release measures
Personal Precautions Ensure adequate ventilation. Use personal protective equipment. Keep people away from
and upwind of spill/leak. Evacuate personnel to safe areas.
Environmental Precautions Do not flush into surface water or sanitary sewer system. Do not allow material to
contaminate ground water system. Prevent product from entering drains. Local authorities
should be advised if significant spillages cannot be contained. See Section 12 for additional
ecological information. Avoid release to the environment. Collect spillage.
Methods for Containment and Clean
Up
Soak up with inert absorbent material. Keep in suitable, closed containers for disposal.
7. Handling and storage
Handling Use only under a chemical fume hood. Wear personal protective equipment. Do not get in
eyes, on skin, or on clothing. Do not ingest. Do not breathe vapors or spray mist.
Storage Keep containers tightly closed in a dry, cool and well-ventilated place. Corrosives area.
8. Exposure controls / personal protection
Exposure Guidelines This product does not contain any hazardous materials with occupational exposure
limitsestablished by the region specific regulatory bodies.
Health
3
Flammability
0
Instability
1
Physical hazards
N/A
______________________________________________________________________________________________
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9. Physical and chemical properties
Physical State Liquid
Appearance Light yellow
Odor Chlorine
Odor Threshold No information available
pH No information available
Melting Point/Range  0  °C  /  32  °F
Boiling Point/Range No information available
Flash Point Not applicable
Evaporation Rate > 1 (Ether = 1.0)
Flammability (solid,gas) Not applicable
Flammability or explosive limits
Upper No data available
Lower No data available
Vapor Pressure 14 mmHg
Vapor Density No information available
Specific Gravity 1.1
Solubility Soluble in water
Partition coefficient; n-octanol/water No data available
Autoignition Temperature No information available
Decomposition Temperature No information available
Viscosity No information available
Molecular Formula NaOCl
Molecular Weight 75.4492
10. Stability and reactivity
Reactive Hazard Yes
Stability Stable under normal conditions.
Conditions to Avoid Incompatible products. Excess heat.
Incompatible Materials Strong oxidizing agents, Strong acids, Strong bases, Strong reducing agents
Hazardous Decomposition Products Hydrogen chloride gas, Sodium oxides, Thermal decomposition can lead to release of
irritating gases and vapors
Hazardous Polymerization Hazardous polymerization does not occur.
Hazardous Reactions None under normal processing.
Engineering Measures Use only under a chemical fume hood. Ensure that eyewash stations and safety showers
are close to the workstation location.
Personal Protective Equipment 
Eye/face Protection Wear appropriate protective eyeglasses or chemical safety goggles as described by
OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard
EN166. Tightly fitting safety goggles. Face-shield.
Skin and body protection Long sleeved clothing.
Respiratory Protection Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard
EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if
exposure limits are exceeded or if irritation or other symptoms are experienced.
Hygiene Measures
______________________________________________________________________________________________
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11. Toxicological information
Acute Toxicity 
Product Information
Oral LD50 Based on ATE data, the classification criteria are not met. ATE > 2000 mg/kg.
Dermal LD50 Based on ATE data, the classification criteria are not met. ATE > 2000 mg/kg.
Vapor LC50 Based on ATE data, the classification criteria are not met. ATE > 20 mg/l.
Component Information
Component LD50 Oral LD50 Dermal LC50 Inhalation
Water - Not listed Not listed
Sodium hypochlorite LD50 = 8200 mg/kg  ( Rat ) LD50 > 10000 mg/kg  ( Rabbit ) > 10500 mg/l (Rat) 1h
Toxicologically Synergistic
Products
No information available
Delayed and immediate effects as well as chronic effects from short and long-term exposure  
Irritation Causes burns by all exposure routes
Sensitization No information available
Carcinogenicity The table below indicates whether each agency has listed any ingredient as a carcinogen.
Component CAS-No IARC NTP ACGIH OSHA Mexico
Water 7732-18-5 Not listed Not listed Not listed Not listed Not listed
Sodium hypochlorite 7681-52-9 Not listed Not listed Not listed Not listed Not listed
Mutagenic Effects No information available
Reproductive Effects No information available.
Developmental Effects No information available.
Teratogenicity No information available.
STOT - single exposure Respiratory system
STOT - repeated exposure None known
Aspiration hazard No information available
Symptoms  / effects,both acute and
delayed
Product is a corrosive material.  Use of gastric lavage or emesis is contraindicated.
Possible perforation of stomach or esophagus should be investigated: Ingestion causes
severe swelling, severe damage to the delicate tissue and danger of perforation
Endocrine Disruptor Information No information available
Other Adverse Effects The toxicological properties have not been fully investigated.
12. Ecological information
Ecotoxicity 
The product contains following substances which are hazardous for the environment. Very toxic to aquatic organisms.
Component Freshwater Algae Freshwater Fish Microtox Water Flea
Sodium hypochlorite EC50: = 0.095 mg/L, 24h
(Skeletonema costatum)
Pimephales promelas:
LC50=0.82-0.98 mg/L 96h
- 2.1 mg/L EC50 = 96 h
0.033-0.044 mg/L EC50  48
h
Persistence and Degradability No information available
Bioaccumulation/ Accumulation No information available.
Mobility .
______________________________________________________________________________________________
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13. Disposal considerations
Waste Disposal Methods Chemical waste generators must determine whether a discarded chemical is classified as a
hazardous waste.  Chemical waste generators must also consult local, regional, and
national hazardous waste regulations to ensure complete and accurate classification.
14. Transport information
DOT 
UN-No UN1791
Proper Shipping Name HYPOCHLORITE SOLUTIONS
Hazard Class 8
Packing Group III
TDG 
UN-No UN1791
Proper Shipping Name HYPOCHLORITE SOLUTION
Hazard Class 8
Packing Group III
IATA 
UN-No UN1791
Proper Shipping Name HYPOCHLORITE SOLUTION
Hazard Class 8
Packing Group III
IMDG/IMO 
UN-No UN1791
Proper Shipping Name HYPOCHLORITE SOLUTION
Hazard Class 8
Packing Group III
15. Regulatory information
All of the components in the product are on the following Inventory lists:  X = listed
International Inventories
Component TSCA DSL NDSL EINECS ELINCS NLP PICCS ENCS AICS IECSC KECL
Water X X - 231-791-2 - X - X X X
Sodium hypochlorite X X - 231-668-3 - X X X X X
Legend:
X - Listed
E - Indicates a substance that is the subject of a Section 5(e) Consent order under TSCA.
F - Indicates a substance that is the subject of a Section 5(f) Rule under TSCA.
N - Indicates a polymeric substance containing no free-radical initiator in its inventory name but is considered to cover the designated
polymer made with any free-radical initiator regardless of the amount used.
P - Indicates a commenced PMN substance
R - Indicates a substance that is the subject of a Section 6 risk management rule under TSCA.
S - Indicates a substance that is identified in a proposed or final Significant New Use Rule
T - Indicates a substance that is the subject of a Section 4 test rule under TSCA.
XU - Indicates a substance exempt from reporting under the Inventory Update Rule, i.e. Partial Updating of the TSCA Inventory Data Base
Production and Site Reports (40 CFR 710(B).
Y1 - Indicates an exempt polymer that has a number-average molecular weight of 1,000 or greater.
Y2 - Indicates an exempt polymer that is a polyester and is made only from reactants included in a specified list of low concern reactants
that comprises one of the eligibility criteria for the exemption rule.
U.S. Federal Regulations  
TSCA 12(b) Not applicable
SARA 313 Not applicable
SARA 311/312 Hazard Categories See section 2 for more information
CWA (Clean Water Act)
______________________________________________________________________________________________
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Component CWA - Hazardous
Substances
CWA - Reportable
Quantities
CWA - Toxic Pollutants CWA - Priority Pollutants
Sodium hypochlorite X 100 lb - -
Clean Air Act Not applicable
OSHA Occupational Safety and Health Administration
Not applicable
CERCLA Not applicable
Component Hazardous Substances RQs CERCLA EHS RQs
Sodium hypochlorite 100 lb -
California Proposition 65 This product does not contain any Proposition 65 chemicals
U.S. State Right-to-Know
Regulations
Component Massachusetts New Jersey Pennsylvania Illinois Rhode Island
Water - - X - -
Sodium hypochlorite X X X - -
U.S. Department of Transportation
Reportable Quantity (RQ): N
DOT Marine Pollutant N
DOT Severe Marine Pollutant N
U.S. Department of Homeland Security
This product does not contain any DHS chemicals.
Other International Regulations 
Mexico - Grade No information available
16. Other information
Prepared By Regulatory Affairs
Thermo Fisher Scientific
Email: EMSDS.RA@thermofisher.com
Creation Date 30-Apr-2010
Revision Date 17-Jan-2018
Print Date 17-Jan-2018
Revision Summary This document has been updated to comply with the US OSHA HazCom 2012 Standard
replacing the current legislation under 29 CFR 1910.1200 to align with the Globally
Harmonized System of Classification and Labeling of Chemicals (GHS).
Disclaimer
The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at the
date of its publication. The information given is designed only as a guidance for safe handling, use, processing, storage,
transportation, disposal and release and is not to be considered a warranty or quality specification. The information
relates only to the specific material designated and may not be valid for such material used in combination with any other
materials or in any process, unless specified in the text
End of SDS
______________________________________________________________________________________________
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Material Safety Data Sheet
Ammonium sulfate MSDS
Section 1: Chemical Product and Company Identification
Product Name: Ammonium sulfate
Catalog Codes: SLA2851, SLA2011, SLA1168, SLA2674
CAS#: 7783-20-2
RTECS: BS4500000
TSCA: TSCA 8(b) inventory: Ammonium sulfate
CI#: Not available.
Synonym:   Sulfluric Acid, Diammonium Salt
Chemical Name: Ammonium Sulfate
Chemical Formula: (NH4)2SO4
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Ammonium sulfate 7783-20-2 100
Toxicological Data on Ingredients: Ammonium sulfate: ORAL (LD50): Acute: 2840 mg/kg [Rat]. 640 mg/kg [Mouse].
Section 3: Hazards Identification
Potential Acute Health Effects: Hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available. Repeated or prolonged exposure is not known to aggravate medical condition.
Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention.
Skin Contact:
In case of contact, immediately flush skin with plenty of water. Cover the irritated skin with an emollient. Remove contaminated
clothing and shoes. Cold water may be used.Wash clothing before reuse. Thoroughly clean shoes before reuse. Get medical
attention.
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Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek medical attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if symptoms appear.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: May be combustible at high temperature.
Auto-Ignition Temperature: Not available.
Flash Points: CLOSED CUP: Higher than 93.3°C (200°F).
Flammable Limits: Not available.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances:
Flammable in presence of oxidizing materials. Slightly flammable to flammable in presence of heat.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available. Explosive in presence of oxidizing materials.
Fire Fighting Media and Instructions:
SMALL FIRE: Use DRY chemical powder. LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
Special Remarks on Fire Hazards:
A mixture of ammonium sulfate and potassium chlorate decomposes with incandescence when heated. When a little
ammonium sulfate is added to fused potassium nitrite, a vigorous reaction occurs attended by flame. Non combustible. This
substance itself does not burn, but may decompose upon heating to produce corrosive and/or toxic fumes.
Special Remarks on Explosion Hazards:
If accidently mixed with oxidizers like potassium chlorate, potassium nitrate or potassium nitrite, there is an explosion hazard
during fire. A mixture of ammonium sulfate and ammonium nitrate can easily be exploded by potassium or sodium-potassium
alloy.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by spreading water on
the contaminated surface and dispose of according to local and regional authority requirements.
Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water on the
contaminated surface and allow to evacuate through the sanitary system.
Section 7: Handling and Storage
Precautions:
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Keep away from heat. Keep away from sources of ignition. Do not ingest. Do not breathe dust. Wear suitable protective
clothing. In case of insufficient ventilation, wear suitable respiratory equipment. If ingested, seek medical advice immediately
and show the container or the label. Avoid contact with skin and eyes. Keep away from incompatibles such as oxidizing
agents.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area.
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection:
Splash goggles. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Crystals solid.)
Odor: Odorless.
Taste: Not available.
Molecular Weight: 132.14 g/mole
Color: brownish gray to white
pH (1% soln/water): Not available.
Boiling Point: Not available.
Melting Point: 280°C (536°F)
Critical Temperature: Not available.
Specific Gravity: 1.77 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility:
Soluble in cold water. Insoluble in acetone.
Section 10: Stability and Reactivity Data
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Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Excess heat, incompatible materials.
Incompatibility with various substances:
Highly reactive with oxidizing agents. Reactive with alkalis.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity:
Incompatible with the following: Potassium + ammonium nitrate, potassium chlorate, potassium nitrate, potassium nitrite,
sodium hypochlorite, sodium/potassium alloy + ammonium nitrate. Substance should not contact either zinc or copper bearing
materials. Reacts with alkali to release ammonia.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Inhalation. Ingestion.
Toxicity to Animals: Acute oral toxicity (LD50): 640 mg/kg [Mouse].
Chronic Effects on Humans: Not available.
Other Toxic Effects on Humans: Hazardous in case of skin contact (irritant), of ingestion, of inhalation.
Special Remarks on Toxicity to Animals:
Lowest Published Lethal Dose/Conc: LDL [Domestic animal - Goat, Sheep) - Route: Oral; Dose: 3500 mg/kg
Special Remarks on Chronic Effects on Humans:
It may be a possible mutagen. It has been tested for mutagenicity, but so far tests have been inconclusive or test information
has not been made available.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: Causes skin irritation. Eyes: Causes eye irritation. Inhalation: May cause respiratory tract
irritation. Ingestion: When ingested, its osmolarity can draw water from the body into the bowel, acting as a laxative. However,
if enough is absorbed systemically it may produce Ammonia poisoning. Symptoms may include gastrointestinal (digestive)
tract irritation with nausea, vomiting, hypermotility, diarrhea. May also affect eyes (Mydriasis), behavior/central nervous system
(somnolence, tremor, convulsions, muscle contraction or spasticity), and respiratory system (respiratory stimulation, dyspnea).
Also, with ingestion of large doses of Ammonium Sulfate arises the possibility of sufficient absorption to produce diuresis, an
excessive discharge of urine, and kidney damage (renal tubular disorder, abnormal renal function). Chronic Potential Health
Effects: One Russian occupational standard study discussed chronic exposure effects which may include cardiac contraction,
neurotoxicity, and hypertension. This has not been confirmed in other ammonium sulfate exposed workers.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
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Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations:
Rhode Island RTK hazardous substances: Ammonium sulfate Pennsylvania RTK: Ammonium sulfate Florida: Ammonium
sulfate Massachusetts RTK: Ammonium sulfate New Jersey: Ammonium sulfate TSCA 8(b) inventory: Ammonium sulfate
Other Regulations: EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
R16- Explosive when mixed with oxidizing substances. R36/38- Irritating to eyes and skin. S24/25- Avoid contact with skin and
eyes.
HMIS (U.S.A.):
Health Hazard: 2
Fire Hazard: 1
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 2
Flammability: 1
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Splash goggles.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/10/2005 08:14 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
p. 6
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
p. 1
          2
          3           0
He a lt h
Fire
Re a c t iv it y
Pe rs o n a l
Pro t e c t io n
3
2
0
H
Material Safety Data Sheet
Acetic acid MSDS
Section 1: Chemical Product and Company Identification
Product Name: Acetic acid
Catalog Codes: SLA3784, SLA1438, SLA2101, SLA3604,
SLA1258
CAS#: 64-19-7
RTECS: AF1225000
TSCA: TSCA 8(b) inventory: Acetic acid
CI#: Not applicable.
Synonym:   Acetic acid; glacial acetic acid
Chemical Name: Acetic Acid, Glacial
Chemical Formula: C2-H4-O2
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Acetic acid 64-19-7 100
Toxicological Data on Ingredients: Acetic acid: ORAL (LD50): Acute: 3310 mg/kg [Rat]. 4960 mg/kg [Mouse]. 3530 mg/kg
[Rat]. DERMAL (LD50): Acute: 1060 mg/kg [Rabbit]. VAPOR (LC50): Acute: 5620 ppm 1 hours [Mouse].
Section 3: Hazards Identification
Potential Acute Health Effects:
Very hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation. Hazardous in case of skin
contact (corrosive, permeator), of eye contact (corrosive). Liquid or spray mist may produce tissue damage particularly on
mucous membranes of eyes, mouth and respiratory tract. Skin contact may produce burns. Inhalation of the spray mist may
produce severe irritation of respiratory tract, characterized by coughing, choking, or shortness of breath. Inflammation of the
eye is characterized by redness, watering, and itching. Skin inflammation is characterized by itching, scaling, reddening, or,
occasionally, blistering.
Potential Chronic Health Effects:
Hazardous in case of skin contact (irritant), of ingestion, of inhalation. CARCINOGENIC EFFECTS: Not available.
MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells. Mutagenic for bacteria and/or yeast. TERATOGENIC
EFFECTS: Not available. DEVELOPMENTAL TOXICITY: Not available. The substance may be toxic to kidneys, mucous
membranes, skin, teeth. Repeated or prolonged exposure to the substance can produce target organs damage. Repeated
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or prolonged contact with spray mist may produce chronic eye irritation and severe skin irritation. Repeated or prolonged
exposure to spray mist may produce respiratory tract irritation leading to frequent attacks of bronchial infection.
Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention immediately.
Skin Contact:
In case of contact, immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing
and shoes. Cover the irritated skin with an emollient. Cold water may be used.Wash clothing before reuse. Thoroughly clean
shoes before reuse. Get medical attention immediately.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek immediate medical
attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention immediately.
Serious Inhalation:
Evacuate the victim to a safe area as soon as possible. Loosen tight clothing such as a collar, tie, belt or waistband. If
breathing is difficult, administer oxygen. If the victim is not breathing, perform mouth-to-mouth resuscitation. WARNING: It may
be hazardous to the person providing aid to give mouth-to-mouth resuscitation when the inhaled material is toxic, infectious or
corrosive. Seek immediate medical attention.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if symptoms appear.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: Flammable.
Auto-Ignition Temperature: 463°C (865.4°F)
Flash Points: CLOSED CUP: 39°C (102.2°F). OPEN CUP: 43°C (109.4°F).
Flammable Limits: LOWER: 4% UPPER: 19.9%
Products of Combustion: These products are carbon oxides (CO, CO2).
Fire Hazards in Presence of Various Substances:
Flammable in presence of open flames and sparks, of heat. Slightly flammable to flammable in presence of oxidizing
materials, of metals.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available. Slightly explosive in presence of oxidizing materials.
Fire Fighting Media and Instructions:
Flammable liquid, soluble or dispersed in water. SMALL FIRE: Use DRY chemical powder. LARGE FIRE: Use alcohol foam,
water spray or fog. Cool containing vessels with water jet in order to prevent pressure build-up, autoignition or explosion.
Special Remarks on Fire Hazards:
Reacts with metals to produces flammable hydrogen gas. It will ignite on contact with potassium-tert-butoxide. A mixture of
ammonium nitrate and acetic acid ignites when warmed, especially if warmed.
Special Remarks on Explosion Hazards:
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Acetic acid vapors may form explosive mixtures with air. Reactions between acetic acid and the following materials
are potentially explosive: 5-azidotetrazole, bromine pentafluoride, chromium trioxide, hydrogen peroxide, potassium
permanganate, sodium peroxide, and phorphorus trichloride. Dilute acetic acid and dilute hydrogen can undergo an
exothermic reaction if heated, forming peracetic acid which is explosive at 110 degrees C. Reaction between chlorine
trifluoride and acetic acid is very violent, sometimes explosive.
Section 6: Accidental Release Measures
Small Spill:
Dilute with water and mop up, or absorb with an inert dry material and place in an appropriate waste disposal container. If
necessary: Neutralize the residue with a dilute solution of sodium carbonate.
Large Spill:
Flammable liquid. Corrosive liquid. Keep away from heat. Keep away from sources of ignition. Stop leak if without risk. If the
product is in its solid form: Use a shovel to put the material into a convenient waste disposal container. If the product is in
its liquid form: Absorb with DRY earth, sand or other non-combustible material. Do not get water inside container. Absorb
with an inert material and put the spilled material in an appropriate waste disposal. Do not touch spilled material. Use water
spray curtain to divert vapor drift. Prevent entry into sewers, basements or confined areas; dike if needed. Call for assistance
on disposal. Neutralize the residue with a dilute solution of sodium carbonate. Be careful that the product is not present at a
concentration level above TLV. Check TLV on the MSDS and with local authorities.
Section 7: Handling and Storage
Precautions:
\Keep away from heat. Keep away from sources of ignition. Ground all equipment containing material. Do not ingest. Do not
breathe gas/fumes/ vapor/spray. Never add water to this product. In case of insufficient ventilation, wear suitable respiratory
equipment. If ingested, seek medical advice immediately and show the container or the label. Avoid contact with skin and
eyes. Keep away from incompatibles such as oxidizing agents, reducing agents, metals, acids, alkalis.
Storage:
Store in a segregated and approved area. Keep container in a cool, well-ventilated area. Keep container tightly closed and
sealed until ready for use. Avoid all possible sources of ignition (spark or flame).
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Provide exhaust ventilation or other engineering controls to keep the airborne concentrations of vapors below their respective
threshold limit value. Ensure that eyewash stations and safety showers are proximal to the work-station location.
Personal Protection:
Splash goggles. Synthetic apron. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Gloves
(impervious).
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Vapor respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits:
TWA: 10 STEL: 15 (ppm) [Australia] TWA: 25 STEL: 27 (mg/m3) [Australia] TWA: 10 STEL: 15 (ppm) from NIOSH TWA: 25
STEL: 37 (mg/m3) from NIOSH TWA: 10 STEL: 15 (ppm) [Canada] TWA: 26 STEL: 39 (mg/m3) [Canada] TWA: 25 STEL: 37
(mg/m3) TWA: 10 STEL: 15 (ppm) from ACGIH (TLV) [United States] [1999] TWA: 10 (ppm) from OSHA (PEL) [United States]
TWA: 25 (mg/m3) from OSHA (PEL) [United States]Consult local authorities for acceptable exposure limits.
Section 9: Physical and Chemical Properties
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Physical state and appearance: Liquid.
Odor: Pungent, vinegar-like, sour (Strong.)
Taste: Vinegar, sour (Strong.)
Molecular Weight: 60.05 g/mole
Color: Colorless. Clear (Light.)
pH (1% soln/water): 2 [Acidic.]
Boiling Point: 118.1°C (244.6°F)
Melting Point: 16.6°C (61.9°F)
Critical Temperature: 321.67°C (611°F)
Specific Gravity: 1.049 (Water = 1)
Vapor Pressure: 1.5 kPa (@ 20°C)
Vapor Density: 2.07 (Air = 1)
Volatility: Not available.
Odor Threshold: 0.48 ppm
Water/Oil Dist. Coeff.: The product is more soluble in water; log(oil/water) = -0.2
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water, diethyl ether, acetone.
Solubility:
Easily soluble in cold water, hot water. Soluble in diethyl ether, acetone. Miscible with Glycerol, alcohol, Benzene, Carbon
Tetrachloride. Practically insoluble in Carbon Disulfide.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Heat, ignition sources, incompatible materials
Incompatibility with various substances: Reactive with oxidizing agents, reducing agents, metals, acids, alkalis.
Corrosivity:
Highly corrosive in presence of stainless steel(304). Slightly corrosive in presence of aluminum, of copper. Non-corrosive in
presence of stainless steel(316).
Special Remarks on Reactivity:
Reacts violently with strong oxidizing agents, acetaldehyde, and acetic anhydride. Material can react with metals, strong
bases, amines, carbonates, hydroxides, phosphates, many oxides,cyanides, sulfides, chromic acid, nitric acid, hydrogen
peroxide, carbonates. ammonium nitrate, ammonium thiosulfate, chlorine trifluoride, chlorosulfonic acid, perchloric acid,
permanganates, xylene, oleum, potassium hydroxide, sodium hydroxide, phosphorus isocyanate, ethylenediamine, ethylene
imine.
Special Remarks on Corrosivity: Moderate corrosive effect on bronze. No corrosion data on brass
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Absorbed through skin. Dermal contact. Eye contact. Inhalation. Ingestion.
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Toxicity to Animals:
WARNING: THE LC50 VALUES HEREUNDER ARE ESTIMATED ON THE BASIS OF A 4-HOUR EXPOSURE. Acute oral
toxicity (LD50): 3310 mg/kg [Rat]. Acute dermal toxicity (LD50): 1060 mg/kg [Rabbit]. Acute toxicity of the vapor (LC50): 5620
1 hours [Mouse].
Chronic Effects on Humans:
MUTAGENIC EFFECTS: Mutagenic for mammalian somatic cells. Mutagenic for bacteria and/or yeast. May cause damage to
the following organs: kidneys, mucous membranes, skin, teeth.
Other Toxic Effects on Humans:
Extremely hazardous in case of inhalation (lung corrosive). Very hazardous in case of skin contact (irritant), of ingestion, .
Hazardous in case of skin contact (corrosive, permeator), of eye contact (corrosive).
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: May affect genetic material and may cause reproductive effects based on
animal data. No human data found.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: Extremely irritating and corrosive. Causes skin irritation (reddening and itching,
inflammation). May cause blistering , tissue damage and burns. Eyes: Extremely irritating and corrosive. Causes eye irritation,
lacrimation, redness, and pain. May cause burns, blurred vision, conjunctivitis, conjunctival and corneal destruction and
permanent injury. Inhalation: Causes severe respiratory tract irritation. Affects the sense organs (nose, ear, eye, taste),
and blood. May cause chemical pneumonitis, bronchitis, and pulmonary edema. Severe exposure may result in lung tissue
damage and corrosion (ulceration) of the mucous membranes. Inhalation may also cause rhinitis, sneezing, coughing,
oppressive feeling in the chest or chest pain, dyspnea, wheezing, tachypnea, cyanosis, salivation, nausea, giddiness,
muscular weakness. Ingestion: Moderately toxic. Corrosive. Causes gastrointestinal tract irritation (burning and pain of the
mouth, throat, and abdomen, coughing, ulceration, bleeding, nausea, abdomial spasms, vomiting, hematemesis, diarrhea.
May Also affect the liver (impaired liver function), behavior (convulsions, giddines, muscular weakness), and the urinary
system - kidneys (Hematuria, Albuminuria, Nephrosis, acute renal failure, acute tubular necrosis). May also cause dyspnea
or asphyxia. May also lead to shock, coma and death. Chronic Potential Health Effects: Chronic exposure via ingestion may
cause blackening or erosion of the teeth and jaw necrosis, pharyngitis, and gastritis. It may also behavior (similar to acute
ingestion), and metabolism (weight loss). Chronic exposure via inhalation may cause asthma and/or bronchitis with cough,
phlegm, and/or shortness of breath . It may also affect the blood (decreased leukocyte count), and urinary system (kidneys).
Repeated or prolonged skin contact may cause thickening, blackening, and cracking of the skin.
Section 12: Ecological Information
Ecotoxicity:
Ecotoxicity in water (LC50): 423 mg/l 24 hours [Fish (Goldfish)]. 88 ppm 96 hours [Fish (fathead minnow)]. 75 ppm 96 hours
[Fish (bluegill sunfish)]. >100 ppm 96 hours [Daphnia].
BOD5 and COD: BOD-5: 0.34-0.88 g oxygen/g
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The products of degradation are less toxic than the product itself.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.
Section 14: Transport Information
DOT Classification:
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CLASS 3: Flammable liquid. Class 8: Corrosive material
Identification: : Acetic Acid, Glacial UNNA: 2789 PG: II
Special Provisions for Transport: Not available.
Section 15: Other Regulatory Information
Federal and State Regulations:
New York release reporting list: Acetic acid Rhode Island RTK hazardous substances: Acetic acid Pennsylvania RTK: Acetic
acid Florida: Acetic acid Minnesota: Acetic acid Massachusetts RTK: Acetic acid New Jersey: Acetic acid California Director's
List of Hazardous Subtances (8 CCR 339): Acetic acid TSCA 8(b) inventory: Acetic acid CERCLA: Hazardous substances.:
Acetic acid: 5000 lbs. (2268 kg)
Other Regulations:
OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200). EINECS: This product is on the
European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada):
CLASS B-3: Combustible liquid with a flash point between 37.8°C (100°F) and 93.3°C (200°F). CLASS E: Corrosive liquid.
DSCL (EEC):
R10- Flammable. R35- Causes severe burns. S23- Do not breathe gas/fumes/vapour/spray [***] S26- In case of contact with
eyes, rinse immediately with plenty of water and seek medical advice. S45- In case of accident or if you feel unwell, seek
medical advice immediately (show the label where possible).
HMIS (U.S.A.):
Health Hazard: 3
Fire Hazard: 2
Reactivity: 0
Personal Protection: H
National Fire Protection Association (U.S.A.):
Health: 3
Flammability: 2
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves (impervious). Synthetic apron. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Wear
appropriate respirator when ventilation is inadequate. Splash goggles.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/09/2005 03:35 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
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no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Material Safety Data Sheet
Sodium acetate anhydrous MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium acetate anhydrous
Catalog Codes: SLS2710, SLS1918, SLS1123
CAS#: 127-09-3
RTECS: AJ4300010
TSCA: TSCA 8(b) inventory: Sodium acetate anhydrous
CI#: Not applicable.
Synonym:   Acetic acid, sodium salt
Chemical Name: Sodium acetate
Chemical Formula: CH3COONa
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Sodium acetate anhydrous 127-09-3 100
Toxicological Data on Ingredients: Not applicable.
Section 3: Hazards Identification
Potential Acute Health Effects:
Hazardous in case of ingestion, of inhalation. Slightly hazardous in case of skin contact (irritant), of eye contact (irritant).
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available. Repeated or prolonged exposure is not known to aggravate medical condition.
Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention if irritation occurs.
Skin Contact:
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Wash with soap and water. Cover the irritated skin with an emollient. Get medical attention if irritation develops. Cold water
may be used.
Serious Skin Contact: Not available.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention if symptoms appear.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if symptoms appear.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: May be combustible at high temperature.
Auto-Ignition Temperature: Not available.
Flash Points: Not available.
Flammable Limits: Not available.
Products of Combustion: These products are carbon oxides (CO, CO2).
Fire Hazards in Presence of Various Substances:
Slightly flammable to flammable in presence of open flames and sparks, of heat. Non-flammable in presence of shocks.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available.
Fire Fighting Media and Instructions:
SMALL FIRE: Use DRY chemical powder. LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
Special Remarks on Fire Hazards: Combustible when exposed to heat or flame.
Special Remarks on Explosion Hazards: Not available.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. If necessary: Neutralize the residue with
a dilute solution of acetic acid. Finish cleaning by spreading water on the contaminated surface and dispose of according to
local and regional authority requirements.
Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Neutralize the residue with a dilute solution
of acetic acid. Finish cleaning by spreading water on the contaminated surface and allow to evacuate through the sanitary
system.
Section 7: Handling and Storage
Precautions:
Keep away from heat. Keep away from sources of ignition. Empty containers pose a fire risk, evaporate the residue under a
fume hood. Ground all equipment containing material. Do not ingest. Do not breathe dust. Wear suitable protective clothing. In
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case of insufficient ventilation, wear suitable respiratory equipment. If ingested, seek medical advice immediately and show the
container or the label. Keep away from incompatibles such as oxidizing agents, acids.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area.
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection: Safety glasses. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Granular, crystalline powder.)
Odor: Odorless to acetic (Slight.)
Taste: Not available.
Molecular Weight: 82.03 g/mole
Color: Colorless. White.
pH (1% soln/water): 11 [Basic.]
Boiling Point: Not available.
Melting Point: 324°C (615.2°F)
Critical Temperature: Not available.
Specific Gravity: 1.528 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility: Easily soluble in cold water, hot water.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
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Instability Temperature: Not available.
Conditions of Instability: Excess heat, incompatible materials, moisture.
Incompatibility with various substances: Reactive with oxidizing agents, acids.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity:
Hygroscopic; keep container tightly closed. Incompatible (violent reaction) with fluorine diketene, potassium nitrate. Also
incompatible wth nitric acid. Emits fumes of acetic acid upon heating and on contact with strong acids.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Inhalation. Ingestion.
Toxicity to Animals:
WARNING: THE LC50 VALUES HEREUNDER ARE ESTIMATED ON THE BASIS OF A 4-HOUR EXPOSURE. Acute oral
toxicity (LD50): 3530 mg/kg [Rat]. Acute dermal toxicity (LD50): >10000 mg/kg [Rabbit]. Acute toxicity of the dust (LC50):
>30000 mg/m  1 hours [Rat]. 3
Chronic Effects on Humans: Not available.
Other Toxic Effects on Humans:
Hazardous in case of ingestion, of inhalation. Slightly hazardous in case of skin contact (irritant).
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: Not available.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: May cause skin irritation. Eyes: May cause eye irritation. Ingestion: May cause digestive
tract irritation with abdominal pain, nausea, and vomiting. May affect behavior, and urinary system. Inhalation: May cause
respiratory tract irritation. Symptoms may include coughing, sore throat, labored breathing, and chest pain.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
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Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: Sodium acetate anhydrous
Other Regulations: EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
This product is not classified according to the EU regulations. Not applicable.
HMIS (U.S.A.):
Health Hazard: 2
Fire Hazard: 1
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 2
Flammability: 1
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Safety glasses.
Section 16: Other Information
References:
-Hawley, G.G.. The Condensed Chemical Dictionary, 11e ed., New York N.Y., Van Nostrand Reinold, 1987. -SAX, N.I.
Dangerous Properties of Indutrial Materials. Toronto, Van Nostrand Reinold, 6e ed. 1984. -The Sigma-Aldrich Library of
Chemical Safety Data, Edition II. Registery of Toxic Effects of Chemical Substances. Hazardous Substance Data Bank.
Other Special Considerations: Not available.
Created: 10/09/2005 06:28 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Material Safety Data Sheet
Water MSDS
Section 1: Chemical Product and Company Identification
Product Name: Water
Catalog Codes: SLW1063
CAS#: 7732-18-5
RTECS: ZC0110000
TSCA: TSCA 8(b) inventory: Water
CI#: Not available.
Synonym:   Dihydrogen oxide
Chemical Name: Water
Chemical Formula: H2O
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Water 7732-18-5 100
Toxicological Data on Ingredients: Not applicable.
Section 3: Hazards Identification
Potential Acute Health Effects:
Non-corrosive for skin. Non-irritant for skin. Non-sensitizer for skin. Non-permeator by skin. Non-irritating to the eyes. Non-
hazardous in case of ingestion. Non-hazardous in case of inhalation. Non-irritant for lungs. Non-sensitizer for lungs. Non-
corrosive to the eyes. Non-corrosive for lungs.
Potential Chronic Health Effects:
Non-corrosive for skin. Non-irritant for skin. Non-sensitizer for skin. Non-permeator by skin. Non-irritating to the eyes.
Non-hazardous in case of ingestion. Non-hazardous in case of inhalation. Non-irritant for lungs. Non-sensitizer for lungs.
CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available.
Section 4: First Aid Measures
Eye Contact: Not applicable.
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Skin Contact: Not applicable.
Serious Skin Contact: Not available.
Inhalation: Not applicable.
Serious Inhalation: Not available.
Ingestion: Not Applicable
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: Not applicable.
Explosion Hazards in Presence of Various Substances: Not Applicable
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards: Not available.
Section 6: Accidental Release Measures
Small Spill: Mop up, or absorb with an inert dry material and place in an appropriate waste disposal container.
Large Spill: Absorb with an inert material and put the spilled material in an appropriate waste disposal.
Section 7: Handling and Storage
Precautions: No specific safety phrase has been found applicable for this product.
Storage: Not applicable.
Section 8: Exposure Controls/Personal Protection
Engineering Controls: Not Applicable
Personal Protection: Safety glasses. Lab coat.
Personal Protection in Case of a Large Spill: Not Applicable
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Liquid.
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Odor: Odorless.
Taste: Not available.
Molecular Weight: 18.02 g/mole
Color: Colorless.
pH (1% soln/water): 7 [Neutral.]
Boiling Point: 100°C (212°F)
Melting Point: Not available.
Critical Temperature: Not available.
Specific Gravity: 1 (Water = 1)
Vapor Pressure: 2.3 kPa (@ 20°C)
Vapor Density: 0.62 (Air = 1)
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: Not applicable
Solubility: Not Applicable
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Not available.
Incompatibility with various substances: Not available.
Corrosivity: Not available.
Special Remarks on Reactivity: Not available.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Absorbed through skin. Eye contact.
Toxicity to Animals:
LD50: [Rat] - Route: oral; Dose: > 90 ml/kg LC50: Not available.
Chronic Effects on Humans: Not available.
Other Toxic Effects on Humans:
Non-corrosive for skin. Non-irritant for skin. Non-sensitizer for skin. Non-permeator by skin. Non-hazardous in case of
ingestion. Non-hazardous in case of inhalation. Non-irritant for lungs. Non-sensitizer for lungs. Non-corrosive to the eyes. Non-
corrosive for lungs.
Special Remarks on Toxicity to Animals: Not available.
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Special Remarks on Chronic Effects on Humans: Not available.
Special Remarks on other Toxic Effects on Humans: Not available.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: Water
Other Regulations: EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
This product is not classified according to the EU regulations. Not applicable.
HMIS (U.S.A.):
Health Hazard: 0
Fire Hazard: 0
Reactivity: 0
Personal Protection: a
National Fire Protection Association (U.S.A.):
Health: 0
Flammability: 0
Reactivity: 0
Specific hazard:
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Protective Equipment:
Not applicable. Lab coat. Not applicable. Safety glasses.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/10/2005 08:33 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
Tris Base, Molecular Biology Grade
Identification of the substance/preparation and of the company/undertaking
SAFETY DATA SHEET
Product name
Conforms to 93/112/EC and ISO 11014-1
1.
Emergency
telephone number
:
Chemical formula C4H11NO3
Manufactured by EMD Biosciences, Inc.
10394 Pacific Center Court
San Diego, CA  92121
(858)450-5558/(800)854-3417
FAX: (858)453-3552
Supplier
:
:
:
Call Chemtrec®
(800)424-9300 (within U.S.A.)
(703)527-3887 (outside U.S.A.)
Order
Number
Customer
Number
Catalog # : 648310
Synonym tris(Hydroxymethyl)aminomethane; 1,3-Propanediol,
2-amino-2-(hydroxymethyl)-
:
Composition / information on ingredients2.
Substance/Preparation Substance:
CAS No.Chemical name* EC Number Symbol R-Phrases
1) tris(Hydroxymethyl)aminomethane; 1,3-Propanediol,
2-amino-2-(hydroxymethyl)-
77-86-1 201-064-4 Xi R36/38
Hazards identification3.
Physical/chemical hazards
Human health hazards CAUTION!
Not applicable.:
:
MAY CAUSE EYE AND SKIN IRRITATION.
Do NOT induce vomiting unless directed to do so by medical personnel.  Never give anything by mouth to an
unconscious person.  Loosen tight clothing such as a collar, tie, belt or waistband.  Get medical attention if
symptoms appear.
Skin Contact
Check for and remove any contact lenses.  In case of contact, immediately flush eyes with plenty of water for at
least 15 minutes.  Cold water may be used.  Get medical attention.
In case of contact, immediately flush skin with plenty of water.  Cover the irritated skin with an emollient.
Remove contaminated clothing and shoes.  Cold water may be used.Wash clothing before reuse.  Thoroughly
clean shoes before reuse.  Get medical attention.
4.
Hazardous in case of skin contact (irritant).  Skin inflammation is characterized by itching, scaling, reddening,
or, occasionally, blistering.
Skin Contact
Hazardous in case of eye contact (irritant).Eye Contact
Aggravating conditions Repeated or prolonged exposure is not known to aggravate medical condition.
First-Aid measures
If inhaled, remove to fresh air.  If not breathing, give artificial respiration.  If breathing is difficult, give oxygen.
Get medical attention.
Ingestion
Effects and symptoms
Inhalation
Eye Contact
:
:
:
:
:
:
:
First-aid measures
Fire-fighting measures5.
Suitable
Hazardous thermal (de)composition
products
These products are carbon oxides (CO, CO2), nitrogen oxides (NO, NO2...).
SMALL FIRE:  Use DRY chemical powder.
LARGE FIRE:  Use water spray, fog or foam.  Do not use water jet.
Extinguishing Media
:
:
Flammability of the Product May be combustible at high temperature.:
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Fire fighters should wear positive pressure self-contained breathing apparatus (SCBA) and full turnout gear.
Be sure to use an approved/certified respirator or equivalent.Protection of fire-fighters
Special fire-fighting procedures :
:
Personal precautions Splash goggles.  Full suit.  Dust respirator.  Boots.  Gloves.  A self-contained breathing apparatus should be
used to avoid inhalation of the product.  Suggested protective clothing might not be sufficient; consult a
specialist BEFORE handling this product.
6. Accidental release measures
:
:Small Spill and Leak Use appropriate tools to put the spilled solid in a convenient waste disposal container.  Finish cleaning by
spreading water on the contaminated surface and dispose of according to local and regional authority
requirements.
Use a shovel to put the material into a convenient waste disposal container.  Finish cleaning by spreading
water on the contaminated surface and allow to evacuate through the sanitary system
Large Spill and Leak :
Handling
Handling and storage
Storage
7.
Keep away from heat.  Keep away from sources of ignition.  Empty containers pose a fire risk, evaporate the
residue under a fume hood.  Ground all equipment containing material.  Do not ingest.  Do not breathe dust.
Wear suitable protective clothing.  If ingested, seek medical advice immediately and show the container or the
label.  Avoid contact with skin and eyes.  Keep away from incompatibles such as oxidizing agents, alkalis.
Packaging materials
Use original container.
Keep container tightly closed.  Keep container in a cool, well-ventilated area.  Do not store above 20°C (68°F).
:
:
:
Recommended use
Ingredient Name Occupational Exposure Limits
Engineering measures Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below
recommended exposure limits.  If user operations generate dust, fume or mist, use ventilation to keep exposure
to airborne contaminants below the exposure limit.
1) Tris Base, Molecular Biology Grade Not available.
8. Exposure controls/personal protection
Wash hands after handling compounds and before eating, smoking, using lavatory, and at the end of day.Hygiene measures
Skin and body
Personal protective equipment
Dust respirator.  Be sure to use an approved/certified respirator or equivalent.
Lab coat.
Gloves.Hands
Splash goggles.Eyes
Respiratory system
:
:
:
:
:
:
Protective Clothing
(Pictograms)
:
Physical and chemical properties
Physical state
Melting Point
Solubility
Solid. (Solid crystalline powder.)
171.2 to 172.3°C (340.2 to 342.1°F)
Easily soluble in cold water.
White.Color
Flash point Not available.
Risks of explosion of the product in presence of mechanical impact:  Not available.
Risks of explosion of the product in presence of static discharge: Not available.
9.
Explosive properties
:
:
:
:
:
:
Molecular Weight 121.1 g/mole:
Hazardous Decomposition Products
Conditions to avoid Not available.
Stability and reactivity
These products are carbon oxides (CO, CO2), nitrogen oxides (NO, NO2...).
The product is stable.Stability
10.
Reactive with oxidizing agents, alkalis.
:
:
:
Materials to avoid :
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LD50: Not available.
LC50: Not available.
Toxicological information
Acute toxicity
Carcinogenic effects
Skin irritation
Mutagenic effects
Reproduction toxicity
Hazardous in case of skin contact (irritant).
Not available.
Not available.
Not available.
Repeated or prolonged exposure is not known to aggravate medical condition.
Not available.
11.
Local effects
Chronic toxicity
:
:
:
:
:
:
Teratogenic effects :
RTECS # : TY2900000
Other Toxic Effects on
Humans Hazardous in case of skin contact (irritant).
Not available.
Not available.
Not available.
:
Ecological information
Ecotoxicity Not available.
12.
:
Toxicity of the Products of
Biodegradation
The product itself and its products of degradation are not toxic.:
Disposal considerations13.
Methods of disposal; Waste of
residues; Contaminated packaging
Waste must be disposed of in accordance with federal, state and local environmental control regulations.:
ADR/RID Class
14.
International transport regulations
Land - Road/Railway
Not controlled under ADR (Europe).
IMDG Class
Sea
Not controlled under IMDG.
Air
IATA-DGR Class Not controlled under IATA.
:
:
:
Transport information
Special Provisions for
Transport
Not applicable.
Regulatory information15.
Safety Phrases S26- In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
R36/38- Irritating to eyes and skin.
Hazard symbol(s)
Risk Phrases
EU Regulations
:
:
:
Classification : Irritant
Clean Water Act (CWA) 307: No products were found.
U.S. Federal Regulations TSCA 8(b) inventory: Tris Base, Molecular Biology Grade
Clean Water Act (CWA) 311: No products were found.
Clean air act (CAA) 112 accidental release prevention: No products were found.
Clean air act (CAA) 112 regulated flammable substances: No products were found.
SARA 302/304/311/312 extremely hazardous substances: No products were found.
SARA 302/304 emergency planning and notification: No products were found.
SARA 302/304/311/312 hazardous chemicals: No products were found.
SARA 311/312 MSDS distribution - chemical inventory - hazard identification: No products were found.
SARA 313 toxic chemical notification and release reporting: No products were found.
:
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CLASS: Irritating substance.HCS Classification
Clean air act (CAA) 112 regulated toxic substances: No products were found.
CEPA DSL: Tris Base, Molecular Biology Grade
WHMIS (Canada) Not controlled under WHMIS (Canada).
:
:
State Regulations :
Other information16.
Date of issue
3/26/2003. Page: 4/4
To the best of our knowledge, the information contained herein is accurate.  However, neither the above named supplier nor any of its
subsidiaries assumes any liability whatsoever for the accuracy or completeness of the information contained herein
Final determination of suitability of any material is the sole responsibility of the user. All materials may present unknown hazards and should be
used with caution.  Although certain hazards are described herein, we cannot guarantee that these are the only hazards that exist.
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Material Safety Data Sheet
Sodium phosphate, dibasic MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium phosphate, dibasic
Catalog Codes: SLS2365, SLS2986, SLS4408
CAS#: 7558-79-4
RTECS: WC4500000
TSCA: TSCA 8(b) inventory: Sodium phosphate, dibasic
CI#: Not available.
Synonym:   Dibasic Sodium Phosphate; Disodium
hydrogen phosphate; Disodium monohydrogen phosphate;
Disodium orthophosphate; Disodium phosphoric acid;
Phosphoric acid, disodium salt; Soda phosphate; Sodium
hydrogen phosphate
Chemical Name: Sodium Monohydrogen Phosphate(2:1:1)
Chemical Formula: Na2HPO4
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Sodium phosphate, dibasic 7558-79-4 100
Toxicological Data on Ingredients: Not applicable.
Section 3: Hazards Identification
Potential Acute Health Effects: Slightly hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of
inhalation.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available. Repeated or prolonged exposure is not known to aggravate medical condition.
Section 4: First Aid Measures
Eye Contact:
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Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention if irritation occurs.
Skin Contact:
Wash with soap and water. Cover the irritated skin with an emollient. Get medical attention if irritation develops. Cold water
may be used.
Serious Skin Contact: Not available.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if symptoms appear.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: Not applicable.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available.
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards: Not available.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by spreading water on
the contaminated surface and dispose of according to local and regional authority requirements.
Large Spill: Use a shovel to put the material into a convenient waste disposal container.
Section 7: Handling and Storage
Precautions:
Do not ingest. Do not breathe dust. Wear suitable protective clothing. In case of insufficient ventilation, wear suitable
respiratory equipment. If ingested, seek medical advice immediately and show the container or the label. Keep away from
incompatibles such as acids, alkalis.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area. Hygroscopic
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Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection: Safety glasses. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Solid powder.)
Odor: Odorless.
Taste: Saline.
Molecular Weight: 141.96 g/mole
Color: White.
pH (1% soln/water): 9.1 [Basic.]
Boiling Point: Not available.
Melting Point:
Decomposition temperature: 240°C (464°F) Converted to Sodium Pyrophosphate @ about 240 deg. C
Critical Temperature: Not available.
Specific Gravity: Not available.
Vapor Pressure: Not applicable.
Vapor Density: 4.9 (Air = 1)
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility:
Easily soluble in hot water. Soluble in cold water. Insoluble in methanol, n-octanol.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability:
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Exposure to moisture and to incompatible materials. When heated to decompostition, it emits toxic fumes of phosphoxides and
sodium oxide.
Incompatibility with various substances: Reactive with acids, alkalis.
Corrosivity: Not available.
Special Remarks on Reactivity:
Hygroscopic; keep container tightly closed. Incompatible with magnesium, alkaloids, antipyrine, chloral hydrate, lead acetate,
pyrogallol, resorcinol, strong mineral acids, strong organic acids.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Inhalation. Ingestion.
Toxicity to Animals: Acute oral toxicity (LD50): 17000 mg/kg [Rat].
Chronic Effects on Humans: Not available.
Other Toxic Effects on Humans: Slightly hazardous in case of skin contact (irritant), of ingestion, of inhalation.
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: Not available.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: Causes mild skin irritation. May cause dermatitis. Eyes: Causes mild eye irritation.
Ingestion: May cause irritation of the digestive tract and may cause purging. It is slowly aborbed. Expected to be a low
ingestion hazard for usual industrial handling. Ingestion of large doses may affect behavior/central nervous system (tetany).
However, if a significant amount of phosphate is absorbed, hypophosphatemia will occur. Severe hypophosphatemia may
result in hypocalcemia and tetany. Cardiovasular, respiratory, neurologic, and musculoskeletal effects may occur secondary
to hypernatremia, hypophosphatemia, and hypocalcemia Inhalation: May cause respiratory tract and mucous membrane
irritation. Low hazard for usual industrial handling. Chronic Potential Health Effects: Skin: High and repeated exposure may
cause dermatitis.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
p. 5
Identification: : Not available. UNNA: 9147 PG: III
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations:
New York release reporting list: Sodium phosphate, dibasic Pennsylvania RTK: Sodium phosphate, dibasic Massachusetts
RTK: Sodium phosphate, dibasic New Jersey: Sodium phosphate, dibasic California Director's List of Hazardous Sustances:
Sodium phosphate, dibasic TSCA 8(b) inventory: Sodium phosphate, dibasic CERCLA: Hazardous substances.: Sodium
phosphate, dibasic: 5000 lbs. (2268 kg)
Other Regulations: EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
This product is not classified according to the EU regulations. S24/25- Avoid contact with skin and eyes.
HMIS (U.S.A.):
Health Hazard: 1
Fire Hazard: 0
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 1
Flammability: 0
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Safety glasses.
Section 16: Other Information
References: -Hawley, G.G.. The Condensed Chemical Dictionary, 11e ed., New York N.Y., Van Nostrand Reinold, 1987.
Other Special Considerations: Not available.
Created: 10/09/2005 06:34 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Material Safety Data Sheet
Sodium carbonate monohydrate MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium carbonate monohydrate
Catalog Codes: SLS1099, SLS2521, SLS3943
CAS#: 5968-11-6
RTECS: Not available.
TSCA: TSCA 8(b) inventory: No products were found.
CI#: Not available.
Synonym:   Disodium Carbonate monohydrate
Chemical Name: Carbonic Acid, disodium salt,
monohydrate
Chemical Formula: Na2CO3.H20
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Sodium carbonate monohydrate 5968-11-6 100
Toxicological Data on Ingredients: Sodium carbonate monohydrate: DUST (LC50): Acute: 468 mg/m 4 hours [Guinea pig].
Section 3: Hazards Identification
Potential Acute Health Effects:
Hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation (lung irritant). Corrosive to
eyes and skin. The amount of tissue damage depends on length of contact. Eye contact can result in corneal damage or
blindness. Skin contact can produce inflammation and blistering. Severe over-exposure can produce lung damage, choking,
unconsciousness or death.
Potential Chronic Health Effects:
Slightly hazardous in case of skin contact (irritant). CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS:
Not available. TERATOGENIC EFFECTS: Not available. DEVELOPMENTAL TOXICITY: Not available. The substance
may be toxic to upper respiratory tract, skin, eyes. Repeated or prolonged exposure to the substance can produce target
organs damage. Repeated exposure of the eyes to a low level of dust can produce eye irritation. Repeated skin exposure can
produce local skin destruction, or dermatitis. Repeated inhalation of dust can produce varying degree of respiratory irritation or
lung damage.
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Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention.
Skin Contact:
In case of contact, immediately flush skin with plenty of water. Cover the irritated skin with an emollient. Remove contaminated
clothing and shoes. Cold water may be used.Wash clothing before reuse. Thoroughly clean shoes before reuse. Get medical
attention.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek immediate medical
attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. If large quantities of this material are swallowed, call a physician immediately. Loosen tight clothing such as a collar,
tie, belt or waistband.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: Not applicable.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available.
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards: Not available.
Special Remarks on Explosion Hazards: Not available.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. If necessary: Neutralize the residue with
a dilute solution of acetic acid. Finish cleaning by spreading water on the contaminated surface and dispose of according to
local and regional authority requirements.
Large Spill:
Corrosive solid. Stop leak if without risk. Do not get water inside container. Do not touch spilled material. Use water spray
to reduce vapors. Prevent entry into sewers, basements or confined areas; dike if needed. Call for assistance on disposal.
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Neutralize the residue with a dilute solution of acetic acid. Finish cleaning by spreading water on the contaminated surface and
allow to evacuate through the sanitary system.
Section 7: Handling and Storage
Precautions:
Keep container dry. Do not ingest. Do not breathe dust. Never add water to this product. Wear suitable protective clothing. In
case of insufficient ventilation, wear suitable respiratory equipment. If ingested, seek medical advice immediately and show the
container or the label. Avoid contact with skin and eyes.
Storage: Hygroscopic. Keep container tightly closed. Keep container in a cool, well-ventilated area.
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection:
Splash goggles. Synthetic apron. Vapor and dust respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Vapor and dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to
avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling
this product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid. (Granular solid.)
Odor: Odorless.
Taste: Not available.
Molecular Weight: 124 g/mole
Color: White.
pH (1% soln/water): 11.6 [Basic.]
Boiling Point: Not available.
Melting Point: Not available.
Critical Temperature: Not available.
Specific Gravity: Density: 2.25 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
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Dispersion Properties: See solubility in water.
Solubility:
Soluble in hot water. Partially soluble in cold water. Soluble in 3 parts of cold water. Soluble in 1.8 parts of boiling water.
Insoluble in alcohol. Soluble in 7 parts of glycero
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Incompatible materials, moisture
Incompatibility with various substances:
Reactive with acids. Slightly reactive to reactive with moisture.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity:
Hygroscopic; keep container tightly closed. Incompatible with aluminum and fluorine. Dries out somewhat in warm, dry air or
above 50 C and becomes anhydrous at 100 C.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Dermal contact. Inhalation. Ingestion.
Toxicity to Animals:
WARNING: THE LC50 VALUES HEREUNDER ARE ESTIMATED ON THE BASIS OF A 4-HOUR EXPOSURE. Acute toxicity
of the dust (LC50): 468 mg/m  4 hours [Guinea pig]. 3
Chronic Effects on Humans: May cause damage to the following organs: upper respiratory tract, skin, eyes.
Other Toxic Effects on Humans: Hazardous in case of skin contact (irritant), of ingestion, of inhalation (lung irritant).
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans: May cause adverse reproductive effects based on animal test data
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: Causes skin irritation with possible burns depending on the concentration, site (abraded
or intact skin), and duration of exposure. Eyes: Causes eye irritation and possible burns. May cause chemical conjunctivitis.
Concentrated solutions may cause permanent corneal injury (permanent corneal opacity). Ingestion: Sodium carbonate
ingestion may cause irritation of the digestive tract resulting in nausea, vomiting, diarrhea, thrist, abdominal pain depending
on concentration and amount ingested. May also affect the cardiovascular system . Inhalation: Dust may cause respiratory
tract and mucous membrane irritation with coughing and shortness of breath (dyspnea), pulmonary edema. Chronic Potential
Health Effects: Chronic inhalation may result in decreased pulmonary function, nasal congestion, nosebleeds, perforation
of the nasal septum. Other effects of chronic exposure are skin (dermatitis and ulceration), and gastrointestinal complaints.
However, the effects of chronic exposure seem to be reversible if exposure is decreased.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
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Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The products of degradation are less toxic than the product itself.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations: No products were found.
Other Regulations: OSHA: Hazardous by definition of Hazard Communication Standard (29 CFR 1910.1200).
Other Classifications:
WHMIS (Canada):
CLASS D-1A: Material causing immediate and serious toxic effects (VERY TOXIC). CLASS E: Corrosive solid.
DSCL (EEC):
R36/37/38- Irritating to eyes, respiratory system and skin. S22- Do not breathe dust. S26- In case of contact with eyes, rinse
immediately with plenty of water and seek medical advice.
HMIS (U.S.A.):
Health Hazard: 2
Fire Hazard: 0
Reactivity: 1
Personal Protection: j
National Fire Protection Association (U.S.A.):
Health: 2
Flammability: 0
Reactivity: 1
Specific hazard:
Protective Equipment:
Gloves. Synthetic apron. Vapor and dust respirator. Be sure to use an approved/certified respirator or equivalent. Wear
appropriate respirator when ventilation is inadequate. Splash goggles.
Section 16: Other Information
References: Not available.
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Other Special Considerations: Not available.
Created: 10/11/2005 12:33 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Material Safety Data Sheet
Sodium bicarbonate MSDS
Section 1: Chemical Product and Company Identification
Product Name: Sodium bicarbonate
Catalog Codes: SLS3241, SLS2446, SLS3868
CAS#: 144-55-8
RTECS: VZ0950000
TSCA: TSCA 8(b) inventory: Sodium bicarbonate
CI#: Not available.
Synonym:   Baking Soda; Bicarbonate of soda; Sodium
acid carbonate; Monosodium carbonate; Sodium hydrogen
carbonate; Carbonic acid monosodium salt
Chemical Name: Sodium Bicarbonate
Chemical Formula: NaHCO3
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Sodium bicarbonate 144-55-8 100
Toxicological Data on Ingredients: Not applicable.
Section 3: Hazards Identification
Potential Acute Health Effects: Slightly hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of
inhalation.
Potential Chronic Health Effects:
CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS: Not available. TERATOGENIC EFFECTS: Not available.
DEVELOPMENTAL TOXICITY: Not available. Repeated or prolonged exposure is not known to aggravate medical condition.
Section 4: First Aid Measures
Eye Contact:
Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Cold water may be used. Get medical attention if irritation occurs.
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Skin Contact:
Wash with soap and water. Cover the irritated skin with an emollient. Get medical attention if irritation develops. Cold water
may be used.
Serious Skin Contact: Not available.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if symptoms appear.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: Non-flammable.
Auto-Ignition Temperature: Not applicable.
Flash Points: Not applicable.
Flammable Limits: Not applicable.
Products of Combustion: Not available.
Fire Hazards in Presence of Various Substances: Not applicable.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available.
Fire Fighting Media and Instructions: Not applicable.
Special Remarks on Fire Hazards: When heated to decomposition it emits acrid smoke and irritating fumes.
Special Remarks on Explosion Hazards: Not available.
Section 6: Accidental Release Measures
Small Spill:
Use appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by spreading water on
the contaminated surface and dispose of according to local and regional authority requirements.
Large Spill:
Use a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water on the
contaminated surface and allow to evacuate through the sanitary system.
Section 7: Handling and Storage
Precautions:
Do not ingest. Do not breathe dust. If ingested, seek medical advice immediately and show the container or the label. Keep
away from incompatibles such as acids.
Storage: Keep container tightly closed. Keep container in a cool, well-ventilated area.
Section 8: Exposure Controls/Personal Protection
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Engineering Controls:
Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended
exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants
below the exposure limit.
Personal Protection: Safety glasses. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent.
Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits: Not available.
Section 9: Physical and Chemical Properties
Physical state and appearance: Solid.
Odor: Odorless.
Taste: Saline. Alkaline.
Molecular Weight: 84.01g/mole
Color: White.
pH (1% soln/water): Not available.
Boiling Point: Not available.
Melting Point: Not available.
Critical Temperature: Not available.
Specific Gravity: Density: 2.159 (Water = 1)
Vapor Pressure: Not applicable.
Vapor Density: Not available.
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: Not available.
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water.
Solubility:
Soluble in cold water. Slightly soluble in alcohol. Solubility in Water: 6.4, 7.6, 8.7, 10.0, 11.3, 12.7, 14.2, 16.5, 19.1 g/100
solution at 0, 10, 20, 30, 40, 50, 60, 80, adn 100 deg. C, respectively. Solubility in Water: 6.9, 8,2, 9.6, 11.1, 12.7, 14.5, 16.5,
19.7, and 23.6 g/100g water at 0, 10, 20, 30, 40, 50, 60, 80, 100 deg. C, respectively.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Incompatible materials, Moisture. Stable in dry air, but slowly decomposes in moist air.
Incompatibility with various substances: Reactive with acids.
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Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity:
Reacts with acids to form carbon dioxide. Dangerous reaction with monoammonium phosphate or a sodium-potassium alloy.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Inhalation. Ingestion.
Toxicity to Animals: Acute oral toxicity (LD50): 3360 mg/kg [Mouse].
Chronic Effects on Humans: Not available.
Other Toxic Effects on Humans: Slightly hazardous in case of skin contact (irritant), of ingestion, of inhalation.
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans:
Sodium Bicarbonate as produced genetic effects in rats (unscheduled DNA synthesis). However, no affects have been found
in humans.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: May cause mild skin irritation. Eyes: May cause mild eye irritation. Inhalation: May
cause respiratory tract irritation. Symptoms may include coughing and sneezing. Ingestion: Symptoms of overexposure to
Sodium Bicarbonate include thirst, abdominal pain, gastroenteritis, and inflammation of the digestive tract. Chronic Potential
Health Effects: Skin: Repeated or prolonged skin contact may cause irritation, drying or cracking of the skin. Ingestion and
Inhalation: Chronic toxicity usually occurs within 4 to 10 days following ingestion of very large amounts. Repeated or prolonged
ingestion or inhalation of large amounts may cause metabolic abnormalities, and sodium retention. Metabolic abnormalities
such as acidosis, hypernatremia, hypochloremia, alkalosis, hypocalcemia, or sodium retention may affect the blood, kidneys,
respiration (cyanosis, apnea secondary to metabolic acidosis or pulmonary edema), and cardiovascular system (tachycardia,
hypotension). Severe toxicity may also affect behavior/central nervous system/nervous system. Neurological changes may
result from metabolic abnormalities. These may include fatigue, irritability, dizziness, mental confusion, paresthesia, seizures,
tetany, cerebral edema Medical Conditions Aggravated by Exposure: Persons with pre-existing skin conditions might have
increased sensitivity. Predisposing conditions that contribute to a mild alkali syndrome include, renal disease, dehydration, adn
electrolyte imbalance, hypertension, sarcoidosis, congestive heart failure, edema, or other sodium retaining conditions.
Section 12: Ecological Information
Ecotoxicity: Not available.
BOD5 and COD: Not available.
Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The product itself and its products of degradation are not toxic.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Waste must be disposed of in accordance with federal, state and local environmental control regulations.
Section 14: Transport Information
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DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations: TSCA 8(b) inventory: Sodium bicarbonate
Other Regulations: Not available.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
This product is not classified according to the EU regulations. Not applicable.
HMIS (U.S.A.):
Health Hazard: 1
Fire Hazard: 0
Reactivity: 0
Personal Protection: E
National Fire Protection Association (U.S.A.):
Health: 1
Flammability: 0
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Safety glasses.
Section 16: Other Information
References: Not available.
Other Special Considerations: Not available.
Created: 10/10/2005 08:26 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
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Material Safety Data Sheet
Propylene glycol MSDS
Section 1: Chemical Product and Company Identification
Product Name: Propylene glycol
Catalog Codes: SLP1162, SLP2974
CAS#: 57-55-6
RTECS: TY2000000
TSCA: TSCA 8(b) inventory: Propylene glycol
CI#: Not applicable.
Synonym:   1,2,-propanediol, 1,2-dihydroxypropane
Chemical Name: Propylene Glycol
Chemical Formula: CH3CHOHCH2OH
Contact Information:
Sciencelab.com, Inc.
14025 Smith Rd.
Houston, Texas 77396
US Sales: 1-800-901-7247
International Sales: 1-281-441-4400
Order Online: ScienceLab.com
CHEMTREC (24HR Emergency Telephone), call:
1-800-424-9300
International CHEMTREC, call: 1-703-527-3887
For non-emergency assistance, call: 1-281-441-4400
Section 2: Composition and Information on Ingredients
Composition:
Name CAS # % by Weight
Propylene glycol 57-55-6 100
Toxicological Data on Ingredients: Propylene glycol: ORAL (LD50): Acute: 20000 mg/kg [Rat]. 22000 mg/kg [Mouse].
DERMAL (LD50): Acute: 20800 mg/kg [Rabbit].
Section 3: Hazards Identification
Potential Acute Health Effects:
Hazardous in case of ingestion. Slightly hazardous in case of skin contact (irritant, permeator), of eye contact (irritant), of
inhalation.
Potential Chronic Health Effects:
Slightly hazardous in case of skin contact (sensitizer). CARCINOGENIC EFFECTS: Not available. MUTAGENIC EFFECTS:
Not available. TERATOGENIC EFFECTS: Not available. DEVELOPMENTAL TOXICITY: Not available. The substance may be
toxic to central nervous system (CNS). Repeated or prolonged exposure to the substance can produce target organs damage.
Section 4: First Aid Measures
Eye Contact:
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Check for and remove any contact lenses. Immediately flush eyes with running water for at least 15 minutes, keeping eyelids
open. Cold water may be used. Get medical attention.
Skin Contact:
In case of contact, immediately flush skin with plenty of water. Cover the irritated skin with an emollient. Remove contaminated
clothing and shoes. Cold water may be used.Wash clothing before reuse. Thoroughly clean shoes before reuse. Get medical
attention.
Serious Skin Contact:
Wash with a disinfectant soap and cover the contaminated skin with an anti-bacterial cream. Seek immediate medical
attention.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical
attention.
Serious Inhalation: Not available.
Ingestion:
Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious
person. If large quantities of this material are swallowed, call a physician immediately. Loosen tight clothing such as a collar,
tie, belt or waistband.
Serious Ingestion: Not available.
Section 5: Fire and Explosion Data
Flammability of the Product: May be combustible at high temperature.
Auto-Ignition Temperature: 371°C (699.8°F)
Flash Points: CLOSED CUP: 99°C (210.2°F). OPEN CUP: 107°C (224.6°F) (Cleveland).
Flammable Limits: LOWER: 2.6% UPPER: 12.5%
Products of Combustion: These products are carbon oxides (CO, CO2).
Fire Hazards in Presence of Various Substances: Slightly flammable to flammable in presence of heat.
Explosion Hazards in Presence of Various Substances:
Risks of explosion of the product in presence of mechanical impact: Not available. Risks of explosion of the product in
presence of static discharge: Not available.
Fire Fighting Media and Instructions:
SMALL FIRE: Use DRY chemical powder. LARGE FIRE: Use water spray, fog or foam. Do not use water jet.
Special Remarks on Fire Hazards: When heated to decomposition it emits acrid smoke and irritating fumes.
Special Remarks on Explosion Hazards: Not available.
Section 6: Accidental Release Measures
Small Spill:
Dilute with water and mop up, or absorb with an inert dry material and place in an appropriate waste disposal container.
Finish cleaning by spreading water on the contaminated surface and dispose of according to local and regional authority
requirements.
Large Spill:
Absorb with an inert material and put the spilled material in an appropriate waste disposal. Finish cleaning by spreading water
on the contaminated surface and allow to evacuate through the sanitary system. Be careful that the product is not present at a
concentration level above TLV. Check TLV on the MSDS and with local authorities.
Section 7: Handling and Storage
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Precautions:
Keep away from heat. Keep away from sources of ignition. Empty containers pose a fire risk, evaporate the residue under a
fume hood. Ground all equipment containing material. Do not ingest. Do not breathe gas/fumes/ vapor/spray. Wear suitable
protective clothing. In case of insufficient ventilation, wear suitable respiratory equipment. If ingested, seek medical advice
immediately and show the container or the label. Avoid contact with skin and eyes. Keep away from incompatibles such as
oxidizing agents, reducing agents, acids, alkalis, moisture.
Storage:
Hygroscopic. Keep container tightly closed. Keep container in a cool, well-ventilated area. Do not store above 23°C (73.4°F).
Section 8: Exposure Controls/Personal Protection
Engineering Controls:
Provide exhaust ventilation or other engineering controls to keep the airborne concentrations of vapors below their respective
threshold limit value. Ensure that eyewash stations and safety showers are proximal to the work-station location.
Personal Protection:
Splash goggles. Lab coat. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Gloves.
Personal Protection in Case of a Large Spill:
Splash goggles. Full suit. Vapor respirator. Boots. Gloves. A self contained breathing apparatus should be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this
product.
Exposure Limits:
TWA: 10 (mg/m3) from AIHA Consult local authorities for acceptable exposure limits.
Section 9: Physical and Chemical Properties
Physical state and appearance: Liquid. (Oily liquid.)
Odor: Practically Odorless.
Taste: Practically Tasteless.
Molecular Weight: 76.1g/mole
Color: Colorless. Clear
pH (1% soln/water): Not available.
Boiling Point: 188°C (370.4°F)
Melting Point: -59°C (-74.2°F)
Critical Temperature: Not available.
Specific Gravity: 1.036 (Water = 1)
Vapor Pressure:
0 kPa (@ 20°C) 0.08 mmHg at 20 C 0.129 mmHg at 25 C
Vapor Density: 2.62 (Air = 1)
Volatility: Not available.
Odor Threshold: Not available.
Water/Oil Dist. Coeff.: The product is more soluble in water; log(oil/water) = -0.9
Ionicity (in Water): Not available.
Dispersion Properties: See solubility in water, acetone.
p. 4
Solubility: Soluble in cold water, hot water, acetone.
Section 10: Stability and Reactivity Data
Stability: The product is stable.
Instability Temperature: Not available.
Conditions of Instability: Incompatible materials, excess heat, exposure to moist air or water
Incompatibility with various substances: Reactive with oxidizing agents, reducing agents, acids, alkalis.
Corrosivity: Non-corrosive in presence of glass.
Special Remarks on Reactivity:
Hygroscopic; keep container tightly closed. Incompatible with chloroformates, strong acids (nitric acid, hydrofluloric acid),
caustics, aliphatic amines, isocyanates, strong oxidizers, acid anhydrides, silver nitrate, reducing agents.
Special Remarks on Corrosivity: Not available.
Polymerization: Will not occur.
Section 11: Toxicological Information
Routes of Entry: Absorbed through skin. Eye contact.
Toxicity to Animals:
Acute oral toxicity (LD50): 18500 mg/kg [Rabbit]. Acute dermal toxicity (LD50): 20800 mg/kg [Rabbit].
Chronic Effects on Humans: May cause damage to the following organs: central nervous system (CNS).
Other Toxic Effects on Humans:
Hazardous in case of ingestion. Slightly hazardous in case of skin contact (irritant, permeator), of inhalation.
Special Remarks on Toxicity to Animals: Not available.
Special Remarks on Chronic Effects on Humans:
May affect genetic material (mutagenic). May cause adverse reproductive effects and birth defects (teratogenic) based on
animal test data.
Special Remarks on other Toxic Effects on Humans:
Acute Potential Health Effects: Skin: May cause mild skin irritation. It may be absorbed through the skin and cause systemic
effects similar to those of ingestion. Eyes: May cause mild eye irritation with some immediate, transitory stinging, lacrimation,
blepharospasm, and mild transient conjunctival hyperemia. There is no residual discomfort or injury once it is washed
away. Inhalation: May cause respiratory tract irritation. Ingestion: It may cause gastrointestinal tract irritation. It may affect
behavior/central nervous system(CNS depression, general anesthetic, convulsions, seizures, somnolence, stupor, muscle
contraction or spasticity, coma), brain (changes in surface EEG), metabolism, blood (intravascular hemolysis, white blood
cells - decreased neutrophil function), respiration (respiratory stimulation, chronic pulmonary edema, cyanosis), cardiovascular
system(hypotension, bradycardia, arrhythmias, cardiac arrest), endocrine system (hypoglycemia), urinary system (kidneys),
and liver. Chronic Potential Health Effects: Skin: Prolonged or repeated skin contact may cause allergic contact dermatitis.
Ingestion: Prolonged or repeated ingestion may cause hyperglycemia and may affect behavior/CNS (symptoms similar to that
of acute ingestion). Inhalation: Prolonged or repeated inhalation may affect behavior/CNS (with symptoms similar to ingestion),
and spleen
Section 12: Ecological Information
Ecotoxicity:
Ecotoxicity in water (LC50): >5000 mg/l 24 hours [Goldfish]. >10000 mg/l 48 hours [guppy]. >10000 mg/l 48 hours [water flea].
BOD5 and COD: Not available.
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Products of Biodegradation:
Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise.
Toxicity of the Products of Biodegradation: The products of degradation are less toxic than the product itself.
Special Remarks on the Products of Biodegradation: Not available.
Section 13: Disposal Considerations
Waste Disposal:
Section 14: Transport Information
DOT Classification: Not a DOT controlled material (United States).
Identification: Not applicable.
Special Provisions for Transport: Not applicable.
Section 15: Other Regulatory Information
Federal and State Regulations:
Pennsylvania RTK: Propylene glycol Minnesota: Propylene glycol TSCA 8(b) inventory: Propylene glycol
Other Regulations: EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances.
Other Classifications:
WHMIS (Canada): Not controlled under WHMIS (Canada).
DSCL (EEC):
R21/22- Harmful in contact with skin and if swallowed. S24/25- Avoid contact with skin and eyes.
HMIS (U.S.A.):
Health Hazard: 2
Fire Hazard: 1
Reactivity: 0
Personal Protection: h
National Fire Protection Association (U.S.A.):
Health: 0
Flammability: 1
Reactivity: 0
Specific hazard:
Protective Equipment:
Gloves. Lab coat. Vapor respirator. Be sure to use an approved/certified respirator or equivalent. Splash goggles.
Section 16: Other Information
References:
-Hawley, G.G.. The Condensed Chemical Dictionary, 11e ed., New York N.Y., Van Nostrand Reinold, 1987. -SAX, N.I.
Dangerous Properties of Indutrial Materials. Toronto, Van Nostrand Reinold, 6e ed. 1984. -The Sigma-Aldrich Library of
Chemical Safety Data, Edition II. -Supplier MSDS -LOLI -RTECS -HSDB
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Other Special Considerations: Not available.
Created: 10/10/2005 08:24 PM
Last Updated: 05/21/2013 12:00 PM
The information above is believed to be accurate and represents the best information currently available to us. However, we
make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume
no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for
their particular purposes. In no event shall ScienceLab.com be liable for any claims, losses, or damages of any third party or for
lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if ScienceLab.com
has been advised of the possibility of such damages.
Oxygen
Molecular oxygen; Oxygen molecule; Pure oxygen; O2; UN 1072; Dioxygen; Oxygen 
USP, Aviator’s Breathing Oxygen (ABO)
Gas.
SAFETY DATA SHEET
GHS product identifier
Other means of 
identification
Product type
Section 1. Identification
:
:
:
Chemical name : oxygen
Supplier's details :
Oxygen
Product use : Synthetic/Analytical chemistry.
Synonym : Molecular oxygen; Oxygen molecule; Pure oxygen; O2; UN 1072; Dioxygen; Oxygen 
USP, Aviator’s Breathing Oxygen (ABO)
SDS # : 001043
Airgas USA, LLC and its affiliates
259 North Radnor-Chester Road
Suite 100
Radnor, PA 19087-5283
1-610-687-5253
1-866-734-3438:24-hour telephone
Section 2. Hazards identification
OXIDIZING GASES - Category 1
GASES UNDER PRESSURE - Compressed gas
Classification of the 
substance or mixture
:
Signal word : Danger
Hazard statements : May cause or intensify fire; oxidizer.
Contains gas under pressure; may explode if heated.
Hazard pictograms :
Precautionary statements
Prevention : Keep away from clothing, incompatible materials and combustible materials.  Keep 
reduction valves, valves and fittings free from oil and grease.
Response : In case of fire:  Stop leak if safe to do so.
Storage : Protect from sunlight.  Store in a well-ventilated place.
Disposal : Not applicable.
GHS label elements
General : Read and follow all Safety Data Sheets (SDS’S) before use.  Read label before use.
Keep out of reach of children.  If medical advice is needed, have product container or 
label at hand.  Close valve after each use and when empty.  Use equipment rated for 
cylinder pressure.  Do not open valve until connected to equipment prepared for use.
Use a back flow preventative device in the piping.  Use only equipment of compatible 
materials of construction.  Open valve slowly.  Use only with equipment cleaned for 
Oxygen service.
Hazards not otherwise 
classified
: None known.
OSHA/HCS status : This material is considered hazardous by the OSHA Hazard Communication Standard 
(29 CFR 1910.1200).
Date of issue/Date of revision : 2/3/2018 Date of previous issue : 1/27/2017 Version : 0.03 1/11
Oxygen
Section 3. Composition/information on ingredients
oxygen 100 7782-44-7
Ingredient name CAS number%
There are no additional ingredients present which, within the current knowledge of the supplier and in the 
concentrations applicable, are classified as hazardous to health or the environment and hence require reporting 
in this section.
Chemical name : oxygen
Other means of 
identification
: Molecular oxygen; Oxygen molecule; Pure oxygen; O2; UN 1072; Dioxygen; Oxygen 
USP, Aviator’s Breathing Oxygen (ABO)
CAS number : 7782-44-7
Substance/mixture
CAS number/other identifiers
:
Occupational exposure limits, if available, are listed in Section 8.
Substance
Any concentration shown as a range is to protect confidentiality or is due to batch variation.
Product code : 001043
As this product is a gas, refer to the inhalation section.
Immediately flush eyes with plenty of water, occasionally lifting the upper and lower 
eyelids.  Check for and remove any contact lenses.  Continue to rinse for at least 10 
minutes.  Get medical attention.
Flush contaminated skin with plenty of water.  Remove contaminated clothing and 
shoes.  Get medical attention if symptoms occur.  Wash clothing before reuse.  Clean 
shoes thoroughly before reuse.
Remove victim to fresh air and keep at rest in a position comfortable for breathing.  If 
not breathing, if breathing is irregular or if respiratory arrest occurs, provide artificial 
respiration or oxygen by trained personnel.  It may be dangerous to the person providing 
aid to give mouth-to-mouth resuscitation.  Get medical attention if adverse health effects 
persist or are severe.  If unconscious, place in recovery position and get medical 
attention immediately.  Maintain an open airway.  Loosen tight clothing such as a collar,
tie, belt or waistband.
Section 4. First aid measures
Eye contact
Skin contact
Inhalation
Ingestion :
:
:
:
Notes to physician : Treat symptomatically.  Contact poison treatment specialist immediately if large 
quantities have been ingested or inhaled.
Description of necessary first aid measures
Specific treatments : No specific treatment.
Most important symptoms/effects, acute and delayed
Inhalation : No known significant effects or critical hazards.
As this product is a gas, refer to the inhalation section.:Ingestion
Skin contact : Contact with rapidly expanding gas may cause burns or frostbite.
Contact with rapidly expanding gas may cause burns or frostbite.:Eye contact
Over-exposure signs/symptoms
Skin contact
Ingestion
Inhalation No specific data.
No specific data.
No specific data.
:
:
:
Eye contact : No specific data.
Potential acute health effects
Indication of immediate medical attention and special treatment needed, if necessary
Frostbite : Try to warm up the frozen tissues and seek medical attention.
Date of issue/Date of revision : 2/3/2018 Date of previous issue : 1/27/2017 Version : 0.03 2/11
Oxygen
Section 4. First aid measures
Protection of first-aiders : No action shall be taken involving any personal risk or without suitable training.  It may 
be dangerous to the person providing aid to give mouth-to-mouth resuscitation.
See toxicological information (Section 11)
Section 5. Fire-fighting measures
Promptly isolate the scene by removing all persons from the vicinity of the incident if 
there is a fire.  No action shall be taken involving any personal risk or without suitable 
training.  Contact supplier immediately for specialist advice.  Move containers from fire 
area if this can be done without risk.  Use water spray to keep fire-exposed containers 
cool.  If involved in fire, shut off flow immediately if it can be done without risk.
Hazardous thermal 
decomposition products
Specific hazards arising 
from the chemical
No specific data.
Contains gas under pressure.  Oxidizing material.  This material increases the risk of 
fire and may aid combustion.  Contact with combustible material may cause fire.  In a 
fire or if heated, a pressure increase will occur and the container may burst or explode.
Fire-fighters should wear appropriate protective equipment and self-contained breathing 
apparatus (SCBA) with a full face-piece operated in positive pressure mode.
Special protective 
equipment for fire-fighters
Use an extinguishing agent suitable for the surrounding fire.
Extinguishing media
:
:
:
None known.
Suitable extinguishing 
media
:
Unsuitable extinguishing 
media
:
Special protective actions 
for fire-fighters
:
Section 6. Accidental release measures
Environmental precautions
Personal precautions, protective equipment and emergency procedures
Immediately contact emergency personnel.  Stop leak if without risk.  Use spark-proof 
tools and explosion-proof equipment.  Note: see Section 1 for emergency contact 
information and Section 13 for waste disposal.
:
: No action shall be taken involving any personal risk or without suitable training.
Evacuate surrounding areas.  Keep unnecessary and unprotected personnel from 
entering.  Shut off all ignition sources.  No flares, smoking or flames in hazard area.
Avoid breathing gas.  Provide adequate ventilation.  Wear appropriate respirator when 
ventilation is inadequate.  Put on appropriate personal protective equipment.
Ensure emergency procedures to deal with accidental gas releases are in place to avoid 
contamination of the environment.  Inform the relevant authorities if the product has 
caused environmental pollution (sewers, waterways, soil or air).
Large spill :
Immediately contact emergency personnel.  Stop leak if without risk.  Use spark-proof 
tools and explosion-proof equipment.
Small spill :
Methods and materials for containment and cleaning up
For non-emergency 
personnel
For emergency responders : If specialized clothing is required to deal with the spillage, take note of any information in 
Section 8 on suitable and unsuitable materials.  See also the information in "For non-
emergency personnel".
Section 7. Handling and storage
Precautions for safe handling
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Section 7. Handling and storage
Advice on general 
occupational hygiene
Conditions for safe storage,
including any 
incompatibilities
Eating, drinking and smoking should be prohibited in areas where this material is 
handled, stored and processed.  Workers should wash hands and face before eating,
drinking and smoking.  Remove contaminated clothing and protective equipment before 
entering eating areas.  See also Section 8 for additional information on hygiene 
measures.
Store in accordance with local regulations.  Store in a segregated and approved area.
Store away from direct sunlight in a dry, cool and well-ventilated area, away from 
incompatible materials (see Section 10).  Cylinders should be stored upright, with valve 
protection cap in place, and firmly secured to prevent falling or being knocked over.
Cylinder temperatures should not exceed 52 °C (125 °F).  Separate from reducing 
agents and combustible materials.  Store away from grease and oil.  Keep container 
tightly closed and sealed until ready for use.  See Section 10 for incompatible materials 
before handling or use.
:
:
Protective measures Put on appropriate personal protective equipment (see Section 8).  Contains gas under 
pressure.  Avoid breathing gas.  Do not puncture or incinerate container.  Use 
equipment rated for cylinder pressure.  Close valve after each use and when empty.
Protect cylinders from physical damage; do not drag, roll, slide, or drop.  Use a suitable 
hand truck for cylinder movement.
  Avoid contact with eyes, skin and clothing.  Empty containers retain product residue 
and can be hazardous.  Keep away from clothing, incompatible materials and 
combustible materials.  Keep reduction valves free from grease and oil.
:
oxygen None.
Section 8. Exposure controls/personal protection
Ingredient name Exposure limits
Hand protection Chemical-resistant, impervious gloves complying with an approved standard should be 
worn at all times when handling chemical products if a risk assessment indicates this is 
necessary.  Considering the parameters specified by the glove manufacturer, check 
during use that the gloves are still retaining their protective properties.  It should be 
noted that the time to breakthrough for any glove material may be different for different 
glove manufacturers.  In the case of mixtures, consisting of several substances, the 
protection time of the gloves cannot be accurately estimated.
Safety eyewear complying with an approved standard should be used when a risk 
assessment indicates this is necessary to avoid exposure to liquid splashes, mists,
gases or dusts.  If contact is possible, the following protection should be worn, unless 
the assessment indicates a higher degree of protection:  safety glasses with side-
shields.
Eye/face protection
:
:
Environmental exposure 
controls
: Emissions from ventilation or work process equipment should be checked to ensure 
they comply with the requirements of environmental protection legislation.  In some 
cases, fume scrubbers, filters or engineering modifications to the process equipment 
will be necessary to reduce emissions to acceptable levels.
Appropriate engineering 
controls
: Good general ventilation should be sufficient to control worker exposure to airborne 
contaminants.
Wash hands, forearms and face thoroughly after handling chemical products, before 
eating, smoking and using the lavatory and at the end of the working period.
Appropriate techniques should be used to remove potentially contaminated clothing.
Wash contaminated clothing before reusing.  Ensure that eyewash stations and safety 
showers are close to the workstation location.
Hygiene measures :
Control parameters
Individual protection measures
Occupational exposure limits
Skin protection
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Section 8. Exposure controls/personal protection
Based on the hazard and potential for exposure, select a respirator that meets the 
appropriate standard or certification.  Respirators must be used according to a 
respiratory protection program to ensure proper fitting, training, and other important 
aspects of use.  Respirator selection must be based on known or anticipated exposure 
levels, the hazards of the product and the safe working limits of the selected respirator.
Respiratory protection :
Body protection Personal protective equipment for the body should be selected based on the task being 
performed and the risks involved and should be approved by a specialist before 
handling this product.
:
Other skin protection : Appropriate footwear and any additional skin protection measures should be selected 
based on the task being performed and the risks involved and should be approved by a 
specialist before handling this product.
Section 9. Physical and chemical properties
Physical state
Melting point
Relative density
Solubility
Gas. [Compressed gas.]
-218.4°C (-361.1°F)
Not applicable.
Not available.
Odorless.Odor
pH
Colorless. Blue.Color
Evaporation rate Not available.
Auto-ignition temperature
Flash point
Not available.
 [Product does not sustain combustion.]
0.65
Not available.
Viscosity Not applicable.
Not available.Odor threshold
Partition coefficient: n-
octanol/water
:
:
:
:
:
:
:
:
:
:
:
:
:
Appearance
Boiling point : -183°C (-297.4°F)
Flammability (solid, gas) : Extremely flammable in the presence of the following materials or conditions: reducing 
materials, combustible materials and organic materials.
Lower and upper explosive 
(flammable) limits
: Not available.
Decomposition temperature : Not available.
Solubility in water : Not available.
: 32 g/moleMolecular weight
Flow time (ISO 2431) : Not available.
Vapor pressure
Vapor density 1.1  (Air = 1)
Not available.:
:
Specific Volume (ft 3/lb) : 12.0482
Gas Density (lb/ft 3) : 0.083 
Critical temperature : -118.15°C (-180.7°F)
Section 10. Stability and reactivity
The product is stable.Chemical stability :
Possibility of hazardous 
reactions
: Hazardous reactions or instability may occur under certain conditions of storage or use.
Conditions may include the following:
contact with combustible materials
Reactions may include the following:
risk of causing fire
Reactivity : No specific test data related to reactivity available for this product or its ingredients.
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Section 10. Stability and reactivity
Hazardous decomposition 
products
Conditions to avoid No specific data.
Under normal conditions of storage and use, hazardous decomposition products should 
not be produced.
Highly reactive or incompatible with the following materials:
combustible materials
reducing materials
grease
oil
:
:
Incompatible materials :
Under normal conditions of storage and use, hazardous polymerization will not occur.Hazardous polymerization :
Section 11. Toxicological information
Acute toxicity
Not available.
Carcinogenicity
Not available.
Mutagenicity
Not available.
Teratogenicity
Not available.
Reproductive toxicity
Not available.
Irritation/Corrosion
Not available.
Sensitization
Not available.
Information on the likely 
routes of exposure
Inhalation : No known significant effects or critical hazards.
As this product is a gas, refer to the inhalation section.:Ingestion
Skin contact : Contact with rapidly expanding gas may cause burns or frostbite.
Contact with rapidly expanding gas may cause burns or frostbite.:Eye contact
Symptoms related to the physical, chemical and toxicological characteristics
Specific target organ toxicity (single exposure)
Specific target organ toxicity (repeated exposure)
Not available.
Not available.
Aspiration hazard
Not available.
Information on toxicological effects
: Not available.
Potential acute health effects
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Section 11. Toxicological information
Not available.
No known significant effects or critical hazards.General :
No known significant effects or critical hazards.Carcinogenicity :
No known significant effects or critical hazards.Mutagenicity :
No known significant effects or critical hazards.Teratogenicity :
Developmental effects : No known significant effects or critical hazards.
Fertility effects : No known significant effects or critical hazards.
Skin contact
Ingestion
Inhalation No specific data.
No specific data.
No specific data.
:
:
:
Eye contact : No specific data.
Potential chronic health effects
Delayed and immediate effects and also chronic effects from short and long term exposure
Numerical measures of toxicity
Not available.
Acute toxicity estimates
Potential immediate 
effects
: Not available.
Short term exposure
Potential delayed effects : Not available.
Potential immediate 
effects
: Not available.
Long term exposure
Potential delayed effects : Not available.
Section 12. Ecological information
LogPow BCF Potential
Bioaccumulative potential
Other adverse effects : No known significant effects or critical hazards.
Product/ingredient name
oxygen 0.65 - low
Toxicity
Not available.
Persistence and degradability
Soil/water partition 
coefficient (KOC)
: Not available.
Mobility in soil
Not available.
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Section 13. Disposal considerations
The generation of waste should be avoided or minimized wherever possible.  Disposal 
of this product, solutions and any by-products should at all times comply with the 
requirements of environmental protection and waste disposal legislation and any 
regional local authority requirements.  Dispose of surplus and non-recyclable products 
via a licensed waste disposal contractor.  Waste should not be disposed of untreated to 
the sewer unless fully compliant with the requirements of all authorities with jurisdiction.
Empty Airgas-owned pressure vessels should be returned to Airgas.  Waste packaging 
should be recycled.  Incineration or landfill should only be considered when recycling is 
not feasible.  This material and its container must be disposed of in a safe way.  Empty 
containers or liners may retain some product residues.  Do not puncture or incinerate 
container.
:Disposal methods
Section 14. Transport information
OXYGEN,
COMPRESSED
2.2 (5.1)
-
OXYGEN,
COMPRESSED
2.2 (5.1)
-
OXYGEN,
COMPRESSED
UN1072
2.2 (5.1)
-
UN1072 UN1072
Limited quantity Yes.
Quantity limitation Passenger aircraft/rail: 75 kg.  Cargo aircraft: 150 kg.
Special provisions A52
Quantity limitation Passenger and Cargo Aircraft: 75 kg.  Cargo Aircraft Only: 150 kg.
DOT IMDG IATA
UN number
UN proper 
shipping name
Transport 
hazard class(es)
Packing group
Additional information
Environmental 
hazards
Special precautions for user
Transport in bulk according 
to Annex II of MARPOL and 
the IBC Code
No. No. No.
Transport within user’s premises: always transport in closed containers that are 
upright and secure. Ensure that persons transporting the product know what to do in the 
event of an accident or spillage.
: Not available.
:
TDG
UN1072
OXYGEN,
COMPRESSED
2.2
-
No.
Product classified as per the following sections of the Transportation of Dangerous 
Goods Regulations: 2.13-2.17 (Class 2), 2.23-2.25 (Class 5).
Explosive Limit and Limited Quantity Index 0.125
ERAP Index 3000
Passenger Carrying Ship Index 50
Passenger Carrying Road or Rail Index 75
Special provisions 42
Mexico
UN1072
OXYGEN,
COMPRESSED
2.2 (5.1)
-
No.
DOT Classification
TDG Classification
IATA
:
:
:
“Refer to CFR 49 (or authority having jurisdiction) to determine the information required for shipment of the 
product.” 
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Section 15. Regulatory information
U.S. Federal regulations
This material is listed.Massachusetts
:
:
Clean Air Act  Section 112
(b) Hazardous Air 
Pollutants (HAPs)
: Not listed
Clean Air Act Section 602 
Class I Substances
: Not listed
Clean Air Act Section 602 
Class II Substances
: Not listed
DEA List I Chemicals 
(Precursor Chemicals)
: Not listed
DEA List II Chemicals 
(Essential Chemicals)
: Not listed
New York : This material is not listed.
New Jersey : This material is listed.
Pennsylvania : This material is listed.
State regulations
TSCA 8(a) CDR Exempt/Partial exemption: This material is listed or exempted.
SARA 302/304
SARA 304 RQ : Not applicable.
No products were found.
Composition/information on ingredients
International regulations
Chemical Weapon Convention List Schedules I, II & III Chemicals
Montreal Protocol (Annexes A, B, C, E)
Not listed.
Stockholm Convention on Persistent Organic Pollutants
Not listed.
Rotterdam Convention on Prior Informed Consent (PIC)
Not listed.
Not listed.
UNECE Aarhus Protocol on POPs and Heavy Metals
Not listed.
Inventory list
Australia : This material is listed or exempted.
Canada : This material is listed or exempted.
China : This material is listed or exempted.
Europe : This material is listed or exempted.
Japan : Japan inventory (ENCS): Not determined.
Japan inventory (ISHL): Not determined.
Republic of Korea : This material is listed or exempted.
Malaysia : Not determined.
New Zealand : This material is listed or exempted.
Philippines : This material is listed or exempted.
SARA 311/312
Classification : Refer to Section 2:  Hazards Identification of this SDS for classification of substance.
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Section 15. Regulatory information
Taiwan : This material is listed or exempted.
Turkey : Not determined.
United States : This material is listed or exempted.
Thailand : Not determined.
Viet Nam : Not determined.
Section 16. Other information
2/3/2018
History
Date of printing
Date of issue/Date of 
revision
Version
Date of previous issue
:
:
:
:
Key to abbreviations : ATE = Acute Toxicity Estimate
BCF = Bioconcentration Factor
GHS = Globally Harmonized System of Classification and Labelling of Chemicals
IATA = International Air Transport Association
IBC = Intermediate Bulk Container
IMDG = International Maritime Dangerous Goods
LogPow = logarithm of the octanol/water partition coefficient
MARPOL = International Convention for the Prevention of Pollution From Ships, 1973 
2/3/2018
1/27/2017
0.03
Hazardous Material Information System (U.S.A.)
0
0
3
0
0
0
/
National Fire Protection Association (U.S.A.)
Health
Special
Instability/Reactivity
Flammability
Health
Flammability
Physical hazards
Caution: HMIS® ratings are based on a 0-4 rating scale, with 0 representing minimal hazards or risks, and 4 
representing significant hazards or risks. Although HMIS® ratings and the associated label are not required on 
SDSs or products leaving a facility under 29 CFR 1910.1200, the preparer may choose to provide them. HMIS® 
ratings are to be used with a fully implemented HMIS® program. HMIS® is a registered trademark and service 
mark of the American Coatings Association, Inc.
The customer is responsible for determining the PPE code for this material. For more information on HMIS® 
Personal Protective Equipment (PPE) codes, consult the HMIS® Implementation Manual.
Reprinted with permission from NFPA 704-2001, Identification of the Hazards of Materials for Emergency 
Response Copyright ©1997, National Fire Protection Association, Quincy, MA 02269. This reprinted material is 
not the complete and official position of the National Fire Protection Association, on the referenced subject 
which is represented only by the standard in its entirety.
Copyright ©2001, National Fire Protection Association, Quincy, MA 02269. This warning system is intended to 
be interpreted and applied only by properly trained individuals to identify fire, health and reactivity hazards of 
chemicals. The user is referred to certain limited number of chemicals with recommended classifications in 
NFPA 49 and NFPA 325, which would be used as a guideline only. Whether the chemicals are classified by NFPA 
or not, anyone using the 704 systems to classify chemicals does so at their own risk.
Procedure used to derive the classification
Classification Justification
OXIDIZING GASES - Category 1 Expert judgment
GASES UNDER PRESSURE - Compressed gas According to package
OX
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Section 16. Other information
To the best of our knowledge, the information contained herein is accurate. However, neither the above-named 
supplier, nor any of its subsidiaries, assumes any liability whatsoever for the accuracy or completeness of the 
information contained herein.
Final determination of suitability of any material is the sole responsibility of the user. All materials may present 
unknown hazards and should be used with caution. Although certain hazards are described herein, we cannot 
guarantee that these are the only hazards that exist.
Notice to reader
Indicates information that has changed from previously issued version.
References : Not available.
as modified by the Protocol of 1978. ("Marpol" = marine pollution)
UN = United Nations
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